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Abstract
Magnetic resonance (MR) imaging is a powerful technique for the non-invasive in-vivo imaging
of the human brain. In this thesis several robust techniques are developed that allow the fully-
automatic analysis of MR brain images. In particular an approach is presented that quantifies the
volume of more than 100 individual structures within the whole brain. This methodology is ex-
tended to measure structural volume changes based on images acquired at multiple time points.
The possibility to quantify volumetric change of numerous brain structures simultaneously sets the
method apart from many established approaches that measure change of individual structures only.
The presented methodology is robust in the presence of disease-related atrophy or severe brain de-
formation. The proposed algorithms are evaluated on widely used reference datasets. The obtained
results compare favourable to state-of-the-art techniques. The methods are employed to perform a
cross-sectional and a longitudinal analysis of a large cohort of Alzheimer’s disease (AD) patients.
Employing the extracted information (volume, atrophy) as features it is shown that AD related dis-
ease states can be classified with high accuracy. In addition a prospective cohort of traumatic brain
injury (TBI) patients is studied. Structural volumes are extracted at the acute disease stage and the
extent of structural change occurring within the months following the head trauma is quantified.
The results show that cerebral white matter atrophy is increased in TBI and that the involvement
of individual brain structures, such as the hippocampus or the thalamus, is particularly predictive
for the outcome of the head injury. These results confirm the methods’ potential to support large
scale imaging studies by robustly extracting markers with clinical interpretation from MR brain
images. In addition, a novel evaluation measure is proposed to quantitatively assess the accuracy of
automatically calculated image segmentations with respect to a reference segmentation.
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1 Introduction
Over the last decades there have been substantial advances in neuroimaging which now allow the
in-vivo imaging of both brain anatomy and brain function. Neuroimaging has opened exciting
areas of research that aim to investigate the deeper cause and progression of many neurological dis-
eases. Analysing medical images manually is a very time consuming endeavour that requires expert
knowledge. It is expensive and not scalable to large studies or image databases. Furthermore, man-
ual approaches are subject to inter-/intrarater variability and can be of limited sensitivity towards
subtle yet important information encoded in the images. To address these challenges, the focus of
this thesis is the development of robust methods for the automatic analysis of magnetic resonance
(MR) brain images. Based on two clinical applications the developed techniques will be employed
to investigate the potential to extract imaging biomarkers, such as structural volume and atrophy, in
the context of both Alzheimer’s disease (AD) and traumatic brain injury (TBI).
This introductory chapter gives a brief overview of neuroimaging techniques in Section 1.1. The
need for advances in the understanding, diagnosis and treatment of both AD and TBI is further
outlined in Section 1.2 and Section 1.3 respectively. The motivation for this work is summarised in
Section 1.4. Finally, Section 1.5 describes the main contributions of this thesis and its organisation.
1.1 Neuroimaging
Amultitude of neuroimaging techniques that exploit different physical concepts has emerged. There
is, however, no single imaging technique that allows the comprehensive analysis of an individual
brain. Rather, the optimal imaging modality and imaging sequence needs to be chosen based on the
clinical question that is to be answered.
In the following a brief overview over widely used imaging techniques is provided. Table 1.1
summarises different imaging modalities with their respective characteristics. A more detailed
overview can be found in the literature (Ryan and Alexander, 2007; Belanger et al., 2007; Shenton
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et al., 2012; Nasrallah and Dubroff, 2013).
1.1.1 Computed Tomography
Computed tomography (CT) is an established technique that reconstructs a three-dimensional (3D)
object based on multiple projection images (radiographs) obtained through ionising radiation (X-
rays). To obtain the radiographs from varying viewing angles an X-ray source and the corresponding
detector are rotated around a fixed axis of the object. The 3D volume can then be reconstructed
using tomographic reconstruction. CT is fast, available in most hospitals and often the primary
imaging modality for patients suffering an acute head injury as it is sensitive to injuries that require
immediate action, such as skull fractures, brain swelling or intracranial haemorrhage (Shenton et al.,
2012).
1.1.2 Magnetic Resonance Imaging
Another established imaging modality is magnetic resonance imaging (MRI). In MRI hydrogen
nuclei (protons) are aligned in a strong uniform magnetic field. Common field strengths are 1.5 or
3 Tesla (T). Unique spatial positions can be encoded with magnetic gradient fields. The aligned
protons are subsequently excited using radio-frequency pulses. While the protons return to their
initial state they also emit a radio-frequency signal that is then measured by receiver coils in the
scanner. Tissue contrast can be obtained by measuring this signal which decays exponentially
dependent on the characteristics of the respective tissue. There are numerous MR sequences to
obtain specific tissue contrasts. Commonly used sequences include: T1-weighted (T1w) MRI,
which measures the spin-lattice relaxation time and provides good white matter (WM)/grey matter
(GM) contrast; T2-weighted (T2w) MRI, which measures the spin-spin relaxation time and has
advantages for the visualisation of for example oedema or haemorrhage; fluid-attenuated inversion-
recovery (FLAIR), which is sensitive to e.g. lesions and contusions; susceptibility weighted imaging
(SWI), which is another sequence and very sensitive to hemorrhagic lesions and microbleeds. To
illustrate differences between protocols, several MR sequences of the same patient are shown in
Figure 1.1. During image acquisition the patient can be subjected to substantial acoustic noise
caused by rapid changes of the magnetic gradient fields. Furthermore, as a result of the required
uniform and strong magnetic field the scanner gantry is usually designed to be quite narrow which
can be problematic for claustrophobic patients. In contrast to CT, MRI does not rely on ionising
37
T1-weighted MRI T2-weighted FLAIR GRE
PD DWI (FA) DWI (MD) CT
Figure 1.1: Brain images acquired with different imaging sequences/modalities from a patient with
traumatic brain injury. The good tissue contrast in T1-weighted MR images and the
pronounced contusions in the FLAIR sequence are apparent. Furthermore, gradient
echo (GRE) and proton density (PD) weighted images are shown. Diffusion derived
fractional anisotropy (FA) and mean diffusivity (MD) maps are also shown. CT is well
suited to image bone injuries, oedema or intracranial bleeding.
radiation and is considered safe.
1.1.3 Diffusion Weighted Imaging
Diffusion weighted imaging (DWI) or diffusion tensor imaging (DTI) is a variant of MRI that al-
lows a more detailed analysis of WM anatomy or tissue microstructure. In DWI local diffusion of
water molecules can be measured so that microscopic information about the diffusion properties can
be inferred. The motion of these water molecules is influenced by the highly heterogeneous charac-
teristics of biological tissues, including compartments and barriers of varying diffusivity (Hagmann
et al., 2006). While CT or standard MR imaging can visualise macroscopic structures, DWI al-
lows the assessment of changes at the microstructure level. DWI has been shown to be particularly
valuable to examine WM pathology for example in the context of TBI (Kinnunen et al., 2011;
Shenton et al., 2012). The measurement of diffusion with respect to multiple directions allows the
calculation of a so-called diffusion tensor. Based on this diffusion tensor, further quantities such as
voxel-wise scalar values describing the level of anisotropy, the FA index, or the mean diffusivity
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can be derived. More advanced methods, such as tractography, can extract WM fibre bundles based
on which global brain connectivity can be investigated.
1.1.4 Functional Magnetic Resonance Imaging
In functional magnetic resonance imaging (fMRI) brain activity is measured using the distinct mag-
netic attributes of oxygenated and non-oxygenated blood. The principle of blood-oxygen-level-
dependent (BOLD) fMRI is that regional blood flow increases due to corresponding brain activity
(Belanger et al., 2007). These changes in blood flow can be measured while the patient is asked to
perform specific cognitive tasks (task fMRI) or during normal brain activity (resting-state fMRI).
1.1.5 Positron Emission Tomography
Positron emission tomography (PET) allows functional imaging of the brain by measuring the up-
take of a radioactive tracer. The tracer is usually injected into the patient’s blood stream and de-
signed to accumulate at certain receptors in the brain. While the tracer decays (b-decay) positrons
are emitted that annihilate with electrons after travelling very short distances in the surrounding
tissue. During this process two gamma-rays are emitted into opposite directions to conserve mo-
mentum. The gamma-rays are then measured by circular gamma-detectors, which allows the recon-
struction of the spatial activation pattern. Important in PET imaging is the choice of an appropriate
tracer. Most widely used is 18-fluorodeoxyglucose (FDG) a tracer based on glucose that allows
the quantification of brain metabolism. In the context of AD, AV45 is another tracer of interest
as it binds to amyloid beta (Ab) which is a relevant biomarker protein in dementia. Using PET
imaging, the reduced brain metabolism and increased amyloid concentration in a patient with AD
in comparison to a healthy person is illustrated in Figure 1.2.
1.2 Alzheimer’s Disease
1.2.1 Prevalence
The first patient with a dementia type that is now referred to as AD was reported more than a cen-
tury ago (Alzheimer, 1907). Meanwhile, AD is one of the major challenges in neurology (Citron,
2004; Klafki et al., 2006) and the main cause for people aged 60 or older to live with a disability
(Ferri et al., 2006). It is expected that in 2013 around 35.6 million people worldwide (Prince et al.,
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T1-weighted MRI FDG-PET AV45-PET
control
AD
Figure 1.2: Example of T1w MR image (left), FDG-PET image (middle) and AV45-PET image
(right) in coronal view for a healthy control (top, male, 66 years) and patient with AD
(bottom, male, 75 years). The PET images are superimposed on the structural MR image
with red indicating high signal and blue low signal respectively. The PET images show
reduced metabolic activity (FDG) and increased amyloid beta (Ab) binding (AV45-
PET) in patients with AD.
2013) suffered from AD, a substantial increase from around 25 million in 2006 (Ferri et al., 2006;
Brookmeyer et al., 2007). This number is expected to double every 20 years resulting in more than
100 million humans affected by AD in 2050 (Brookmeyer et al., 2007; Prince et al., 2013). With
increasing age the prevalence of AD increases, for example from 0.9% at 65 years of age to 14.7%
at 85 years of age respectively (Brookmeyer et al., 2007). At age 65 the lifetime risk of suffering
an AD dementia is estimated at around 10.5% (Sperling et al., 2011). Genetic risk factors related
to the apolipoprotein E (ApoE) genotype are well established (Lehtovirta et al., 1996; Roberson
and Mucke, 2006). Carriers of the ApoE e4 allele are at increased risk compared to non-carriers
(Roberson and Mucke, 2006). The risk of developing AD could be reduced substantially if screen-
ing and disease delaying drugs were available (Sperling et al., 2011). Unfortunately, there is only
symptomatic treatment available and effective drugs to delay or even cure AD remain unavailable
(Citron, 2004; Klafki et al., 2006; Blennow et al., 2006; Roberson and Mucke, 2006; Davatzikos
et al., 2011; Karran and Hardy, 2014).
More than a third of AD patients are expected to require care that is equivalent to a nursing-home
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(Brookmeyer et al., 2007) and that is often provided by the patient’s family (Ferri et al., 2006).
This endeavour is, however, not only psychologically and practically demanding but also imposes
a substantial financial burden to both caregivers and society (Ferri et al., 2006).
1.2.2 Diagnosis and disease progression
To obtain a diagnosis of probable AD, the National Institute of Neurological and Communicative
Disorders (NINCDS)-Alzheimers Disease and Related Disorders Association (ADRDA) criterion
was formulated in McKhann et al. (1984). It relies on clinical tests such as the mini-mental state
examination (MMSE) (Folstein et al., 1975). A definiteAD diagnosis can only be obtained based on
histopathological evidence (McKhann et al., 1984). Here, the main pathological characteristics of
AD are the selective loss of neurons as well as accumulated Ab plaques and neurofibrillary tangles
(McKhann et al., 1984; Braak and Braak, 1991; Wenk, 2003; Klafki et al., 2006; Heppner et al.,
2015). It is assumed that abnormal processing of Ab, even if it does not cause cognitive impairment
directly (Jack Jr et al., 2010b), initiates a cascade of degenerative processes that eventually manifests
as AD (Wenk, 2003; Karran et al., 2011; Falahati et al., 2014; Heppner et al., 2015). Thus, many
efforts to tackle AD focus on the blockage of Ab peptides and the prevention of further neuronal
degeneration (Citron, 2004; Roberson and Mucke, 2006). However, several clinical phase III trials
targeting Ab have been not successful (Karran et al., 2011; Golde et al., 2011; Karran and Hardy,
2014). Ab targeted therapies might be effective in preventing AD, however they are potentially
ineffective in symptomatic patients (Golde et al., 2011). There is increasing discussion related to
the Ab cascade hypothesis (Karran et al., 2011; Golde et al., 2011; Karran and Hardy, 2014) with
proposed modifications being a more central role of tau and the inclusion of neuroinflammation
(Heppner et al., 2015).
Next to Ab, tau proteins, which stabilise microtubules, play an important role (Klafki et al.,
2006; Karran et al., 2011). In a hypothetical model, Klafki et al. (2006) describe how pathological
conditions, possibly triggered by Ab, can lead to an abnormal hyperphosphorylation of tau. This
affects the function of the tau proteins and potentially leads to a destabilisation of microtubules
and structural alterations such as the aggregation of tau as neurofibrillary tangles (Klafki et al.,
2006). Eventually tau pathology can cause synaptic dysfunction and neuronal loss (Klafki et al.,
2006; Karran et al., 2011). Even though tau pathology is considered a downstream event of Ab
accumulation (Karran et al., 2011) it seems to correlate better with cognitive decline (Heneka and
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Obanion, 2007; Karran and Hardy, 2014). There is increased interest in tau-based drug discovery
despite tau targeting therapies being more difficult than those directed to Ab (Brunden et al., 2010).
Heneka and Obanion (2007) state that Ab plaques or tau pathology might not explain all AD
related symptoms and that Ab potentially activates microglial cells resulting in an inflammatory re-
sponse. Neuroinflammation markers are typically increased in patients with AD related pathology
(Szekely et al., 2004; Klafki et al., 2006; Heneka and Obanion, 2007). Insoluble Ab peptides, neu-
rofibrillary tangles but also degenerating tissue are stimuli for neuroinflammation (Akiyama et al.,
2000). The inflammatory processes can impair both brain function, especially in the earlier disease
stages, and brain structure (Heneka and Obanion, 2007). The molecules evoked by neuroinflam-
mation may be toxic to cells ultimately resulting in cell death (Heneka and Obanion, 2007). It has
also been shown that the long-term use of nonsteroidal anti-inflammatory drugs has the potential to
reduce the risk of AD (Szekely et al., 2004; Klafki et al., 2006; Heneka and Obanion, 2007).
Treatment within the rather long pre-symptomatic phase of AD might offer a unique chance
to delay the disease onset (Szekely et al., 2004; Golde et al., 2011; Sperling et al., 2011). The
first biomarkers indicating AD induced brain damage relate to Ab, which is usually measured via
cerebrospinal fluid (CSF) directly or indirectly via tracer retention in PET brain images (Jack Jr
et al., 2010b; Falahati et al., 2014). Further, it has been shown in many studies that with progression
of the disease there is significant atrophy in medial temporal lobe (MTL) structures such as the
hippocampus, amygdala, and entorhinal and parahippocampal cortices (Jack Jr. et al., 1997; Wenk,
2003; Jack Jr et al., 2010b; Klo¨ppel et al., 2012). A hypothetical model for AD progression is
illustrated in Figure 1.3. The pronounced atrophy in MTL regions is shown in Figure 1.4.
1.2.3 Diagnostic role of neuroimaging
Recently, the NINCDS-ADRDA criterion for AD has been revised (Dubois et al., 2007; Jack Jr.
et al., 2011; McKhann et al., 2011; Albert et al., 2011; Sperling et al., 2011) to take novel insights
into account. The updated criterion now better discriminates AD from other dementia types (McK-
hann et al., 2011) such as Lewy Body dementia (McKeith et al., 2007), vascular dementia (Roman
et al., 1993) and frontotemporal dementia (McKhann et al., 2001). Biomarker evidence available
through PET or structural MRI has been incorporated. Particular emphasis has been placed on
atrophy in MTL regions (Klo¨ppel et al., 2012).
The diagnostic potential of biomarkers based on structural imaging has been outlined in Frisoni
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Figure 1.3: Hypothetical trajectories of biomarkers during the progression of AD. Figure adapted
from Jack Jr et al. (2010a); Aisen et al. (2010).
et al. (2010) or Klo¨ppel et al. (2012). These biomarkers can support or indicate a diagnosis when-
ever trained neuroradiologists are not available or accelerate expert diagnoses without scarifying
accuracy (Klo¨ppel et al., 2008; Klo¨ppel et al., 2012). Automatically extracted biomarkers could
further increase objectivity in the disease assessment and could allow for improved differential di-
agnosis to rule out other forms of dementia (Frisoni et al., 2010; Klo¨ppel et al., 2012). Another
important avenue is the use of biomarkers for AD screening or for the recruitment for pharmaceuti-
cal trials (Klo¨ppel et al., 2012; Falahati et al., 2014), where homogeneous patient cohorts might be
required.
Subtle alterations in brain structures can be measured using MRI. Klo¨ppel et al. (2008) showed
that automatic methods can perform comparable to trained radiologists when classifying MR im-
ages of patients with AD. However, there is uncertainty that information based on individual brain
structures is sufficient to fully characterise the complex progression of AD or even allow for a dif-
ferential dementia diagnosis (Klo¨ppel et al., 2008; Falahati et al., 2014). It might thus be desirable
to analyse a number of structures of the whole brain rather than a limited number of selected brain
structures only.
1.2.4 Mild Cognitive Impairment
Of particular interest are patients with mild cognitive impairment (MCI), who usually show slightly
impaired memory but no other AD like symptoms that would impact their daily living (Dubois
et al., 2007; Gerardin et al., 2009). MCI is not very well defined and can be considered as a
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Figure 1.4: Three examples of MR images (brain extracted) of subjects from the ADNI1 cohort
visualised in a coronal view. A healthy control subject (male, 84.8 years at baseline) is
shown in the top row. A MCI patient (female, 71.8 years at baseline) that converted to
AD after three years is shown in the middle row. An AD patient (male, 77.5 years at
baseline) is shown in the bottom row. Left: baseline MR image, Middle: 2 year follow-
up MR image, Right: difference image of rigidly aligned images. The differences are
visually very subtle but the increased atrophy in the medial temporal lobe (blue arrows)
and the enlarged ventricles (red arrows) are apparent in the difference image.
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surrogate class for the early stages of multiple types of dementia. The unclear definition potentially
causes high variability between clinical centres and should be considered when conducting clinical
trials (Dubois et al., 2007). As an example subtle anatomical changes over a period of two years are
illustrated in Figure 1.4 for a healthy control subject, a MCI subject converting to AD and a patient
with AD.
Subjects with MCI do not fulfil the clinical AD criterion (Petersen et al., 1999; Dubois et al.,
2007), but are at increased risk of conversion to AD (Dubois and Albert, 2004; Davatzikos et al.,
2011). However, not all subjects with MCI will go on to develop AD (Dubois et al., 2007; Cuingnet
et al., 2011). Discriminating these patients with stable MCI (sMCI) from patients with progressive
MCI (pMCI), those converting to AD, is of particular relevance to clinicians, patients and caregivers
alike. It is believed that identifying potential AD patients before any functional impairment has
occurred offers a better opportunity for early intervention and to evaluate the disease progression
(Dubois et al., 2007; Colliot et al., 2008). The targeted treatment of early disease mechanisms in the
early phases of AD is likely to be more effective than later treatment when the disease is advanced
(Dubois et al., 2007). Reliably identifying patients with stable or progressive MCI is thus of high
value when treatment decisions have to be made (Davatzikos et al., 2011), but also when clinical
trials are being conducted (Dubois et al., 2007; Gerardin et al., 2009; Klo¨ppel et al., 2012).
Modern neuroimaging can help to improve the accuracy of MCI diagnosis by adding positive
predictive value when combined with other clinical measures (Dubois et al., 2007; Klo¨ppel et al.,
2008; Colliot et al., 2008; Cuingnet et al., 2011).
1.2.5 Potential of neuroimaging
It is becoming clear that structural MRI in combination with other criteria, such as PET or CSF-
based markers measuring Ab, can offer a powerful approach to detect pathological AD-related
change years before the onset of a fully developed and probably irreversible AD dementia (Frisoni
et al., 2010; Sperling et al., 2011). Structural MRI will play an important role in both future diag-
nosis but also treatment of AD (Fennema-Notestine et al., 2009; Frisoni et al., 2010; Klo¨ppel et al.,
2012). The development of automatic and robust techniques to automatically and systematically
assess whole-brain MR images is thus an important factor to further increase the usability of struc-
tural imaging in the context of AD (Frisoni et al., 2010).
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1.3 Traumatic Brain Injury
1.3.1 Prevalence
With an estimated annual global incidence of 6.8 million cases, TBI imposes a significant burden
on patients, their families, and health services (Maas et al., 2008; Irimia et al., 2012). TBI is often
referred to as the “silent epidemic” as symptoms, such as memory loss or cognitive deficits, tend
to be less apparent (Langlois et al., 2004). However, a report summarsing TBI-related data in the
United States for the years 1996 to 2001 (Langlois et al., 2004) underlines the relevance of this
disease: there were annually at least 1.4 million new cases of TBI. Most of these patients were
treated in an emergency department (79.6%), but a substantial number was hospitalised (16.8%)
or even died (3.6%). While most children required treatment in the emergency department only
(>90%), the report also suggests that the mortality increases with age to more than 7% for those
aged 55 or older (Langlois et al., 2004). Next to assaults (11%) and motor-vehicle accidents (20%),
falls (28%) are the most common cause of TBI (Langlois et al., 2004). The mortality for men is
almost three times higher than for females (Langlois et al., 2004).
Research findings on TBI obtained while doing sports (De Beaumont et al., 2009) or in military
conflicts (Taber et al., 2006) have increasingly brought the disease into the focus of the public (Ir-
imia et al., 2011). Moderate and severe TBIs are further assumed to be an important risk-factor for
dementias such as AD in late life (Plassman et al., 2000; Shively et al., 2012; Bigler, 2013; Smith
et al., 2013; Sharp et al., 2014).
1.3.2 Focal and diffuse injury
TBI is typically caused by blunt force injury, penetrating injury, or blast injury and its pathology de-
pendent on the forces associated with the event (Smith, 2011). The pathological processes following
the injury are highly complex and the exact mechanism causing functional impairment not entirely
understood (Warner et al., 2010a; Smith, 2011). A common categorisation of disease-related pro-
cesses distinguishes primary and secondary injuries (Graham et al., 2000; Smith, 2011; Sharp et al.,
2014).
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Primary injuries have a focal component caused by events such as the direct impact of an object
hitting the head. Common consequences that should be differentiated include skull fractures, con-
tusions, haemorrhage and haematomas (Meythaler et al., 2001; Smith, 2011; Sharp et al., 2014).
Intracranial haemorrhages are the most common cause for rapid clinical deterioration and the com-
plications are generally dependent on location and size of the haematoma (Smith, 2011). Expanding
haematomas and/or brain swelling can also lead to an increased intracranial pressure that potentially
result in serious conditions such as brain ischemia (Smith, 2011). Another injury mechanism, dif-
fuse injury, is initiated by the strong accelerating or decelerating forces during the injury event.
This is referred to as diffuse axonal injury (DAI) and assumed to be the predominant mechanism
of TBI (Meythaler et al., 2001; Warner et al., 2010b; Shenton et al., 2012; Sharp et al., 2014). TBI
often results in both focal and diffuse injury which can evolve over time (Smith, 2011). DAI is
usually a local injury of discrete regions and not necessarily an injury to the whole brain (Meythaler
et al., 2001; Warner et al., 2010b). DAI is also a major determinant of disease outcome (Graham
et al., 2000) and considered a continuous process that develops from focal axonal changes to ongo-
ing axonal separation (Bu¨ki and Povlishock, 2006). Pathology related to DAI can be characterised
by microscopic characteristics such as widespread damage of axons (Meythaler et al., 2001; Ding
et al., 2008).
Next to the consequences of the primary head injury such as focal lesions, it is assumed that com-
plex secondary pathophysiological processes continue damaging brain cells and thus contribute to
TBI (Meythaler et al., 2001; Ding et al., 2008; Warner et al., 2010b; Sharp et al., 2014). Neurode-
generative diseases, inflammation, infections or increased intracranial pressure can potentially be
initiated by TBI and the resulting damage of WM tracts (Ramlackhansingh et al., 2011; Smith et al.,
2013; Sharp et al., 2014). It is hypothesised that neuroinflammatory processes following a head in-
jury can lead to increased Ab deposition and formation of tangles, both hall marks of AD (Griffin
et al., 1998; Smith, 2011). A comprehensive description of TBI-related pathology and long-term
secondary processes triggered by the injury event is given in Smith (2011).
1.3.3 Clinical characterisation
The acute stage of TBI is often clinically characterised with the Glasgow Coma Score (GCS). The
GCS is a clinical score that quantifies a patient’s level of consciousness at the acute stage of the
injury (Teasdale and Jennett, 1974). The GCS is often assessed several times during the first hours
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and days after the injury e.g. at the injury site and at hospital admission.
The GCS is the most common criteria to determine the severity (e.g. mild, moderate, severe) of
a brain injury (Sherer et al., 2008; Schoenberger et al., 2009; Arlinghaus et al., 2011; Smith, 2011).
Limitations that reduce the prognostic potential of the GCS include inconsistencies and controversy
regarding the ideal time of assessment (Sherer et al., 2008). Next to the GCS other parameters such
as loss of consciousness (LOC) duration and post-traumatic amnesia (PTA) duration have been
shown to correlate with the outcome of TBI (Asikainen et al., 1998; Schoenberger et al., 2009;
Arlinghaus et al., 2011). Intercorrelations among GCS, LOC and PTA haven been investigated
and confirmed in Sherer et al. (2008). Regardless of their predictive value, severity criteria defined
based on these parameters have substantial limitations (Malec et al., 2007; Arlinghaus et al., 2011):
First, many cases might remain unclassified if essential parameters are absent (Malec et al., 2007).
Second, there are several confounding factors that can reduce the usefulness of GCS, LOC and PTA
such as intoxication, intubation, sedation or facial injuries (Sherer et al., 2008; Arlinghaus et al.,
2011).
The more recently proposed Mayo classification system (Malec et al., 2007) addresses many of
these limitations by using positive evidence (Arlinghaus et al., 2011). The Mayo system distin-
guishes between moderate-severe (definite) TBI, mild (probable) TBI and symptomatic (possible)
TBI. Patients are associated with the most severe group of which at least one predefined criterion is
fulfilled. The system is thus not directly affected by missing data. The criteria include GCS, LOC
and PTA but also other symptoms such as blurred vision, dizziness or headache. Further, radiolog-
ical imaging findings such as fractures, contusions, haematomas or haemorrhage are incorporated
(Malec et al., 2007).
Also assessed at the acute stage is the Marshall Classification Score (MCS) (Marshall et al.
(1991), cf . Appendix C), a score based on the worst acute CT image within 24 hours of injury.
MCS takes into account brain pathology such as lesion load or the presence of oedema and midline
shift caused by the injury.
In contrast to this, the Glasgow Outcome Score (GOS) (Jennett and Bond (1975); Jennett et al.
(1981), cf . Appendix D) is a clinical measure categorising the outcome of TBI at the chronic stage
and is assessed around six months after injury or once the TBI outcome is considered stable.
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1.3.4 Neuroimaging in TBI
Even though most of the cases of TBI are mild or moderate, a substantial fraction of up to 50%
might suffer from a long-term disability (Thornhill et al., 2000; McAllister et al., 2006; Belanger
et al., 2010; Shenton et al., 2012). This is particularly relevant as many of these mild TBI (mTBI)
cases affect young adults with many more years to live (Shenton et al., 2012). Evidence from neu-
roimaging such as MRI or CT is often very subtle or completely absent, so that persistent symptoms
tend to be explained through post-traumatic stress disorders or depression (Shenton et al., 2012).
Four examples of subjects with TBI are visualised in Figure 1.5. These examples illustrate the
heterogeneity of structural changes that can be subtle in both mild and severe TBI but also very
apparent and variable.
Although patterns of brain alteration have been shown to be predictors of outcome, such use of
imaging data is mainly based on expert interpretation of visually inspected X-ray CT images. In
Maas et al. (2007) the authors confirmed in a multivariable analysis the predictive value of indi-
vidual characteristics quantified from CT for 6-months outcome prediction. In Jacobs et al. (2010)
it was shown for subjects with mTBI that CT-based criteria are a valuable indicator to identify
patients at risk of deterioration. However, they are only of limited value to predict the eventual out-
come when compared to criteria such as patient age, alcohol intake or extra-cranial injuries (Jacobs
et al., 2010).
1.3.5 Importance of multiple modalities
TBI is a very heterogeneous disorder and thus images from multiple modalities (cf . Section 1.1) are
required to characterise the disease (Sharp and Ham, 2011; Shenton et al., 2012). While contusions
and lesions can be well assessed on MR FLAIR sequences, CT imaging is the modality of choice
to rule out skull fractures or other gross injuries that require immediate action (Shenton et al.,
2012). CT provides critical information when treatment decisions at the acute TBI stage need to
be made (Maas et al., 2007; Jacobs et al., 2010). Next to this T1w MRI provides good tissue
contrast allowing the accurate segmentation of distinct anatomical structures. The definition of
these regions of interest (ROIs) is an important step towards a ROI-based analysis of information
from DWI or functional imaging. As DWI is sensitive to micro-structural changes in WM it has
great potential to allow a better understanding of DAIs (Kinnunen et al., 2011; Shenton et al., 2012;
Sharp et al., 2014). In Bonnelle et al. (2012) the authors employed DWI and fMRI to investigate the
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Figure 1.5: Four examples of MR images (brain extracted) of subjects from a prospective TBI co-
hort visualised in coronal or axial view. Top row: patient with mild TBI (male, 72
years, GCS: 14, GOSe: 8, MCS: 1, fall accident). Second row: patient with moderate
TBI (female, 55 years, GCS: 2, GOSe: 4, MCS: 4, fall accident). Third row: moderate
TBI patient (male, 38 years, GCS: 11, GOSe: 5, MCS: n/a, car accident). Bottom row:
patient with severe TBI (female, 33 years, GCS: 4, GOSe: 3, MCS: 2, car accident).
Left: baseline MR image acquired in the acute phase (days after the injury), Middle:
follow-up MR image acquired in the chronic phase (months after the injury), Right:
difference image of rigidly aligned images. Enlarged ventricles (red arrows), a subdural
haematoma (blue arrow) and deformed/compressed frontal region (yellow arrow) are
indicated in the difference images.
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importance of structural integrity for brain network function following TBI. Examples of typical
imaging sequences acquired in the context of TBI are illustrated in Figure 1.1.
In this thesis particular focus is placed on structural MR images, in which subtle volumetric
changes can be assessed. There is consensus that there is ongoing structural atrophy following TBI
(Bigler, 2001). However, as these structural changes might be difficult to assess visually on MRI or
CT there is a high need for advanced methods that allow the quantification of atrophy (Bigler, 2001).
The advancement of sensitive neuroimaging techniques is thus critical as it offers the potential to
better understand, diagnose and treat TBI (Bigler, 2001; Shenton et al., 2012; Irimia et al., 2012).
1.3.6 TBI: An understudied disease
In contrast to other diseases of the human brain, such as AD, there is only a limited number of stud-
ies investigating the spatial distribution of structural changes (Bendlin et al., 2008; Warner et al.,
2010b). Recently, studies have found that next to a reduction in total brain volume several distinct
structures such as amygdala, hippocampus or thalamus are involved in TBI (Bigler, 2001; Strang-
man et al., 2010; Warner et al., 2010b,a; Ramlackhansingh et al., 2011; Irimia et al., 2012). The
need for accurate prognostic assessments was formulated already by Jennett et al. (1981), however,
prediction of TBI outcome remains a challenge. World-wide, TBI and the related processes are
an understudied research area (Meythaler et al., 2001) and standard models to predict the outcome
of TBI patients remain unavailable (Irimia et al., 2012). It is stated in Irimia et al. (2012) that
the combination of volumetric measures with brain connectivity/integrity measures from DTI (e.g.
Bendlin et al. (2008); Kinnunen et al. (2011)) or with functional measures obtained through fMRI
(e.g. McAllister et al. (2006); Sharp et al. (2011); McDonald et al. (2012)) might be key for future
TBI research. Further, more recent MR imaging protocols such as SWI have great potential in the
context of DAI due to their sensitivity to microbleeds (Sharp and Ham, 2011).
1.4 Motivation
Falahati et al. (2014) concluded that ROI based biomarkers offer advantages over, often very high
dimensional, voxel-based features. Integrating information that can be readily interpreted by a
clinician is easier than the integration of abstract features calculated by complex machine learning
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techniques (Falahati et al., 2014).
One of the main goals of this thesis is to develop methodology that automatically extracts struc-
tural ROIs of the whole brain. Based on these ROIs both structural volume and structural atrophy
can be readily quantified. Particular focus is placed on the methods’ robustness when applied to
diseased brain anatomy. In AD substantial brain atrophy poses challenges to automatic methods.
In TBI, lesions, contusions but also resections of brain tissue are common obstacles that render the
automatic extraction of biomarkers difficult. Visual examples of MR brain images of both patients
with AD and TBI are shown in Figure 1.6. The focus of this work lies on the volumetric analysis
of single time point images but also on the consistent estimation of structural atrophy from im-
age sequences. The developed methods should support and be applicable in both cross-sectional
and longitudinal studies. Of particular interest is the evaluation of biomarkers extracted with the
proposed techniques in clinically relevant scenarios, specifically in the context of both AD and TBI.
1.5 Contributions and organisation of the thesis
1.5.1 Contributions
The following gives an itemised overview over the main contributions of this thesis:
• Multi-Atlas Label Propagation with Expectation-Maximisation based refinement
A fully-automatic segmentation framework called Multi-Atlas Label Propagation with Ex-
pectation-Maximisation based refinement (MALP-EM) is developed. MALP-EM allows the
segmentation of a whole brain MR image into multiple distinct ROIs. The approach combines
established segmentation techniques and adapts them to increase robustness. A thorough
validation on a benchmark dataset and visual expert quality assessment of the segmentations
based on selected subjects from a TBI cohort is conducted. The experiments confirm both
the method’s high accuracy and its robustness.
• Consistent quantification of structural atrophy
Two methods are proposed that measure structural atrophy from longitudinal MRIs acquired
at multiple time points. While one method relies on intensity differences to estimate the
relative volume change of individual structures, the other approach simultaneously segments
the image sequences into numerous ROIs.
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Figure 1.6: Top row: Example of a healthy control subject (male, 65.1 years) from the ADNI1
cohort visualised in coronal, axial and sagittal view. Middle row: Three examples of
MR images of subjects with AD from the ADNI1 cohort (from left to right: female,
84.5 years in coronal; male, 80.2 years in axial; male, 77.5 years in sagittal view).
Bottom row: Three examples of MR images of subjects with TBI from a retrospec-
tive TBI cohort (from left to right: male, 23 years, GCS=5, GOS=1, MCS=5; male,
45 years, GCS=7, GOS=3, MCS=5; male 42 years, GCS=14, GOS=4, MCS=5). Indi-
cated with arrows: enlarged ventricles (red), pronounced hippocampal/medial temporal
lobe atrophy (blue), skull fracture/deformation (green), tissue resection (white), subdu-
ral haematoma (orange).
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• Analysis of Alzheimer’s disease and traumatic brain injury cohorts using the developed
methods
The developed methods are applied to a large AD cohort from the Alzheimer’s Disease Neu-
roimaging Initiative (http://adni.loni.ucla.edu, last accessed 29 June 2015) (ADNI)
and a prospective TBI cohort, acquired in the course of the TBIcare project (http://www.
tbicare.eu, last accessed: 24 June 2015). Both cross-sectional biomarkers (i.e. structural
volumes) and longitudinal biomarkers (i.e. structural atrophy) are extracted. The biomarkers’
potential to support AD disease diagnosis and predict its progression is investigated. Further,
correlations with clinical variables such as the GOS are identified in the context of TBI.
• Patch-based Evaluation of Image Segmentation
A novel similarity measure called Patch-based Evaluation of Image Segmentation (PEIS) is
presented. PEIS allows to visualise and quantitatively assess the accuracy of a given image
segmentation with respect to a ’ground truth’.
1.5.2 Thesis overview
In Chapter 2 a detailed overview over existing, atlas-based automatic brain segmentation methods
is provided. Furthermore, the role of quantitative biomarkers extracted from MRI is reviewed in
the context of both AD and TBI. A robust whole-brain segmentation framework is described and
evaluated in Chapter 3. In Chapter 4 two alternative approaches to accurately measure longitudinal
volume change in image series are described. The developed methods are employed to extract
biomarkers based on structural volume and atrophy to analyse an AD cohort in Chapter 5 and
a TBI cohort in Chapter 6. A novel approach to quantify and visualise the similarity of image
segmentations is presented in Chapter 7. The thesis concludes with a discussion of the presented
results, their limitations and an outline of future research directions in Chapter 8. A full list of
articles published during the work towards this thesis is provided in Appendix A.
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2 Background
The extraction of a single or multiple ROIs from a subject’s brain image is essential for the calcu-
lation of many biomarkers which are clinically useful. The process of subdividing an image into
distinct regions is referred to as segmentation. Once a brain scan is segmented into its individual
anatomical components, volumes or shape related measures can be readily quantified.
In this chapter, an overview of existing atlas-based segmentation methods is given in Section
2.1. Even though most techniques are applicable to the segmentation of other organs and imaging
modalities, particular focus is placed on methods for the segmentation of T1w MR brain images
into anatomical structures. In Section 2.2 several publicly available brain atlases are described that
are essential for automatic methods as they allow the incorporation of expert knowledge into the
segmentation process. In Section 2.3 and Section 2.4 the literature on biomarkers from structural
MRI is reviewed with respect to both AD and TBI.
2.1 Atlas-based segmentation methods
In atlas-based methods the segmentation of a brain image is inferred by aligning M brain atlases
denoted by Am with m = 1, . . . ,M with the image. A brain atlas is usually created by an expert by
manually or semi-automatically annotating a given volumetric brain scan. The term atlas comprises
the annotated atlas intensity image IAm and the corresponding reference segmentation LAm, thusAm =
{IAm,LAm}. A single brain atlas is illustrated in Figure 2.1. A detailed overview over a selection of
commonly used brain atlases is provided in Section 2.2.
The aim of whole-brain segmentation is to segment a target image Itgt into K distinct structural
ROIs. The unsegmented image Itgt 2 W is indexed as Itgt = {y1,y2, . . . ,yN} where yi 2 R+. Here
yi (i = 1, . . . ,N) denotes the intensity value of the i-th voxel. The corresponding, inferred label
map Ltgt is indexed accordingly as Ltgt = {l1, l2, . . . , lN}. The probabilistic (or soft) segmentation
is denoted by Ptgt = {p1,p2, . . . ,pN}, where pi is a K-valued vector with ||pi||1 = 1 and pi(k)   0
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Figure 2.1: A brain atlas Am consists of an intensity image IAm with corresponding segmentation
LAm. The reference segmentation is ideally created manually by an expert who follows a
detailed segmentation protocol. This process is very time consuming and not scalable.
Therefore it can only be performed on a small number of images.
describes the probability of voxel i belonging to structure k 2 {1, . . . ,K}. It can be observed that
the label map Ltgt is defined as:
li = argmax
k
pi(k) (2.1)
If pi is multi-modal li can be chosen as any of the modes, for example at random (Heckemann et al.,
2006).
In the following an overview over widely used atlas-based segmentation approaches and their es-
sential building blocks, brain extraction, atlas alignment, label fusion and segmentation refinement
is provided. A schematic illustration of this procedure is provided in Figure 2.2.
2.1.1 Brain extraction
A prerequisite of most anatomical segmentation approaches is the availability of a binary brain
mask discriminating the actual brain from non-brain tissue such as the skull, the neck or the eyes.
The calculation of this mask is, however, not trivial. Many brain extraction methods tend to produce
either too restrictive or too generous masks and there is no consensus of what constitutes an ideal
brain mask (Eskildsen et al., 2012).
A rough categorisation can be made by distinguishing manual approaches (Eritaia et al., 2000),
semi-automatic approaches (Freeborough et al., 1997) and automatic approaches (Sandor and Leahy,
1997; Smith, 2002; Se´gonne et al., 2004; Leung et al., 2011; Eskildsen et al., 2012; Manjo´n et al.,
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Figure 2.2: Schematic illustration of a typical segmentation pipeline with the common building
blocks: brain extraction, atlas alignment, label fusion and segmentation refinement.
The unsegmented target image and the estimated segmentation are outlined in blue, the
atlas images are outlined in red and the propagated atlas labels in orange respectively.
2014; Heckemann et al., 2015). Approaches that require user interaction usually require substan-
tial expertise, have poor inter- and intrarater reliability and are very time consuming, which can be
prohibitive when large cohorts are to be analysed (Freeborough et al., 1997; Warfield et al., 2004;
Eskildsen et al., 2012).
Skull-stripping is not the focus of this work, but a brief overview over existing automatic ap-
proaches is provided in the following.
2.1.1.1 Deformable models
Sandor and Leahy (1997) (Brain Surface Extractor (BSE)) employ an edge-detector and morpho-
logical operations to calculate a brain mask. In Smith (2002); Se´gonne et al. (2004) a deformable
model is automatically fit to the brain surface. Smith (2002) (Brain Extraction Tool (BET)) calcu-
late the center of gravity and an approximate radius of the head by thresholding the image using
robust minimum/maximum estimates of the image intensities. Based on this information a brain
surface tessellation is initialised that iteratively evolves. The process is constrained by both inten-
sity and smoothness terms. Se´gonne et al. (2004) obtain an initial estimate of the brain mask using
a watershed algorithm. The surface of this approximate but robust estimate is then employed as
initialisation of an active contour model (Kass et al., 1988) that integrates both geometric and atlas-
based information (Se´gonne et al., 2004). A quantitative comparison of these methods (Sandor and
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Leahy, 1997; Smith, 2002; Se´gonne et al., 2004) can be found in Fennema-Notestine et al. (2006).
2.1.1.2 Database of extracted reference images
More recent and potentially more accurate methods for brain extraction rely on a database of brain
extracted reference MRIs (Leung et al., 2011; Eskildsen et al., 2012; Manjo´n et al., 2014; Hecke-
mann et al., 2015). In Leung et al. (2011) the authors nonrigidly align the reference images to the
subject that is to be extracted (cf . Section 2.1.2) and perform label fusion (cf . Section 2.1.3.1). In
Heckemann et al. (2015) an atlas-based approach was developed with particular focus on robust-
ness that relies on iterative refinement of the brain mask. Other approaches such as Eskildsen et al.
(2012); Manjo´n et al. (2014) follow a patch-based label fusion approach using linear registration
only (cf . Section 2.1.3.4). Approaches for brain extraction tend to employ similar methodology to
the techniques for the segmentation of anatomical structures. A comprehensive summary of rele-
vant literature is provided in Leung et al. (2011) or Eskildsen et al. (2012).
In the remainder of this review it is assumed that Itgt and the atlas images IAm are brain extracted.
Skull-stripping the atlas images is often trivial as the corresponding expert label maps LAm can be
binarised and employed as mask. The calculation of accurate brain masks for both AD or patients
with TBI is, however, more complicated. In these cases the presence of severe atrophy (e.g. as
observed in AD) or brain injury (e.g. subdural haematoma (SDH) as observed in TBI) might pose
substantial challenges for an automatic brain extraction technique.
2.1.2 Atlas alignment
To exploit the labelling information encoded in the atlases most segmentation methods rely on
aligning each individual atlas Am with Itgt. This process is commonly referred to as image regis-
tration and usually driven by the image intensities of the corresponding images. Image registration
is highly complex and an active area of research that received continuous attention over the last
decades. Therefore, it is only briefly discussed here. A comprehensive overview and evaluation of
established registration approaches can be found in Zitova´ and Flusser (2003); Klein et al. (2009);
Sotiras et al. (2013).
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Figure 2.3: Schematic process of registering a source image Isrc to a target image Itgt with calculated
transformation f. The difference image of Isrc, f(Isrc), and Itgt is shown before and
after registration respectively. The target image is outlined in blue, the source image is
outlined in red (before) and orange (after registration).
2.1.2.1 Formulation of the registration problem
In general, image registration seeks to calculate a transformation f :W!W that transforms a source
(moving) image Isrc such that its similarity with a target (fixed) image Itgt is maximised. The process
of image registration is illustrated in Figure 2.3. For a given similarity measure S(·, ·) :RN⇥RN !
R the optimisation problem can be formulated as:
fˆ= argmin
f
[ S(Itgt,f(Isrc))+R (f)] (2.2)
Here R is a regularisation term. In nonrigid registration, regularisation of the usually ill-posed
optimisation problem is an important factor to encourage smooth and ideally even diffeomorphic
transformations (Rueckert et al., 1999; Vercauteren et al., 2009). Sotiras et al. (2013) summarise im-
portant characteristics for deformable image registration algorithms that can be particularly relevant
in the context of biomedical applications:
• Inverse consistency: The forward and backward transformations are calculated simultane-
ously and penalties are introduced that ensure/encourage that the forward and backward
transformations are the inverse of the other. The backward transformation is calculated by
exchanging the roles of Itgt and Isrc.
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• Symmetry: A symmetric registration approach can be obtained by using either a completely
symmetric similarity measure S or by aligning both images simultaneously to a common
target. The final transformation is then obtained by composition. Symmetry is a stronger
attribute than inverse consistency.
• Topology Preservation: The calculated transformation is continuous, at least locally one-to-
one and has a continuous inverse.
• Diffeomorphism: This attribute includes topology preservation but further guarantees that
both the transformation and its inverse are differentiable.
Many of the widely used registration algorithms, however, fulfil none of these attributes (Joshi et al.,
2004; Sotiras et al., 2013). This can be seen by the definition of the similarity measure in Equation
2.2 where only the source image is interpolated yielding an asymmetric formulation. Approaches
that are both inverse consistent/symmetric and diffeomorphic were proposed for example in Joshi
et al. (2004); Avants et al. (2008); Vercauteren et al. (2009). While the mentioned characteristics
are desirable, especially for morphometric studies that derive further information from the transfor-
mations (e.g. deformation-based morphometry (DBM)), they are not a necessary requirement for
accurate label propagation as evaluated in Klein et al. (2009); Landman and Warfield (2012). How-
ever, for other applications such as atlas construction they can be key to obtain unbiased estimates
(Joshi et al., 2004).
2.1.2.2 Similarity measures
To quantify image similarity several measures have been proposed. Common choices for S include
sum of squared differences (SSD), mutual information (Collignon et al., 1995; Viola and Wells III,
1997) (MI), normalised mutual information (Studholme et al., 1999) (NMI) or cross-correlation
(CC). A definition of these similarity measures is provided in Table 2.1. The basic assumption
of SSD is that intensities of perfectly matched images are identical (Roche et al., 1999). This
assumption can be relaxed when using CC (affine relationship of intensities) or MI/NMI (statistical
relationship) (Roche et al., 1999; Artaechevarria et al., 2009). SSD and CC are often used to register
images from the same modality/sequence, while the statistical measures have been successfully
applied to multi-modal registration.
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Table 2.1: Overview over possible measures to quantify similarity between two images I and J:
SSD, MI, NMI and CC. Note that SSD is a measure of dissimilarity. MI and NMI re-
quire the calculation of individual histograms (hI,hJ) and the joint histogram (hI,J) of the
intensity images. The measures can then be calculated based on the joint, H(I,J), and
the marginal entropies, H(I) and H(J). B denotes the number of bins of each histogram
dimension which are indexed by bi and b j.
Measure Definition Value range Similarity/
Dissimilarity
SSD(I,J) ÂNi=1(I(i)  J(i))2 SSD   0 Dissimilarity
MI(I,J) H(I)+H(J) H(I,J) MI   0 Similarity
with:
H(I) = ÂBbi=1 hI(bx)log(hI(bi))
H(J) = ÂBbj=1 hJ(by)log(hJ(b j))
H(I,J)= ÂBbi=1ÂBbj=1 hI,J(bi,b j)log(hI,J(bi,b j))
NMI(I,J) H(I)+H(J)H(I,J) 1  NMI  2 Similarity
CC(I,J) Cov(I,J)p
Var(I)
p
Var(J)
-1  CC  1 Similarity⇤
⇤ negative CC values indicate negative correlation which might be considered similar in some applications
2.1.2.3 Transformation models
In image registration the degrees of freedom (DOFs) of f are essential as they determine the level
of detail of the computed transformation. Generally, it can be distinguished between rigid, affine
and non-rigid image alignment.
Rigid registration establishes the optimal alignment of two images by allowing translations and
rotations only. Affine registration additionally compensates for transformations that include shear
and scale. The recovery of both rigid and affine transformations requires the solution of a low-
dimensional optimisation problem that can be solved efficiently. An accurate affine transformation
is usually a crucial prerequisite for a subsequent non-rigid registration (Rueckert et al., 1999).
The aim of non-rigid registration is the recovery of a deformation field that brings both images
into optimal alignment. Here, the deformation field can be described by a transformation model
which is often built on cosine or B-spline basis functions (Ashburner and Friston, 1999; Rueckert
et al., 1999; Andersson et al., 2007; Klein et al., 2009; Modat et al., 2010). Next to these approaches,
non-parametric methods that do not model the transformation explicitly have been successfully ap-
plied. Popular examples include the so-called Demons algorithm (Thirion, 1998; Vercauteren et al.,
2009) or the symmetric registration method proposed in Avants et al. (2008). The parameter space
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of the resulting optimisation problem is large and can exceed millions of parameters, especially if
no transformation model is used (Klein et al., 2009; Vercauteren et al., 2009).
In the context of atlas alignment for image segmentation it should be noted that non-rigid transfor-
mations can be calculated at different levels of detail. For example, when an explicit transformation
model based on B-spline basis functions is used, the control point spacing and thus the number of
parameters can be varied. Usually a finer control point spacing yields a more accurate registration
result, however, it comes at a substantially increased computational cost.
2.1.2.4 Large deformation registration problem
The accurate registration of an atlas and unsegmented MR image can be difficult if the target image
differs from the available atlases due to general anatomical variability or pathological changes. Also
intensity inhomogeneities or noise can facilitate an accurate registration difficult (Vovk et al., 2007).
There have been several methods proposed to address the large deformation registration problem
in adult brains in the context of AD. In Heckemann et al. (2010) the authors proposed Multi-Atlas
Propagation with Enhanced Registration (Heckemann et al., 2010, 2011) (MAPER). MAPER em-
ploys automatically calculated brain tissue segmentations to guide the registration process. This
allows a robust image alignment, even if the target image shows severe brain atrophy. In another
approach, Wolz et al. (2010a) described an iterative approach to improve segmentation accuracy by
propagating atlas labels over a learned manifold while refining intermediate segmentations based
on image intensities using graph-cuts (GC) (cf . Section 2.1.4). It was shown by Gerber et al. (2010)
that coordinates within a low-dimensional space, a nonlinear manifold, allow for a meaningful im-
age comparison and statistical tests.
A manifold of the anatomical variation in a given dataset is also learned in Hamm et al. (2010). In
this work it was shown that the problem of recovering a large deformation between two images can
be simplified by solving a series of small deformation registration problems (Hamm et al., 2010).
The small deformations are calculated along the shortest path between the images on the learned
manifold (Hamm et al., 2010).
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2.1.2.5 Registration in the presence of pathology
A particularly challenging endeavour is the alignment of the atlas images to a target image with
severe pathology such as focal lesions, tumours or surgical resections. The major problem here is
that the assumption of an one-to-one mapping is clearly violated. Correspondences of pathological
regions are missing in the atlas images which are usually acquired from healthy subjects (Bauer
et al., 2013).
Several early approaches address this problem by excluding image regions with pathology when
evaluating the similarity measure (Brett et al., 2001; Stefanescu et al., 2004; Angelini et al., 2007;
Andersen et al., 2010; Bauer et al., 2013). Brett et al. (2001) proposed cost-function masking based
on manually obtained masks of lesions or other image artefacts. In Stefanescu et al. (2004) the
authors integrate a confidence map into the registration algorithm giving zero confidence to voxels
within an automatically obtained outlier region.
Alternative approaches are based on models that simulate growth, for example of a tumour, within
the healthy atlas or template image (Bach Cuadra et al., 2004; Angelini et al., 2007; Zacharaki et al.,
2009; Niethammer et al., 2011; Bauer et al., 2013). Bach Cuadra et al. (2004) model radial tumour
growth starting from a manually placed seed voxel. Also based on a seed, Zacharaki et al. (2009)
simulate tumour growth using a biomechanical model in an atlas image before registering it to
an image of a tumour patient. In Niethammer et al. (2011), the authors formulated a geometric
metamorphosis model to address the challenges arising in the registration of images from TBI,
tumour or stroke patients.
Other approaches register and segment the images simultaneously to identify missing correspon-
dences (Periaswamy and Farid, 2006; Chitphakdithai and Duncan, 2010; Parisot et al., 2012). Re-
cently, Liu et al. (2014) presented a promising approach based on low-rank matrix decomposition to
register multiple images of patients with TBI simultaneously to a reference image. In another recent
approach a similarity measure is introduced that is based on the angle between gradient orientations
(Pszczolkowski et al., 2014). This reduces bias in the similarity measure caused by image regions
with intensity outliers such as pathologies.
Methods that rely on strong prior knowledge such as masks or tumour growth models are not al-
ways applicable. The manual annotation of masks is very time consuming (Andersen et al., 2010).
Further, it is not obvious whether growth models can be beneficial in the presence of heteroge-
neous pathologies as they are often observed in patients with TBI. Pathology specific adaptations
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(e.g. confidence maps) might be more challenging but are likely superior to simplistic masking ap-
proaches (Bauer et al., 2013). Assessing the quality or validity of a calculated transformation is
difficult, especially in the presence of pathology (Angelini et al., 2007). A more comprehensive
overview on image analysis in the context of brain tumours can be found in Angelini et al. (2007);
Bauer et al. (2013).
In the following, fm denotes the calculated transformation from the atlas space of Am to the
coordinate system of Itgt and Afm denotes the propagated atlas respectively. In the following, the
superscript f is neglected for readability. Once the atlas label maps, LAm, reside in the same coordi-
nate system as the unsegmented target image, Itgt, a consensus segmentation can be inferred using
a variety of label fusion techniques (cf . Section 2.1.3).
2.1.3 Label fusion
2.1.3.1 Majority vote fusion
In majority vote fusion (MVF), also called “vote-rule” or “decision” fusion, each of the M propa-
gated atlas labels LAm contributes equally to the final segmentation. A certain voxel is thus labelled
according to the opinion on which the majority of the propagated atlas segmentations agree. For-
mally the probability of voxel i being labelled as structure k can be calculated as:
pi(k) =
1
M
M
Â
m=1
d(LAm(i),k) (2.3)
Here, d(·, ·) is the Kronecker delta defined as:
d(v,w) =
8>><>>:
1 if v= w
0 otherwise
(2.4)
The actual segmentation estimate Ltgt is then readily inferred through Equation 2.1.
MVF was first described by Rohlfing et al. (2004) where it was applied to the segmentation of
bee brains. Heckemann et al. (2006) successfully employed MVF to segment MR brain images
and presented a model that describes the basic assumption of label fusion. In this model it is
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Figure 2.4: Left: Schematic process of fusing K atlas labels that have been aligned to the target im-
age into a consensus segmentation. Right: Illustrations of the increasing segmentation
accuracy with increasing number of fused atlas labels. The model described in Equa-
tion 2.5 is shown for esys = 0.144, erand = 0.1 (red) with corresponding asymptotic limit
(blue). A qualitative plot indicating the increased accuracy when atlas selection is used
is also shown (green). The diagram is based on and adapted from Heckemann et al.
(2006); Aljabar et al. (2009).
assumed that there are two major sources of segmentation errors: 1) Systematic errors (esys) due to
deviations of the (manual) reference segmentation from the true segmentation or due to consistent
registration bias. 2) Random errors (erand) introduced due to inaccuracies in individual reference
labels or image registrations (Heckemann et al., 2006). With this assumption random errors can
be corrected by fusing several label estimates. However, the systematic errors asymptotically limit
the segmentation accuracy as the number of fused atlases increases (Heckemann et al., 2006). In
Heckemann et al. (2006) the following relation is suggested to model the segmentation accuracy
SImodel, measured as Dice coefficient (Dice, 1945) or so-called similarity index (SI), dependent on
the number of atlases K:
SImodel = 1  esys  erandp
K
(2.5)
Figure 2.4 illustrates the schematic process and the qualitative behaviour of label fusion approaches
using the model from Equation 2.5.
According to Artaechevarria et al. (2009) MVF is the most simple and most popular label fusion
strategy, and does not require any a priori knowledge except for the actual segmentations that are
to be fused. MVF has its origins in the more general combination of classifiers as for example Xu
et al. (1992), Kittler et al. (1998) or Kuncheva (2004).
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2.1.3.2 Atlas selection
If only a single atlas from a given atlas database is to be used, a carefully selected atlas that is similar
to Itgt allows a higher segmentation accuracy than choosing an atlas at random. This was confirmed
in a variety of applications, such as the segmentation of CT images of the head (Han et al., 2008) or
the segmentation of bee brains (Rohlfing et al., 2004) and human brains in MRI (Wu et al., 2007).
However, the fusion of multiple atlases (e.g. using MVF) substantially outperforms the segmen-
tation based on a single atlas only (Rohlfing et al., 2004; Heckemann et al., 2006; Aljabar et al.,
2009). Klein et al. (2007) and Aljabar et al. (2009) thus suggested to combine these approaches and
perform label fusion on a selection of atlases from a larger database.
As selection criterion, the image similarity between the aligned atlas images and Itgt can be cal-
culated using a variety of similarity measures such as SSD, MI (Collignon et al., 1995; Viola and
Wells III, 1997; Klein et al., 2007), NMI (Studholme et al., 1999; Wu et al., 2007), or CC (Aljabar
et al., 2009) (cf . Table 2.1). Further, image similarity can be assessed on different alignment levels,
e.g. after affine or nonlinear registration (Rohlfing et al., 2004; Klein et al., 2007; Wu et al., 2007),
but also in a template space (Aljabar et al., 2009). When the selection is performed in a template
space all atlas images can be pre-registered to this template. This reduces the computational burden
dramatically as during atlas selection a single registration, aligning Itgt to the template, suffices.
Only the selected atlases are then aligned with Itgt in a non-rigid fashion (Aljabar et al., 2009). In
addition to image similarity, other criteria such as characteristics of the required deformation to
align the images (Rohlfing et al., 2004) or meta-information (age, sex, etc.) (Aljabar et al., 2009)
can be used.
In summary, atlas selection addresses two limitations of standard multi-atlas label fusion: First,
the accurate nonlinear alignment (cf . Section: 2.1.2) of numerous atlases to the unsegmented image
Itgt is computationally intensive. Second, it was shown that there is an asymptotic limit of the
segmentation accuracy caused by systematic and anatomical variations (Heckemann et al., 2006;
Aljabar et al., 2009). Segmentation results can substantially improve up to around 20 selected
atlases (Heckemann et al., 2006; Aljabar et al., 2009) (cf . Figure 2.4). However, using more atlases
with an anatomy that increasingly differs from Itgt might even deteriorate segmentation accuracy
(Aljabar et al., 2009). Nevertheless it should be noted that the ideal number of selected atlases
might be strongly dependent on the quality of the atlases, the anatomical variability of the subjects
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and the ROI that is to be segmented.
2.1.3.3 Weighted vote fusion
Instead of selecting atlases, and thus potentially neglecting relevant information, another approach
is to weight the contribution of each individual atlas. A detailed description and comparison of this
category of label fusion can be found in Artaechevarria et al. (2009).
In globally weighted fusion (GWF) the probabilistic label estimates are calculated based on
global, atlas-dependent voting weights wgm as:
pi(k) =
ÂMm=1w
g
md(LAm(i),k)
ÂKk0=1ÂMm=1w
g
md(LAm(i),k0)
(2.6)
Here, the voting weight wgm of each atlas is generally determined by the image similarity of the
transformed atlas MRIs IAm and the subject image Itgt. Potential measures to quantify this similarity
of intensity images include SSD, MI, NMI or CC (Artaechevarria et al., 2009). The calculation of
global voting weights based on these measures, wgSSDm , w
gCC
m , w
gMI
m , w
gNMI
m , is described in Table
2.1. As the SSD increases with increasing image dissimilarity the voting weight is defined as the
inverse of the actual SSD, wgSSDm = SSD(IAm,Itgt) 1. Artaechevarria et al. (2009) further introduced
a gain parameter p that potentiates the respective weights, e.g. (wgNMIm )p. However it was found that
the segmentation result is usually not very sensitive towards this parameter and the optimal choice
depends on the dataset (Artaechevarria et al., 2009).
Segmentation accuracy can be further increased by calculating local voting weights wlm(i) within
a location-specific region (Artaechevarria et al., 2009). These regions can be for example a spher-
ical or cubical neighbourhood of the voxel under consideration. The size of the neighbourhood
is a tuneable parameter, however, a neighbourhood radius of r = 5 was shown to yield good re-
sults (Artaechevarria et al., 2009). In locally weighted fusion (LWF) the probabilistic segmentation
estimates are calculated as:
pi(k) =
ÂMm=1wlm(i)d(LAm(i),k)
ÂKk0=1ÂMm=1wlm(i)d(LAm(i),k0)
(2.7)
It was shown that weighted fusion overall outperformsMVF (Artaechevarria et al., 2009; Sabuncu
et al., 2010). LWF is usually superior to GWF and particularly useful in image regions with high
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contrast (Artaechevarria et al., 2009; Sabuncu et al., 2010). The ideal fusion strategy is thus de-
pendent on the brain anatomy that is to be segmented. LWF with SSD often performs well (Ar-
taechevarria et al., 2009; Wang et al., 2013b). However, when compared to NMI, SSD is more
sensitive to noise in low-contrast regions and relies on the assumption of similar intensity profiles
of the images (Roche et al., 1999; Artaechevarria et al., 2009).
2.1.3.4 Patch-based label fusion
Inspired by the work on non-local means filtering for image denoising (Buades et al., 2005; Coupe´
et al., 2008), Coupe´ et al. (2010) proposed a patch-based approach to address the problem of label
fusion. Patch-based label fusion was subsequently described thoroughly in Rousseau et al. (2011)
and Coupe´ et al. (2011). In patch-based label fusion techniques, image patches of the unsegmented
image are locally compared to image patches in the atlas images. Usually patches are defined as
3D volumes of a given diameter. For a fixed patch P(Itgt, i) in Itgt with centre voxel i numerous
patches in IAm are taken into account. Specifically, all patches P(IAm, j) with centre j with the spatial
constraint that j lies within a defined neighbourhood Ni of i are considered. Both the size of the
3D patches (patch size) and the size of the neighbourhood (search window size) are parameters that
need to be chosen. An illustration of this process is provided in Figure 2.5. The exact label fusion
procedure can be formalised as:
pi(k) =
ÂMm=1Â j2Ni w
⇤
m(i, j)d(LAm( j),k)
ÂKk0=1ÂMm=1Â j2Ni w⇤m(i, j)d(LAm( j),k0)
(2.8)
Here w⇤m(i, j) is a weight that is calculated based on the similarity of the patch P(Itgt, i), centred at
voxel i in Itgt, and the patch P(IAm, j), centred at voxel j in atlas IAm. A common definition (Buades
et al., 2005; Coupe´ et al., 2011; Rousseau et al., 2011) of this similarity measure is:
w⇤m(i, j) = exp
 ||P(Itgt, i) P(IAm, j)||2
Nh
(2.9)
Here || · || is the L2-norm and N is the number of voxels in the patches. Further, h is a decay
parameter that requires tuning (Coupe´ et al., 2011). If h! • all patches are weighted equally, if
h! 0 only the best matching patch is selected. Potentially, w⇤m(i, j) might be set to zero below a
given threshold (Coupe´ et al., 2011).
The main motivation for patch-based label fusion is to remove the computationally expensive
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Figure 2.5: Illustration of the weight calculation when segmenting a voxel i. The weights w⇤m(i, j)
are determined between the fixed reference patch P(Itgt, i) (yellow) and the atlas patches
P(IAm, j) (red). For each atlas image several atlas patches that are shifted within a local
search neighbourhood (cyan) are considered. With a weighted voting approach a prob-
abilistic segmentation (cf . Equation 2.8) is obtained. Illustration adapted and modified
from Coupe´ et al. (2011); Rousseau et al. (2011).
requirement of nonrigidly aligning the reference atlases (cf . Section 2.1.2). The patch-based for-
mulation further relaxes the assumption of an one-to-one mapping between the atlas images IAm and
the unsegmented image Itgt (Rousseau et al., 2011). An approximate alignment, using for example
affine registration (Coupe´ et al., 2011), is sufficient to establish reasonable patch correspondences.
Nevertheless, it must be noted that nonrigid alignment can further improve patch-based segmen-
tation as it allows the more rigorous incorporation of topological constraints (Coupe´ et al., 2011;
Rousseau et al., 2011).
In patch-based label fusion one can discriminate point-wise and multipoint estimators (Rousseau
et al., 2011). In Equation 2.8 a point-wise estimator is described, in which the label probability of
each individual voxel (or point) i is estimated individually. In contrast to this, multipoint estimators
calculate at each individual voxel a label patch estimate (Rousseau et al., 2011). Specifically, in-
stead of considering only the centre label LAm( j) (cf . Equation 2.8) label information from the whole
patch centred at j is fused into a patch estimate. While point-wise estimators are commonly used
and computationally more efficient, it was shown that multipoint estimators can potentially increase
segmentation accuracy (Rousseau et al., 2011). More details on multipoint estimators can be found
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in Katkovnik et al. (2010); Rousseau et al. (2011).
Recent advances in patch-based segmentation include the application of sparsity techniques
(Tong et al., 2013) or the efficient search of patch correspondences using the PatchMatch algo-
rithm (Barnes et al., 2009a; Shi et al., 2014; Ta et al., 2014). Next to image segmentation, it was
proposed to employ patch-based methods to grade subjects according to clinical variables (Coupe´
et al., 2012a,b). In this patch-based grading approach a meaningful clinical label, e.g. AD or healthy
control (HC), is associated with each patch of a reference database. Instead of fusing anatomical
labels LAm( j) these clinical labels are fused in Equation 2.8 within a region. It was shown that the
resulting grading value allows the accurate discrimination of different AD disease states (Coupe´
et al., 2012a,b).
2.1.3.5 Joint label fusion
The label fusion techniques that were presented so far treat each atlas independent from the others
for the calculation of voting weights. Thus, none of these approaches takes into account that similar
or, in general, correlated atlases might produce similar segmentation errors (Wang et al., 2013b). To
address this limitation Wang et al. (2013b) introduced an approach called joint label fusion (JLF) in
which the joint probability distribution of two atlases producing the same labelling error is explicitly
modelled.
In particular the authors aim to minimise the expected error between the true, yet unknown seg-
mentation of Itgt and the consensus segmentation estimate Ltgt. This optimisation problem can be
solved once dependency matrices Mi of size M⇥M are established that model the likelihood that
a pair of the M available atlases make an identical error at voxel i. In Wang et al. (2013b), the
authors calculate the correlation of the intensity similarity of two atlases with respect to Itgt. A local
estimation ofMi is obtained by performing the similarity computation in a local neighbourhood of
the corresponding voxel i. More details on JLF can be found in Wang et al. (2013b).
Many approaches ranking among the top performing methods in the literature are based on JLF
strategies that incorporate the non-local patch-based concept. This was confirmed for the segmenta-
tion of various anatomies in recent Segmentation Challenges (Landman and Warfield, 2012; Asman
et al., 2013a). For example, JLF performs very well for the segmentation of the brain into distinct
ROIs (Landman and Warfield, 2012; Asman et al., 2013a), but also for the segmentation of the
71
myocardium (Asman et al., 2013a; Bai et al., 2015).
2.1.3.6 Statistical label fusion
With origins in the popular Simultaneous Truth And Performance Level Evaluation (Warfield et al.,
2004) (STAPLE) algorithm there is another category of statistical label fusion approaches. Given
several manual label sets, STAPLE was proposed to simultaneously estimate the performance level
parameters of each expert rater and the most probable ground truth. The STAPLE algorithm com-
putes a probabilistic estimate of the true segmentation (Warfield et al., 2004). For the sake of
consistency with existing literature the commonly used notation is employed to outline the STA-
PLE algorithm. This notation is slightly different in comparison to the rest of this section. This also
accommodates the fact that STAPLE was originally described for the estimation of a ground truth
from several expert reference segmentations rather than for the fusion of automatic label estimates.
The following description is adapted fromWarfield et al. (2004), where more details about the exact
implementation of STAPLE can be found.
Let D be a N⇥M matrix that describes the decisions of M raters (or atlases) at N voxels. Let T
be a vector of size N indicating the true but unknown segmentation. For K possible labels D and
T are indexed as Dim 2 {1, . . . ,K} and Ti 2 {1, . . . ,K}. The goal of the STAPLE algorithm is to
estimate a performance tensor qˆ of size M⇥K⇥K that maximises the log-likelihood of observing
the complete data (D,T). Here, element qms0s quantifies the probability that rater m decides on
label s0 given that the true label is s. For a probability mass function f (D,T|q) that describes the
probability of observing the complete data, qˆ can be calculated by solving:
qˆ= argmax
q
ln f (D,T|q) (2.10)
The solution of this problemwould be trivial if the true segmentationTwas known. AsT is however
unknown Warfield et al. (2004) suggested to employ the expectation-maximisation (EM) algorithm
to solve Equation 2.10. In this approach, a ground truth T is estimated in the Expectation-step and
the ideal performance parameters qˆ found in the Maximisation-step. This is repeated iteratively un-
til the model converges. Convergence to a local maximum of Equation 2.10 is guaranteed (Warfield
et al., 2004). There are different strategies to initialise q in the first iteration (Warfield et al., 2004).
Furthermore, spatial prior information can be incorporated through probabilistic priors or smooth-
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ness constraints based on Markov random fields (MRFs) (Warfield et al., 2004).
Next to the basic STAPLE algorithm outlined above, there have been several successful attempts
to incorporate both image intensity information (Cardoso et al., 2013a; Asman and Landman, 2013)
and the concept of non-local patch-based approaches into the STAPLE framework (Asman and
Landman, 2013). Many other extensions include formulations that allow the application to data
with missing labels (Landman et al., 2012), local estimation of rater performances (Commowick
et al., 2012; Asman and Landman, 2012) or the fusion of probabilistic decisions (Akhondi-Asl and
Warfield, 2013).
2.1.4 Refinement of image segmentations
The segmentation estimates obtained by multi-atlas label fusion, as described in the previous Sec-
tion 2.1.3, can be further improved. In the following two successful strategies to the refinement
of image segmentations are presented: The refinement of segmentations based on image intensities
and the refinement based on classifiers that were trained to correct systematic bias of a segmentation
method.
2.1.4.1 Intensity-based refinement
The probabilistic segmentation estimates obtained by automatic label fusion techniques (cf . Section
2.1.3) can be further refined based on the image intensities of Itgt. It was shown that modifying
image segmentations based on the actual image intensities can substantially improve segmentation
results (van der Lijn et al., 2008; Wolz et al., 2009; Lo¨tjo¨nen et al., 2010; Ledig et al., 2015).
Using Bayes’ theorem the refinement task is often modelled as calculating the maximum a pos-
teriori (MAP) estimate as:
Ltgt = argmax
L
p(L|Itgt) = argmax
L
p(Itgt|L)p(L)
p(Itgt)
= argmax
L
p(Itgt|L)p(L) (2.11)
Assuming voxel-wise independence the image likelihood, p(Itgt|L) can be calculated as’Ni=1 p(yi|li)
where p(yi|li) is given by a predefined intensity model. The probability of a segmentation p(L) is
often modelled based on spatial prior knowledge and smoothness constraints between adjacent la-
bels. Since the target image is fixed, the optimisation problem is independent of p(Itgt).
Two popular approaches to solve the optimisation problem stated in Equation 2.11 are based on
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graph-cuts (GC) (Greig et al., 1989; Boykov et al., 2001; van der Lijn et al., 2008; Wolz et al., 2009)
or the expectation-maximisation (EM) algorithm (Van Leemput et al., 1999; Lo¨tjo¨nen et al., 2010;
Ledig et al., 2015). A more detailed introduction of the EM approach will be provided in Chapter 3.
The optimisation problem in Equation 2.11 can be rewritten (Greig et al., 1989; van der Lijn
et al., 2008) as a minimisation problem by taking the negative logarithm as:
Ltgt = argmin
L
(  ln p(Itgt|L)  ln p(L)) = argmin
L
(Eintensity(L)+Eprior(L)) (2.12)
This amended formulation allows the definition of a network graph for which a minimum cut can
be calculated based on the Ford-Fulkerson max-flow/min-cut algorithm (Greig et al., 1989). In
Equation 2.12 the intensity (or data) term, Eintensity(L) = ÂNi=1 ln p(yi|li), quantifies the agreement
of the image data Itgt with the intensity model. A common choice for the intensity model of p(yi|li)
is a Gaussian probability distribution with label-specific parameters (µli ,sli) (van der Lijn et al.,
2008; Wolz et al., 2010b). The second term, Eprior(L), incorporates both spatial prior information
provided through the probabilistic segmentation estimates (e.g. obtained through label fusion) and
smoothness constraints which are often modelled through MRFs (van der Lijn et al., 2008; Wolz
et al., 2010b). The cost function that is minimised by GC can then be summarised as:
E(L) = 
N
Â
i=1
ln p(yi|li)| {z }
Eintensity
 
N
Â
i=1
ln p(li)| {z }
Espatial prior
+
N
Â
i=1
Â
j2Ni
G(li, l j)| {z }
Esmoothness prior
(2.13)
Here p(li) is the prior probability that voxel i has label li. It can be calculated using label fusion (cf .
Section 2.1.3) so that p(li) = pi(li). Furthermore Ni is the set of voxels neighbouring voxel i and
G(li, l j) penalises non-smooth label configurations (G(li, l j)> 0 for li 6= l j). The individual energy
terms can be multiplied with weighting factors to control their individual contribution (Song et al.,
2006; van der Lijn et al., 2008; Wolz et al., 2010b).
GC optimisation was first introduced for binary segmentation problems (Greig et al., 1989;
Boykov et al., 2001; Boykov and Kolmogorov, 2004) for which a global optimum can be found.
However, the optimisation problem can also be formulated as a multiway cut problem and em-
ployed for the segmentation of multiple labels (Boykov et al., 2001; Boykov and Kolmogorov,
2004; Song et al., 2006). For multiway cut problems, Boykov et al. (2001) presented an algorithm
that efficiently calculates approximate solutions of the global minima with optimality bounds. GC
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optimisation typically assigns one strict label to each voxel.
2.1.4.2 Learning-based refinement
Learning-based refinement is based on the assumption that a substantial fraction of falsely labelled
image voxels is due to systematic bias of the employed segmentation method (Wang et al., 2011a).
Systematic bias often originates in different definitions of manual segmentation protocols or in-
accurate translation of the manual protocol to the automatic method (Wang et al., 2011a). The
assumption made by Wang et al. (2011a) is similar to the one made by Heckemann et al. (2006):
In the work by Heckemann et al. (2006) the authors described segmentation inaccuracies in the
context of multi-atlas label propagation as a combination of random variability of propagated labels
and systematic errors.
The main contribution of Wang et al. (2011a) is the proposal to explicitly learn systematic seg-
mentation errors with respect to reference segmentations using machine learning. Specifically, fea-
tures based on image intensities and label context are extracted in a local neighbourhood of each
voxel and combined with spatial information. These features are subsequently employed to train
error detection and error correction classifiers using AdaBoost (Freund and Schapire, 1995) with
respect to reference segmentations (Wang et al., 2011a). These classifiers have been shown to allow
a significant reduction of systematic bias in the context of many applications. In the original work,
Wang et al. (2011a) presented substantial improvements when the method is employed to correct
automatically calculated hippocampus segmentations, brain masks and brain tissue segmentations.
A schematic illustration of the method is provided in Figure 2.6. More details on learning-based
refinement can be found in Wang et al. (2011a).
2.1.5 Remarks
Recently several segmentation challenges were held in conjunction with international conferences.
The methods with particularly good performance for segmenting brain data were often based on JLF
(cf . Section 2.1.3.5) and corrected for systematic segmentation bias (cf . Section 2.1.4.2) (Landman
and Warfield, 2012; Asman et al., 2013a).
The careful design and implementation of each individually outlined building block, brain extrac-
tion, atlas alignment, label fusion, label refinement, is essential and critical to realise a segmentation
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Figure 2.6: Schematic process of training classifiers for the detection and correction of system-
atic segmentation bias. This illustration corresponds to the variant named explicit bias
correction in Wang et al. (2011a). Note that for binary segmentation tasks the error
detection and error correction classifiers are identical. Illustration adapted and modified
from Wang et al. (2011a).
approach that is both accurate and robust. Failure or inaccuracies within a single of these ’modules’
is likely to negatively impact the final segmentation result. It is tempting to consider each of these
blocks separately to reduce the complexity of the task. This further allows the independent imple-
mentation, tuning and validation of each module. It should be mentioned, however, that there is
some evidence that more complex approaches that model and solve several building blocks jointly
(e.g. registraion and segmentation) can increase accuracy (Ashburner and Friston, 2005). Never-
theless, in practice the theoretical advantages of these joint models might be outweighed by the
above-mentioned merits of a modular approach.
2.2 Brain atlases from structural MRI
Atlases of the human brain can be considered as maps that associate a spatial position within the
brain with structural or functional information such as a specific anatomical structure. Early brain
atlases were created based on a single subject or a small number of selected subjects (Mazziotta
et al., 1995). A widely used example is the Talairach space created from postmortem specimen of
a single subject (Talairach and Tournoux, 1988; Mazziotta et al., 1995). While these early atlases
provided great insight into brain anatomy they were limited in their ability to represent the large
intersubject variability of the human brain.
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To address this problem, probabilistic population atlases were created from a population of brain
images that were aligned with and segmented in a common reference space, e.g. in Shattuck et al.
(2008). Popular stereotaxic spaces are given by the MNI-3051 (Evans et al., 1993) and the MNI-
1522 (Mazziotta et al., 1995) brain templates, which are available through the Montreal Neurolog-
ical Institute (http://www.mni.mcgill.ca/, last accessed 29 June 2015) (MNI). Both templates
were created by averaging the contributing MR intensity images (305, and 152 respectively) in a
common space after linear image registration (Evans et al., 1993; Mazziotta et al., 1995). The MNI-
152 template was built by the International Consortium for Brain Mapping (ICBM) from images
acquired with better contrast and at a higher resolution than the images on which the MNI-305
template is based2. The stereotaxic spaces described by these template images can serve as target
to align individual atlases of an atlas database (Hammers et al., 2003; Shattuck et al., 2008), such
as the ones described in this section. The propagated atlas labels can then be averaged using label
fusion techniques (cf . Section 2.1.3) to create a probabilistic brain atlas. The characteristics of the
resulting probabilistic atlas, such as spatial variability of individual structures, directly depends on
the chosen template space (e.g. MNI-305, MNI-152) and the registration approach (e.g. affine or
nonrigid transformation model). As a consequence, a variety of application-specific probabilistic
atlases can be created from atlas databases such as the ones described in the following. A broader
description and history of atlases of the human brain can be found in Mazziotta et al. (1995); Shat-
tuck et al. (2008).
In this thesis the focus is on non-probabilistic brain atlases that can be aligned with a specific
target image. For image segmentation these individual brain atlases need to be aligned with the
unsegmented image. This approach is thus computationally more expensive than the alignment
with a single (probabilistic) atlas only. However, accuracy of the estimated target segmentation can
be substantially improved based on subject-specific atlases created using label fusion (cf . Section
2.1.3).
In the following, five publicly available non-probabilistic brain atlases based on T1w MR im-
ages are introduced. The reviewed brain atlases were selected because they are widely used, pub-
licly available, and contain manually annotated anatomical labels for both cortical and non-cortical
structures. An overview over key characteristics of these atlases is given in Table 2.2.
1http://www.bic.mni.mcgill.ca/ServicesAtlases/MNI305, last accessed 29 June 2015.
2http://www.bic.mni.mcgill.ca/ServicesAtlases/ICBM152Lin, last accessed 29 June 2015.
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However, next to this selection of brain atlases there are alternatives. For example, Klein et al.
(2009) employed next to the IBSR18 (cf . Section 2.2.2) and LBPA40 (cf . Section 2.2.4) atlases, the
CUMC12 (Columbia University Medical Center) and MGH10 (Massachusetts General Hospital)
atlases to evaluate 14 established registration algorithms. Furthermore, Klein and Tourville (2012)
recently created a detailed protocol to label human cortices. Based on this protocol MR images from
101 healthy participants, with origins in nine different publicly available datasets, were segmented.
The expert labels for all images3 were obtained by manually editing label maps that were calculated
using FreeSurfer (http://surfer.nmr.mgh.harvard.edu/, last accessed 29 June 2015, Fischl
and Dale (2000); Fischl et al. (2002, 2004)) (FreeSurfer) to correspond with the protocol.
2.2.1 AAL atlas
The Automated Anatomical Labeling (AAL) brain atlas4 (Tzourio-Mazoyer et al., 2002) distin-
guishes 116 ROIs and is based on a single MR template image with a resolution of 1 mm ⇥ 1 mm
⇥ 1 mm. The template5 was obtained by averaging 27 T1w MR brain images of a male individual
to increase the signal to noise ratio (SNR) (Holmes et al., 1998; Tzourio-Mazoyer et al., 2002). The
MR template was then segmented manually into distinct ROIs based on two-dimensional (2D) axial
slices. The ROIs were outlined only on every second axial slice (Tzourio-Mazoyer et al., 2002).
The atlas segmentations available for download4 are, compared to the MR template, of a lower
resolution of 2 mm ⇥ 2 mm ⇥ 2 mm. The AAL atlas was constructed with a focus on measuring
activation patters within the defined ROIs in functional imaging. To avoid missing some structure-
related activity due to a too conservative definition of ROIs and to account for intersubject variabil-
ity, structures were outlined quite generously, even beyond the GM boundary (Tzourio-Mazoyer
et al., 2002).
In total the template is divided into 116 anatomical structures including the cortical gyri but
also subcortical structures such as hippocampus, amygdala, caudate nucleus, putamen, pallidum,
thalamus and 26 labels subdividing the cerebellum (Tzourio-Mazoyer et al., 2002). Structures in the
left and right hemisphere are treated separately. Ventricles were not segmented. The visualisation
of the atlas in Figure 2.7 clearly shows the generous definition of ROIs including more than one
tissue type.
3available at http://mindboggle.info/, last accessed 29 June 2015.
4http://www.gin.cnrs.fr/spip.php?article217, last accessed 29 June 2015.
5http://www.bic.mni.mcgill.ca/ServicesAtlases/Colin27Highres, last accessed 29 June 2015.
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Figure 2.7: The AAL atlas in axial (left), coronal (middle) and sagittal (right) view plane. T1w MR
template with overlaid segmentation contours in a colour scheme that provides a good
contrast between adjacent labels. The cross-hair in the axial view indicates the position
of the illustrated coronal and sagittal slice.
2.2.2 IBSR18 atlas
The Internet Brain Segmentation Repository (IBSR) V2.06 atlas consists of T1w MR images ac-
quired from 18 subjects (14 male / 4 female, mean age [min; max] of 14 subjects: 38 years [7;
71]7). The slice thickness of all images is 1.5 mm. However, the in-plane resolution varies from
0.8371 mm ⇥ 0.8371 mm to 1 mm ⇥ 1 mm. All images were positionally normalised by rotating
the images into the Talairach orientation. Expert segmentations of 34 anatomical structures8 were
created manually.
Figure 2.8: An example of a subject (IBSR01, male, 37 years) of the IBSR atlas in axial (left),
coronal (middle) and sagittal (right) view plane. T1w MR template with overlaid seg-
mentation contours.
6http://www.nitrc.org/projects/ibsr, last accessed 29 June 2015.
7No exact age provided for four subjects.
8The readme file describes 39 anatomical structures. In contrast to this description labels for cerebral exterior
(left/right), cerebellum exterior (left/right) and amygdala anterior (left/right) are missing while CSF is an additional
label not mentioned in the description (39 6+1= 34).
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The annotated structures include for example hippocampus, amygdala, caudate, pallidum, puta-
men, thalamus, inferior lateral ventricle, lateral ventricle. The cerebellum is split into cerebellum
cortex and cerebellum WM. Structures in the left and right hemisphere are discriminated. Cortical
annotations include cortical GM only. An example of a subject of the IBSR atlas is illustrated in
Figure 2.8.
2.2.3 Hammers atlas
The Hammers brain atlas9 (Hammers et al., 2003, 2007; Gousias et al., 2008) consists of 30 T1w
MR images with corresponding segmentations distinguishing 83 ROIs. The images were acquired
from young healthy adults (15 male/female, median age [min; max] of all subjects: 31 years [20;
54]) and resliced to an isotropic resolution of 0.9375 mm ⇥ 0.9375 mm ⇥ 0.9375 mm (Hammers
et al., 2003; Gousias et al., 2008). All images were acquired at 1.5T with the same scanner (Gousias
et al., 2008). Originally, Hammers et al. (2003) annotated 49 distinct anatomical regions of 20 sub-
jects. Delineations were done in native space. This work was subsequently extended to 30 subjects
and by further subdividing the 49 regions into a total of 83 ROIs (Hammers et al., 2007; Gousias
et al., 2008). Following a well defined protocol (Hammers et al., 2003), the MRIs were manually
annotated on 2D slices in structure-specific orientations. Subsequent control of difficult cases was
conducted by a trained specialist (Hammers et al., 2003). An intrarater reliability study indicates
good reliability (Hammers et al., 2007). Hammers et al. (2003) further created a probabilistic brain
atlas by aligning the individual segmentations to the MNI-152 template space using Statistical Para-
metric Mapping (http://www.fil.ion.ucl.ac.uk/spm/, last accessed 29 June 2015, Ashburner
and Friston (1997, 1999, 2005)) (SPM).
Each of the 30 MRIs is divided into 83 ROIs subdividing the cortex, ventricles and non-cortical
structures such as the hippocampus, amygdala, caudate nucleus, pallidum, putamen, thalamus.
There is no finer separation within the cerebellum. Structures in the left and right hemisphere form
separate ROIs. GM and WM are combined in one common label for most cortical ROIs (Hammers
et al., 2003). An example of a subject of the Hammers atlas is illustrated in Figure 2.9.
9http://wp.doc.ic.ac.uk/brain-development/brain-atlases/, last accessed 13 November 2015.
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Figure 2.9: An example of a subject (a01) of the Hammers atlas in axial (left), coronal (middle) and
sagittal (right) view plane. T1w MR template with overlaid segmentation contours.
2.2.4 LPBA40 atlas
The LONI Probabilistic Brain Atlas (LPBA)10 consists of T1wMR images acquired from 40 healthy
volunteers (20 male/female, mean age [min; max] of all subjects: 29.2 years [19; 39]) (Shattuck
et al., 2008). All images were acquired with the same scanner at 1.5T and subsequently rigidly
aligned to the MNI-3051 (page 77) (Evans et al., 1993) template space. Images were further resampled
to an isotropic resolution of 1 mm⇥ 1 mm ⇥ 1 mm (Shattuck et al., 2008). Manual delineation
of the images into 56 distinct ROIs was then performed in template space following a detailed
protocol (Shattuck et al., 2008). Rater-reliability was assessed. Several versions of a probabilistic
atlas were produced by employing different techniques (e.g. SPM) to nonrigidly align the individual
segmentations to the MNI-305 template space (Shattuck et al., 2008). However, the individual 40
annotated non-probabilistic atlases are available.
Figure 2.10: An example of a subject (S01) of the LPBA atlas in axial (left), coronal (middle) and
sagittal (right) view plane. T1w MR template with overlaid segmentation contours.
10http://www.loni.usc.edu/atlases/Atlas_Detail.php?atlas_id=12, last accessed 29 June 2015.
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The atlas distinguishes hippocampus, caudate, putamen, cerebellum and brainstem but mainly
parcellates cortical ROIs (Shattuck et al., 2008). Amygdala, pallidum and thalamus are absent.
There is no finer separation within the cerebellum. Structures in the left and right hemisphere form
individual ROIs. Cortical structures potentially contain WM that lies between sulci or in the vicinity
of cortical GM (Shattuck et al., 2008). An example of a subject of the LPBA atlas is illustrated in
Figure 2.10.
2.2.5 NMM atlas
The Neuromorphometrics (NMM) brain atlas11 consists of a continuously growing number of man-
ually annotated T1w MR brain images (Worth and Tourville, 2013). The currently available anno-
tated images can be obtained with an academic license for an annual fee. Recently, a subset of 35
images was used as ’gold standard’ and made freely available in the course of the “MICCAI 2012
Grand Challenge and Workshop on Multi-Atlas Labeling” (Landman and Warfield, 2012). In the
following a description of these 35 images is provided.
The 35 images were taken from the Open Access Series of Imaging Studies (OASIS) database
and acquired from 30 individuals (Marcus et al., 2007). Repeat scans were acquired of five of the
subjects in a second session within 90 days of the original scan (Marcus et al., 2007). All images
were acquired at 1.5T with the same scanner (Marcus et al., 2007). Images from the OASIS database
were corrected for bias field inhomogeneities and positionally normalised12. The MR images with
corresponding segmentations are resampled to a resolution of 1 mm⇥ 1 mm⇥ 1 mm. A description
of relevant subsets including information on gender and age is provided in Table 2.3.
Table 2.3: Overview of relevant NMM subsets with respective age and gender information.
subset # of images / subjects gender (# male / # female) age (mean [min; max])
COMPLETE 35 / 30 10 / 20 34.3 [18; 90]
ATLAS 30 / 30 10 / 20 34.3 [18; 90]
REPEAT 10 / 5 2 / 3 24.6 [20; 29]
TRAINING 15 / 15 5 / 10 23 [19; 34]
TEST 20 / 15 5 / 10 45.7 [18; 90]
The manual segmentation into 138 anatomical structures has been carried out by experts13 ac-
11http://www.neuromorphometrics.com/, last accessed 29 June 2015.
12http://www.neuromorphometrics.com/wp-content/uploads/2013/07/DescriptionofLabeledScans.pdf,
last accessed 29 June 2015.
13provided by Neuromorphometrics, Inc. (http://Neuromorphometrics.com/, last accessed 29 June 2015) under
academic subscription.
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cording to publicly available protocols14. All manual segmentations were quality controlled by
another expert12 (page 83). As suggested by Landman and Warfield (2012), the small regions vessel
Figure 2.11: Two examples of subjects of the NMM atlas in axial (left), coronal (middle) and sagit-
tal (right) view plane. T1w MR images of a male subject aged 20 years (OAS1 0285,
top) and a female subject aged 90 years (OAS1 0083, bottom) with overlaid segmen-
tation contours.
and cerebral exterior were excluded in both the left and the right hemisphere. Thus the atlas com-
prises effectively 134 ROIs of which 36 are non-cortical and 98 cortical. The non-cortical structures
comprise several ROIs such as amygdala, caudate nucleus, hippocampus, pallidum, putamen, thala-
mus. The cerebellum is subdivided into WM, cerebellum exterior and the cerebellar vermal lobules.
Cortical ROIs contain a single tissue type (cortical GM) only. Without any further subdivision, cere-
bral WM is pooled together in one ROI for the left and right brain hemisphere respectively. The 134
ROIs contain 63 distinct anatomical structures which have symmetric counterparts in their opposite
hemisphere, in total 126 paired ROIs. The remaining eight unpaired structures are: 3rd ventricle,
4th ventricle, brain stem, CSF, optic chiasm, cerebellar vermal lobules I-V, cerebellar vermal lob-
ules VI-VII, cerebellar vermal lobules VIII-X. A complete list of all ROIs is provided in Appendix
B. Examples of brain MR images of a young male subject (20 years) and a rather old female subject
(90 years) is illustrated with overlaid manual segmentation outlines in Figure 2.11.
14http://neuromorphometrics.org:8080/Seg/ and http://www.braincolor.org, last accessed 29 June 2015.
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2.3 Biomarkers from structural MRI in AD
2.3.1 Motivation and potential
Non-invasive brain MRI has great potential to provide informative biomarkers for characterising
the early onset of AD even before clinical symptoms are apparent or irreversible neuronal damage
has occurred (Scheltens et al., 2002; Mueller et al., 2005; Fennema-Notestine et al., 2009). Assum-
ing disease modifying treatment would be available, it is crucial to identify patients well before a
clinical diagnosis can be made.
Furthermore, clinical trials can meanwhile greatly benefit fromMRI biomarkers as they allow the
definition of more rigorous inclusion criteria leading to more homogeneous study groups (Scheltens
et al., 2002; Fennema-Notestine et al., 2009; Frisoni et al., 2010; Klo¨ppel et al., 2012). It is assumed
that failure of recent trials can be in part attributed to the inhomogeneity of study groups, including
patients that for example suffer from a dementia different to AD (Frisoni et al., 2010; Falahati et al.,
2014). MRI biomarkers could support the differential diagnosis of various types of early dementia.
With imaging information available, MCI subjects that are less likely to convert to AD or have
frontotemporal dementia (FTD), vascular dementia (VD) or Lewy body dementia (LBD) could be
excluded from a trial. This leads to a study cohort with an increased number of patients that actually
convert to AD, which in turn can increase the statistical power of a trial.
There is a vast number of studies that have shown the correlation of biomarkers calculated from
brain MRI with the state or disease progression of an AD patient. It is well known that MTL struc-
tures are among the first regions affected by the disease (Braak and Braak, 1991). Early involvement
of the hippocampus, amygdala and entorhinal cortex is consistently shown in the literature (Braak
and Braak, 1991; Jack Jr. et al., 1997; Wenk, 2003; Blennow et al., 2006; Dubois et al., 2007).
It is assumed that biomarkers derived from these individual structures can be very sensitive to de-
mentia. These biomarkers might however not be sufficiently specific for AD (Frisoni et al., 2010;
Cuingnet et al., 2011). A uniform approach, considering pathological changes of multiple structures
within the whole brain might increase specificity in dementia diagnosis and support a differential
assessment of various dementia types (Klo¨ppel et al., 2008; Frisoni et al., 2010).
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2.3.2 Literature overview
There is a substantial amount of published articles studying biomarkers derived from structural
MRI in the context of AD. A selection of relevant literature is described in the following. A more
complete overview can be found in published surveys such as Scheltens et al. (2002), Ramani et al.
(2006), Frisoni et al. (2010), Cuingnet et al. (2011), Falahati et al. (2014) or Bron et al. (2015) and
references therein.
2.3.2.1 Brain tissue biomarkers
Klo¨ppel et al. (2008) calculated a probabilistic tissue segmentation of subjects with histopatholog-
ically confirmed dementia and HC subjects. After aligning the GM maps to a template space, the
authors trained a linear support vector machine (SVM) to classify small cohorts with high accuracy
(  90%) in AD and HC. The potential of structural imaging to differentiate FTD and AD was also
shown (⇡ 89% accuracy). In Fan et al. (2008), Misra et al. (2009) and Davatzikos et al. (2011)
the authors followed a similar approach and aligned previously extracted tissue maps to a tem-
plate space but recorded the required extent of deformation in regional volumetric maps (Goldszal
et al., 1998). The findings confirmed involvement of MTL structures when comparing stable and
progressive MCI patients (Misra et al., 2009).
2.3.2.2 Morphometry biomarkers
Similar approaches are based on voxel-based morphometry (VBM) (Ashburner and Friston, 2000;
Karas et al., 2004; Che´telat et al., 2005), DBM (Ashburner and Friston, 1999) or tensor-based
morphometry (TBM) (Hua et al., 2008; Koikkalainen et al., 2011) and often used to study group
differences. Here, images or derived information such as tissue segmentations are aligned to a
reference space in which statistical tests on tissue probability maps (VBM) or the respective trans-
formations (DBM, TBM) are performed. Significant group differences were shown in global GM
volume between HCs and patients with AD using VBM (Karas et al., 2004). Local atrophy in the
MTL structures was shown for MCI subjects. In Koikkalainen et al. (2011) the authors used multi-
template TBM to classify HC vs. AD subjects (86%), and sMCI vs. pMCI subjects (72%). In
Hua et al. (2008), TBM was used in a large study to confirm that brain atrophy in selected ROIs
correlates with and is predictive of clinical measurements. It was shown that brain atrophy in MCI
converters is higher than in those that do not convert. Teipel et al. (2007) analysed the deforma-
86
tion maps with respect to a template space using principal component analysis (PCA) and found
significant regional differences between patients with AD, MCIs and HCs.
2.3.2.3 Hippocampal biomarkers
Due to its early involvement in dementia, the focus of many published methods lies on the seg-
mentation of the hippocampus to quantify its volume or shape (Dickerson et al., 2001; Shen et al.,
2002; Barnes et al., 2008; Colliot et al., 2008; Chupin et al., 2009a,b; Lo¨tjo¨nen et al., 2010; Wolz
et al., 2010a; Coupe´ et al., 2011; Coupe´ et al., 2012b; Tong et al., 2013). Of further interest is
the assessment of the temporal change (e.g. hippocampal atrophy), which is discussed in Section
2.3.2.7.
In Dickerson et al. (2001) both hippocampus and entorhinal cortex were manually segmented.
The authors found significant group differences between hippocampal volumes for AD, MCI and
HC subjects. Further findings indicated that volumes of the entorhinal cortex have higher predictive
value to predict conversion from MCI to AD than hippocampal volumes. In Fennema-Notestine
et al. (2009) the authors analysed the whole brain using FreeSurfer and showed group differences
in hippocampal volume and cortical thickness for HCs and patients with AD. Chupin et al. (2009a)
employed an automatic method driven by both anatomical and probabilistic priors to segment the
hippocampus. Accuracies ranging from 76% to 80% were reported for AD vs. HC classification. In
Colliot et al. (2008), the authors classified patients with AD (N = 25) and HCs (N = 25) with 84%
accuracy, and HCs and MCI patients (N = 24) with 73% accuracy based on hippocampal volume.
Further, significant group differences in hippocampal volumes for AD, MCI and HC groups were
confirmed. Gerardin et al. (2009) calculated automatic hippocampus segmentations and derived
coefficients of spherical harmonics (SPHARM) as shape features. It was shown that shape features
can potentially improve classification results obtained using hippocampal volumetry only. The
authors separated AD patients and HCs with 88% accuracy on a small subset of the ADNI cohort
and compared their results to Klo¨ppel et al. (2008) (90%).
2.3.2.4 Cortical thickness biomarkers
Cho et al. (2012) transformed the cortical thickness data of a given subject, extracted using Free-
Surfer, into its spatial frequency components. On the same dataset as the one used in Cuingnet
et al. (2011) high classification accuracy for both AD vs. HC (sensitivity (SENS): 82%, specificity
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(SPEC): 93%) and sMCI vs. pMCI (SENS: 76%, SPEC: 63%) were reported. In Eskildsen et al.
(2013) thickness features were extracted from cortical ROIs that were identified as being discrimi-
native for the prediction of AD. The study showed that predicting the conversion from MCI to AD
becomes more challenging with increasing time to conversion.
2.3.2.5 Comparison and combination of several biomarkers
In Cuingnet et al. (2011) a variety of approaches based on tissue probability maps, cortical thickness
or hippocampal volumetry/shape were compared on an identical subset (N = 509) from the ADNI
cohort. High classification accuracies for the separation of patients with AD and HCs (SENS: 81%,
SPEC: 95%) were shown, with methods exploring the whole-brain outperforming those focused on
the hippocampus. Wolz et al. (2011) also investigated the potential of combining different types
of biomarkers derived from structural MRI (hippocampal volume, cortical thickness, TBM and
manifold-based learning) to increase classification accuracy. On 834 subjects from the ADNI cohort
the authors separated patients with probable AD from HCs with SENS: 93% / SPEC: 85% and
pMCIs from sMCIs with SENS: 67% / SPEC: 69%. The authors further provided classification
results on the same dataset that was used in Cuingnet et al. (2011), which were comparable.
2.3.2.6 Machine learning and patch-based biomarkers
Coupe´ et al. (2012b) presented an increased classification accuracy on the dataset used in Wolz
et al. (2011) by employing a patch-based grading approach (Coupe´ et al., 2012a) to estimate the
AD disease state. Recently Tong et al. (2014) proposed an innovative method based on multiple
instance learning (MIL) using extracted intensity patches as features. Very high classification ac-
curacies were presented on the same dataset that was used in Wolz et al. (2011) (AD/HC, SENS:
86% / SPEC: 93% and pMCI/sMCI, SENS: 69% / SPEC: 74%). In Guerrero et al. (2014), the au-
thors performed population modelling and classification using manifold coordinates learned from
automatically defined brain regions. On a dataset from ADNI, however, different to the one used
in Wolz et al. (2011), good visualisation properties and competitive classification results were pre-
sented (AD/HC, SENS: 86% / SPEC: 85% and pMCI/sMCI, SENS: 75% / SPEC: 67%).
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2.3.2.7 Longitudinal biomarkers
Many studies have shown that structural biomarkers such as volume or shape correlate with AD dis-
ease progression. However, intersubject variability can lead to substantial overlap with the healthy
population and thus limit the discriminative power of these features (Barnes et al., 2008). Ap-
proaches analysing the temporal change of the whole brain or individual structures aim to reduce
this variability by calculating subject specific atrophy rates, which are usually given in per cent
per year. The measurable GM atrophy is a consequence of a substantially accelerated, regionally
selective loss of neurons in patients with AD (Bondareff et al., 1989; West et al., 1994; Bobinski
et al., 1996; Wang et al., 2003).
Scahill et al. (2002) used fluid registration (Freeborough and Fox, 1998; Crum et al., 2001) to
analyse serial MRIs of patients with AD and HCs. The authors found both correlations of global
brain atrophy with disease progression and increased rates of hippocampal atrophy in patients with
AD (Scahill et al., 2002). Due to its early involvement in AD many studies focus on longitudinal
change of hippocampal volume or shape (Fox et al., 1996; Wang et al., 2003; Barnes et al., 2004,
2007; Wolz et al., 2010b; Leung et al., 2010a). In Wang et al. (2003) the authors used a deformation
based approach to confirm significant hippocampal shape and volume differences between clinical
groups of varying severity of dementia as measured by the Clinical Dementia Rating (CDR). Wolz
et al. (2010b) employed 4D segmentation based on GC to show the potential of hippocampal atrophy
rates calculated over 12 months or 24 months respectively to predict conversion from MCI to AD.
In Barnes et al. (2007, 2008); Leung et al. (2010a) the authors employed the boundary shift integral
(Freeborough and Fox, 1997) to measure hippocampal atrophy rates and showed good agreement
with manually obtained atrophy rates.
2.3.2.8 Classification of biomarkers
When performing classification using a number of features there are different established classifiers
for vector-valued features available. The most popular classifiers are SVMs (Cortes and Vapnik,
1995; Vemuri et al., 2008; Magnin et al., 2009; Falahati et al., 2014). Alternatives are random
forests (RFs) (Breiman, 2001; Gray et al., 2013) or linear discriminant analysis (LDA) (Wolz et al.,
2011). Wolz et al. (2011) observed higher classification accuracies using LDA instead of SVM.
However, Aguilar et al. (2013) and Falahati et al. (2014) conclude that most classifiers perform
similar given identical feature sets for classification.
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2.3.3 Limitations and challenges
Most of the published studies can only be compared qualitatively. In many cases different features,
different methodology to extract the features and different classification techniques are used (Fala-
hati et al., 2014). In addition, methods are applied to different cohorts or different subsets thereof.
A further limitation of most studies is the lack of histopathologically confirmed ground truth di-
agnoses, which can only be obtained with brain autopsy. This is why most studies fall back on
clinically obtained diagnoses that are potentially incorrect (Bron et al., 2015).
Recently, Bron et al. (2015) organised the Computer-Aided Diagnosis of Dementia (http://
caddementia.grand-challenge.org, last accessed 29 June 2015) (CADDementia) challenge
and provided an identical reference cohort on which classification approaches could be objectively
evaluated. Based on T1wMR scans, authors can submit classification results (HC, MCI, AD) while
being blinded to the clinically obtained ground truth. Of particular importance for routine use in
clinical practice is the interpretability of biomarkers (Falahati et al., 2014). Many recently devel-
oped methods heavily rely on machine learning techniques, e.g. learned manifolds (Wolz et al.,
2011; Guerrero et al., 2014) or MIL (Tong et al., 2014). Even though these methods are highly
accurate, their interpretation might be difficult and complicate their acceptance for clinical appli-
cation. Thus, it seems desirable to calculate features that are on the one hand easy to interpret
but on the other hand as informative as features obtained through sophisticated machine learning
techniques.
While many studies focus on the separation of patients with AD, pMCI, sMCI and HCs there
is a high need for an improved differential diagnosis of the various dementia types (Klo¨ppel et al.,
2012). This could support both patient specific treatment decisions but also the recruitment process
of clinical trials. It is known that a differential diagnosis of FTD and AD is possible based on
biomarkers derived from structural MRI (Klo¨ppel et al., 2008; Frisoni et al., 2010). In addition,
atrophy in MTL regions could be discriminative to separate LBD from other dementia types (Barber
et al., 1999). Furthermore, a better characterisation of the MCI stage seems desirable. There is
strong evidence that different anatomical brain structures are affected at different stages of the
disease (Dickerson et al., 2001).
However, there is consensus that methods or biomarkers based on individual MTL structures are
most likely not sufficiently informative to address the above-mentioned challenges (Frisoni et al.,
2010). One interesting avenue is to employ recently published, highly detailed and accurate brain
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atlases to form robust whole-brain segmentation methods. This would allow for the quantification
of easily interpretable biomarkers such as volumes, shapes, cortical thickness and atrophy rates.
Discriminative power could then be achieved by combining information from numerous structures
over the whole brain within a single classifier.
2.4 Biomarkers from structural MRI in TBI
2.4.1 Motivation and potential
Accurate quantitative assessment of the neuroanatomic changes occurring during and after TBI is
crucial to assist the understanding of TBI disease progression. There are several studies investigat-
ing microstructural changes based on DWI because of its particular sensitivity to disease-related
alterations in the WM tracts (Benson et al., 2007; Bendlin et al., 2008; Kinnunen et al., 2011).
ROI analyses in conjunction with DWI (Bendlin et al., 2008; Warner et al., 2010a) or PET imaging
(Ramlackhansingh et al., 2011) could enable a better understanding of the secondary processes that
cause ongoing brain atrophy in the chronic phase of TBI. It is becoming clear that the key to a better
understanding of TBI disease progression is the combination of imaging information obtained from
multiple modalities (Sharp and Ham, 2011; Irimia et al., 2012; Shenton et al., 2012). However, as
the focus of this thesis is the extraction of anatomical ROIs the following review will be restricted
to studies based on structural MR imaging.
It is well known that a reduction of total brain volume and cerebral atrophy are common sequelae
of TBI (Blatter et al., 1997; Bigler, 2001; Gale et al., 2005; Bendlin et al., 2008; Ding et al., 2008).
There is also increasing consensus that the volume of structural ROIs has the potential to support
the outcome prediction of TBI (Bigler, 2001; Warner et al., 2010b,a; Irimia et al., 2012). The early
identification of affected brain regions that are likely to degenerate due to the primary injury could
thus be key to an effective disease treatment (Irimia et al., 2012). Immediate and targeted treatment,
enabled and supported by neuroimaging, could improve the final outcome of the disease but also
reduce financial costs through shorter hospital stays (Irimia et al., 2011). In Bigler (2001) the
authors further pointed out that the volumetric measurement of subcortical structures might reveal
irregularities that would be difficult to catch by visual inspection only.
TBI is a very heterogeneous disease as it substantially depends on the type of injury (e.g. vehicle
accident, fall, assault), severity of injury (e.g. vehicle speed, fall height, assault weapon) and loca-
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tion of the impact. It is due to this heterogeneity that comparably large sample sizes are required to
show significant differences in research studies or treatment effects in clinical trials (Irimia et al.,
2012). Performing a quantitative analysis on potentially hundreds of patients based on manual ex-
pert measurements is, however, barely feasible due to both time and financial constraints. Methods
to automatically extract biomarkers from MR brain images are thus a critical building block to en-
able large-scale TBI studies (Irimia et al., 2012). Nevertheless, current research on robust methods
to automatically process MR images of injured brains is very limited (Irimia et al., 2011, 2012).
2.4.2 Literature overview
In the following an overview is given over studies that have investigated the potential of neuroimag-
ing in the context of TBI. Particular focus is put on measures derived from structural MR brain
images. A more detailed summary can be found in overview articles such as Bigler (2001), Irimia
et al. (2012) or Shenton et al. (2012).
2.4.2.1 Morphometry biomarkers
Substantial group differences in GM density between healthy control subjects and patients with
TBI were confirmed using VBM (Salmond et al., 2004; Gale et al., 2005). Salmond et al. (2004)
performed VBM to compare MR images from 22 patients acquired at least six months post injury
to a matched set of control subjects. In this study reduced GM density in thalamus, basal forebrain,
hippocampal formation and regions of the neocortex were identified (Salmond et al., 2004). The
authors explicitly mentioned the difficulty of reliably aligning the MR images to the template space
given potential pathology in the images. To increase robustness, only linear alignment was per-
formed (Salmond et al., 2004). In Gale et al. (2005), the authors employed VBM to compare the
GM density of nine patients with TBI (mild to severe injury) to age and gender matched controls.
Based on follow-up MR images acquired around one year after the injury, the authors found a sig-
nificant decrease in GM concentration in a multitude of brain regions. These regions included the
cerebellum, frontal and temporal cortices, but also subcortical structures (Gale et al., 2005). In Kim
et al. (2008) it is stated that the above-mentioned VBM studies might have limited sensitivity. As
limitations, inaccuracies when aligning the subjects to the reference template and performing the
tissue segmentation on brain images with substantial atrophy are mentioned. The authors suggested
to perform TBM instead and to employ an advanced registration technique (SyN, (Avants et al.,
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2008)) that allows the recovery of large deformations and the estimation of a population specific
template (Kim et al., 2008). Based on a study cohort of 29 patients with at least moderate TBI and
20 HCs, local reductions in WM and subcortical regions such as thalamus, corpus callosum and
caudate were shown in the TBI group.
2.4.2.2 Structural biomarkers
Most of the few existing studies that analysed structural morphometric measures (Strangman et al.,
2010; Warner et al., 2010a,b) were based on the segmentation techniques available in FreeSurfer
and have investigated small patient cohorts (Warner et al., 2010a,b). Warner et al. (2010a) analysed
the relation of axonal injury quantified from DTI with structural volumes in the chronic phase (8
months after injury) of a TBI. Structural volumes of hippocampus, amygdala and thalamus but
also of cortical ROIs were stronger correlated with white matter integrity at the chronic than at the
acute time point (Warner et al., 2010a). This suggests that white matter integrity can change due to
secondary processes far beyond the acute phase (Warner et al., 2010a). In Strangman et al. (2010),
50 patients that sustained TBI were enrolled in a memory rehabilitation program and their individual
progress recorded. The study investigated the predictive value of structural brain volumes with
respect to the outcome of the rehabilitation (Strangman et al., 2010). Ramlackhansingh et al. (2011)
used ROIs segmented from structural MRI and PET to demonstrate that inflammatory processes
remain active for months or years following a brain trauma.
Several studies (Strangman et al., 2010; Warner et al., 2010a,b; Ramlackhansingh et al., 2011)
have identified structures, including thalamus and hippocampus that are affected by TBI and are of
significant value when predicting clinical outcome.
2.4.2.3 Longitudinal biomarkers
Bendlin et al. (2008) performed a longitudinal analysis of 46 patients with TBI with respect to
36 matched HCs using VBM. DTI and T1w MRIs were acquired around two months post injury
and after 12.7 months respectively. The authors found that the vast majority of fibre bundles were
affected in TBI (Bendlin et al., 2008). Further, both structural integrity quantified from DTI and
WM/GM density calculated from T1w images declined while scores related to neuropsychologi-
cal function improved (Bendlin et al., 2008). In Sidaros et al. (2009) longitudinal changes in the
months following a severe TBI were investigated. In this study, 24 patients were compared to 14
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HCs. Specifically, Sidaros et al. (2009) performed TBM on the deformations required to align
the corresponding MR images taken at around eight weeks and 12 months post injury. The authors
found both an increased reduction in brain volume when compared to the HC group and regional in-
volvement of brainstem, thalamus, corpus callosum, putamen and cerebellum (Sidaros et al., 2009).
Regions that are known to be susceptible to DAI were particularly affected by late atrophy (Sidaros
et al., 2009). In Warner et al. (2010b) the authors analysed the correlation of structural brain atrophy
of 25 patients who had sustained a DAI with functional outcome. Several brain structures showed
significantly increased structural atrophy when compared to a control group of 22 age and gender-
matched controls eight months post injury (Warner et al., 2010b). Irimia et al. (2011) compared TBI
related changes assessed from images acquired with multiple MR sequences in three representative
patients. The authors used semi-automatic methods for brain tissue and lesion classification and
created 3D models of TBI pathology.
2.4.3 Limitations and challenges
Many of the conducted studies investigated group differences between patients with TBI and healthy
subjects (Salmond et al., 2004; Kim et al., 2008; Bendlin et al., 2008; Sidaros et al., 2009; Warner
et al., 2010b). However, given that TBI is a very heterogeneous disease, a more personalised anal-
ysis is desirable (Shenton et al., 2012). Comparing heterogeneous groups of patients with TBI to
HCs might be the reason that large sample sizes are necessary to find significant group differences
(Irimia et al., 2012). As discussed in Shenton et al. (2012), biomarkers quantified from anatomi-
cal ROIs could be compared to reference values from HCs in statistical tests to find brain regions
affected by the injury. Here, the segmentation of these ROIs is crucial as it allows the calculation
of structural volumes or atrophy but also derived measures from, for example, DWI. Using DWI,
microstructural changes can be measured based on ROI-specific statistics of FA or MD. Structural
ROIs could further enable a connectivity analysis based on fibre tracts calculated using tractography.
Based on these measurements, ideally extracted from multiple modalities, a patient-specific disease
profile could be created and a derived surrogate measure employed for group analyses (Shenton
et al., 2012). Measuring longitudinal change of the biomarkers is also hoped to enable a better un-
derstanding of the disease progression. For example, the causal relation of secondary degenerative
processes to the primary injury is of high interest (Irimia et al., 2012). Further, disease models could
be created that support the assessment of the disease progression, outcome prediction and especially
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quantification of treatment effects. It is hoped that disease dynamics can be better characterised to
improve the understanding of relevant criteria for favourable patient recovery (Shenton et al., 2012).
The automatic structural segmentation of MR brain images of patients with TBI remains, how-
ever, a difficult endeavour as most existing methods lack robustness towards TBI-related changes
in anatomy (Irimia et al., 2011, 2012). In the presence of gross pathologies such as hemorrhagic
lesions/oedema (in the acute phase) or substantial atrophy (in the chronic phase) most of the estab-
lished segmentation techniques yield unsatisfying results. While in AD brain changes are consistent
with disease progression, MR brain images of patients with TBI can show inconsistent and gross
pathological change. It is this high variability and extent of brain change following a moderate or
severe TBI that makes the segmentation task so demanding.
A more comprehensive discussion of current and potential future research directions is provided
in Irimia et al. (2012) or Shenton et al. (2012).
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3 Robust whole-brain segmentation:
Multi-Atlas Label Propagation using
Expectation-Maximisation (MALP-EM)
This chapter is based on:
C. Ledig, R. A. Heckemann, A. Hammers, J. C. Lopez, V. F. J. Newcombe, A. Makropoulos, J.
Lo¨tjo¨nen, D. Menon and D. Rueckert, “Robust whole-brain segmentation: application to traumatic
brain injury”, Medical Image Analysis, 21(1), pp. 40-58, 2015.
C. Ledig, R. Wolz, P. Aljabar, J. Lo¨tjo¨nen, R. A. Heckemann, A. Hammers, and D. Rueckert,
“Multi-class brain segmentation using atlas propagation and EM-based refinement”, IEEE Interna-
tional Symposium on Biomedical Imaging: From Nano to Macro (ISBI), pp. 896-899, 2012.
Abstract: Existing segmentation methods are of limited robustness when applied to MR brain
images with substantial pathological changes (cf. Section 2.4.3). In the following, this challenge
is addressed by proposing a framework for the robust and fully-automatic segmentation of MR
brain images called Multi-Atlas Label Propagation with Expectation-Maximisation based refine-
ment (MALP-EM). The presented approach is based on a robust registration approach (MAPER),
highly performant label fusion (JLF) and intensity-based segmentation refinement using EM. The
framework is devised to be applicable for the segmentation of brain images with gross changes
in anatomy. It is proposed to account for consistent registration errors by relaxing anatomical
priors obtained by multi-atlas label fusion and to employ a weighting scheme to locally combine
anatomical atlas priors and intensity-refined posterior probabilities. The method is evaluated on
a benchmark dataset used in a recent MICCAI segmentation challenge. In this context it is shown
that MALP-EM is competitive for the segmentation of MR brain images of healthy adults when
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compared to state-of-the-art automatic labelling techniques. To demonstrate the versatility of the
proposed approach, MALP-EM is employed to segment 125 MR brain images into 134 regions from
subjects who had sustained TBI. A specific protocol is employed to assess segmentation quality if
no manual reference labels are available. Based on this protocol, three independent, blinded raters
confirmed on 13 MR brain scans with pathology that MALP-EM is superior to established label
fusion techniques. The robustness of the proposed segmentation approach is visually confirmed on
the full cohort. It is investigated whether derived symmetry-based imaging biomarkers potentially
correlate with and predict clinically relevant variables in TBI such as the MCS or GOS. Specifi-
cally, it is shown that TBI patients with favourable outcomes can be stratified from non-favourable
outcomes with 64.7% accuracy using acute-phase MR images and 66.8% accuracy using follow-
up MR images. Furthermore, the calculated biomarkers allowed to differentiate subjects with the
presence of a mass lesion or midline shift from those with diffuse brain injury with 76.0% accuracy.
The thalamus, putamen, pallidum and hippocampus are particularly affected. Their involvement
predicts TBI disease progression.
The automatic segmentation of the brain into multiple distinct ROIs has great potential as it allows
the extraction of volumetric or atrophy biomarkers. Furthermore, anatomical ROIs are essential for
numerous analyses, such as the investigation of brain connectivity or the calculation of statistics
from DWI images.
In this chapter, a retrospective cohort of TBI patients is employed both to validate the proposed
framework and to present a proof of concept that disease relevant biomarkers can be automatically
extracted. The described method will then be used to analyse large AD and TBI cohorts in Chapter
5 and Chapter 6.
3.1 Introduction
The main motivation for the work described in this chapter was to devise a fully automatic and
robust segmentation method that allows accurate measurement of various brain structures in MR
brain images in the presence of severe pathologies. A subject with highly altered brain configu-
ration is shown with overlaid automatic segmentations in Figure 3.1 to illustrate the difficulty of
the segmentation task. Figure 3.1 shows that established registration techniques such as MAPER
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Figure 3.1: Example of segmentation results obtained on a subject with highly altered brain configu-
ration. Segmentations calculated with MAPER using majority voting (left, Heckemann
et al. (2010)) and SyN (Avants et al., 2008) from the Advanced Normalization Tools
(ANTs) package using either majority voting (middle) or the joint label fusion (right,
Wang et al. (2013b)). Red arrows: substantial oversegmentation of the hippocampus;
yellow arrows: inaccurate cortex segmentation due to gross brain deformation; blue ar-
rows: ventricles incorrectly labelled as background; white arrows: region of missing
tissue prohibits reasonable one-to-one mapping of the atlases.
(Heckemann et al., 2010) or SyN (Avants et al., 2008) struggle to establish a plausible mapping
between the available atlas images and an image of an injured brain. Both the presence of gross de-
formation and the potential absence of brain tissue prevent an accurate anatomical correspondence
estimation. Even the application of a leading label fusion technique (Wang et al., 2013b) is not able
to correct the substantial and consistent errors of alignment.
Thus there is a high need to address the key need in the management of TBI, that was identified
by Irimia et al. (2012): “[...] the key methodological hurdle that must be overcome in order to
make structural neuroimaging a powerful tool for predicting TBI outcome is the current paucity of
automated image processing methods that can allow researchers to analyse large numbers of TBI
CT/MRI volumes without the need for excessive user input or intervention.”
To enable the analysis of large TBI cohorts it is critical to improve on the limitations of exist-
ing automatic segmentation methods. A detailed overview over the relevant building blocks for
atlas-based brain segmentation was provided in Section 2.1. However, in the following a brief in-
troduction to the literature related to the work described in this chapter is provided.
Atlas propagation techniques rely on the accurate registration of the atlas and unsegmented MR
image to determine the spatial transformation of the atlas labels into the target space. This can
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be difficult if the target image differs from the available atlases due to the presence of pathology.
As described in more detail in Section 2.1.2 several methods were proposed to tackle this problem
(Angelini et al., 2007; Bauer et al., 2013). Most of these approaches rely either on a mask ex-
cluding the pathological regions (Brett et al., 2001; Stefanescu et al., 2004; Andersen et al., 2010)
or tumour growth models Bach Cuadra et al. (2004); Zacharaki et al. (2009); Niethammer et al.
(2011). Due to the substantial heterogeneity of TBI these approaches are of limited applicability.
The manual annotation of masks is prohibitive when large cohorts are to be analysed and tumour
growth models do not adequately describe the variety of TBI pathology such as contusions, haem-
orrhage or haematomas. In this chapter, the registration method MAPER was chosen that has been
shown to be highly performant when employed for segmentation of healthy subjects (Landman and
Warfield, 2012). While MAPER is robust in the context of AD related atrophy (Heckemann et al.,
2010) it does not explicitly account for pathology typical in TBI. Misregistration and correspond-
ing labelling errors are thus expected. In the presented approach these problems are addressed
subsequently, after the registration, by using label fusion techniques and exploiting image intensity
information.
A particularly successful strategy to fuse the propagated atlas labels into a consensus segmenta-
tion estimate is JLF, which was recently proposed by Wang et al. (2013b). In this state-of-the-art
approach, as evaluated in Landman andWarfield (2012), segmentation bias is reduced by estimating
joint segmentation errors of different atlas pairs (Wang et al., 2013b). Recently, methods based on
nonlocal patch-based label fusion have been suggested (Coupe´ et al., 2011; Rousseau et al., 2011)
that rely on affine alignment with a template library and thus relax the requirement for accurate
nonrigid registrations. Patch-based methods have been developed further, often with focus on a
particular application. For example Tong et al. (2013) used dictionary learning and sparse coding
for hippocampal segmentation in patients with AD. A detailed overview of atlas-based label fusion
methods is provided in Section 2.1.3 or also by Cabezas et al. (2011).
Atlas-based segmentation can be further improved by incorporating intensity information from
the unseen image through a Gaussian mixture model (GMM) (Van Leemput et al., 1999; Fischl
et al., 2002) (cf . Section 2.1.4). The resulting optimisation problem is often solved using EM
optimisation (Van Leemput et al., 1999; Lo¨tjo¨nen et al., 2010; Cardoso et al., 2011; Ledig et al.,
2012b; Cardoso et al., 2013b) or GC (van der Lijn et al., 2008; Wolz et al., 2010b). While the EM
approach enables simultaneous probabilistic segmentation of multiple brain structures, many graph-
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cut based methods yield binary labels for individual structures. Also approaches that propagate
atlas labels over a graph (Wolz et al., 2010a; Cardoso et al., 2012) or within clusters (Ribbens et al.,
2014) enjoy increasing attention in the community. In the context of brain tissue segmentation
it has been further shown that the relaxation of anatomical atlas priors can improve segmentation
quality (Cardoso et al., 2011, 2013b). Chupin et al. (2009b) automatically correct atlas registration
mismatches of the hippocampus. As an alternative or complement to either approach, Wang et al.
(2011a) proposed to use machine learning techniques to learn systematic segmentation errors that
are then corrected in a post-processing step.
Atlas-based approaches require a number of brain atlases that, in the ideal case, have been gen-
erated by expert manual delineation. In this work an atlas set is used that was the basis of a recent
whole-brain segmentation challenge (MICCAI 2012 Grand Challenge and Workshop on Multi-
Atlas Labeling, Landman and Warfield (2012)). Thus a direct comparison to the methods that were
evaluated in this competition can be provided. In general, other whole-brain atlases (cf . Section
2.2) are suitable for the proposed approach.
It is illustrated in Figure 3.1 that even state-of-the-art label fusion methods based on established
registration techniques can yield unsatisfying segmentation results when applied to MR brain im-
ages that show a substantial structural change. The objective of this work to improve on these
limitations is pursued on three levels. First, the best features of state-of-the-art atlas-based segmen-
tation tools are combined into a new framework, MALP-EM, by building on MAPER and adding
the benefits of JLF and an intensity-based refinement using EM. Second, this method is adapted
for the challenges posed by highly altered brain configurations. To achieve this, a prior relaxation
scheme is used in regions where accurate alignment of the images is impossible due to missing brain
tissue or severe deformation. The proposed approach does not influence or improve the performed
atlas to image registration, which can consistently fail in the presence of pathologies. Instead, it is
proposed to correct based on image intensities the anatomical atlas priors obtained by label fusion.
Further a data-driven and locally adaptive weighting scheme is employed to combine anatomical
atlas prior probabilities and intensity-refined posterior probabilities for maximum benefit. Third,
the modified MALP-EM algorithm is used to segment 125 MR brain scans of a heterogeneous
population of 101 subjects who had sustained TBI. Segmentation accuracy on this TBI cohort is
assessed based on a specific protocol that was independently followed by three blinded raters. The
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protocol enables an expert to rate hippocampus, thalamus, putamen and occipital pole segmentation
quality in the absence of manual reference segmentations. Eventually, biomarkers are derived that
are based on an index that quantifies asymmetry between structures appearing both in the left and
right brain hemisphere (absolute asymmetry index (Galaburda et al., 1987; Bonilha et al., 2013)
(AAI)). It is shown that single time point MR imaging based variables potentially correlate with
and predict outcome-relevant clinical variables.
3.2 Materials and methods
3.2.1 Materials
3.2.1.1 Traumatic brain injury cohort
T1-weighted MR brain images were obtained of 101 TBI patients and provided through the Uni-
versity Division of Anaesthesia, Cambridge University, UK. The images were acquired using an
MPRAGE sequence on a Siemens MAGNETOM TrioTim Syngo with parameters: TR 2300 ms,
TE 2.98 ms, TI 900 ms, flip angle 9°, matrix size 256⇥ 240⇥ 176 and an isotropic voxel size of 1.0
mm ⇥ 1.0 mm ⇥ 1.0 mm. Patients underwent MRI in the acute-phase, as part of the follow-up, or
both. As only 24 patients had MR scans at both time points, the focus of this chapter is on a cross-
sectional analysis. In total 125 datasets were available, including 61 acute and 64 follow-up MR
brain scans. Information about the patients’ gender and age distributions, the elapsed time between
scanning date and injury and the GCS is summarised in Table 3.1. The GCS is a clinical score that
quantifies a patient’s level of consciousness in the acute stage of the injury (Teasdale and Jennett,
1974). The datasets were further grouped by clinical scores using MCS and the GOS, as shown in
Table 3.2. MCS is a score based on the worst acute CT image within 24 hours of injury. MCS takes
into account brain pathology such as lesion load, the presence of oedema and midline shift caused
by the injury. In contrast, the GOS is a clinical measure categorising the outcome of TBI and is
assessed 6 months after injury or once the TBI outcome is considered stable. In Section 3.3.2.3
correlations of these clinical scores with asymmetry biomarkers derived from brain MR scans are
described. Details of the definition of MCS and GOS are provided in Appendix C and Appendix D.
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Table 3.1: Overview of the available MR images with patient gender, patient age, scan time relative
to injury, and GCS.
acute-phase MR image follow-up MR image
# of subjects 61 64
gender (# male / # female) 48/13 40/24
age (mean±standard deviation) 36.6±14.9 years 36.1±14.9 years
time since injury (mean±standard deviation) 3.7±4.2 days 10.0±7.2 months
GCS (median [min; max]) 5 [3;15] 7 [3;15]
Table 3.2: Clinical variables of the 61 acute-phase TBI images (MCS, GOS) and the 64 follow-up
MRIs (GOS). n/a: not available.
MCS n/a DI I (1) DI II (2) DI III (3) DI IV (4) EML (5) NEML (6)
# of subjects per group (acute-phase) 3 4 29 2 0 16 7
GOS n/a D (1) VS (2) SD (3) MD (4) GR (5)
# of subjects per group (acute-phase) 6 8 1 18 17 11
# of subjects per group (follow-up) 0 0 0 21 28 15
3.2.1.2 Atlases
The atlas cohort used in this study consisted of 35 manually annotated MR brain images of 30 sub-
jects of the OASIS database (Marcus et al., 2007). The manual segmentation into 138 anatomical
structures has been carried out by experts according to publicly available protocols1 and were pro-
vided by Neuromorphometrics, Inc. (http://Neuromorphometrics.com/, last accessed 29 June
2015) under academic subscription. The same atlas cohort was used in the recent “MICCAI 2012
Grand Challenge and Workshop on Multi-Atlas Labeling” (Landman and Warfield, 2012). As sug-
gested by Landman and Warfield (2012), the small regions (order of 100 voxels each) “vessel” and
“cerebral exterior” were excluded in the experiments in both the left and the right hemisphere, so
that effectively 134 structures are investigated. In five of the subjects, repeat scans were acquired in
a second session within 90 days of the original scan (Marcus et al., 2007).
The 134 atlas labels comprise 63 anatomical structures which have symmetric counterparts in
their opposite hemisphere, in total 126 labels (cf . Appendix B). The remaining eight unpaired struc-
tures are: 3rd ventricle, 4th ventricle, brain stem, CSF, optic chiasm, cerebellar vermal lobules I-V,
cerebellar vermal lobules VI-VII, cerebellar vermal lobules VIII-X.
The NMM atlas is described in more detail in Section 2.2.5.
1http://neuromorphometrics.org:8080/Seg/ and http://www.braincolor.org, last accessed: 8 December
2014.
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3.2.2 Multi-Atlas Label Propagation with Expectation-Maximisation based
refinement (MALP-EM)
3.2.2.1 Notation
To present the framework called Multi-Atlas Label Propagation with Expectation-Maximisation
based refinement (MALP-EM), the notation introduced in Section 2.1 is employed:
An unsegmented T1-weightedMR target image Itgt 2W is segmented intoK= 134 distinct structural
regions. The image is indexed as Itgt = {y1,y2, . . . ,yn} where yi 2R+, with i= 1, . . . ,n, denotes the
intensity value of the i-th voxel. To incorporate expert knowledge into the segmentation process,
M manually annotated brain atlases are employed which are denoted by Am with m= 1, . . . ,M. fm
denotes the calculated transformation from the atlas space ofAm in the coordinate system of Itgt and
Afm denotes the propagated atlas. A subject specific probabilistic segmentationP= {p1,p2, . . . ,pn}
is created employing multi-atlas label fusion. P is then relaxed based on image intensities toPR and
used as spatial prior in the EM framework. Using an EM approach, an intensity-refined probabilistic
segmentation of Itgt is estimated that is denoted by Z = {z1,z2, . . . ,zn}. Here pi, pRi and zi are
vectors of size K and the kth component represents the probability that a voxel i belongs to a region
k. Thus P denotes the subject specific probabilistic segmentation before intensity-based refinement
and Z after intensity-based refinement respectively. Furthermore, a normal distributionN (µk,sk) is
abbreviated withNk where µk is the mean and sk the standard deviation of the intensity distribution
within label k.
3.2.2.2 Registration and joint label fusion
For each unsegmented image Itgt, M transformations fm are obtained by registering M manually
generated atlases to the coordinate space of Itgt. In this study an enhanced registration approach
is employed that has been developed as part of MAPER. MAPER incorporates tissue probability
maps into a nonrigid registration scheme based on free form deformations (FFDs) (Rueckert et al.,
1999; Modat et al., 2010).
A probabilistic map pk of each anatomical structure k is then formed from the M transformed
atlases Afm using the JLF strategy presented by Wang et al. (2013b). The implementation of JLF is
employed that is publicly available at https://www.nitrc.org/projects/picsl_malf/ (Ver-
sion 1.2, last accessed: 8 December 2014) using standard parameters. JLF has been shown to be
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a leading label fusion technique (Landman and Warfield, 2012). This procedure is illustrated in
Figure 3.2.
Joint label fusion combined with the non-local patch-based concept ranks among the most accu-
rate approaches for label fusion (cf . Section 2.1.3.5). However, based on the parameter choice (e.g.
patch size, search-window size) and number of fused atlases (M) this procedure is computationally
expensive and requires several hours on a single core for a single subject. With the aim to make
the presented framework more applicable in practice, an alternative, computationally more efficient
fusion strategy is proposed in the following.
3.2.2.3 Locally Gaussian weighted label fusion
As alternative to JLF a LWF approach is presented. In contrast to Artaechevarria et al. (2009) where
the weighting of individual patches is determined using SSD it is proposed to employ a Gaussian
weighted sum of squared differences (GSSD) instead. In this approach the spatial distance of voxels
from the voxel of interest is taken into account when comparing neighbourhoods. Further, GSSD
can be calculated very efficiently with Gaussian convolution. For K structures and M propagated
atlases the probabilistic atlas at voxel i for label k is calculated as:
pik =
ÂMm=1wlm(i)d(LAm(i),k)
ÂKk0=1ÂMm=1wlm(i)d(LAm(i),k0)
(3.1)
With the difference image Dm between the image Itgt and atlas image IAm defined as Dm = (Itgt 
IAm)2, wlm(i) and d(·, ·) is given as:
wlm(i) = [Gs ?Dm] 1i , d(v,w) =
8>><>>:
1 if v= w
0 otherwise
(3.2)
Here Gs is a zero-centred Gaussian with parameter s and ? denotes the convolution.
However, the accuracy of locally weighted fusion strategies heavily relies on the assumption that
patches of the propagated atlas MR images IAm and unseen image Itgt are comparable using a certain
measure. The GSSD is obtained on the intensity normalised MR images. In this work the required
intensity normalisation is obtained by linearly rescaling the image intensities, similar to Nyul and
Udupa (1999). Specifically, the image intensities are rescaled to intensity values in the range of 0 to
255 where the rescaling factor is determined based on the robust minimum and maximum estimates
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Figure 3.2: Schematic process of the calculation of the subject specific spatial priors P for an un-
segmented target image Itgt. After brain extraction and bias correction, the available M
atlases are registered to the space of Itgt. Using these transformations, label maps and
corresponding T1-weighted MR images are mapped to the space of Itgt. The label maps
are then averaged into probabilistic priors for the individual structures using the joint
label fusion (Wang et al., 2013b). A subset of the 134 probabilistic labels is shown in
green.
of the image intensities (2% and 98% percentiles) (Smith, 2002). To further improve robustness and
avoid interference from high-intensity non brain voxels that might be present due to errors in the
brain extraction procedure, the robust estimates are calculated using an eroded version (5 iterations
of erosion by one voxel) of the brain extracted image.
3.2.2.4 Relaxation of probabilistic priors
Segmentation refinement based on image intensities relies heavily on the probabilistic priors P. As
a consequence, the segmentation at voxel i cannot be refined if all atlases agreed on a certain label k
(pik close to or equal to 1). In general, this is a sensible constraint assuming that at least a subset of
the propagated atlases votes for the correct label. When segmenting MR images showing significant
pathologies, however, there is evidence that this assumption is no longer justified. Especially in
regions that undergo large deformations, for example the inferior lateral ventricles when the target
region is enlarged due to injury, swelling or atrophy, unanimous bias in all individual segmentations
can be observed. Label fusion approaches can thus return substantial mislabelling of subcortical
grey matter structures such as the hippocampus, as well as of cortical regions. This problem is
illustrated in the top left image of Figure 3.3. The intensity-based EM-refinement is restricted by
these high prior label probabilities P and thus unable to entirely correct this systematic error.
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This problem can be tackled by calculating relaxed priors PR from the label probabilities P.
Specifically the probabilistic priors are relaxed based on the probabilistic label fusion estimates
and the actual image intensities. Assuming a Gaussian distribution, a common parameter set
(µCSF-like,sCSF-like) of eight “CSF-like” structures can be estimated. The set of structures denoted as
“CSF-like” is defined as {background (essentially external CSF), 3rd ventricle, 4th ventricle, CSF,
right/left inferior lateral ventricle, right/left lateral ventricle}. Furthermore, an individual parameter
set (µk,sk) is estimated for each structure k based on the probabilistic prior segmentation P:
µk =
Âipikyi
Âipik
, sk =
s
Âipik(yi µk)2
Âipik
(3.3)
In the actual relaxation step a fraction aik of the prior probability pik is redistributed from a
structure k to one of the eight CSF-like structures kCSF. At an image voxel i, kCSF is determined as
the CSF-like structure with the highest prior probability or set to background otherwise:
kCSF =
8>><>>:
arg max
k is CSF-like
pik if pik 6= 0 for at least one k 2 CSF-like
background else
(3.4)
Then aik is calculated based on the probability that the voxel with intensity yi comes either from
the intensity distribution N Pk estimated in label k or N PCSF-like accordingly. Specifically, a is set to:
aik =
8>><>>:
0 if N Pk (yi) N PCSF-like(yi)
max(0,min(0.5 pikCSF ,pik)) else
(3.5)
This means that it is not allowed for a CSF-like label to exceed 50% probability and only voxels
are corrected that have a higher probability of belonging to the CSF-like label kCSF, as defined in
Equation 3.4, than to k. Finally the relaxed prior probability PR is calculated as:
pRik =
8>><>>:
pik+Âl 6=kCSF ail if k = kCSF
pik aik else
(3.6)
The two images on the left in Figure 3.4 show where the voxel priors are relaxed by the proposed
method, both for a distinctly deformed brain and for a brain with a normal configuration.
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Figure 3.3: Schematic process of the segmentation refinement using prior relaxation, EM-
optimisation and spatially weighted combination of probabilistic label maps on the ex-
ample of the hippocampal region. If registration consistently fails joint label fusion
tends to label a significant number of voxels belonging to the inferior lateral ventricle
as hippocampus. These wrongly labelled low-intensity voxels lead to a high variance
of the estimated intensity distribution within the hippocampus label (top left). The red
interval (top left intensity distribution) indicates for which voxels prior relaxation will
be carried out. EM-refinement then allows correction of the mislabeled CSF voxels
leading to a sharper intensity distribution within the hippocampus (top right). The seg-
mentations obtained using label fusion and EM-optimisation are finally merged into a
consensus segmentation (bottom right). This combination is based on spatially vary-
ing weights that are calculated based on the overlap of intra-label intensity distributions
(bottom left).
The whole pipeline including registration, label fusion and prior relaxation is illustrated in Fig-
ure 3.2 and Figure 3.3.
3.2.2.5 Intensity-based label refinement through expectation-maximisation
The relaxed probabilistic priors PR are then refined based on the observed intensities of Itgt by
employing the widely used EM-optimisation presented by Van Leemput et al. (1999). For the sake
of readability and consistency with existing literature the notation is followed which was also used
in Van Leemput et al. (1999); Cardoso et al. (2011); Ledig et al. (2012b).
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Given the parameters F= {(µ1,s1),(µ2,s2), . . . ,(µK ,sK)} of K structural classes the likelihood
of observing, the log-transformed, intensity yi at voxel i is given as:
f (yi|F) =Â
k
f (yi|zi = ek,F) f (zi = ek) (3.7)
It is commonly assumed that the probability of a voxel i to have intensity yi, f (yi|zi = ek,F), given
that it belongs to class k, (zi = ek), is described by a normal distribution (Wells III et al., 1996;
Van Leemput et al., 1999; Zhang et al., 2001; Cardoso et al., 2011). Thus f (yi|zi) is modeled as
f (yi|zi = ek,F) = Nk(yi) where Nk denotes the Gaussian distribution with corresponding param-
eters (µk,sk). The prior probability f (zi = ek) that a voxel i belongs to structure k is given by
the relaxed version of the probabilistic label estimates after multi-atlas label propagation, PR (cf .
Section 3.2.2.4).
Smoothness of the final segmentation is enforced with a global and stationary MRF, which is in-
tegrated using the mean field approximation (Zhang, 1992), following the example of Van Leemput
et al. (1999) and Cardoso et al. (2011). This also allows the incorporation of topological knowledge
next to the spatial information provided by the prior estimates PR. The MRF is implemented by
expanding f (zi = ek) = pRik to
f (zi = ek|p(q)Si ,G) =
pRike
 UMRF (ek|p(q)Si ,G)
ÂKj=1pRi je
 UMRF (ej|p(q)Si ,G)
(3.8)
The MRF energy functionUMRF is calculated based on the probabilistic label estimates in iteration
q, p(q)ik , in the first-order neighbourhood of voxel i, Si, as:
UMRF(ek|p(q)Si ,G) = (3.9)
K
Â
j=1
Gk j(Â
l2S xi
sx p
(q)
l j + Â
l2S yi
syp
(q)
l j + Â
l2S zi
sz p
(q)
l j ) (3.10)
Here, G denotes a K⇥K matrix defining the connectivity between class k and j and s= { 1dx , 1dy , 1dz }
accounts for anisotropic voxel spacing in world coordinates. The connectivity matrix G is defined
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as:
G(k, j) =
8>>>>>><>>>>>>:
0, if k = j
b, if structures k and j share a boundary
g, if structures k and j are distant
(3.11)
Here b and g, with 0  b  g, are parameters describing the penalty for certain neighbourhood
configurations. By assuming that voxels are statistically independent, the probability of observing
an image Itgt, given that the parametersF are known, is given by f (Itgt|F)=’i f (yi|F). This model
can be solved by interleaving the expectation of the class probabilities p(q)ik and the maximisation of
the model by updating the model parameters F(q). It is assumed that the label probabilities p(q+1)ik
are known in iteration (q+1) so that the model parameters can be updated as:
µ(q+1)k =
Âi p
(q+1)
ik yi
Âi p
(q+1)
ik
, s(q+1)k =
vuutÂi p(q+1)ik (yi µ(q+1)k )2
Âi p
(q+1)
ik
(3.12)
Given the updated model parameters F the estimate of the class probabilities in the next iteration is
given as:
p(q+1)ik =
f (yi|zi = ek,F(q)) f (zi = ek|p(q)Si ,G)
ÂKj=1 f (yi|zi = ej,F(q)) f (zi = ej|p(q)Si ,G)
(3.13)
Usually the model converges after a few iterations. In this chapter ten iterations were performed
to better control the runtime of the algorithm. Furthermore, the parameters for describing the MRF
were set to b= 1.0 and g= 1.5.
In order to increase samples for small non-cortical brain structures and thus increase the ro-
bustness of the parameter estimate, symmetric brain structures (e.g. hippocampus left/right) are
modelled with a single Gaussian distribution. This also allows a more consistent segmentation and
thus subsequent volume comparison or symmetry inference. Furthermore, all voxels in cortical
brain structures are modelled with a single Gaussian distribution.
3.2.2.6 Weighting scheme for merging fusion-based and EM-based segmentations
Adjacent brain structures often have very similar intensity distributions, which makes an intensity-
based refinement of their shared boundary difficult. Examples are adjacent cortical brain regions or
the boundary between the hippocampus and the amygdala.
Furthermore, the presented intensity-based optimisation approach tends to calculate well-separated
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intensity distributions by reducing the intraclass variances (s2k) within labels. However, this often
degrades segmentation results as it does not necessarily reflect manual labelling protocols. For
example, the boundary between thalamus and adjacent white matter is determined by geometric
characteristics, rather than by intensity characteristics (Hammers et al., 2003). As the boundaries of
subcortical structures are not only defined by intensities, their intensity profile tends to have a wider
spread (larger sk). This has been observed for subcortical structures such as the thalamus, caudate
or putamen. For instance, the standard EM-optimisation is likely to relabel high intensity, ’thalamus
voxels’ in the vicinity of the thalamus/white matter boundary as ’white matter’. This results in a
reduced intraclass variance for the thalamus class and higher model likelihood. The segmentation
accuracy is reduced, however, as the estimated boundary does not represent the manual protocol of
the expert rater.
While intensity-based EM-refinement often provides little or no value for subcortical regions of
healthy brains, it is a powerful technique to correct consistent registration failures, e.g. in the hip-
pocampal region or in cortical regions. Here, the label estimate of a certain class k often contains
several types of brain tissue resulting in large intraclass variance. These intensity distributions can
effectively be optimised using the intensity-based refinement as described in Section 3.2.2.5.
In this work it is proposed to not rely exclusively on either label fusion or EM-refined fusion,
but to combine their probabilistic estimates into a common segmentation. Here, a simple global
formulation of the proposed model is described before introducing the spatially variant extension
in Section 3.2.2.7.
Depending on a global weighting factor G 2 [0;1] the spatial priors obtained by label fusion P
and the posteriors calculated based on intensity-based EM-optimisation Z are combined.
Specifically the final posterior probability zik is combined with the spatial prior pik to calculate a
new probabilistic estimate zmergedik as:
zmergedik = (1.0 G)zik+Gpik (3.14)
3.2.2.7 Locally varying weighting parameter G
A straightforward extension of this formulation is to model the weighting parameter G dependent on
the spatial position i. This allows a variable weight for the contribution of either registration-driven
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(multi-atlas label propagation) or intensity-driven (EM-refinement) label estimates in the final seg-
mentation. With the known characteristics of EM-refined results (cf . Section 3.2.2.6) in mind, the
aim is to formulate a model, which favours the geometry-driven and registration-based priors over
the intensity-based refinement if there are no indications of substantial registration failures. On the
other hand, the model must be flexible and consider the intensity-refined posterior probabilities if
it is assumed that the multi-atlas propagation failed. This is often observed if the subject of interest
shows severe structural changes of the brain due to disease related atrophy, traumatic deformation,
or surgical resection of brain tissue (cf . Figure 3.1).
The basic assumption for an automatic choice of G is that the EM-refined segmentation Z should
get a higher weight with increasing deviation from the segmentation obtained through label fusion
P.
Here, it is assumed that if a label has a similar intensity distribution before and after the intensity-
based refinement, the result obtained through the label fusion P is reliable for this label, and thus
Gi should be close to 1. In contrast, if for example the hippocampal label in P erroneously contains
ventricular CSF, the intensity distribution has a rather large standard deviation, because the label
contains two tissue types. However, after intensity-based refinement the intensity distribution of the
label in Z is rather sharp, because the mislabelling of CSF is corrected due to the intensity-based
refinement. In this case – two or more intensity distributions within a label based on P and Z – the
aim is to set Gi⌧ 1. This means that the more the EM-refined segmentation deviates from the prior
the more it contributes to the final segmentation estimate.
To model this behaviour, Gi is chosen dependent on the most likely labels assigned to a certain
voxel by the label fusion, kmax,i = arg max
k
pik, and the EM-refinement, zmax,i = arg max
k
zik. Specif-
ically, the overlap of the normal distributions is used which are estimated on label zmax,i in both Z
and P, and for kmax,i accordingly. Specifically, Gi is calculated as:
Gi =
Z +•
 •
min(N Pkmax,i(y),N
Z
kmax,i(y))dy
Z +•
 •
min(N Pzmax,i(y),N
Z
zmax,i(y))dy (3.15)
This weighting approach is exemplified in Figure 3.3. In this example, the common scenario is
shown, in which joint label fusion labels a voxel as hippocampus, and the intensity-based refine-
ment approach labels the same voxel as CSF. The two images on the right in Figure 3.4 illustrate ex-
emplary weights (1 Gi) for MR images of brains showing little and substantial structural changes.
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3.3 Experiments and results
The goal of this work was to devise a robust segmentation framework that can be employed to
segment brain MR images with potentially changed brain structure. Specifically the aim was to
segment a cohort of TBI patients and to extract biomarkers that can be correlated with clinical
variables.
However, before applying the proposed methodology to clinical data in Section 3.3.2 quantitative
experiments were conducted that investigate the method’s performance and characteristics on a
well-studied benchmark dataset. For this dataset reference labels, which were manually annotated
by experts, are available. This allows the calculation of label overlaps, the conduction of a test-retest
analysis and the comparison of the method to other state-of-the-art approaches in Section 3.3.1.
3.3.1 Quantitative evaluation on a benchmark dataset using manual labels
For evaluating MALP-EM, the dataset provided in the course of the “MICCAI 2012 Grand Chal-
lenge andWorkshop on Multi-Atlas Labeling” (Landman andWarfield, 2012) was used (cf . Section
2.2.5 and Section 3.2.1.2). The dataset consists of 35 T1-weighted MR images with corresponding
labels created manually by experts. As in the Grand Challenge, the cohort was divided into a
training set of 15 subjects (10 female, 5 male, age: 23±4.3 (mean±SD) years, minimum age 19,
maximum age 34) and a test set of 15 subjects (10 female, 5 male, age 45.7±24.4, minimum age 18,
maximum age 90). Including the 5 repeat scans, the test set consists of 20 images. These subsets
are also summarised in Table 2.3 in Section 2.2.5.
3.3.1.1 Label overlaps
In total seven different approaches were compared:
• MAPER: Standard MAPER with MVF as proposed by Heckemann et al. (2010);
• MALP-LWF (Multi-Atlas Label Propagation with LWF): Segmentations obtained through
locally weighted label fusion using GSSD as similarity measure (cf . Section 3.2.2.3) (Ar-
taechevarria et al., 2009; Ledig et al., 2012b).
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Figure 3.4: Illustration of the relaxation weights (left column) and the spatially varying combination
weights as 1 Gi (right column) for the two example subjects in Figure 3.8 (top row,
subject with pathological changes) and Figure 3.10 (bottom row, subject with a close-
to-normal brain configuration). It is noted that in cortical regions and regions where
the label fusion fails, both increased prior relaxation (white arrows) and combination
weights (red arrows) favouring EM-based segmentations are apparent.
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• MALP-JLF (Multi-Atlas Label Propagation with JLF): Segmentations obtained through joint
label fusion using the implementation of Wang et al. (2013b) with standard parameters2.
• MALP-EMLWFGi (Multi-Atlas Label Propagation with Expectation-Maximisation based refine-
ment): MALP-LWF followed by the proposed prior relaxation (Section 3.2.2.4), the EM-
refinement (Section 3.2.2.5) and the spatially varying merging strategy (Section 3.2.2.7);
• MALP-EMGi : MALP-JLF followed by the proposed prior relaxation (Section 3.2.2.4), the
EM-refinement (Section 3.2.2.5) and the spatially varying merging strategy (Section 3.2.2.7);
• MALP-EMGi-BC: MALP-EMGi with additional learning-based segmentation bias correction2
as proposed by Wang et al. (2011a). This is considered as the setup yielding the highest
accuracy on the benchmark dataset.
• PICSL-BC (PICSL research group - Bias Correction): best performing method in the Grand
Challenge (Landman and Warfield, 2012) using SyN registration from the ANTs software
with JLF (Wang et al., 2013b) and bias correction (Wang et al., 2011a).
As discussed in Section 2.1.3 and Section 3.2.2.2 the two configurations based on locally weighted
fusion, MALP-LWF and MALP-EMLWFGi , are expected to be outperformed by the approaches based
on JLF. However, as they are substantially more computationally efficient the aim is to investigate
whether they could be a viable alternative in practice. An overview over the compared methods is
provided in Table 3.3.
Table 3.3: Overview over all compared methods and their respective building blocks.
Method Registration Label Fusion Additional Processing
MAPER MAPER (cf . Sec. 3.2.2.2) (Heckemann et al., 2010) Majority Voting none
MALP-LWF MAPER LWF (cf . Sec. 3.2.2.3) none
MALP-JLF MAPER JLF (Wang et al., 2013b) none
MALP-EMLWFGi MAPER LWF proposed (cf . Sec. 3.2.2.4, 3.2.2.5, 3.2.2.6, 3.2.2.7)
MALP-EMGi MAPER JLF proposed (cf . Sec. 3.2.2.4, 3.2.2.5, 3.2.2.6, 3.2.2.7)
MALP-EMGi-BC MAPER JLF proposed + bias correction (Wang et al., 2011a)
PICSL-BC ANTs (SyN) (Avants et al., 2008) JLF bias correction
Each of the 20 test images was segmented into 134 regions. To evaluate the quality of the re-
spective segmentations, Dice overlaps (SIs, Dice (1945)) were calculated with the available manual
segmentations. SI values for the different segmentation methods are shown in Table 3.4. Individual
SI values of non-cortical structures are shown in Table 3.5.
2Implementation publicly available at https://www.nitrc.org/projects/picsl_malf/ (Version 1.2, last accessed:
8 December 2014).
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The results were also compared to the best performing method in the Grand Challenge (Land-
man and Warfield, 2012) called PICSL-BC. PICSL-BC employs the joint label fusion presented in
Wang et al. (2013b) and the learning-based wrapper method presented in Wang et al. (2011a) where
segmentation bias with respect to the gold-standard segmentations is learned. Moreover, PICSL-
BC has been evaluated on the same images (including the same split into training and test images)
using the same 134 regions. No significant differences (Student’s two-sided paired t-test, p > 0.01)
were found between the proposed flexible MALP-EMGi and PICSL-BC for the averaged similarity
indices over all classes. Applying additional segmentation bias correction (Wang et al., 2011a) to
MALP-EMGi significantly (p < 10 4) improved segmentation results. Since normal distribution
cannot be assumed for similarity indices, hypothesis testing was repeated using the non-parametric
Wilcoxon signed-rank test. All differences shown in Table 3.4 remained significant at least at p
< 10 2.
Furthermore, it was found that MALP-JLF performs significantly better than MALP-LWF. How-
ever, employing the proposed prior relaxation and intensity refinement the difference in accu-
racy is less pronounced. No significant differences could be found for subcortical structures be-
tween MALP-EMLWFGi and MALP-EMGi . Given the substantially reduced computation time (locally
weighted fusion (GSSD): ⇡ 15 minutes; joint label fusion: ⇡ 7 hours), LWF is a potential alter-
native in practice. In the following of this chapter the more accurate setup, MALP-EMGi based on
joint label fusion, will be investigated.
Table 3.4: Similarity indices (SI) in % averaged (unweighted) over 20 subjects for all 36 non-
cortical classes, all 98 cortical classes and all 134 classes. The methods that were
compared are MAPER using majority vote, MALP-LWF using locally weighted fusion,
MALP-JLF using joint label fusion, MALP-EMLWFGi /MALP-EMGi with a local merging
strategy and optional segmentation bias correction (BC), and PICSL-BC. *,** = signifi-
cantly (*: p< 10 2; **: p< 10 4) different to the method in the column to the left. bold
= significantly best results.
MAPER MALP-LWF MALP-JLF MALP-EMLWFGi MALP-EMGi MALP-EMGi-BC PICSL-BC
SI 36 subcort. 82.0 82.5⇤ 82.7⇤⇤ 82.9 82.9 83.4⇤ 83.8
SI 98 cort. 72.4 72.9⇤⇤ 73.2⇤⇤ 73.7⇤ 73.8⇤ 74.9⇤⇤ 73.9⇤
SI 134 classes 74.9 75.5⇤⇤ 75.8⇤⇤ 76.1⇤ 76.3⇤ 77.2⇤⇤ 76.5⇤
3.3.1.2 Evaluation of the influence of the weighting factor G
As illustrated in Figure 3.5, a weighting factor of G = 0.8 yields the best segmentation results on
the training dataset. This result shows that joint label fusion yields accurate labels for the majority
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Figure 3.5: MALP-EMG applied to the 15 training images with varying G. Here G = 1.0 is equiv-
alent to exclusive joint label fusion and i denotes the spatially varying choice of Gi.
Median similarity index with first and third quantiles of 36 non-cortical structures (left),
98 cortical structures (middle) and all 134 regions (right).
of voxels. For voxels with a high uncertainty (more than one label has a high non-zero probability)
the EM-refined result should be considered as additional weighting. Using the more flexible model
with a spatially varying Gi, comparable overlaps to G = 0.8 are observed. This is encouraging,
because a global and fixed G leads to a stricter model that is assumed to perform well on healthy,
normal data while only a data-driven choice of Gi allows the flexibility to cope with MR images of
potentially injured brains of TBI subjects.
3.3.1.3 Test-retest reliability
To investigate the consistency of segmentations calculated with the proposed method, its test-retest
reliability was assessed. This characteristic was quantified using the 5 subjects in the set for whom
repeat images are available. The intraclass correlation coefficient (ICC) (two-way random single
measures, absolute agreement) following Shrout and Fleiss (1979) was used. Specifically, the re-
producibility was assessed of label volumes calculated on images of the same subject at different
time points (scan interval less than 90 days). The assumption is that brains of healthy subjects do
not change substantially within short periods. ICC is widely used to quantify test-retest reliability
(Kempton et al., 2011; Nugent et al., 2013).
On the manual segmentations an average ICC of 0.80± 0.28 for non-cortical and 0.78± 0.25
for cortical regions was calculated. Using the proposed method MALP-EMGi an average ICC of
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0.97± 0.04 for non-cortical and 0.94± 0.08 for cortical regions was obtained. These results are
slightly better than the average ICC obtained using joint label fusion only (non-cortical: 0.96±0.06,
cortical: 0.94±0.09).
Furthermore, the relative volume difference (Dvol) between a structure’s volume at two time
points, Vt1 and Vt2 , was assessed. In this work the relative volume difference is defined as:
Dvol = 100%
|Vt1 Vt2 |
0.5(Vt1 +Vt2)
(3.16)
On the manual segmentations an average Dvol of 8.3± 7.5% for non-cortical and 12.3± 8.4% for
cortical regions was calculated. Using the proposed method MALP-EMGi an average Dvol of 2.4±
1.4% for non-cortical and 4.1± 2.3% for cortical regions was obtained. These results are similar
to the average Dvol obtained using joint label fusion only (non-cortical: 2.7±2.5%, cortical: 3.8±
2.2%). More extensive quantitative results can be found in Table 3.5.
Table 3.5: SIs in % averaged over 20 test images. ICC (two-way random single measures, absolute
agreement, Shrout and Fleiss (1979)) and relative volume differences (Dvol) based on 5
subjects with available repeat scans for all 36 considered non-cortical structures. Signifi-
cantly different SI compared to column to the left indicated at p< 10 2 (⇤) and p< 10 4
(⇤⇤).
similarity index (SI) intraclass correlation (ICC) / relative volume difference (Dvol)
MAPER MALP-JLF MALP-EMGi MALP-EMGi BC Manual MALP-JLF MALP-EMGi
3rd ventricle 85.2 85.6 79.8⇤⇤ 85.8⇤⇤ 0.855 / 17.8±11.4% 0.994 / 3.6±2.4% 0.978 / 5.9±3.3%
4th ventricle 86.7 87.3⇤ 87.1 87.1 0.991 / 3.0±2.3% 0.999 / 1.5±0.7% 0.998 / 1.6±1.6%
accumbens area R 77.9 78.4 76.7 78.0 0.673 / 13.8±10.5% 0.961 / 3.6±2.6% 0.984 / 2.0±2.6%
accumbens area L 77.3 77.3 77.6 78.7 0.755 / 11.2±10.3% 0.728 / 7.1±6.9% 0.867 / 5.9±2.4%
amygdala R 80.2 80.6 79.4 81.4⇤ 0.605 / 10.9±14.0% 0.893 / 3.6±2.6% 0.929 / 3.7±1.7%
amygdala L 81.3 81.9 81.7 83.1⇤ 0.897 / 6.0±4.1% 0.925 / 4.4±3.2% 0.982 / 2.5±2.1%
brain stem 93.7 93.8⇤ 93.7 94.0⇤⇤ 0.957 / 3.5±1.8% 0.993 / 1.1±0.7% 0.993 / 1.2±0.7%
caudate R 87.0 87.5 86.8 87.9⇤ 0.955 / 3.1±1.8% 0.992 / 1.2±1.0% 0.991 / 1.4±0.9%
caudate L 87.0 87.8⇤ 87.4 88.0 0.956 / 3.4±2.4% 0.998 / 0.6±0.3% 0.996 / 0.8±0.5%
cerebellum exterior R 92.5 92.9⇤⇤ 93.4⇤⇤ 93.5 0.985 / 2.1±1.4% 0.993 / 1.2±1.7% 0.995 / 1.2±1.4%
cerebellum exterior L 92.1 92.6⇤⇤ 93.1⇤ 93.2 0.978 / 2.2±2.2% 0.989 / 1.6±1.9% 0.988 / 2.0±1.5%
cerebellum white matter R 88.9 89.1 90.5⇤⇤ 89.9 0.978 / 3.8±2.6% 0.992 / 1.4±1.7% 0.995 / 1.3±1.0%
cerebellum white matter L 89.0 89.2⇤ 90.6⇤⇤ 90.2 0.884 / 5.3±5.3% 0.972 / 2.1±2.1% 0.975 / 2.2±1.7%
cerebral white matter R 93.3 93.3 93.7⇤ 94.0 0.952 / 3.1±1.8% 0.992 / 1.1±1.2% 0.993 / 1.0±1.0%
cerebral white matter L 93.2 93.2 93.6⇤ 93.9 0.969 / 2.2±1.9% 0.995 / 0.9±0.9% 0.996 / 0.8±0.8%
cerebrospinal fluid 77.7 79.8 77.3⇤ 81.0⇤⇤ 0.794 / 11.6±9.9% 0.859 / 4.7±3.9% 0.824 / 4.0±6.1%
hippocampus R 85.1 86.3⇤ 86.4 86.8 0.815 / 8.4±7.3% 0.997 / 0.9±0.5% 0.991 / 1.5±1.0%
hippocampus L 85.2 86.5⇤⇤ 86.3 86.9⇤ 0.870 / 7.6±7.6% 0.996 / 1.0±0.5% 0.996 / 0.9±1.1%
inf lat ventricle R 55.6 63.2⇤⇤ 68.8⇤⇤ 70.9 0.794 / 20.4±8.6% 0.993 / 4.4±3.3% 0.992 / 3.8±2.8%
inf lat ventricle L 55.5 62.2⇤⇤ 67.1⇤⇤ 67.2 0.983 / 12.9±7.6% 0.991 / 5.9±4.7% 0.996 / 4.1±3.8%
lateral ventricle R 91.9 92.5⇤ 93.0 93.0 0.999 / 9.4±8.3% 1.000 / 2.6±1.6% 1.000 / 3.1±2.1%
lateral ventricle L 92.3 93.0⇤ 93.5 93.3 0.999 / 9.1±7.0% 1.000 / 2.8±1.6% 1.000 / 2.4±1.7%
pallidum R 86.6 87.5⇤⇤ 87.6 87.6 0.468 / 8.8±1.4% 0.948 / 2.4±1.4% 0.937 / 2.8±1.7%
pallidum L 85.1 86.7⇤⇤ 86.6 86.7 0.640 / 4.7±3.3% 0.917 / 2.2±1.7% 0.914 / 2.1±2.4%
putamen R 91.0 91.3 91.1 90.8 0.961 / 2.9±1.5% 0.995 / 1.0±0.6% 0.990 / 1.4±1.0%
putamen L 90.8 91.1 91.1 91.0 0.978 / 2.0±1.8% 0.980 / 1.4±1.8% 0.972 / 1.6±2.2%
thalamus proper R 91.7 92.1⇤ 91.4⇤ 92.0⇤⇤ 0.950 / 2.4±1.6% 0.990 / 1.0±0.9% 0.985 / 1.4±0.9%
thalamus proper L 91.9 92.1 91.5⇤ 91.9⇤ 0.876 / 3.5±3.0% 0.988 / 0.9±0.9% 0.978 / 1.4±1.0%
ventral DC R 88.6 88.8 ⇤ 88.1⇤⇤ 88.9⇤⇤ 0.835 / 4.6±2.9% 0.996 / 1.0±0.3% 0.988 / 1.8±0.8%
ventral DC L 88.7 88.7 88.1⇤ 88.9⇤ 0.862 / 4.8±2.8% 0.994 / 1.0±0.7% 0.985 / 1.6±1.4%
optic chiasm 52.0 49.1 53.9 43.5 -0.355 / 40.5±38.4% 0.801 / 14.4±10.3% 0.947 / 5.9±3.5%
cerebellar vermal lobules I-V 81.9 82.3 82.7 83.2 0.470 / 11.5±11.1% 0.993 / 2.3±1.3% 0.990 / 2.6±1.8%
cerebellar vermal lobules VI-VII 77.0 77.8 78.1 79.7⇤⇤ 0.867 / 4.9±2.2% 0.902 / 3.1±1.9% 0.859 / 3.5±2.8%
cerebellar vermal lobules VIII-X 87.0 87.5 87.6 87.7 0.962 / 5.0±3.8% 0.995 / 1.6±1.1% 0.998 / 1.2±0.8%
basal forebrain R 43.9 44.5 44.6 47.2 0.722 / 12.2±6.9% 0.880 / 3.7±2.8% 0.945 / 2.1±2.0%
basal forebrain L 45.4 45.0 45.0 46.8 0.040 / 18.8±7.5% 0.926 / 3.8±3.4% 0.887 / 3.5±1.8%
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3.3.2 Segmentation and analysis of a TBI cohort
MALP-EMGi (in the following referred to as MALP-EM) was used to automatically segment 125
MR brain scans of TBI subjects with potential pathology. This cohort is described in Section 3.2.1.1.
For the segmentation all available atlas datasets were used, except the 5 repeat images, i.e., a total
of 30 (cf . dataset ATLAS in Table 2.3 in Chapter 2).
All MR images were corrected for intensity inhomogeneities using the N4 algorithm (Tustison
et al., 2010). The images were further brain extracted with a fully-automatic in-house brain extrac-
tion method called Extended Tissue Classification. In this method, first, an EM classifier based on
Van Leemput et al. (1999) was applied for producing a coarse tissue segmentation, which is used as
an initial brain mask. Thereafter, a deformable model-based approach combined with morphologi-
cal operations was applied to tune the mask.
3.3.2.1 Quantitative evaluation on TBI datasets using expert validation scores
A specific scoring protocol was devised by J. C. Lopez (JCL), R. A. Heckemann (RAH) and A.
Hammers (AH) to semi-quantitatively assess the quality of automatically generated segmentations
of TBI images. The protocol was developed for four paired regions that frequently showmorpholog-
ical change in patients with TBI (hippocampus, thalamus, putamen, and occipital pole). Thalamus,
putamen and occipital cortices were selected because these structures are frequently implicated in
TBI and its sequelae (Warner et al., 2010a; Strangman et al., 2010; Ramlackhansingh et al., 2011).
The hippocampus was added because it is a challenging structure to segment (cf . Figure 3.1). Con-
sideration of the hippocampus is biologically justified, as it is typically involved in dementia, which
in turn is a frequent long-term consequence of severe TBI. The protocol calls for the raters to assign
a score on a six point scale (0, worst to 5, best). Three experienced raters (JCL, 1 year of clinical
service; RAH, 12 years of clinical service; AH, 16 years of clinical service) developed the protocol
by consensus, using 9 images with corresponding segmentations calculated with both MALP-EM
and joint label fusion (MALP-JLF). All raters had basic (JCL) or advanced (RAH, AH) training in
neuroanatomy, neuropathology, radiology, and neuroimaging. The 9 images had been selected from
the TBI cohort using an ad-hoc approach that ensured that the sample was broadly representative
(MCS 2-6; 4 baseline and 5 follow-up scans). The detailed protocol is published as supplementary
material to Ledig et al. (2015).
118
Table 3.6: Mean (standard deviation (SD)) of the expert scores for the assessed segmentation qual-
ity of hippocampus, thalamus, putamen and occipital pole. Significant improvement is
indicated (*: p < 0.05; **: p < 10 4). ICC (two-way random single measures, absolute
agreement) between all available raters.
hippocampus thalamus putamen occipital pole
MALP-JLF MALP-EMGi MALP-JLF MALP-EMGi MALP-JLF MALP-EMGi MALP-JLF MALP-EMGi
rater A 2.81(1.30) 3.23(1.48) 2.42(1.27) 3.12(1.63)* 2.81(2.25) 3.04(2.20) 3.42(1.39) 3.81(1.58)*
rater B 3.00(1.13) 3.23(1.03) 2.88(1.07) 3.62(1.20)** 3.81(1.30) 3.96(1.37) 2.58(0.90) 3.08(0.93)*
rater C 2.04(0.96) 2.65(0.89)* 2.00(0.69) 3.08(1.02)** 2.85(1.19) 3.19(1.27)* - -
all raters 2.62(1.20) 3.04(1.18)** 2.44(1.09) 3.27(1.32)** 3.15(1.69) 3.40(1.69)* 3.00(1.24) 3.44(1.33)*
ICC 0.64 0.53 0.67 0.23
Based on this protocol the three independent raters assessed 13 images using the tool rview from
the Image Registration Toolkit (https://github.com/BioMedIA/IRTK, last accessed: 8 Decem-
ber 2014) (IRTK). All raters were blind to the method (MALP-JLF or MALP-EM). Results of both
methods were presented in a balanced, randomised fashion. The raters viewed both methods’ re-
sults of each subject back to back in order to break the tie if the two scores were equal. None of
the raters was directly involved in the development of MALP-EM. The set of test scans did not in-
tersect with the set of scans used for protocol development. Ten scans were randomly chosen with
the constraint that five scans be of subjects with MCS < 4 and five with MCS   4. In addition, a
non-rater chose three further subjects to ensure scans with severe pathology were represented in the
evaluation set. Structures in the left and right brain hemisphere were rated separately.
The findings obtained through this expert validation confirm that MALP-EM is superior to JLF
in the segmentation of brain images of TBI patients with severe pathology. The average expert
scores are shown in Table 3.6. The distribution of the scores for the individual structures is shown
in Figure 3.6. Further, Figure 3.7 shows the fraction of test images on which a method performs
better than the other.
To further assess interrater variance the ICC (two-way random single measures, absolute agree-
ment) between the available raters was calculated. The calculated ICCs are summarised in Table
3.6. Moderate interrater agreement was observed between all three raters for hippocampus, thala-
mus and putamen. The interrater agreement for the occipital pole, which was rated by two raters of
rather different experience, is at a lower level. However, both raters agreed that MALP-EM yields
significantly improved results on this structure.
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Figure 3.6: Distribution of expert scores for investigated structures. Note that structures in the
left/right brain hemisphere were rated separately. This results in 78 ratings per struc-
ture (3 raters ⇥ 13 subjects ⇥ 2 hemispheres). Occipital pole was not rated by rater C.
Comparison of MALP-JLF (left bars) and MALP-EM (right bars).
Figure 3.7: Fraction of test images on which a method performs better than the other3. Raters B and
C were asked to rate which segmentation was better, even if scores were tied.
3Fractions might not exactly add up to 100% due to rounding effects.
3.3.2.2 Qualitative confirmation of the robustness using MALP-EM on images with
pathology
Segmentation quality was considered sufficient if no major parts of the brain were missing due to a
overly restrictive brain extraction, and the cortical grey matter/white matter and visually dominant
non-cortical boundaries (e.g. ventricles/grey matter) were matched by label boundaries. Inclusion
or exclusion of structures that are not present in the atlases (e.g. lesions or contusions) was not
regarded as failure. In a small subset (⇡ 5  10%) of the processed images, local inaccuracies in
the shape of brain extractions were accepted in the cortical region, e.g. Figure 3.8, if most cortical
and especially subcortical structures were segmented reasonable, considering the pathology.
Five segmentations of insufficient quality were identified after visual inspection. One failure
originated in misregistration due to significant intensity inhomogeneities that remained after the
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Figure 3.8: Segmentations obtained with MALP-JLF (top) and MALP-EM (bottom) of a subject
with a markedly changed brain configuration on MRI (male, age: 45 years, GOS = 3,
follow-up MRI, taken one month after injury, axial(left)/coronal(right) view). While
the label fusion clearly fails to match various intensity boundaries, for example in the
hippocampal region, MALP-EM is able to correct this problem to a large extent due to
the strong intensity contrast of CSF and grey matter structures. Red arrows highlight
improvements obtained using MALP-EM over pure joint label fusion. White arrows
highlight errors due to inconsistent brain extraction.
N4 bias correction. On this single subject the bias correction was reapplied using the generated
brain mask to further reduce inhomogeneities. Registration and segmentation were subsequently
successful; therefore the image was retained. For another three subjects the generated brain mask
was of insufficient quality. One of the corresponding scans was acquired from a subject with a
follow-up image for which the brain extraction was fine. Thus the brain mask of the follow-up
time point was used to extract the brain at the acute stage. The subsequent segmentation result was
satisfactory. The remaining two subjects (cf . Figure 3.9), which showed a substantially changed
brain structure and the MR images had very poor quality, could not be processed. A single image
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Figure 3.9: Axial slices of the two subjects for which the brain extraction was not successful. left:
male, age: 56, GOS = 3, MCS = 5, follow-up MR image taken two months after injury,
right: male, age: 16, GOS = 3, MCS = 5, follow-up MR image taken seven months after
injury.
was excluded due to consistency problems in the NIfTI format file after image conversion. In
conclusion, none of these failures were directly related to MALP-EM. Overall 122 out of 125
available scans could be processed successfully.
On visual inspection, all segmentations of these 122 images were considered reasonable, allowing
for pathology. Visual examples of calculated segmentation results are shown in Figure 3.8. The
image pair illustrates the advantages of MALP-EM over sole label fusion in images with substantial
pathology. Figure 3.8 also clearly reveals improved segmentation results obtained with MALP-
EM at boundaries of anatomical regions with large intensity contrast. Improvements in both the
hippocampal region and at the cortical grey matter/cerebrospinal fluid boundary are particularly
striking.
Labels obtained with MALP-EM on images with little pathology (cf . Figure 3.10) are visually
convincing for both non-cortical and cortical structures in most instances. When substantial pathol-
ogy is present (Figure 3.8), some inaccuracies were observed. A frequent problem is unlabelled
cortical grey matter due to imperfections of the brain mask. Voxels excluded during brain extrac-
tion are not reconsidered during the segmentation process. A subject for which this problem is most
striking is illustrated in Figure 3.8. However, this subject was kept for the analysis since even in
subjects with significant pathology only a few cortical and no subcortical structures are affected
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Figure 3.10: Typical segmentation result obtained using MALP-EMGi of a subject with a close-to-
normal brain configuration in axial(left)/coronal(right) view (female, age: 17 years,
GOS = 5, MCS = 2, follow-up MRI, taken nine months after injury).
by this problem. In regions showing severe deformations or atrophy, such as the hippocampal re-
gion in the subject shown in Figure 3.8, the nonrigid atlas alignment may consistently fail. Due to
the proposed prior relaxation step and spatially varying label combination it was possible to relax
this problem and improve upon non-intensity based approaches. It can be concluded from visual
comparison that MALP-EM is superior to standard label fusion.
3.3.2.3 Separation of GOS and MCS groups using absolute asymmetry indices
To assess the clinical usefulness of the presented method, the available TBI subjects were clinically
classified based on morphometric results. The classification of the brain images performed by an
experienced clinician was employed as a gold-standard reference. Correlations with two clinical
variables were assessed. First, correlations with a widely used clinical scheme primarily devised
for categorising admission X-ray CT images, applied to acute-phase MR images (MCS) and sec-
ond, one of the most common clinical outcome scores used in TBI (GOS). The focus was on the
particularly relevant differentiation between patients who would not be able to live an independent
life (GOS< 4) and those with a more favourable outcome. The comparison with the GOS provided
a means of estimating the prognostic value of automatically segmented acute-phase MR images.
For the MCS, images were additionally dichotomised into those without (MCS < 4 =ˆ DI I, DI II
and DI III) or with (MCS   4 =ˆ DI IV, EML, NEML) significant mass effect and midline shift.
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Table 3.7: Classification results in % obtained separating MCS < 4 vs. MCS   4 and GOS <
4 vs. GOS   4 based on absolute asymmetry indices of either acute-phase (MCS and
GOS) or follow-up (GOS) MR images only. Results shown are averaged over 1000 cross
validation runs. bold = best.
based on acute-phase MR images based on follow-up MR images
MCS < 4 (Negatives) vs. MCS   4 (Positives) GOS < 4 (P) vs. GOS   4 (N) GOS < 4 (P) vs. GOS   4 (N)
subcort. cortical all subcort. cortical all subcort. cortical all
balanced accuracy 60.8 76.0 72.5 64.7 61.5 61.8 66.8 59.3 62.6
sensitivity 39.6 60.9 56.7 45.4 44.4 44.4 47.4 42.5 42.1
specificity 82.0 91.2 88.2 84.0 81.8 78.5 86.3 76.0 83.1
subjects per group 34 vs. 23 27 vs. 28 19 vs. 43
MALP-EM was employed for individual and independent cross-sectional experiments at the acute
stage (60 subjects) and at the follow-up stage (62 subjects).
As classifier a LDA implemented through the MATLAB function classify was used. For vali-
dation, 1000 repetitions of a 10-fold cross validation were performed. As feature structural asym-
metry was quantified of the paired 63 structures (cf . Section 3.2.1.2 and Appendix B). The AAI was
employed based on a structure’s volume (V) in the left and right hemisphere, which is defined as:
AAI= 100%
|Vleft Vright|
0.5(Vleft+Vright)
(3.17)
Specifically, the sum of the absolute asymmetry indices of either all 14 non-cortical structures, all
49 cortical structures or all 63 structures was used.
The results for distinguishing two MCS (MCS < 4, MCS   4) and GOS (GOS < 4, GOS  
4) groups respectively, using either acute-phase or follow-up images, are summarised in Table 3.7.
Since the clinical variables MCS and GOS were missing for 3 (MCS), respectively 5 (GOS) sub-
jects, the number of subjects was reduced in each classification experiment accordingly. As groups
were unbalanced the balanced accuracy (Brodersen et al., 2010) (bACC) measure, the average of
sensitivity and specificity, was employed to report classification accuracy. Table 3.7 shows that the
presented method yields 76% accuracy in distinguishing groups of MCS categories based on acute-
phase images. The Marshall classification system is not a linear scale as it takes both midline shift
and the size of lesions into account (cf . Appendix C). However, in the classification experiment it
was possible to discriminate between classes without (MCS < 4) and with (MCS   4) significant
midline shift or mass effect.
Furthermore, it could be estimated from a single acute-phase MRI whether a TBI patient will be
able to live an independent life (GOS   4) or not with 64.7% accuracy. In comparison, when pre-
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Figure 3.11: Receiver operating characteristic (ROC) curves for classifying subjects according to
MCS using the sum of cortical AAI (left), and according to GOS at baseline (middle)
and follow-up time point (right) using the accumulated non-cortical AAI.
dicting outcome based on the MCS score at baseline 59.3% accuracy was calculated. Based on the
segmentations of non-cortical structures in the follow-up images, 66.8% accuracy was achieved in
GOS classification. The classification results are summarised in Table 3.7. The high specificity for
MCS classification shows that the presented method does very well in detecting normal appearing
brains at the acute stage. The high specificity for GOS classification confirms that the presented ap-
proach is able to predict a favourable outcome of a TBI. These findings suggest that structural brain
asymmetry could be a sufficient criterion to indicate an unfavourable disease outcome. On the other
hand, symmetry seems to be a necessary criterion for favourable disease outcome. It is not, how-
ever, a sufficient criterion to rule out an unfavourable outcome. Receiver operating characteristic
(ROC) curves for these classification experiments are shown in Figure 3.11.
A detailed summary of results for individual non-cortical structures for both MCS and GOS clas-
sification is provided in Table 3.8, Table 3.9 and Table 3.10, including p-values for group separation.
These results suggest structural asymmetry of non-cortical brain structures does not correlate well
with MCS.
P-values were calculated for group separation using MALP-JLF without the proposed process-
ing. Unlike MALP-EM, this setup did not reveal any significant symmetry differences between
GOS groups for the thalamus (at the acute time point) or for the caudate, hippocampus and inferior
lateral ventricle (at the follow-up time point). All the structures that show significant symmetry
differences between groups of clinical variables in the MALP-JLF setup were also found in the
MALP-EM setup.
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Table 3.8: Classification results in % (10-fold cross-validation, 1000 runs) obtained separatingMCS
< 4 vs. MCS   4 based on AAIs of acute-phase MR images. Significant group differ-
ences indicated by + (p < 0.05) and ++ (p < 0.01).
Classification of MCS < 4 (Negatives) vs. MCS   4 (Positives) (acute scans)
structure bACC SENS SPEC mean AAI (SD) for MCS < 4 and MCS   4 p-value significance
all non-cortical 60.8 39.6 82.0 175.9 (88.4) 308.9 (231.1) 3.50e-03 ++
all cortical 76.0 60.9 91.2 759.3 (151.6) 1072.2 (354.8) 2.74e-05 ++
all 72.5 56.7 88.2 935.3 (200.4) 1381.1 (556.7) 7.25e-05 ++
accumbens area 62.8 45.8 79.9 16.4 (13.6) 32.7 (35.8) 1.90e-02 +
amygdala 50.6 23.7 77.5 15.2 (16.0) 24.7 (44.2) 2.55e-01 o
caudate 50.6 31.2 69.9 6.9 (7.0) 12.2 (17.8) 1.18e-01 o
cerebellum exterior 66.0 52.6 79.3 4.2 (4.2) 8.7 (7.1) 3.67e-03 ++
cerebellum white matter 49.9 39.3 60.4 10.9 (8.4) 15.3 (13.5) 1.37e-01 o
cerebral white matter 48.4 35.1 61.8 2.7 (1.7) 4.6 (7.0) 1.22e-01 o
hippocampus 37.0 8.5 65.6 8.5 (7.0) 12.3 (26.5) 4.21e-01 o
inf lat ventricle 68.5 55.5 81.4 24.0 (19.1) 51.9 (43.7) 1.74e-03 ++
lateral ventricle 55.5 36.4 74.6 24.9 (18.7) 47.4 (48.7) 1.78e-02 +
pallidum 59.6 28.1 91.1 9.5 (15.3) 22.0 (31.7) 5.26e-02 o
putamen 57.2 36.2 78.2 11.9 (22.0) 16.3 (23.1) 4.63e-01 o
thalamus 55.0 30.7 79.4 5.6 (8.5) 10.3 (14.5) 1.22e-01 o
ventral DC 38.6 38.0 39.1 8.3 (7.8) 8.2 (5.5) 9.88e-01 o
forebrain 54.9 34.8 75.1 27.1 (24.6) 42.2 (50.3) 1.37e-01 o
Table 3.9: Classification results in % (10-fold cross-validation, 1000 runs) obtained separating GOS
< 4 vs. GOS   4 based on AAIs of acute-phase MR images. Significant group differ-
ences indicated by + (p < 0.05) and ++ (p < 0.01).
Classification of GOS < 4 (Positives) vs. GOS   4 (Negatives) (acute scans)
structure bACC SENS SPEC mean AAI (SD) for GOS < 4 and GOS   4 p-value significance
all non-cortical 64.7 45.4 84.0 272.8 (213.8) 183.2 (121.4) 6.02e-02 o
all cortical 63.1 44.4 81.8 954.2 (372.6) 821.7 (198.6) 1.04e-01 o
all 61.5 44.4 78.5 1227.0 (556.6) 1004.8 (290.4) 6.77e-02 o
accumbens area 59.7 44.0 75.4 29.7 (33.9) 15.0 (11.0) 3.36e-02 +
amygdala 58.9 33.5 84.3 25.4 (41.4) 13.4 (14.8) 1.56e-01 o
caudate 54.7 37.6 71.9 9.9 (13.3) 7.9 (12.4) 5.64e-01 o
cerebellum exterior 60.0 73.4 46.5 5.2 (5.1) 7.7 (6.6) 1.27e-01 o
cerebellum white matter 43.9 36.0 51.9 13.6 (12.6) 12.8 (9.6) 7.78e-01 o
cerebral white matter 47.2 35.1 59.3 3.8 (6.3) 3.1 (2.5) 5.51e-01 o
hippocampus 51.0 26.3 75.7 12.6 (23.6) 7.8 (9.4) 3.20e-01 o
inf lat ventricle 42.6 34.3 50.8 35.0 (34.8) 33.1 (33.9) 8.34e-01 o
lateral ventricle 56.4 39.8 72.9 39.1 (40.6) 24.3 (30.1) 1.28e-01 o
pallidum 57.8 26.1 89.5 21.4 (29.8) 8.7 (15.5) 5.21e-02 o
putamen 60.5 39.1 82.0 18.6 (28.3) 9.8 (14.6) 1.48e-01 o
thalamus 58.2 34.2 82.1 10.8 (15.1) 4.6 (5.5) 4.61e-02 +
ventral DC 37.4 39.5 35.2 8.4 (5.3) 8.4 (8.4) 9.99e-01 o
forebrain 52.1 33.3 70.9 39.0 (48.6) 26.6 (24.5) 2.36e-01 o
In an additional set of 1000 rounds of the 10-fold cross-validation, the p-value for the group
separation on the training set was determined in each run using an unpaired two-sided Student’s
t-test for each of the 63 symmetry features (AAI). A histogram of the 10 most significant structures
in each run was calculated. Figure 3.12 shows the histogram for the GOS separation and thus the
regions that are particularly correlated with the disease outcome. The plots show the 10 consistently
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Table 3.10: Classification results in % (10-fold cross-validation, 1000 runs) obtained separating
GOS < 4 vs. GOS   4 based on AAIs of follow-up MR images. Significant group
differences indicated by + (p < 0.05) and ++ (p < 0.01).
Classification of GOS < 4 (Positives) vs. GOS   4 (Negatives) (follow-up scans)
structure bACC SENS SPEC mean AAI (SD) for GOS < 4 and GOS   4 p-value significance
all non-cortical 66.8 47.4 86.3 340.0 (219.8) 187.5 (101.1) 3.84e-04 ++
all cortical 59.3 42.5 76.0 950.9 (357.7) 792.2 (166.8) 1.97e-02 +
all 62.6 42.1 83.1 1290.9 (522.9) 979.6 (227.2) 1.70e-03 ++
accumbens area 64.8 36.9 92.8 54.4 (58.6) 25.2 (40.4) 2.66e-02 +
amygdala 57.2 40.1 74.3 20.5 (19.4) 12.3 (15.0) 7.54e-02 o
caudate 55.7 42.1 69.2 12.9 (13.9) 7.5 (6.9) 4.54e-02 +
cerebellum exterior 57.2 43.8 70.6 6.7 (4.4) 4.5 (4.9) 1.07e-01 o
cerebellum white matter 59.9 54.1 65.7 10.2 (7.4) 6.7 (4.6) 2.62e-02 +
cerebral white matter 51.7 23.8 79.7 7.7 (15.3) 4.9 (9.3) 3.75e-01 o
hippocampus 57.8 38.3 77.4 16.4 (16.1) 8.4 (6.9) 7.84e-03 ++
inf lat ventricle 57.4 46.8 67.9 61.7 (48.1) 38.2 (25.1) 1.42e-02 +
lateral ventricle 64.4 47.4 81.4 33.5 (31.1) 14.9 (10.3) 8.10e-04 ++
pallidum 57.4 42.1 72.7 22.9 (23.1) 11.6 (11.5) 1.20e-02 +
putamen 59.8 31.9 87.7 32.2 (51.2) 8.0 (10.2) 4.06e-03 ++
thalamus 59.0 33.1 85.0 24.2 (24.1) 10.8 (16.4) 1.33e-02 +
ventral DC 36.7 32.5 40.9 8.0 (4.2) 7.9 (5.0) 9.25e-01 o
forebrain 47.8 42.4 53.1 28.7 (24.9) 26.5 (21.3) 7.25e-01 o
most relevant structures for GOS group separation using acute-phase (left) or follow-up (right) MR
images. This experiment reveals that asymmetry in subcortical structures is particularly correlated
with poor patient recovery. Notably, asymmetry in the thalamus, pallidum, hippocampus, putamen
and occipital pole was found to discriminate TBI patients with favourable from non-favourable
outcome. Both thalamus and hippocampus are known to be involved in TBI disease progression
(Bigler, 2001) and were found to have predictive value in previous studies based on MR imaging
(Strangman et al., 2010; Warner et al., 2010b,a; Irimia et al., 2012). The presented results also
confirm the findings of Ramlackhansingh et al. (2011), where inflammation markers following a
head trauma were significantly raised in the thalamus, putamen and occipital cortices.
3.4 Discussion and future work
In this work a framework called Multi-Atlas Label Propagation with Expectation-Maximisation
based refinement (MALP-EM) was introduced for robust segmentation of MR brain images. Build-
ing on state-of-the-art registration and label fusion techniques, it was proposed to relax spatial
priors obtained through multi-atlas label propagation and to combine segmentation results obtained
with registration- and intensity-based approaches to exploit individual benefits. For prior relaxation
incorrect label priors were detected at low intensity voxels or cisterns and the corresponding proba-
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Figure 3.12: Relevance of individual brain structures for GOS group separation. Sorted histogram
of how often a structure’s absolute asymmetry index (AAI) was one of the 10 most
significant indices in the 10000 (1000 rounds of 10-fold cross-validation) runs. The 10
structures that were picked most often based on acute-phase (left) or follow-up (right)
MR images.
bilities redistributed to the most probable CSF-like structure. Here it was assumed that low intensity
voxels belong to cisterns that are filled with CSF. Potentially these low intensity voxels could also,
especially in TBI patients, result from oedema, haemorrhage, or direct injury. The described re-
laxation approach is in theory applicable to the redistribution of prior probabilities between other
structure pairs. However, here it was only described and implemented for the correction of misla-
belled CSF-like structures. The intensity profile of CSF is particularly distinct from other GM or
WM regions and thus redistribution less ambiguous.
The employed atlas is built from healthy patients and the described model does not allow for the
detection of outliers or the classification of lesions, which is very challenging (Rao et al., 2014).
Dependent on the disease, segmentation failures due to pathologies, such as contusions in TBI,
could be addressed by an explicit lesion segmentation (Rao et al., 2014) or an outlier detection
approach (Asman et al., 2013b). This is, however, left for future work. In general, imaging features
derived from automatic segmentations, such as structural volumes, need to be interpreted carefully,
when pathologies are present.
It was shown that MALP-EM significantly improves segmentation quality compared to non-
intensity refined label fusion. Specifically, it was observed that significant improvements can be
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obtained by combining results from joint label fusion and EM-refined fusion using a locally varying
weighting factor G. This approach is similar to the weighting of different energy terms in the
formulation presented by van der Lijn et al. (2008). The formulation described in this chapter allows
any combination of segmentation results calculated with independent models or unrelated labelling
techniques. In the future it will be interesting to investigate how more sophisticated combination
strategies and intensity models can further improve this approach.
Previously, the objective evaluation procedure of the “MICCAI Multi-Atlas-Segmentation Chal-
lenge 2012” (Landman and Warfield, 2012) has shown MALP-EM to be among the leading seg-
mentation methods. While the implementation of MALP-EM which was used in the challenge was
preliminary and highly tuned, the implementation used for the work in this chapter is more generic
and less dependent on parameter settings. Thanks to an improved registration and more sophisti-
cated and general fusion strategy, significantly higher overlaps could be achieved for both MAPER
(overall SI: 74.9% vs. 74.1%) and MALP-EM (overall SI: 76.4% vs. 75.8%) than in the Grand
Challenge. Additional application of a learning-based segmentation bias correction method (Wang
et al., 2011a) further improves the segmentation results (overall SI: 77.2%), yielding small but sig-
nificant improvements over the best method (PICSL-BC; overall SI: 76.5%) in the Grand Challenge.
It must be acknowledged that the development of MALP-EM benefitted from prior experience from
participating in the Grand Challenge, where the timeframe for algorithm development and tuning
was tight. However, the testing set from the Grand Challenge was not used to tune MALP-EM.
While the segmentation bias correction significantly improves label overlaps on the MICCAI
Segmentation Challenge dataset, this post processing technique was not employed to segment the
TBI subjects. The reasoning is that it is difficult to justify the application of a correction classifier
that was trained exclusively on a homogeneous cohort of healthy subjects to a heterogeneous cohort
of brain scans with severe pathology.
To evaluate MALP-EM on a TBI cohort, a specifically developed protocol was employed for the
expert assessment of segmentation quality of the hippocampus, thalamus, putamen and occipital
pole. The protocol is publicly available as supplementary material to Ledig et al. (2015). Using the
protocol-based ratings of three independent experts, it was shown on 13 subjects of the TBI cohort
that the proposed modifications based on image intensities improve on pure label fusion.
The proposed method is shown to be robust: 120 out of 125 TBI images were segmented success-
fully into 134 regions. After manual intervention on the preprocessing step, the successful record
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increased to 122/125. This is a solid basis for future research into image-based quantification of
MR brain images acquired from patients with head injury. Derived morphometric biomarkers, such
as a structural asymmetry index, can serve as features for automatic classifiers, predicting how the
image will be rated by an expert (MCS) and prognosticating clinical outcome (GOS). Given that
MCS is assessed at the acute stage quantifying brain pathology it seems reasonable that structural
asymmetry in acute MRIs correlates well with this score. In contrast to this, GOS is an outcome
score assessed several months after the injury. It was expected that MRI features derived from
follow-up scans are more consistent with the outcome measure than features available at the acute
stage. The segmentation setup for the TBI subjects inherently differs from the intra-atlas experi-
ments (15 training, 20 test images) in that more atlases were used for the segmentation of the TBI
subjects, the image source (scanner) differs from the atlas database, and, most importantly, sub-
jects with potentially substantial pathology are to be segmented. Visual inspection confirmed the
robustness and advantages of the proposed method under these new challenges (cf . Figure 3.8).
The generated segmentations of the TBI dataset are a valuable resource for investigating further
potential biomarkers for TBI disease progression.
The work presented in this chapter also motivates further research and discussion about how
meaningful or generalisable high Dice overlaps on a homogeneous cohort of healthy patients are.
More informative similarity measures are desirable (cf . Chapter 7). In many studies, e.g. Alzheimer’s
disease or TBI, the subjects of interest show high variability in both brain appearance and disease
burden. More restrictive models might lead to a high labelling accuracy on subjects that are very
similar to the atlas cohort. However, they are potentially too rigid to cope with images of subjects
with significant pathology. Here more flexible formulations might be desirable, even if they are
slightly less performant in intra-atlas cohort validations.
To conclude from the conducted experiments, MALP-EM yields a segmentation accuracy that is
on healthy subjects comparable to other state-of-the-art methods while offering sufficient flexibility
to cope with gross pathology. Most inaccuracies, as visually confirmed in the segmented TBI
datasets, were due to minor problems in the brain extraction. This highlights the necessity of further
improvement of fully automatic brain extraction tools, which is a very challenging task for brains
in the presence of pathology.
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3.5 Conclusion
In this chapter a fully automatic, robust and accurate segmentation framework called MALP-EM
was presented. This includes a new paradigm: The spatially weighted combination of probabilistic
segmentation results obtained through different techniques into a common segmentation exploit-
ing individual benefits. Extensive quantitative evaluation on a manually annotated atlas cohort of
healthy subjects confirmed that MALP-EM significantly improves on existing label fusion tech-
niques. Based on the ratings of three independent experts, MALP-EM is superior to joint label
fusion for hippocampus, thalamus, putamen and occipital pole segmentation on TBI brain scans.
The benefits regarding robustness through intensity based refinement were demonstrated on 125
MR brain images of TBI subjects. Using MALP-EM 122 out of 125 available TBI brain images
were segmented into 134 different anatomical regions. Correlations between asymmetry indices of
paired structures and clinical variables were observed, using acute-phase or follow-up MR images.
Furthermore, evidence was found that subcortical brain structures such as the thalamus, putamen
and hippocampus have strong potential to predict the clinical outcome of individual TBI patients.
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4 Longitudinal analysis of MR brain images
In the previous chapter a robust approach called MALP-EM for the segmentation of individual brain
MR images was introduced. The aim in this chapter is to extend this approach for the simultaneous
segmentation of time series of MR brain images. This is particularly valuable in longitudinal stud-
ies where automatically quantified structural atrophy rates are essential to monitor and examine a
subject’s progression over the course of a disease.
In the context of dementia several methods have been published that place particular focus on the
measurement of hippocampal atrophy, a hallmark of AD. With this in mind the performance of two
popular approaches, the Boundary Shift Integral (BSI) (Leung et al., 2010b) and four-dimensional
(4D) GC (Wolz et al., 2010b), is calculated as reference on a subset of 309 subjects from the ADNI
cohort. In the first part of this chapter, Section 4.1, potential extensions to the BSI are presented
that exploit the availability of probabilistic hippocampus segmentations. However, this method is,
like many other established techniques, limited to measure atrophy within a single structure only. In
Section 4.2 this limitation is addressed. Specifically, a 4D extension of the framework introduced in
Chapter 3 is proposed that is called Multi-Atlas Label Propagation with Expectation-Maximisation
based refinement in 4D (MALP-EM4D). This extension allows the consistent and symmetric es-
timation of atrophy rates for a large number of structures of the whole brain simultaneously. The
method is quantitatively assessed by measuring atrophy of the hippocampus, the ventricles and
the whole brain while comparing to state-of-the-art BSI based approaches (Freeborough and Fox,
1997; Leung et al., 2010b). Further, the effects of differential bias correction (DBC) and different
intrasubject registration approaches are investigated within the framework.
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4.1 PBSI: A probabilistic extension of the Boundary Shift Integral
This section is based on:
C. Ledig, R. Wolz, P. Aljabar, J. Lo¨tjo¨nen and D. Rueckert, “PBSI: A symmetric probabilistic
extension of the Boundary Shift Integral”, MICCAI Workshop on Novel Imaging Biomarkers for
Alzheimer’s Disease and Related Disorders (NIBAD), pp. 125-132, 2012.
Abstract: The BSI is a widely used technique to measure brain or hippocampal atrophy in
dementia. In this section the BSI method is extended through the use of probabilistic posteriors ob-
tained through a 4D EM segmentation framework. A complete framework is presented that refines
spatial probabilistic priors for a baseline and a follow-up MR image simultaneously and incor-
porates this spatial information in a probabilistic Boundary Shift Integral (PBSI) measure. The
method exploits the probabilistic information to calculate an accurate ROI on which the PBSI mea-
sure is evaluated. To ensure a consistent estimate, a symmetric strategy is followed by transforming
baseline and follow-up images to a common, intermediate coordinate system. Furthermore, the
aligned intensity images are corrected for any potential differential bias field. The resulting atro-
phy measure is used to compute group separation between cognitive normal subjects, patients with
MCI and patients with AD. The approach is compared to state-of-the-art methods using 309 sub-
jects from the ADNI cohort. The focus is on a prediction of the conversion from MCI to AD, which
is technically challenging but clinically very useful. The presented atrophy rates are consistent with
those in the literature and allow good classification accuracy for separating stable and progressive
MCI patient groups.
4.1.1 Introduction
Hippocampal volume loss has been shown to be a good marker for the presence of AD (Jack Jr.
et al., 1997; Barnes et al., 2007; Leung et al., 2010a). Decline in hippocampal volume is also pre-
dictive at the stage of MCI (Leung et al., 2010a). Accurate atrophy measurements based on MR
images could thus assist the diagnosis of AD before a conventional clinical diagnosis is established.
Furthermore it could support the assessment of the potential of disease-modifying therapies (Le-
ung et al., 2012). Manual labeling of the hippocampal region is time consuming (Leung et al.,
2010a) and leads to intra- and interrater variability. This motivates the need for accurate and au-
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tomatic methods. For example, in Chupin et al. (2009a) the scans of single time points were non-
rigidly aligned with a probabilistic atlas which was then employed to segment the hippocampus.
To quantify hippocampal atrophy automatically in longitudinal studies based on structural MR im-
ages several techniques have been proposed: These techniques are either based on the automatic
segmentation of the hippocampal area, using for example GC (Wolz et al., 2010b), or on methods
based on intensity differences of aligned images such as the BSI (Barnes et al., 2007; Leung et al.,
2010a, 2012) (cf . Section 2.3.2.7).
In this work a model is presented that exploits advantages of both segmentation- and registration-
based approaches, by incorporating subject-specific probabilistic spatial information into the origi-
nal BSI formulation (Freeborough and Fox, 1997). The method relies on probability maps that are
enhanced with a 4D EM algorithm (Van Leemput et al., 1999). This approach refines prior informa-
tion based on the intensities of the images. Registration bias towards either of the two time points
is avoided by following a symmetric registration strategy (Yushkevich et al., 2010; Leung et al.,
2012) and the application of differential bias field correction (Lewis and Fox, 2004). The proposed
method is evaluated on a subset of the ADNI-1 cohort by comparing classification accuracies, at-
rophy rates and samples sizes to two established methods based on GC (Wolz et al., 2010b) or the
BSI (Leung et al., 2010a).
4.1.2 Method
4.1.2.1 Notation and prerequisites
In the following a pair of T1w MR images is considered, It and It+1, of the same subject acquired
at two different time points, t and t+1. Let the n voxels in an MR image be indexed by i= 1, . . . ,n.
Denoting the intensity at a voxel as yi 2 R+ an image can be defined as It = {y1,y2, . . . ,yn}. For
a given image I the corresponding probabilistic segmentation is given as Sprob = {z1,z2, . . . ,zn},
where zi is a vector of size K and the kth component represents the probability that a voxel be-
longs to a structural class k. Since hippocampal atrophy is characteristic for AD, the focus in this
section is on the segmentation of the hippocampus. The component of Sprob that is representing
the hippocampus label is abbreviated, for a certain time point and thus for an image It , as pt . The
rigid transformation from the coordinate system of It to that of It+1 is denoted as RIt ,It+1 . RIt+1,It is
defined accordingly. Parameters are denoted as lower case Greek letters and sets with W.
It is assumed that individual brain masks are available for all baseline images It and that subject-
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specific probabilistic priors ptprior for the hippocampal region in the baseline scan exist. These priors
can be calculated with, for example, multi-atlas propagation techniques such as LEAP (Wolz et al.,
2010a) or MALP-EM (cf . Chapter 3). Subsequent time points It+1 can be brain extracted using
a rigid transformation RIt ,It+1 of the baseline masks. While this is not symmetric it substantially
reduces the computational cost and the need for quality control associated with the calculation of
brain masks. Further it ensures that the outline of the brain images from distinct time points is
consistent. All brain extracted images are intensity normalised (Nyul and Udupa, 1999; Smith,
2002), since the BSI is defined on intensity differences on normalised images (Freeborough and
Fox, 1997).
4.1.2.2 Symmetrising the process
In order to process both time points simultaneously each pair of baseline and follow-up images is
rigidly transformed to their common intermediate space. This is important to reduce bias introduced
by asymmetric interpolation (Yushkevich et al., 2010) or by randomly defining one of the coordinate
systems of It or It+1 as reference coordinate system (Leung et al., 2012). The process is carried out
using the rigid transformation RavgIt ,It+1 obtained by averaging the transformations RIt ,It+1 and R
 1
It+1,It
as described in Leung et al. (2012). Probabilistic spatial hippocampus priors, which are required
for each baseline scan, are then also mapped to this common space. Note that alternatively an affine
registration approach could be chosen. The effect of using affine registration instead will not be
investigated here, but is further explored in Section 4.2.
4.1.2.3 Posteriors through 4D-EM optimisation
The challenge is to estimate the underlying but unknown probabilistic segmentations Stprob,St+1prob
by means of the observed intensities yti , y
t+1
i and the available subject-specific probabilistic priors
ptprior and p
t+1
prior. A common assumption (Van Leemput et al., 1999; Ledig et al., 2015) is that the
observed log-transformed intensities of voxels that belong to a certain class k are normally dis-
tributed with mean µk and standard deviation sk. The overall parameters for this intensity model
are thus F = {(µ1,s1),(µ2,s2), . . . ,(µK ,sK)}. By assuming the same parameters F for both time
points, both images are modelled and segmented simultaneously in a 4D EM framework. Smooth-
ness within the segmentations is enforced with a global and stationary MRF (Van Leemput et al.,
1999).
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The model thus consists of one Gaussian intensity distribution (µ1,s1), that models the intensity
distribution within the hippocampus at both time points, and K  1 Gaussian distributions mod-
elling the intensities in the background. Since different tissue types, including cerebrospinal fluid,
white matter and non-hippocampal grey matter, are expected within the neighbourhood of the hip-
pocampus, the parameter defining the number of tissues was set to K = 4. In the following, the
background is thus modelled with three distinct intensity distributions. Prior spatial information is
incorporated via a thresholded version of the available subject-specific probabilistic segmentation
of the hippocampus, where the same baseline prior is used for both time points. This yields:
ptprior(i) = p
t+1
prior(i) =
8>><>>:
a, if ptprior(i)> a
ptprior(i), else
(4.1)
Thresholding the priors at a slightly relaxes the priors, which is important to allow non-hippocampal
voxels in the follow-up image to change their label. A mask on which the 4D EM refinement is car-
ried out, can be obtained by dilating a region defined by the spatial priors ptprior and p
t+1
prior.
4.1.2.4 Probabilistic Boundary Shift Integral
The volume change Dv between a structure in the follow-up scan It+1 and the corresponding struc-
ture in the baseline scan It is calculated based on a modified version of the BSI, which was proposed
by Freeborough and Fox (1997). To incorporate the spatial information provided by the probabilistic
segmentations Stprob,St+1prob into the measure, the PBSI is proposed. A novel spatially dependent
weighting function g(i) ⌘ g(Stprob,St+1prob, i) is introduced that can be defined to adapt the model
to the application. The PBSI is calculated on a ROI W covering the boundary of the hippocampus
with the surrounding tissue and is defined as:
Dv= vvoxel
xhigh xlow Âi2W
g(i)(clip(It+1(i),xlow,xhigh)  clip(It(i),xlow,xhigh)) (4.2)
Here the thresholds xlow and xhigh are to be defined such that xlow represents intensities outside
and xhigh inside the hippocampus respectively. Further, vvoxel denotes the volume of a voxel in the
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image. The clipping function is defined as:
clip(yi,xlow,xhigh) =
8>>>>>><>>>>>>:
xlow, if yi < xlow
yi, if xlow  yi  xhigh
xhigh, if yi > xhigh
(4.3)
Since probabilistic segmentations (Stprob,St+1prob) of the hippocampus in the baseline and follow-
up scans are available, the ROI W can be obtained completely automatically. In order to calculate
W, the definition given in Freeborough and Fox (1997) is generalised and WPBSI is computed based
on the probability maps. Here, the fuzzy union and intersection of two probabilistic maps
[ (pi, p j) := max(pi, p j) \ (pi, p j) := min(pi, p j) (4.4)
and the binarised versions depending on thresholds h and z are used:
\h (pi, p j) :=
8>><>>:
1, if h \(pi, p j)
0, else
[z (pi, p j) :=
8>><>>:
1, if z [(pi, p j)
0, else
(4.5)
The ROIWPBSI is then defined as the difference, W¯\ W˘, of a region W¯ describing the outer boundary
of the ROI and an interior region lying completely within the hippocampus W˘. The sets W˘ and W¯
are defined as:
W˘= ene
h
\h(Stprob,St+1prob)
i
W¯= rnd
h
[z(Stprob,St+1prob)
i
(4.6)
The operators ene and rnd denote the ne- and nd-times application of the erosion and dilation oper-
ators. A common choice is nbine = nbind = 1 for both the erosion and dilation operator (Freeborough
and Fox, 1997). In the model presented here the erosion can be controlled by varying h for W˘. The
model also allows to control the calculation of W¯ via the parameter z. The proposed procedure is
illustrated in Figure 4.1. Figure 4.2 shows an example of a ROI, computed based on either hard
segmentations (WBSI) or the proposed method (WPBSI).
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Stprob [z(Stprob,St+1prob) W¯= r1
h
[z(Stprob,St+1prob)
i
St+1prob W˘=
h
\h(Stprob,St+1prob)
i
WPBSI = W¯\ W˘
Figure 4.1: Construction of the ROI WPBSI which is also shown in Figure 4.2 with parameters h =
0.95, ne = 0 and z = 0.90, nd = 1. Probabilistic hippocampus segmentations (green)
and binary masks (red) are overlaid over the respective subject MR image.
Figure 4.2: Binary ROIs (red) for the calculation of the respective integrals. ROI calculation based
on hard labels (WBSI, left) [nbine = 1 and nbind = 1] and based on the proposed method
with probabilistic labels (WPBSI, right) [h= 0.95, ne = 0 and z= 0.90, nd = 1].
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Abbreviation Description
4D-GC Results based on 4D graph-cuts from Wolz et al. (2010b)
DRC-HBSI3 Hippocampus BSI Leung et al. (2010b,a)
4D-EM (no DBC) volumes of 4D-EM segmentation without DBC
4D-EM volumes of 4D-EM with DBC (Lewis and Fox, 2004).
BSIWBSI1 reimplementation of the BSI, ROI defined based on binary labels
PBSIWPBSI1 g⌘ 1 and ROI defined based on probabilistic labels
PBSIWBSIg g=max(0.5, ptprob, p
t+1
prob) and ROI defined based on binary labels
PBSIWPBSIg g=max(0.5, ptprob, p
t+1
prob) and ROI defined based on probabilistic labels
Table 4.1: Compared methods.
4.1.3 Experiments and results
The method was evaluated on 309 subjects1 from the ADNI-1 cohort (Mueller et al., 2005) based on
segmentations of the left hippocampus. The cohort consisted of the 84 HC, 153 subjects with MCI
and 72 patients with AD for which a 12 month follow-up scan and spatial priors calculated with the
method described in Wolz et al. (2010a) were available. A further criterion for the definition of this
subset was the availability of results from all reference methods summarised in Table 4.1 and those
considered in Section 4.2. In addition it was ensured that all subjects were consistently diagnosed
throughout the study. This means that subjects were excluded that reverted at some point to a less
severe disease state, e.g. from MCI to HC or from AD to MCI.
The MCI group was further divided into 68 non-converting, sMCI and 60 converting, pMCI
patients respectively. Progressive MCI patients were defined as those subjects converting within
two years from diagnosed MCI (at baseline) to diagnosed AD. Stable MCI patients were defined
as those being consistently diagnosed as MCI throughout the study, based on the available time
points with imaging information. Patients with MCI that converted to AD after two years were thus
excluded from the sMCI/pMCI analysis2.
The main focus throughout the conducted experiments was on classification accuracy, and the
calculation of sample sizes and realistic atrophy rates (cf . Section 4.2.3.2 for the definition of at-
rophy that is used in this thesis). In the following, five different approaches are compared against
1A list of these subjects including diagnosis can be found at: http://www.doc.ic.ac.uk/˜cl6311/PhD_thesis/
ADNI1_309.csv, last accessed 29 June 2015.
2The definition of sMCI/pMCI is identical to the one which is used in Chapter 5, with one expection: Stable MCI
patients who were not diagnosed at least 24 months after baseline were not excluded to avoid a further reduction of
study subjects.
3provided by the Dementia Research Centre (DRC) through Dr. Kelvin K. Leung.
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volume changes computed on the left hippocampus with the two state-of-the-art methods based on
either graph-cuts (4D-GC) (Wolz et al., 2010b) or the hippocampus BSI (DRC-HBSI) (Leung et al.,
2010a,b). The atrophy computation based on label volumes obtained by the 4D-EM segmentation
is denoted as 4D-EM. This approach is expected to perform similar to 4D-GC which also performs
intensity based refinement of spatial priors computed with LEAP (Wolz et al., 2010a). Next to these,
atrophy rates are calculated based on a reimplementation of the standard BSI, with a ROI based on
hard labels (WBSI, Figure 4.2), and different versions of the PBSI with ROIs being either WBSI or
WPBSI. The weighting function g was defined as either g ⌘ 1 (‘PBSI1’), which represents the stan-
dard BSI with the ROI determined according to the proposed method, or g=max(0.5, ptprob, p
t+1
prob)
(‘PBSIg’). The latter version decreases the weight of voxels that do not clearly represent hippocam-
pal tissue. The compared methods are summarised in Table 4.1.
4.1.3.1 Preprocessing strategy and parameters
For brain extraction brain masks were employed that were obtained by a fully-automatic procedure
called pincram as described in Heckemann et al. (2015). Then robustly intensity-scaled versions
of the T1w MR images were calculated and the baseline It , the 12 month follow-up scans It+1 and
the probabilistic priors obtained through LEAP (Wolz et al., 2010a) mapped to a common space as
described in Section 4.1.2.2.
The spatial priors for the left hippocampus were thresholded with parameter a = 0.8. The spatial
priors for the three different background classes (WM, GM, CSF) were built in an ad-hoc manner
based on the probability fraction left undefined by the hippocampal prior (1-pprior(i)) and the image
intensities. As the hippocampus and all background classes are potentially adjacent, the MRF
parameters (cf . Equation 3.10) were set to 0.15 for all classes. No MRF constraints were imposed
across both time points. Given that the same spatial hippocampus prior was used for both time
points this is necessary to ensure high sensitivity and to avoid penalising the detection of a decrease
in label volume over time. For a maximum intensity value of 255, the lower and upper bounds for
the clipping function were set to xlow = 75 and xhigh = 125. As parameters for erosion and dilation
h = 0.95, ne = 0 and z = 0.90, nd = 1 were used respectively. Parameters were chosen without
explicit training and were kept fixed for all experiments. The chosen parameters are summarised in
Table 4.2.
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Symbol Value Description
a 0.8 upper threshold for spatial hippocampus priors
K 4 hippocampus + three background tissue classes
MRFspatial 0.15 spatial MRF connectivity strength
MRFtemporal 0 no temporal regularisation
nbine 1 number of erosions of ROI (based on binary labels)
nbind 1 number of dilations of ROI
h 0.95 threshold for interior ROI (based on probabilistic labels)
ne 0 number of erosions of ROI
z 0.9 threshold for outer boundary of ROI
nd 1 number of dilations of ROI
ymax 255 maximum image intensity after normalisation
xhigh 125 upper bound of clipping function
xlow 75 lower bound of clipping function
Table 4.2: Summary of parameter setting.
4.1.3.2 Classification accuracy
For classification a 6-fold cross-validation was performed using LDA. SENS , SPEC and accuracy
(ACC) averaged over 100 runs are shown in Table 4.3. On this dataset, the reimplementation of the
standard BSI, BSIWBSI , yielded the highest accuracy for all performed classification experiments.
Both BSIWBSI and the PBSI based methods performed slightly better than the reference methods.
When directly comparing the proposed BSI-based approaches to DRC-HBSI, it needs to be consid-
ered that the preprocessing procedures were different. Differential bias correction was beneficial
for the 4D-EM approach and classification results obtained with 4D-EM similar to those calculated
with 4D-GC.
4.1.3.3 Atrophy rates
Mean and standard deviation of the volume changes used for classification are shown in Table 4.4.
Since volume loss depends on different factors, such as age, it is difficult to accurately predict atro-
phy rates (Chupin et al., 2009a). However, compared to other methods and rates based on manual
segmentations, as for example those in Leung et al. (2010a), PBSI1 and in particular the reimple-
mentation of the BSI seems to consistently overestimate atrophy rates. This may be due to the fact
that BSI potentially includes too many voxels at the boundaries. This is especially pronounced in
the standard BSI where the ROI is defined using hard labels and no spatial information is consid-
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Table 4.3: Classification results for separating AD groups obtained with 4D-GC, DRC-HBSI, 4D-
EM, BSIWBSI , PBSIWPBSI1 , PBSI
WBSI
g and PBSI
WPBSI
g . 4D-EM was also evaluated without
DBC. Results shown for the left hippocampus in % calculated by averaging 100 runs of
a 6-fold cross validation.
Method Statistics AD-CN MCI-CN AD-MCI pMCI-sMCI
4D-GC SENS/SPEC 71/76 59/63 61/64 64/73
ACC 74 60 63 69
DRC-HBSI SENS/SPEC 74/77 61/70 66/65 67/68
ACC 76 64 65 68
4D-EM (no DBC) SENS/SPEC 70/79 57/64 63/60 62/67
ACC 75 60 61 65
4D-EM SENS/SPEC 73/77 58/59 66/65 63/72
ACC 75 58 66 68
BSIWBSI SENS/SPEC 76/86 62/72 62/69 72/74
ACC 81 66 67 73
PBSIWPBSI1 SENS/SPEC 72/83 59/72 63/66 71/78
ACC 78 64 65 75
PBSIWBSIg SENS/SPEC 69/85 60/74 54/68 63/76
ACC 77 65 64 70
PBSIWPBSIg SENS/SPEC 71/86 59/75 58/69 67/79
ACC 79 65 65 73
ered. Thus a decrease in intensity might contribute to the measured atrophy rate without considering
if a voxel belongs to the hippocampus at all. This might also be the reason for the increased clas-
sification accuracy as non-hippocampal voxels can provide additional discriminative information.
The presented framework relaxes this problem by incorporating spatial information and thus al-
lows the calculation of more realistic rates when compared to the rates found in a meta-analysis of
hippocampal atrophy rates in AD (Barnes et al., 2009a).
4.1.3.4 Sample sizes
In a hypothetical two-arm study, the required study population size to measure a specified change
in atrophy rate for a given disease group (g) is of particular interest. For a power (1  b) and
significance level a the sample size can be calculated (Fox et al., 2000; Leung et al., 2010a) as:
N = (z1 b+ z1 a/2)2⇥
(2s2g)
D2
(4.7)
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Table 4.4: Mean volume change of the left hippocampus in % (top) and sample sizes for atro-
phy measurement on the MCI and AD group (bottom). Compared methods are 4D-GC,
DRC-HBSI, 4D-EM, BSIWBSI , PBSIWPBSI1 , PBSI
WBSI
g and PBSI
WPBSI
g . 4D-EMwas also eval-
uated without the DBC. Standard deviation in parentheses. Corrected sample sizes were
computed on the excess change over normal aging.
4D-GC DRC-HBSI 4D-EM (no DBC) 4D-EM BSIWBSI PBSIWPBSI1 PBSI
WBSI
g PBSI
WPBSI
g
Normal -1.1 (1.8) -1.5 (2.5) -1.3 (2.0) -1.5 (2.1) -2.2 (2.7) -1.6 (1.9) -1.2 (1.6) -1.4 (1.8)
Atrophy sMCI -1.4 (2.3) -2.7 (3.3) -1.9 (2.5) -2.2 (2.4) -3.6 (3.8) -2.7 (2.9) -1.9 (2.1) -2.2 (2.5)
rates pMCI -3.4 (2.5) -5.5 (3.5) -3.7 (2.9) -4.2 (2.5) -7.3 (3.7) -5.7 (3.0) -4.1 (2.4) -5.0 (3.0)
AD -3.7 (2.4) -6.0 (3.6) -4.3 (2.7) -4.9 (2.8) -7.7 (4.4) -6.0 (3.5) -4.3 (2.9) -5.3 (3.5)
sMCI (uncor.) 676 370 439 284 280 297 288 305
sMCI (CN-cor.) 17313 1829 4081 3141 1838 1988 2320 2229
pMCI (uncor.) 134 103 154 92 63 69 84 90
Sample pMCI (CN-cor.) 302 193 367 233 128 136 171 174
sizes MCI (uncor.) 300 218 270 185 147 155 169 178
MCI (CN-cor.) 1128 578 968 746 434 443 518 502
AD (uncor.) 105 94 100 85 80 83 108 107
AD (CN-cor.) 215 167 202 182 155 157 212 198
Here D is the change in atrophy that is to be shown between the treatment groups. In this thesis
sample sizes were calculated to detect a 25% change in atrophy rate (D= 0.25µg) with 80% power
(z0.8 ⇡ 0.84) at a 5% significance level (z1 0.05/2 ⇡ 1.96). These parameter choices are commonly
found in the literature (Leung et al., 2010a; Wolz et al., 2010b; Yushkevich et al., 2010). Following
recent communication in the neuroimaging community (Fox et al., 2011) discussing the importance
of relating atrophy rates in dementia to normal atrophy during aging, sample sizes were corrected
for normal aging. This is important as in the uncorrected case it is assumed that 100% treatment
effect would effectively reduce the structural atrophy to zero (Leung et al., 2010a). To explicitly
correct for this, Equation 4.7 was evaluated with D = 0.25(µg  µhealthy) to reduce the maximal
treatment effect to the level of normal aging. It must be noted that in Equation 4.7 it is assumed that
measurements of healthy atrophy have the same variance as measurements from diseased subjects
(sg ⇡ shealthy) (Leung et al., 2010a), which, however, usually leads to a more conservative estimate.
Estimated sample sizes for the MCI (pMCI and sMCI) and AD patient groups with respect to
normal aging are presented in Table 4.4. Performing DBC reduces sample sizes and yields more
realistic atrophy rates for the 4D-EM approach. In terms of sample sizes, the proposed 4D-EM
performs competitive with respect to the reference method based on GC, while calculating realistic
atrophy rates. All instances of the (P)BSI perform comparable with PBSIWPBSIg producing the most
realistic atrophy rates (Barnes et al., 2009a; Leung et al., 2010a).
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4.1.4 Conclusion
A symmetric probabilistic extension of the boundary shift integral (PBSI) was presented and em-
ployed to analyse a population of 309 subjects with respect to their clinical diagnoses. In the
presented experiments accuracies above 70% were obtained for the clinically highly relevant clas-
sification of MCI conversion. The calculated sample sizes are comparable to those obtained with
state-of-the-art reference methods and relative volume changes are similar to published atrophy
rates. The presented model offers a spatially dependent weighting function g that allows to incorpo-
rate prior information into the BSI computation. While the accurate determination of the ROI seems
of less importance, the incorporation of spatial information using g might be the key to robust atro-
phy measurement. In future it will be interesting to investigate the influence of the parameters and
to employ this approach for atrophy measurement on other brain structures.
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4.2 Consistent and robust 4D whole-brain segmentation
This section is based on:
C. Ledig, W. Shi, A. Makropoulos, J. Koikkalainen, R. A. Heckemann, A. Hammers, J. Lo¨tjo¨nen
and D. Rueckert, “Consistent and robust 4D whole-brain segmentation: application to traumatic
brain injury”, IEEE International Symposium on Biomedical Imaging: From Nano to Macro (ISBI),
pp. 673-676, 2014.
Abstract: A consistent approach to automatically segmenting longitudinal MR brain images in
the presence of pathologies is proposed. Using symmetric intrasubject registration, corresponding
scans are aligned. In an EM framework the availability of probabilistic segmentation estimates
is exploited to calculate a consistent segmentation for images acquired at multiple time points. A
novel technique is introduced to perform symmetric DBC for images in presence of pathologies. To
achieve a consistent segmentation across multiple time points, a coupling term is proposed based on
local image similarities using a spatially and temporally varying MRF. The consistency of the devel-
oped method was demonstrated by segmenting repeat scans into 134 regions. Furthermore, based
on the dataset of 309 subjects from the ADNI cohort (cf. Section 4.1) atrophy rates and sample sizes
are investigated for the hippocampus, ventricles and the whole brain. Here the proposed method
is compared to established reference measurements available through the Ventricle Boundary Shift
Integral (VBSI) and Brain Boundary Shift Integral (BBSI). The influence of intrasubject registration
(rigid, affine) and DBC is investigated. Using a second clinical dataset, the approach has been
further applied to segment baseline and follow-up scans from 56 patients who have sustained TBI.
Significant correlations between regional atrophy rates and clinical outcome are reported: Patients
with poor outcome showed a much higher thalamic atrophy rate ( 4.8±4.6%) than patients with
favourable outcome ( 0.8±2.2%).
4.2.1 Introduction
As described in Chapter 1 both AD and TBI are serious and common health problems affecting a
large number of individuals. In dementia research the accurate measurement of structural atrophy
has the potential to predict disease progression but also to monitor drug efficacy in clinical trials.
In the context of TBI the quantification of anatomical atrophy is crucial to better understand the
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structural changes during the weeks and months following the event of the actual trauma.
Several methods have been published that address the problem of quantifying brain changes over
time based on MR images. One popular representative is “CLASSIC” (Xue et al., 2006), a method
that uses adaptive clustering for tissue segmentation of MR scans taken at multiple time points. An-
other longitudinal segmentation method presented by Lorenzo-Valdes et al. (2004) is based on EM
optimisation and has been applied to 4D cardiac sequences. This asymmetric approach uses sta-
tionary temporal MRFs and affine alignment with a probabilistic spatiotemporal atlas. Several other
methods have been proposed that address primarily brain tissue segmentation such as Wang et al.
(2011b) which uses level sets. In Bendlin et al. (2008) indications for brain volume loss following a
TBI have been identified using tissue segmentation techniques on structural MR scans and DTI. In
Wang et al. (2012a,b) the authors longitudinally segment multi-modal image sequences of patients
with TBI into distinct tissue and lesion types using personalised atlas construction. The method re-
lies on an appearance model and requires user input as initialisation. This approach was extended in
Wang et al. (2013a) to extract biomarkers such as tissue/lesion volumes or cortical thickness mea-
surements and applied to analyse five TBI patients. Wolz et al. (2010b) simultaneously segment
the hippocampi of longitudinally acquired images using GC. Here, images of follow-up time points
are affinely aligned to the baseline and its subject-specific prior. In Reuter et al. (2012) the authors
build on FreeSurfer and propose an unbiased method to analyse longitudinal whole-brain image se-
ries. In this approach, an intrasubject template is built from information extracted cross-sectionally
from individual time points. Individual time points are then re-processed using both information
transferred from the within-subject template and time point specific data. A further discussion of
relevant literature can be found in Chapter 2.
Recent research suggests that a fully symmetric process can significantly reduce bias, e.g. in
atrophy measurement (Leung et al., 2012; Reuter et al., 2012). The advantages of a longitudinal
segmentation of several time points over multiple, single time point segmentations are well estab-
lished (Xue et al., 2006; Wolz et al., 2010b).
In this section a novel method is proposed, an extension of Ledig et al. (2012b, 2015), for consis-
tent segmentation of serial images into many anatomical regions, rather than tissue classes. Image
alignment and DBC is performed in a symmetric fashion. To achieve consistency, an approach is
presented that can perform DBC in the presence of significant pathology in the images. Further an
approach is introduced to determine a spatially and temporally varying, fully data driven temporal
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coupling of the longitudinal segmentation based on MRFs. As far as known, the presented method
is one the first consistent segmentation approaches that segment a series of intrasubject whole-brain
MR images into a large number of anatomical structures while being robust to pathology. The
conducted experiments show quantitative evidence for improved segmentation consistency while
maintaining high accuracy. The method’s performance is confirmed with respect to established at-
rophy measurements based on the BSI on the subset of 309 subjects from the ADNI cohort that was
employed in Section 4.1. Further, it is demonstrated on a cohort of TBI patients that the proposed
method is robust and has the potential to quantify imaging biomarkers, specifically atrophy, that
correlate well with clinical outcome.
4.2.2 Method
In the following of this section the proposed methods are described for a symmetric, consistent multi
time point whole brain segmentation. This 4D extension of the framework presented in Chapter 3
is called MALP-EM4D.
First in Section 4.2.2.1, subject specific probabilistic priors are calculated for scans at individual
time points. These priors and the intensity images are transformed to a common intermediate space
using a symmetric registration technique (Leung et al., 2012). These priors are then employed to
segment longitudinal brain images using a 4D EM optimisation in Section 4.2.2.2. To enable a
flexible spatially and temporally varying longitudinal coupling and thus consistent segmentation a
temporal coupling weight is calculated based on intensity normalised images in Section 4.2.2.3.
An innovative way is described to apply DBC to images that may contain pathologies in Section
4.2.2.4.
4.2.2.1 Spatial priors and symmetric longitudinal image alignment
Assuming preprocessed, brain extracted (pincram, Heckemann et al. (2015)) and bias corrected
(N4, Tustison et al. (2010)) images subject specific probabilistic labels are derived from M avail-
able atlases using the multi-atlas label propagation approach described in Chapter 3. For the un-
segmented images at T time points, It at t = 0 . . .T  1, individual transformations ftm, m= 1 . . .M
are calculated by registering M manually labelled atlases to It. For the image alignment, MAPER
(Heckemann et al., 2010) is employed, an approach that incorporates tissue probability maps into
the registration and relies on a non-rigid registration based on FFDs (Rueckert et al., 1999; Modat
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et al., 2010). Using the resulting transformations theM label maps are mapped to the space of image
It. For each time point t, a probabilistic atlas is created using MALP-EM with a locally weighted
multi-atlas fusion strategy based on GSSD as described in Chapter 3. In the following, ptik denotes
the probabilistic prior for label k at voxel i and at time point t.
As shown in Leung et al. (2012); Yushkevich et al. (2010), asymmetric image registration can
introduce significant bias into longitudinal image analyses. Thus, a symmetric setup is used based
on global rigid or affine (12 DOFs) registration similar to Yushkevich et al. (2010); Leung et al.
(2012). All images and priors of all T time points are transformed to a common intermediate space
(Leung et al., 2012).
4.2.2.2 4D-EM segmentation
The probabilistic segmentation of the aligned multi time point scans, residing in their common
rigid/affine intermediate space, is then estimated simultaneously. Based on the subject and time
point specific priors, a 4D extension of the EM algorithm (Ledig et al., 2012b, 2015) is employed.
The same Gaussian distributions, described by F, are employed for all time points. Spatial
smoothness of the final segmentations is enforced through a global and stationary MRF (Cardoso
et al., 2011). To also enforce longitudinal consistency, novel spatially and temporally varying con-
straints are proposed. The strength of the temporal coupling is formulated as a function of the local
intensity similarity of the aligned images. This is crucial both to allow for flexibility in regions with
potential pathology and to enforce consistency in regions with no or very little change. A GMM
(cf . Chapter 3) is assumed to model the probability of observing intensity yti at a voxel i at time
point t
f (yti|Ft,(q)) =Â
k
f (yti|zti = k,F(q))
ptike
 UMRF(k|p(q)Ni )
ÂKj=1pti je
 UMRF( j|p(q)Ni )
(4.8)
where Ni is the set of first-order neighbours of voxel i, k a label index and zti the labelling of voxel
i at time point t.
The MRF energy UMRF that is dependent on the probabilistic label estimates p at iteration q is
represented as:
UMRF(k|p(q)Ni ) =
K
Â
j=1
Gk jv j , vk = Â
l2N x,y,zi
pt,(q)lk + Â
l2N ti
gt,li p
l,(q)
ik (4.9)
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Here G denotes a K ⇥K matrix defining the connectivity between class k and j. The vector v
of size K denotes the accumulated class probabilities in the 8-neighborhood Ni of voxel i. The
class probabilities of adjacent time points are weighted by temporal weighting factors, gt,t±1i . The
following sections describe the calculation of gt,t±1i , and the DBC. These steps are performed once
before the first iteration of the EM algorithm.
4.2.2.3 Voxel-wise coupling weights for temporal consistency
To reduce segmentation bias, it is proposed to couple the segmentation of corresponding images
from multiple time points through a spatially and temporally varying MRF. While the spatial MRF
weights are stationary, the temporal weights are determined based on the similarity of temporally
adjacent intensity normalised images (Nyul and Udupa, 1999; Smith, 2002). At time point t local
patch similarities are calculated between time point t and t+1, or t and t 1 respectively. Specif-
ically, the Gaussian weighted sum of absolute differences (GSAD) is calculated where the kernel
width determines the “patch size”. From the GSAD value at a given voxel wt,t±1i , the coupling
weights gt,t±1i to obtain temporal consistency are derived based on a logistic function of the form:
gt,t±1i = c 
c
1.0+a · exp( b ·wt,t±1i )
(4.10)
Here c determines the maximal value of gi while a and b determine the shape of the S-curve. gt,t±1i
is close to c in areas where the data suggests no presence of pathologies or significant structural
changes (small wi) and close to 0 otherwise. Example plots of g are visualised in Figure 4.3.
4.2.2.4 Differential Bias Correction
Lewis and Fox (2004) proposed a straightforward way to estimate the differential bias fields of
aligned longitudinal image pairs by applying a median filter to the difference image, calculated
between log-transformed images. This approach is extended by Leung et al. (2012) to multiple
time points. However, the basic assumption of this approach, that the differential bias field is given
as the low frequency component of the difference image, does not necessarily hold in the presence
of pathologies. A violation of this assumption is given by the image pair in Figure 4.5. Here,
significantly enlarged ventricles or pathological changes appear as low frequency intensity change
and thus falsely influence the bias field estimation with the approach presented in Lewis and Fox
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Figure 4.3: Example coupling weights gi dependent on local patch similarity wi for different choices
of parameter b. In this work, b is automatically determined based on the image intensi-
ties as b = 5.0/median[wt,t+1i ]. The figure shows typical results for intrasubject repeat
scans (red), follow-up images of healthy subjects, or of patients with AD or mild TBI
(green, blue). For highly pathological cases such as the one illustrated in Figure 4.5
rather high values for b are determined (purple). Note: The low values of wi are due to
the fact that the weights are calculated on the log-transformed image intensities.
(2004); Leung et al. (2012).
An alternative way is proposed to adapt bias field estimation to increase its robustness towards
pathologies. The formulation presented in Leung et al. (2012) is extended to estimate pairwise
differential bias fields dbft,t
0
poly, for time points t, t
0, based on a polynomial model. After estimating
a differential bias field dbft,t 0 based on the difference image, a second order polynomial is fit to
dbft,t 0 using weighted least squares optimisation to calculate dbft,t
0
poly. As weights the quantities
g are exploited which were previously derived from patch similarities. Employing the temporal
coupling weights g, the influence of pathological areas to the bias field estimation can be reduced.
This allows the estimation of a differential bias field based on low frequency intensity changes
within brain regions that are not subject to substantial pathological change. A symmetric bias field
correction is then performed as described in Leung et al. (2012) using all pairwise estimates dbft,t
0
poly.
DBC can be considered as a preprocessing step for the described 4D-EM segmentation (cf . Section
4.2.2.2) and is performed once after the voxel-wise coupling weights have been calculated (cf .
Section 4.2.2.3).
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4.2.3 Experiments and results
4.2.3.1 Materials and parameters
As brain atlases the dataset was used which was provided as part of the “MICCAI 2012 Grand
Challenge and Workshop on Multi-Atlas Labeling” (Landman and Warfield, 2012). It consists
of 35 T1-weighted MR brain images with isotropic voxel sizes of 1 mm ⇥ 1 mm ⇥ 1 mm from
the OASIS database (Marcus et al., 2007). The corresponding 134 anatomical labels have been
created manually by experts4. The scans have been acquired from 30 subjects (20 female, 10 male,
mean±SD age: 34.3±20.7 years) where 5 subjects have been scanned twice. The duplicates were
acquired within 90 days of the original scan (Marcus et al., 2007). A more detailed description of
the atlas dataset can be found in Section 2.2.5.
In addition the proposed method was applied to the same 309 subjects from the ADNI-1 cohort
that were used in Section 4.1. Atrophy rates and sample sizes were calculated for the hippocampus,
ventricles and the whole brain. Results are compared to DRC-HBSI (cf . Section 4.1) measurements,
KN-BBSI (Leung et al., 2010b) and VBSI measurements downloaded from ADNI named ‘Fox Lab
- BSI Measures, version November 3rd 2014‘. These BSI measures were calculated using affine
registration and DBC.
From a cohort of patients who had sustained TBI, 56 intrasubject pairs of MR brain images were
segmented which were acquired several months apart (mean 6.7±1.2 months). Acquisition param-
eters were: resolution 240 ⇥ 256 ⇥ 170; spacing 1 mm ⇥ 1 mm ⇥ 1 mm; sagittal slices. More
details on this cohort can be found in Chapter 6.
The proposed method was evaluated in three ways: First, consistency and accuracy were eval-
uated on the 5 pairs of intrasubject repeat scans. Second automatically calculated atrophy rates
and sample sizes were compared to those obtained using state-of-the-art BSI based measurements.
The effect of DBC and affine vs. rigid intrasubject image alignment was investigated. Finally, the
method was applied to the TBI cohort to evaluate the clinical relevance of the calculated atrophy
measurements.
To segment the five pairs of repeat scans, which are part of the atlas cohort, the subset of 15
atlases that served as training data in the Grand Challenge was used. These M = 15 scans were
4provided by Neuromorphometrics, Inc. under academic subscription (http://Neuromorphometrics.com/).
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Figure 4.4: Simulated atrophy calculation for fixed baseline volume (vt1 ) and varying follow-up vol-
ume (vt2 ). Calculation based on Dfracv (t1, t2) = 100%(vt2  vt1)/vt1 (red) and the logarith-
mic transform Dlogv (t1, t2) = 100%ln(vt2/vt1) (green) with corresponding approximation
error (blue).
distinct from the 5 ⇥ 2 repeat datasets. For the segmentation of the TBI data all M = 30 atlases
were used, excluding the five repeat scans. More details on the atlas subsets is provided in Section
2.2.5.
Parameters: Parameters were set mainly based on results from previous experiments. For the
GSSD in the locally weighted atlas fusion sGSSD was set to 2.5. As spatial MRF weights, entries
(k,k) of the connectivity matrix G were set to 0. Entries (k, j) were set to 1.0 if structures k and
j shared a boundary, and to 2.5 otherwise. For the logistic function in Section 4.2.2.3, parameters
were chosen heuristically as c = 20.0, a = 100 and b = 5.0/median[wt,t+1i ]. b was modelled de-
pendent on the median of the occurring GSAD values wi (sGSAD = 1.0) within the images. This
adapts the logistic function to different similarity levels of image pairs in a data-driven fashion. As
in Lewis and Fox (2004), a median filter of kernel size 5 was used to estimate the differential bias
field.
4.2.3.2 Calculation of atrophy rates
In Section 4.1 atrophy rates were calculated based on the BSI or as Dfracv (t1, t2)= 100%(vt2  vt1)/vt1 .
For the remainder of this thesis, atrophy rates are calculated using the logarithmic transform as
Dv(t1, t2) = Dlogv (t1, t2) = 100%ln(vt2/vt1). This is a very close numerical approximation (cf . Fig-
ure 4.4, and Table 4.4 and Table 4.7) and has the advantage of being multiplicatively symmetric
and transitive in the sense that Dv(t1, t3) = Dv(t1, t2)+Dv(t2, t3). Note that atrophy rate and volume
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ICC manual MAPER no coupling proposed (DBC) (weighted DBC)
36 subcortical .80±.28 .95±0.08 .95±.15 .98±.08 .97±.09
98 cortical .78±.25 .95±0.09 .94±.07 .99±.02 .99±.02
134 structures .78±.25 .95±0.09 .94±.10 .99±.04 .98±.05
Table 4.5: Intraclass correlation coefficient (ICC) (mean±SD) based on label volumes averaged
over 5 image pairs for all 36 subcortical and all 98 cortical regions obtained manually,
with MAPER, and the proposed method without and with the temporal constraints as
described in Section 4.2.2.3-4.2.2.4. Proposed method evaluated with unweighted, stan-
dard DBC and weighted DBC. Bold = significantly better than without coupling (paired,
two-sided Student’s t-test, p < 0.05).
change is used interchangeable, which means that a positive atrophy rate indicates an increase in
volume.
4.2.3.3 Test-retest reliability
To investigate the consistency of imaging biomarkers derived using the proposed segmentation
method it is crucial to evaluate its test-retest reliability. Since five testing subjects in the testing
set have duplicate scans this could be quantified. The ICC was employed to quantify test-retest
reliability, following Shrout and Fleiss (1979) in the scheme ICC(2,1). ICCs for both manual and
automated segmentations are summarised in Table 4.5. Overall, the proposed method yielded a
significantly higher ICC than the reference methods.
4.2.3.4 Subject-atlas label overlaps
Enforcing identical segmentations at both time points leads to high ICC values, but high ICCs do
not necessarily reflect a high segmentation accuracy which needs to be assessed with measures of
overlap. The accuracy of segmenting both time points with and without the temporal constraints
was assessed quantitatively. Table 4.6 shows overlap results based on the Dice coefficient (Dice,
1945) (DC) or also called SI. The DC was calculated on the 10 repeat scans by comparing to
the gold standard. Enforcing temporal consistency did not deteriorate segmentation accuracy, but
rather improved it for some structures. In this work, the DC was calculated in an intermediate
coordinate system to which the reference segmentations were transformed using nearest-neighbour
interpolation. The presented scores should thus not be directly compared to the Grand Challenge
(Landman and Warfield, 2012) or the results presented in Chapter 3.
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36 subcort. 98 cort. 134 structures
proposed (weighted DBC) 82.1 72.6 75.1
proposed (DBC) 82.1 72.6 75.1
no coupling 80.5 72.5 74.7
Table 4.6: Average Dice coefficient (Dice, 1945) (DC) values comparing the proposed approach
without or with temporal constraints to the gold-standard segmentations of the 10 images
of the 5 pairs of repeat scans. Proposed method evaluated with unweighted, standard
DBC and weighted DBC. Bold significantly better than without coupling (paired, two-
sided Student’s t-test, p < 0.001).
4.2.3.5 Longitudinal analysis of 309 subjects from ADNI
The proposed approach MALP-EM4D was also compared to established measurements calculated
with the BSI using the same dataset that was used in Section 4.1 of 309 subjects from the ADNI-1
cohort. Atrophy rates for distinct patient groups and sample sizes were calculated as described in
Section 4.1.3.4. Measurements were compared on the left hippocampus (Table 4.7), the ventricles
(Table 4.8) and the whole brain (Table 4.9). The proposed method yields realistic atrophy rates for
all investigated structures. While sample sizes for the ventricles are slightly lower using MALP-
EM4D, the BSI based measurements yielded a better group separation on the left hippocampus
and the whole brain. The conducted experiments suggest that an affine registration approach might
be preferable to rigid registration to align intrasubject MR images. In Paling et al. (2004) the au-
thors discussed variations in scanner voxel size as possible explanation for reduced measurement
bias when using affine registration. However, no significant benefits when using affine registration
were found (Paling et al., 2004) so that rigid registration should be considered a reasonable option
(Yushkevich et al., 2010). In contrast to the results presented in Section 4.1, where no temporal
coupling was used in the EM optimisation, no clear benefit was observed using DBC. The per-
formed experiments indicate that the regularisation imposed by the 4D MRF largely compensates
for existing differential bias. Nevertheless, performing DBC slightly decreased measured atrophy
rates, suggesting that small changes in intensity signal are removed. Employing a fixed temporal
coupling weight (g = 1) does not necessarily deteriorate group separation, however it tends to yield
unrealistically low atrophy rates due to a loss in sensitivity.
Further MALP-EM4D was employed with affine registration and unweighted differential bias
field correction (as in Leung et al. (2012)) to analyse left/right counterparts of the hippocampus
and ventricles individually. The results are summarised in Table 4.10. While similar sample sizes
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Table 4.7: Mean atrophy rates of the left hippocampus in % (top) and sample sizes for atrophy mea-
surement on the MCI and AD group (bottom). Compared methods are the DRC-HBSI
(cf . Section 4.1), MALP-EM and different instances of the proposed method. Standard
deviation in parentheses. Corrected sample sizes were computed on the excess change
over normal aging.
Method DRC-HBSI MALP-EM MALP-EM4D MALP-EM4D MALP-EM4D MALP-EM4D MALP-EM4D
Coupling fixed varying varying varying varying
Registration affine rigid affine affine affine
Diff. bias correction unweighted none none unweighted weighted
Normal -1.5 (2.5) -1.9 (3.9) -0.6 (2.1) -1.2 (1.8) -1.2 (1.7) -1.2 (1.6) -1.2 (1.7)
Atrophy sMCI -2.6 (3.2) -2.3 (5.7) -1.4 (2.7) -2.0 (2.7) -2.0 (2.7) -2.0 (2.6) -2.0 (2.6)
rates pMCI -5.3 (3.3) -3.1 (4.3) -2.0 (1.7) -4.3 (2.8) -4.3 (2.9) -4.1 (2.8) -4.3 (2.9)
AD -5.7 (3.4) -3.2 (4.3) -2.4 (2.2) -4.8 (3.8) -5.0 (3.8) -4.7 (3.8) -4.9 (3.8)
sMCI (uncor.) 364 1496 864 462 437 429 447
sMCI (CN-cor.) 1816 40622 2568 3399 2695 2850 2743
pMCI (uncor.) 99 476 167 110 114 117 114
Sample pMCI (CN-cor.) 187 3004 336 218 219 235 217
sizes MCI (uncor.) 214 834 453 268 272 269 275
MCI (CN-cor.) 572 7803 1152 829 793 837 797
AD (uncor.) 90 447 202 157 148 161 155
AD (CN-cor.) 162 2561 359 284 258 292 269
Table 4.8: Mean atrophy rates of the ventricles in % (top) and sample sizes for atrophy measure-
ment on the MCI and AD group (bottom). Compared methods are the VBSI, MALP-EM
and different instances of the proposed method.
Method VBSI MALP-EM MALP-EM4D MALP-EM4D MALP-EM4D MALP-EM4D MALP-EM4D
Coupling fixed varying varying varying varying
Registration affine rigid affine affine affine
Diff. bias correction unweighted none none unweighted weighted
Normal 4.2 (4.1) 3.2 (3.8) 2.2 (2.4) 3.4 (3.5) 3.3 (3.4) 2.9 (3.0) 3.2 (3.3)
Atrophy sMCI 5.0 (4.9) 4.1 (4.6) 3.0 (2.8) 4.4 (4.0) 4.3 (3.9) 3.7 (3.4) 4.1 (3.8)
rates pMCI 8.8 (4.5) 7.6 (4.3) 5.4 (3.2) 7.7 (4.1) 7.5 (4.0) 6.8 (3.7) 7.3 (4.0)
AD 9.6 (5.8) 8.3 (5.3) 6.1 (3.9) 8.6 (5.4) 8.3 (5.2) 7.5 (4.6) 8.2 (5.1)
sMCI (uncor.) 241 308 219 215 206 216 214
sMCI (CN-cor.) 9550 6472 3595 4262 3988 4208 4140
pMCI (uncor.) 64 80 85 72 71 77 74
Sample pMCI (CN-cor.) 236 243 248 228 224 231 232
sizes MCI (uncor.) 129 155 140 126 124 132 128
MCI (CN-cor.) 836 751 666 668 652 661 669
AD (uncor.) 92 101 104 100 98 95 97
AD (CN-cor.) 297 272 263 272 267 250 260
were observed for corresponding structures in both brain hemispheres, atrophy seems to be more
pronounced in the right brain hemisphere on this dataset.
The potential of combining atrophy rates from different structures is summarised in Table 4.11.
Here atrophy rates of distinct structures were combined by calculating the arithmetic mean of the
individual rates. Atrophy rates for the cortical and deep GM were calculated based on the actual
volumes of the tissues. These results are encouraging as they show the potential of combining
biomarkers of multiple structures instead of focusing on individual structures only. Sample sizes
that were calculated based on the inferior lateral ventricles and all ventricular structures are lower
than those obtained with the considered reference methods.
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Table 4.9: Mean atrophy rates of the whole brain in % (top) and sample sizes for atrophy measure-
ment on the MCI and AD group (bottom). Compared methods are the KN-BBSI (Leung
et al., 2010b), MALP-EM and different instances of the proposed method.
Method KN-BBSI MALP-EM MALP-EM4D MALP-EM4D MALP-EM4D MALP-EM4D MALP-EM4D
Coupling fixed varying varying varying varying
Registration affine rigid affine affine affine
Diff. bias correction unweighted none none unweighted weighted
Normal -0.7 (0.6) -0.4 (0.7) -0.5 (0.4) -0.7 (0.8) -0.7 (0.8) -0.6 (0.6) -0.7 (0.7)
Atrophy sMCI -0.9 (0.7) -0.6 (0.7) -0.7 (0.5) -0.9 (0.8) -1.0 (0.9) -0.8 (0.8) -0.9 (0.8)
rates pMCI -1.6 (0.8) -0.8 (1.0) -0.9 (0.6) -1.2 (0.9) -1.3 (1.0) -1.1 (0.9) -1.2 (0.9)
AD -1.7 (1.0) -0.9 (0.9) -1.1 (0.6) -1.5 (1.1) -1.7 (1.1) -1.4 (0.9) -1.6 (1.0)
sMCI (uncor.) 162 426 149 205 214 220 221
sMCI (CN-cor.) 3491 3272 3075 3256 3736 3779 3852
pMCI (uncor.) 63 391 107 154 147 143 144
Sample pMCI (CN-cor.) 209 1231 598 799 746 668 683
sizes MCI (uncor.) 112 432 132 203 195 190 194
MCI (CN-cor.) 634 1985 1271 1772 1668 1502 1550
AD (uncor.) 82 250 76 128 103 96 100
AD (CN-cor.) 239 648 278 402 319 291 300
Table 4.10: Mean atrophy rates of other structures in % (top) and sample sizes for atrophy mea-
surement on the MCI and AD group (bottom) using MALP-EM4D with affine registra-
tion, unweighted DBC and the proposed spatially varying temporal coupling.
Structure hippocampus R hippocampus L inf lat. vent. R inf. lat. vent. L lat. vent. R lat. vent. L
Normal -0.9 (1.9) -1.2 (1.6) 1.5 (3.3) 2.1 (4.3) 3.1 (3.2) 3.2 (3.3)
Atrophy sMCI -2.0 (3.1) -2.0 (2.6) 3.0 (4.6) 3.2 (4.2) 4.0 (3.8) 3.9 (3.9)
rates pMCI -3.7 (3.2) -4.1 (2.8) 6.2 (5.2) 6.4 (5.5) 7.2 (4.3) 7.1 (4.1)
AD -5.6 (5.3) -4.7 (3.8) 8.6 (6.8) 7.5 (5.2) 7.9 (5.2) 7.7 (4.7)
sMCI (uncor.) 599 429 611 442 230 261
sMCI (CN-cor.) 1958 2850 2498 3696 4375 8410
pMCI (uncor.) 186 117 182 182 90 82
Sample pMCI (CN-cor.) 325 235 319 393 275 266
sizes MCI (uncor.) 336 269 315 306 144 148
MCI (CN-cor.) 733 837 717 1018 720 851
AD (uncor.) 229 161 159 122 107 92
AD (CN-cor.) 326 292 234 232 291 268
Table 4.11: Mean atrophy rates of combined structures in % (top) and sample sizes for atrophy
measurement on the MCI and AD group (bottom) using MALP-EM4D with affine
registration, unweighted DBC and the proposed spatially varying temporal coupling.
Structures were combined by averaging individual atrophy rates (†) or calculating atro-
phy rates on merged structures (‡). ?: includes 3rd and 4th ventricle.
Structure hippocampus† inf. lat. vent.† lat. vent.† ventricles† ventricles?,‡ cortical GM‡ deep GM‡
Normal -1.1 (1.5) 1.8 (3.5) 3.1 (3.2) 2.5 (3.1) 2.9 (3.0) -0.9 (1.1) -0.9 (1.2)
Atrophy sMCI -2.0 (2.4) 3.1 (3.9) 3.9 (3.7) 3.5 (3.4) 3.7 (3.4) -1.1 (1.3) -0.9 (1.3)
rates pMCI -3.9 (2.6) 6.3 (4.4) 7.2 (4.0) 6.7 (3.7) 6.8 (3.7) -1.7 (1.4) -1.2 (0.9)
AD -5.1 (3.8) 8.0 (5.2) 7.8 (4.8) 7.9 (4.5) 7.5 (4.6) -2.0 (1.6) -1.4 (1.2)
sMCI (uncor.) 367 413 226 236 216 342 558
sMCI (CN-cor.) 1651 2365 5459 2676 4208 11186 1083247
pMCI (uncor.) 113 123 80 77 77 180 147
Sample pMCI (CN-cor.) 212 239 251 191 231 877 2316
sizes MCI (uncor.) 223 233 136 140 132 268 338
MCI (CN-cor.) 577 636 730 537 661 2521 42739
AD (uncor.) 139 105 96 81 95 166 189
AD (CN-cor.) 221 173 269 171 250 581 1659
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4.2.3.6 Longitudinal analysis of TBI patients
To evaluate the proposed method in a realistic clinical research setting, the longitudinal size change
of individual brain structures was assessed with respect to a standard clinical outcome score, the
extended Glasgow Outcome Score (GOSe). All 56⇥2 TBI brain images were preprocessed using
the N4 algorithm to correct for intensity inhomogeneities (Tustison et al., 2010). Pincram (Heck-
emann et al., 2015) was employed for brain extraction. Subsequently MALP-EM4D was applied
to the 56 image pairs. Clinical GOSe scores were available (GOSe 3: 4 subjects, GOSe 4: 3,
GOSe 5: 4, GOSe 6: 11, GOSe 7: 15, GOSe 8: 19). Visual inspection confirmed the robustness
of the method for all processed images. Figure 4.5 shows results calculated on one of the most
pathological subjects.
In a preliminary experiment to underline the potential of the proposed method, the TBI subjects
were split into two groups5. Following Jennett et al. (1981) the subjects were split into those with
GOSe 3-5 (severe or lower moderate disability) and GOSe 6-8 (upper moderate disability, good
recovery).
Atrophy rates for all 134 structures were calculated and structures identified for which the size
change rate was significantly different (two-sided unpaired Student’s t-test) between the groups.
Paired structures appearing both in the left and right brain hemisphere were combined. The four
most significant subcortical structures were cerebral white matter (p< 10 6), thalamus (p⇡ 10 4),
lateral ventricles (p ⇡ 10 4) and caudate (p < 10 3). This is in line with published literature that
suggests atrophy both in the thalamus and caudate (cf . Section 2.4). Without temporal coupling
group differences were far less marked, e.g. for the thalamus and caudate there was no significant
difference. An exception was the pallidum which was found significant only without the temporal
coupling (p < 10 3).
The boxplots shown in Figure 4.5 illustrate the substantial reduction of the size of the thalamus
(GOSe 3-5:  4.8± 4.6% vs. GOSe 6-8:  0.8± 2.2%) and the caudate ( 7.8± 12% vs. 1.1±
4.5%). In contrast, ventricles expand faster, due to brain atrophy in more severely injured patients
(15.8± 16.7% vs. 1.6± 8.4%). Such a clear group separation is crucial for outcome prediction:
100 iterations of a 6-fold cross validation were run to separate GOSe groups 3-5 and 6-8 based on
thalamic atrophy using LDA. While the classification accuracy without temporal coupling was 62%
5Note that confounding factors such as age differences between the groups were not considered in this preliminary
experiments. This is in contrast to the analysis presented in Chapter 6.
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a) b) c)
d) e) f)
g)
Figure 4.5: Visual results for a TBI subject (TBI066, GOSe = 3) with significant pathologies ob-
tained with the proposed method. (a,d) T1-weighted baseline, (b,e) 7.9 month follow-up
scan with overlaid segmentations and (c,f) corresponding differential bias fields. Results
were calculated with unweighted (a,b) and with weighted (d,e) differential bias field
correction. (c) differential bias field estimated as presented in Lewis and Fox (2004),
(f) proposed polynomial fitted bias field. (g) corresponding temporal coupling weights
according to Equation 4.10 (high weights in red). Boxplots of volume change in the
thalamus and caudate calculated with (black) / without (blue) the proposed temporal
coupling as described in Section 4.2.2.3-4.2.2.4 for GOSe groups 3-5 vs. 6-8.
.
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(SENS: 62%, SPEC: 62%) a high accuracy of 81% (70%, 83%) was observed using the proposed
method with temporal coupling. Similar results were observed for the caudate: without temporal
coupling 63% (31%, 71%), with temporal coupling 83% (65%, 87%).
4.2.4 Conclusion
A novel method was presented that enables the symmetric and consistent segmentation of patholog-
ical serially acquired MR brain images into a large number of anatomical structures. The segmen-
tation consistency was significantly improved in comparison to manual and state-of-the-art proce-
dures. On the same subset of subjects with potential AD that was used in Section 4.1 it was shown
that the proposed method allows the calculation of atrophy rates for multiple structures simulta-
neously. Computed atrophy rates are realistic and sample sizes comparable to those calculated by
established techniques that focus on individual structures only. By application to a novel cohort
of patients with TBI, it was confirmed that MALP-EM4D allows the derivation of discriminative
prognostic markers in longitudinal imaging. The findings also indicate the method’s potential to as-
sist in the challenging task of monitoring the development of pathological conditions. In the future,
the potential of the derived measurements as markers of AD (cf . Chapter 5) and TBI (cf . Chapter
6) disease progression needs to be investigated in greater detail. A further promising avenue would
be the integration of a deformation model to estimate the structural disease progression over time.
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5 Automated brain morphometry in patients
with Alzheimer’s disease
Abstract: In Chapter 3 and Chapter 4 methodology was developed and evaluated to segment
T1w MR brain images into numerous distinct anatomical structures based on the manually anno-
tated NMM brain atlas described in Section 2.2.5. In this chapter, these techniques are applied to
analyse the ADNI cohort. The aim is the automatic extraction of clinically-relevant features (struc-
tural volumes, atrophy rates) from brain images of healthy subjects and patients with probable AD.
Specifically, a cross-sectional analysis is performed of images acquired at baseline and a longitu-
dinal analysis using also the MR images acquired during the month-12 (m12) or month-24 (m24)
follow-up visits. The presented results demonstrate that the extracted volumetric features are infor-
mative and confirm several findings published in the literature. Atrophy rates for numerous distinct
brain structures are calculated and their discriminative power investigated to separate both AD pa-
tients from healthy controls but also progressive from stable MCI patients. The effect of age, gender
and head size on structural volumes is briefly investigated.
ADNI is a multi-center study (over 50 acquisition sites in North America) with the aim to identify
biomarkers that support the early detection of AD and that allow an improved understanding of the
progression of the disease. Collected biomarkers include clinical information (e.g. demographics,
cognitive assessment), imaging biomarkers (MRI, PET, DWI), genetic data (e.g. ApoE genotype)
and also biospecimen data (e.g. from blood or CSF). The first ADNI study, ADNI-1, started in 2004
and was subsequently continued as ADNI-GO and ADNI-2, which is still ongoing. Throughout
the three studies more than 1500 participants were enrolled including healthy control subjects and
patients diagnosed with different stages of MCI or AD. More information on ADNI can be found
at: http://adni.loni.usc.edu or http://www.adni-info.org (last accessed 29 June 2015).
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In the following, an overview over the imaging data is given in Section 5.1. The employed
methodology is summarised in Section 5.2. In Section 5.3 the extracted imaging features and the
classification setup is described. In Section 5.4 a widely used approach is described to correct for
multiple nuisance variables. In Section 5.5.1 the effect of correcting for nuisance factors is investi-
gated and a cross-sectional analysis performed using imaging information acquired at baseline. A
longitudinal analysis is conducted in Section 5.5.2. Finally a discussion of the results is provided in
Section 5.6 and Section 5.7 concludes this chapter.
5.1 Materials
In this chapter a subset of T1w MR brain images is analysed from all phases (ADNI-1/-GO/-2) of
the ADNI study. On 19/02/2015 the image repository and the respective clinical information was
updated based on the ADNIMERGE package1. The repository contained 7128 images of which
1723 were baseline images. As imaging data is still added to the ADNI database the cohort is
continuously growing. This is why at the time of this analysis not all of the 7128 images have
been processed. Subjects were not explicitly selected and no images were excluded due to reasons
related to image processing. Specifically, 5074 images were processed of which 1674 were baseline
images. In the following a subset from these 5074 processed images is selected based on clinical
information. Here the clinical information from the complete repository was used, i.e. also from
follow-up images that were not processed.
Certain criteria were defined for the inclusion/exclusion of individual subjects which are sum-
marised below:
• All subjects that reverted at any time point from a more severe to a less severe disease stage,
i.e. AD!MCI or MCI! HC, were excluded from both the cross-sectional (N=68) and the
longitudinal analysis.
• All subjects with baseline diagnosis early MCI (N=277) or subjective memory complaints
(SMC) (N=76) were excluded from both the cross-sectional and the longitudinal analysis.
• The sMCI group was defined as those subjects that were diagnosed as MCI (called ’late
MCI’ in ADNI-GO/-2) at baseline and remained at the MCI stage for at least two years and
1The ADNIMERGE package is updated daily and summarises commonly used data from all three ADNI studies (ADNI-
1/-GO/-2). More information can be found at: http://adni.bitbucket.org/ADNIMERGE-package.html, last
accessed 15 July 2015.
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until the most recent diagnosis which was available. This means that subjects for which this
information was not available, e.g. because the repository did not contain a corresponding
m24 or later visit, were excluded (N=130).
• The pMCI group was defined as those subjects that were diagnosed as MCI at baseline and
converted within two years follow-up to a probable AD diagnosis.
• Subjects that were diagnosed as MCI at baseline but converted to probable AD more than
two years later (N=54) were excluded from the analyses and neither considered as sMCI nor
pMCI.
• The m12 image (I373205) of one subject (ADNI 007 S 4568) was reviewed after irregular
volume measurements and excluded manually from the analysis due to poor image quality2.
• All subjects summarised in Table 5.1 fulfil the above criteria. For the longitudinal analysis,
however, all subjects that converted at any time of the study from HC to a symptomatic stage
(e.g. MCI or even AD) were excluded (N=52).
Table 5.1 gives an overview over the baseline images considered in the conducted analyses. Lists
of the processed filenames that also include the unique image identifier and diagnosis are available
online345.
Table 5.1: Overview of the processed subjects from the ADNI cohort, including age and clinical
information at baseline.
all HC/CN sMCI pMCI AD
# of subjects/images at baseline 1069 404 166 177 322
gender (# male / # female) 581 / 488 202 / 202 98 / 68 104 / 73 177 / 145
years of age (median [min; max]) 74.6 [48.1; 91.4] 74.2 [59.8; 89.6] 74.4 [55.9; 91.4] 74.3 [48.1; 88.3] 75.8 [55.1; 91.4]
ApoE4 (# 0 / # 1 / # 2)† 547 / 407 / 113 293 / 101 / 9 93 / 60 / 13 57 / 91 / 29 104 / 155 / 62
MMSE (median [min; max]) 27 [18; 30] 29 [24; 30] 28 [24; 30] 26 [23; 30] 23 [18; 27]
FAQ (median [min; max])‡ 1 [0; 30] 0 [0; 6] 1 [0; 21] 5 [0; 21] 13 [0; 30]
CDRSB (median [min; max]) 1.5 [0; 10] 0 [0; 1] 1.5 [0.5; 4] 2 [0.5; 5] 4.5 [1; 10]
FieldStrength (1.5T/3T) 653 / 416 223 / 181 112 / 54 129 / 48 189 / 133
# of subjects/images at month 12 802 195 149 168 290
# of subjects/images at month 24 532 168 107 140 117
†: not available for 2 subjects, ‡: not available for 1 subject
ApoE: apolipoprotein E
MMSE: mini-mental state examination
FAQ: functional activities questionnaire
CDRSB: clinical dementia rating scale sum of boxes
2The ADNI cohort provides another (accelerated) m12 image for this subject of good quality. However, this other image
was not processed to avoid inconsistencies with the script that chooses an image in case of multiple possibilities.
3http://www.doc.ic.ac.uk/˜cl6311/PhD_thesis/ADNI_baseline_1069.csv, last accessed 29 June 2015.
4http://www.doc.ic.ac.uk/˜cl6311/PhD_thesis/ADNI_m12_802.csv, last accessed 29 June 2015.
5http://www.doc.ic.ac.uk/˜cl6311/PhD_thesis/ADNI_m24_532.csv, last accessed 29 June 2015.
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5.2 Methods
As the preprocessed images were downloaded from ADNI no additional preprocessing was per-
formed, such as smoothing or a correction for intensity inhomogeneities (Tustison et al., 2010).
Brain masks were calculated for all available baseline images using pincram (Heckemann et al.,
2015). Brain masks were visually reviewed and some were recalculated with an updated pincram
atlas database. Follow-up images were brain extracted utilising the corresponding baseline brain
masks which were transformed using rigid intrasubject registration. To avoid failures of this rigid
registration procedure a threshold was set on the image similarity of the follow-up image and trans-
formed baseline image. Transformations leading to an image similarity below a set threshold were
recalculated with updated parameters.
All baseline and follow-up (m12, m24) images were subsequently segmented using MALP-EM
as described in Chapter 3. Specifically, the 30 manually annotated brain atlases (cf . Section 2.2.5)
were propagated based on transformations calculated with the robust registration approachMAPER.
For the fusion of the propagated atlases the locally weighted fusion approach was chosen as it is
computationally more efficient and of similar accuracy compared to the patch-based joint label
fusion (Wang et al., 2013b). The probabilistic segmentation output and the intensity normalised,
brain extracted images were then employed to perform the consistent longitudinal segmentation
described as MALP-EM4D in Chapter 4. The standard, unweighted differential bias correction
approach was applied as described in Lewis and Fox (2004). Implementation and parameters were
otherwise identical to the experiments presented in Chapter 4.
5.3 Features and classification
For the cross-sectional analysis at baseline structural volumes were extracted for each individual
brain label available through the NMM brain atlas (cf . Section 2.2.5). Note that the baseline seg-
mentations were calculated with MALP-EM and not MALP-EM4D as the latter exploits informa-
tion of later scanning time points, which is not available at baseline.
For the longitudinal analysis structural volumes were extracted based on the respective MALP-
EM4D segmentations and atrophy rates calculated as described in Section 4.2.3.2.
As features all available structural volumes were employed, however, corresponding volumes
of the left and right brain hemisphere were merged (98/2=49 cortical plus 28/2+7=21 non-cortical
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features). Note that the seven non-cortical structures 3rd ventricles, 4th ventricle, brain stem, CSF,
cerebellar vermal lobule I-V, cerebellar vermal lobule VI-VII and cerebellar vermal lobule VIII-X
have no symmetric counterpart. An exception are the amygdala, hippocampus, inferior lateral ven-
tricles and the lateral ventricles. As it is expected that these structures are particularly informative
their respective left/right volumes were retained as separate features (8 features). This allows to
investigate whether there is substantial asymmetric involvement of these structures in the disease
progression. Individual structures were further summarised as ventricles, cortical grey matter, deep
grey matter, white matter, brain tissue and total brain volume (brain tissue including ventricles/CSF)
(6 features). The optic chiasm was excluded from the analysis due to its very small size. In total 86
features were considered, including age and gender.
For classification a 6-fold cross-validation (CV) was chosen using a LDA classifier for individ-
ual features. When combining multiple features both SVM and RF classifiers were employed to
investigate their respective performance. For individual features (LDA) 100 CV repetitions and for
the multi-feature classifiers (SVM, RF) 20 repetitions of the CV were performed. A classification
framework was implemented using MATLAB that relies on classify (LDA), TreeBagger (RF,
100 trees) and libSVM (SVM, (Chang and Lin, 2011)). For the SVM classification the features
were normalised individually to the range 0 to 1. This avoids that features with larger magnitude
have a stronger impact on the classification. The normalisation statistics were calculated based only
on the respective training set to avoid exploiting information from the test set and thus the introduc-
tion of bias. Both the LDA classifier, which was used for single-feature classification only, and the
RF classifier do not require feature normalisation.
Significance levels were quantified as p-values of two-sided, unpaired Student’s t-tests. Further,
effect sizes were calculated as Cohen’s d6 by dividing the differences of the sample means (absolute
value) by their pooled standard deviation (Cohen, 1988; Fennema-Notestine et al., 2009; Wang
et al., 2013b). Reporting the effect size in addition to the p-value is important as it quantifies the
magnitude of a group difference, while a low p-value only confirms its existence (Sullivan and
Feinn, 2012).
6According to Cohen (1988) an effect size of d = 0.2 can be considered as small, of d = 0.5 as medium and of d = 0.8
as large.
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Figure 5.1: Top: Dependence of hippocampal volume on age (left), gender (middle) and brain vol-
ume (right). Bottom: Corresponding volumes corrected for nuisance factors age, gender
and brain size. Overlaid regression lines for distinct disease groups with corresponding
regression lines.
5.4 Correction of nuisance factors
It is known that the volume of many individual brain structures reduces during the course of normal,
healthy aging. Also strong correlations between structural volumes and overall head size are well
established (Barnes et al., 2010). Even though less pronounced, significant gender-specific differ-
ences between groups with identical brain sizes were reported in the literature (Luders et al., 2009;
Barnes et al., 2010). The variation of structural volumes was calculated by fitting linear regressors
with respect to age, gender and brain volume based on the processed healthy control subjects. The
results are illustrated for the hippocampus in Figure 5.1.
The division of each structural volume by head or brain size is potentially inadequate (Barnes
et al., 2010). In this work a multivariate linear regression approach was followed as described in
Koikkalainen et al. (2012) to investigate and correct for three nuisance factors, namely: age, gender
and brain size. Specifically, a separate linear regressor is fit using the processed healthy control
subjects for each individual structure using the above-mentioned predictor variables. Each multi-
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Figure 5.2: Example cross-sectional segmentation results of baseline images of a healthy control
subject (top, ADNI 005 S 0553, male, 85 years of age) and a patient diagnosed AD
(bottom, ADNI 018 S 0286, male, 66 years of age) in axial (left), coronal (middle) and
sagittal (right) view-plane.
variate regressor is defined by the slope for each predictor cage, cgender and csize and an intercept b.
Assuming M distinct features, feature m of subject n, denoted as Fmn , is corrected as:
F˜mn = F
m
n   (cmageagen+ cmgendergendern+ cmsizesizen+bm) (5.1)
To correct for head size, the total brain size (sum of all structures) was used as an approximation
of the intracranial volume (ICV). This is a commonly used approximation (Buckner et al., 2004;
Smith et al., 2007; Barnes et al., 2010).
5.5 Results
5.5.1 Cross-sectional analysis
This cross-sectional analysis investigates the potential of volumes of individual brain ROIs to dis-
criminate different AD disease stages. An example segmentation result of a healthy control subject
and a patient diagnosed with AD is illustrated in Figure 5.2.
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Figure 5.3: Boxplots7 of structural volumes at baseline for six selected structures before (top two
rows) and after (bottom two rows) correcting for nuisance factors for distinct disease
groups. Note that the corrected volumes need to be read with respect to a healthy pop-
ulation of matched age, gender and brain size. Structures were selected based on their
performance in classifying the investigated disease groups (cf . Table 5.3).
7Boxplots were created with the ggplot2 package of R. Data points were jittered along x-axis for better visualisation.
A more detailed description of geom boxplot including the definition of error bars can be found at: http://docs.
ggplot2.org/0.9.3/geom_boxplot.html, last accessed: 12 June 2015.
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Table 5.2: Balanced classification accuracies in % for separating healthy control and AD subjects
(effect sizes in parentheses) after correcting for different nuisance factors (100 runs, 6-
fold cross-validation, LDA). Highest effect size in bold.
structures / correction none age brain size gender age, brain size, gender
Ventricles 65 (0.70) 65 (0.72) 68 (0.86) 65 (0.71) 71 (0.90)
CorticalGreyMatter 61 (0.53) 62 (0.53) 67 (0.86) 62 (0.67) 67 (0.90)
amygdala 75 (1.35) 76 (1.40) 79 (1.48) 77 (1.42) 80 (1.56)
hippocampus 75 (1.33) 75 (1.38) 77 (1.45) 76 (1.40) 78 (1.52)
EntA 73 (1.28) 74 (1.33) 75 (1.39) 76 (1.41) 78 (1.51)
InfLatVent 72 (1.10) 72 (1.16) 73 (1.19) 72 (1.14) 77 (1.27)
ITG 66 (0.89) 66 (0.89) 71 (1.13) 71 (1.07) 71 (1.17)
MTG 64 (0.74) 63 (0.73) 69 (0.97) 66 (0.86) 69 (0.97)
The distribution of the uncorrected volumes of six selected structures is shown in Figure 5.3 for
the four disease groups (HC, sMCI, pMCI and AD). The reduced grey matter volume of structures
in the medial temporal lobe and the increased ventricular volume in patients with AD is apparent.
In the following Section 5.5.1.1 the effect of correcting the structural volumes for patient age,
gender and brain size is evaluated. In Section 5.5.1.2 these corrected volumes will be employed to
investigate their potential for the classification relevant disease stages in AD.
5.5.1.1 Benefit of correcting for nuisance factors
The effect of correcting for the nuisance factors patient age, gender and head size is summarised
in Table 5.2. The conducted correction substantially increased classification accuracies and effect
sizes obtained on individual structures. The benefit of the performed correction for all investigated
structures, including effect sizes, can be found in Appendix E in Table E.1 and Table E.2. A visu-
alisation of the distributions of hippocampal volume in Figure 5.4 confirms that group separation
is improved (higher peaks) after the correction procedure. This is in agreement with the results
presented in Koikkalainen et al. (2012). Correcting for brain size had the biggest effect. In the con-
ducted experiment correcting for gender had a stronger impact than correcting for age. Correcting
for all three nuisance factors, age, gender and brain size, was most beneficial in terms of both clas-
sification accuracy and effect size. Note that experiments were performed to regress out magnetic
field strength as small but significant differences were observed between volume measurements of
the healthy control subjects scanned at 1.5T and 3T. However, preliminary results suggested that
correcting for field strength has no significant benefit. This was not further pursued and no explicit
correction for field strength differences applied in the following.
A visual illustration of the volumes before and after correction is provided in Figure 5.1 and
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Figure 5.4: Density plot of the hippocampal volumes before (left) and after (right) correction for
age, gender and brain size. Note that the corrected volumes need to be interpreted with
respect to the healthy reference group and have therefore zero-mean for HCs.
Figure 5.3. It can be seen that the healthy control population has zero mean after the correction and
the overall dependence on nuisance factors is clearly reduced.
For the cross-sectional analysis the corrected volumes are used. This means that feature values
are no longer actual volumes, but rather volume differences with respect to a healthy population of
matched age, gender and brain size. Note that the three independent variables patient age, gender
and head size were not corrected.
5.5.1.2 Disease classification using structural volumes
An overview over the results of the conducted classification experiments is given in Table 5.3.
The classification results for all structures can be found in Appendix E in Table E.1 (uncorrected
volumes, AD vs. HC), Table E.2 (AD vs. HC) and Table E.3 (pMCI vs. sMCI).
The volume of the amygdala allows the best group separation between AD and HC with an
effect size (Cohen’s d) of 1.56 and a bACC of 80% (SENS: 76%, SPEC: 84%). Other structures
in the MTL region such as the hippocampus (bACC: 78%) or the entorhinal area (bACC: 78%)
were similarly discriminative (d > 1.5). Established findings that overall brain tissue, and cortical
grey matter in particular, are of smaller size in patients with AD were confirmed. By combining
all considered structural volumes as features in a SVM (bACC: 89%, SENS: 86%, SPEC: 92%)
or RF (bACC: 86%, SENS: 83%, SPEC: 90%) accuracy was further improved. As indicated in
Table 5.3 numerous structural differences were highly significant even after Bonferroni correction
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Table 5.3: Classification results in % (6-fold cross-validation, LDA 100 runs, RF/SVM 20 runs)
obtained separating AD from CN (top) and stable from progressive MCI (bottom). In-
dividual structures are sorted by effect size. The 20 structures with highest effect size
are listed explicitly. Significant group differences indicated by + (p < 0.05) and ++ (p
< 0.001). Bonferroni corrected significance in parentheses. Features were corrected for
age, gender and brain size.
AD patients (N = 322, PositivesP) vs. Healthy Controls (N = 404, NegativesN) (baseline analysis, †volumes corrected for age/gender/brain size)
structure ACC (bACC) SENS SPEC mean (SD) [mm3]P,† mean (SD) [mm3]N,† effect size (d) p-value sig. (corr.)
RandomForest (all features) 87 (86) 83 90
SVM (all features) 90 (89) 86 92
BrainTissue 72 (71) 63 78 -17942.8 (22718.7) 0 (17403.6) 0.900 <0.00001 ++ (++)
CorticalGreyMatter 68 (67) 63 72 -23635.9 (28907.3) 0 (24078.1) 0.898 <0.00001 ++ (++)
Ventricles 72 (71) 63 79 17757.3 (22639.6) 0 (17293.9) 0.895 <0.00001 ++ (++)
WhiteMatter 57 (56) 51 61 7242.2 (29309.8) 0 (28686.1) 0.250 0.00086 ++ (o)
DeepGreyMatter 52 (52) 50 54 -1549.1 (13310.2) 0 (11142.2) 0.127 0.08834 o (o)
Brain 54 (55) 56 53 1199158.5 (132290.9) 1212115.6 (118623.9) 0.104 0.16526 o (o)
Amygdala 80 (80) 76 84 -452.0 (332.0) 0 (250.5) 1.561 <0.00001 ++ (++)
Hippocampus 78 (78) 75 80 -1115.4 (817.7) 0 (660.7) 1.519 <0.00001 ++ (++)
EntA 78 (78) 76 80 -801.3 (583.3) 0 (485.3) 1.509 <0.00001 ++ (++)
LeftHippocampus 79 (78) 76 81 -588.1 (423.1) 0 (364.6) 1.502 <0.00001 ++ (++)
RightAmygdala 80 (80) 77 83 -232.2 (182.6) 0 (139.4) 1.452 <0.00001 ++ (++)
LeftAmygdala 78 (78) 75 81 -219.8 (179.7) 0 (135.5) 1.403 <0.00001 ++ (++)
RightHippocampus 76 (75) 71 79 -527.3 (488.0) 0 (339.1) 1.280 <0.00001 ++ (++)
InfLatVent 78 (77) 65 89 1330.8 (1367.4) 0 (702.2) 1.267 <0.00001 ++ (++)
LeftInfLatVent 77 (76) 66 86 649.5 (677.1) 0 (360.6) 1.237 <0.00001 ++ (++)
ITG 71 (71) 69 73 -2588.0 (2506.9) 0 (1954.5) 1.168 <0.00001 ++ (++)
RightInfLatVent 75 (73) 59 87 681.3 (814.9) 0 (391.3) 1.106 <0.00001 ++ (++)
PHG 68 (68) 64 72 -739.8 (832.6) 0 (702.4) 0.970 <0.00001 ++ (++)
MTG 69 (69) 69 70 -2534.0 (2853.0) 0 (2411.3) 0.969 <0.00001 ++ (++)
AnG 68 (67) 65 70 -1880.5 (2345.6) 0 (1973.2) 0.876 <0.00001 ++ (++)
TMP 66 (65) 64 67 -1521.7 (1967.2) 0 (1539.3) 0.873 <0.00001 ++ (++)
LateralVentricle 71 (70) 62 78 15972.2 (21196.2) 0 (16214.4) 0.859 <0.00001 ++ (++)
LeftLateralVentricle 70 (69) 61 76 8584.7 (11586.9) 0 (8816.1) 0.847 <0.00001 ++ (++)
RightLateralVentricle 70 (69) 59 78 7387.5 (10387.1) 0 (7883.2) 0.814 <0.00001 ++ (++)
STG 65 (65) 64 66 -1100.3 (1610.7) 0 (1478.6) 0.715 <0.00001 ++ (++)
3rdVentricle 67 (66) 63 70 434.3 (699.9) 0 (591.1) 0.677 <0.00001 ++ (++)
progressive MCI (N = 177, PositivesP) vs. stable MCI (N = 166, NegativesN) (baseline analysis, †volumes corrected for age/gender/brain size)
structure ACC (bACC) SENS SPEC mean (SD) [mm3]P,† mean (SD) [mm3]N,† effect size (d) p-value sig. (corr.)
RandomForest (all features) 68 (68) 72 64
SVM (all features) 67 (67) 70 64
BrainTissue 60 (60) 51 69 -12652.2 (20144.6) -4372.1 (20741.3) 0.405 0.00021 ++ (+)
Ventricles 60 (60) 51 70 12483.5 (20045.3) 4427.7 (20676.8) 0.396 0.00029 ++ (+)
CorticalGreyMatter 56 (56) 55 56 -16743.9 (27348.8) -6929.4 (26948.6) 0.361 0.00091 ++ (o)
Brain 51 (51) 52 49 1222424.9 (131084.2) 1238635.5 (118830.2) 0.129 0.23200 o (o)
WhiteMatter 48 (48) 47 49 5966.3 (27919.1) 4607.3 (26735.5) 0.050 0.64592 o (o)
DeepGreyMatter 47 (47) 46 48 -1874.6 (11838.0) -2050.0 (11988.8) 0.015 0.89167 o (o)
Amygdala 65 (65) 63 68 -387.4 (308.7) -149.4 (352.2) 0.720 <0.00001 ++ (++)
LeftAmygdala 62 (62) 61 64 -191.6 (161.2) -70.4 (189.7) 0.690 <0.00001 ++ (++)
InfLatVent 64 (64) 54 74 1034.0 (1097.9) 358.6 (903.1) 0.670 <0.00001 ++ (++)
LeftInfLatVent 65 (65) 56 75 480.0 (538.2) 156.3 (451.1) 0.650 <0.00001 ++ (++)
RightAmygdala 65 (65) 63 67 -195.8 (176.7) -79.0 (184.1) 0.648 <0.00001 ++ (++)
EntA 61 (61) 61 60 -678.3 (565.7) -294.0 (622.8) 0.647 <0.00001 ++ (++)
RightInfLatVent 64 (64) 54 74 554.0 (689.1) 202.3 (527.5) 0.571 <0.00001 ++ (++)
Hippocampus 61 (61) 63 60 -1042.8 (817.1) -604.7 (786.1) 0.546 <0.00001 ++ (++)
RightHippocampus 63 (63) 61 64 -514.7 (442.9) -287.7 (408.3) 0.532 <0.00001 ++ (++)
MTG 60 (60) 59 60 -2305.3 (2698.1) -925.8 (2708.9) 0.510 <0.00001 ++ (++)
AnG 60 (60) 61 59 -1579.0 (2223.0) -495.7 (2084.0) 0.502 <0.00001 ++ (++)
LeftHippocampus 61 (61) 62 60 -528.1 (429.6) -317.0 (425.8) 0.493 <0.00001 ++ (++)
CSF 59 (59) 54 64 156.4 (533.9) -61.6 (491.3) 0.424 0.00010 ++ (+)
3rdVentricle 59 (59) 55 64 376.2 (661.3) 113.9 (639.9) 0.403 0.00023 ++ (+)
LateralVentricle 60 (61) 51 70 11080.2 (18700.0) 3986.3 (19536.4) 0.371 0.00066 ++ (o)
RightLateralVentricle 60 (60) 51 69 5078.1 (9151.1) 1656.3 (9510.1) 0.367 0.00077 ++ (o)
LeftLateralVentricle 59 (59) 51 68 6002.1 (10336.4) 2330.0 (10722.7) 0.349 0.00136 + (o)
STG 57 (57) 57 56 -1048.8 (1509.9) -513.8 (1583.2) 0.346 0.00149 + (o)
ITG 57 (57) 57 56 -1510.5 (2300.7) -691.2 (2482.3) 0.343 0.00165 + (o)
TMP 58 (58) 58 58 -875.3 (1703.2) -310.1 (1766.7) 0.326 0.00275 + (o)
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for multiple comparisons.
For the classification of pMCI vs. sMCI the structural volumes of the amygdala (bACC: 65%,
SENS: 63%, SPEC: 68%) and inferior lateral ventricles (bACC: 64%, SENS: 54%, SPEC: 74%)
were most discriminative. Combining all extracted structural volumes into a single RF classifier
further increased classification accuracies to bACC: 68%, SENS: 72%, SPEC: 64%.
5.5.2 Longitudinal analysis
This longitudinal analysis investigates the volume change of individual ROIs with respect to dis-
ease stage. Atrophy was measured for the m12 or m24 follow-up images with respect to their
corresponding baseline images. The calculated atrophy rates and the resulting sample sizes are pre-
sented in Section 5.5.2.1. Their potential as features to discriminate disease stages is investigated
in Section 5.5.2.2. An example segmentation result obtained on a subject diagnosed with AD using
MALP-EM4D is shown in Figure 5.5.
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Figure 5.5: Example longitudinal segmentation results of baseline (left) and month 24 (middle)
follow-up images of a patient diagnosed AD (ADNI 018 S 0286) in axial view-plane.
Substantial hippocampal atrophy (measured: -7.81%) and ventricular enlargement
(16.5%) is apparent in the difference image after affine registration (right).
5.5.2.1 Atrophy rates and sample sizes
Atrophy rates for selected structures can be found in Table 5.5 for AD/HC and in Table 5.6 for
pMCI/sMCI. Corresponding atrophy rates for all investigated structures can be found in Appendix
E. The distribution of the volume change of six selected structures is shown in Figure 5.6 for the
four investigated disease groups (HC, sMCI, pMCI and AD).
In AD patients grey matter structures such as the hippocampus (HC: -1.1%, AD: -4.8%) or the
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Figure 5.6: Boxplots of volume changes for selected brain structures (top) and surrogate structures
(bottom) from baseline to month 24 follow-up image for different disease groups. Fea-
tures selected based on their performance in classifying the investigated disease groups
(cf . Table 5.5 and Table 5.6).
medial temporal gyrus (HC: -1.1%, AD: -3.8%) are subject to significant volume loss between
baseline and m12. In contrast to this ventricles expand substantially faster in AD patients (HC:
2.8%, AD: 7.2%). Overall sMCI patients show atrophy patterns similar to HC, while MCI patients
converting to AD are, in terms of atrophy, very similar to AD patients. Atrophy rates measured
between the baseline and m24 follow-up image are in the order of twice the rates measured between
baseline and the m12 follow-up image. The results indicate that atrophy in the entorhinal area is
slightly higher in pMCI patients than in patients with AD. At m12 an atrophy rate of -4.0% (±3.7)
for pMCI and -3.7% (±4.1) for AD patients was measured, at m24 for pMCI -7.4% (±4.7) and
-7.0% (±5.5) for AD patients respectively.
Based on the atrophy rates sample sizes were calculated as outlined in Section 4.1.3.4. The
sample sizes were thus calculated to detect a 25% change in atrophy rate with 80% power at a 5%
significance level. The atrophy rates and sample sizes for selected structures are summarised in
Table 5.4.
The lowest sample sizes (corrected for normal aging) were computed for the inferior lateral
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Table 5.4: Mean volume change of selected structures in % with corresponding sample sizes for
different disease groups. Standard deviation in parentheses. Measurements based on vol-
ume change from baseline to 12 months (top table) or 24 months (bottom table) follow-up
visit. Corrected sample sizes were computed on the excess change over normal aging.
bl!m12 hippocampus inf. lat. vent. lat. vent. med. temp. gyr. brain tissue ventricles white matter cort. GM deep GM
Normal -1.1 (1.7) 1.8 (3.3) 3.0 (3.2) -1.1 (1.5) -0.5 (0.8) 2.8 (3.0) -0.2 (0.7) -0.8 (1.4) -0.8 (1.3)
Atrophy sMCI -1.7 (2.2) 2.6 (3.8) 3.6 (3.3) -1.4 (1.8) -0.6 (0.8) 3.4 (3.1) -0.4 (0.7) -0.8 (1.3) -0.7 (1.3)
rates pMCI -4.1 (3.2) 6.7 (5.6) 7.1 (4.6) -3.1 (2.4) -1.2 (1.0) 6.8 (4.3) -0.6 (0.9) -1.8 (1.7) -1.3 (1.2)
AD -4.8 (3.7) 7.5 (5.5) 7.6 (4.9) -3.8 (2.7) -1.3 (1.1) 7.2 (4.6) -0.8 (1.0) -1.9 (2.3) -1.4 (1.6)
sMCI (uncor.) 412 548 217 384 383 215 966 674 739
sMCI (CN-cor.) 3130 5190 7499 8823 17269 6337 2834 18432936 1429741
Sample pMCI (uncor.) 155 175 104 143 168 100 488 235 218
sizes pMCI (CN-cor.) 284 321 309 351 535 285 864 813 1349
AD (uncor.) 148 134 104 133 182 101 413 366 336
AD (CN-cor.) 244 228 285 270 493 265 640 640 1133
bl!m24 hippocampus inf. lat. vent. lat. vent. med. temp. gyr. brain tissue ventricles white matter cort. GM deep GM
Normal -2.0 (2.3) 3.5 (4.5) 6.3 (4.0) -2 (1.6) -1.1 (0.8) 5.8 (3.7) -0.6 (0.8) -1.6 (1.7) -1.3 (1.3)
Atrophy sMCI -3.7 (3.8) 6.2 (6.5) 7.5 (6.0) -2.6 (2.6) -1.2 (1.0) 7.1 (5.6) -0.8 (1.0) -1.7 (1.5) -1.2 (1.0)
rates pMCI -8.9 (5.1) 14.6 (8.9) 14.4 (7.9) -6.1 (3.9) -2.3 (1.5) 13.7 (7.4) -1.6 (1.3) -3.2 (2.5) -2.1 (1.4)
AD -10.2 (6.2) 15.9 (8.8) 15.4 (8.5) -6.8 (4.1) -2.6 (1.3) 14.7 (7.8) -1.8 (1.4) -3.5 (2.4) -2.3 (1.8)
sMCI (uncor.) 264 274 158 246 173 158 370 215 176
sMCI (CN-cor.) 1166 1446 6179 4588 23154 5166 4764 102542 23243
Sample pMCI (uncor.) 82 92 76 105 99 73 163 155 107
sizes pMCI (CN-cor.) 136 160 241 233 372 220 412 618 782
AD (uncor.) 93 76 75 92 67 71 145 123 162
AD (CN-cor.) 142 126 217 185 216 195 316 420 980
ventricles with 228 for bl!m12 and 126 for bl!m24. However, the measured atrophy of other
structures such as the hippocampus or the medial temporal gyrus provided sample sizes at a similar
level.
5.5.2.2 Disease classification using structural volume change
The potential of structural atrophy rates to separate the clinical groups AD vs. HC and pMCI vs.
sMCI was investigated in the following. P-values, effect sizes and classification accuracies were
calculated to quantify group separation. The results are summarised in Table 5.5 (AD vs. HC) and
Table 5.6 (pMCI vs. sMCI). As features the atrophy rates calculated between the baseline and m12
follow-up image were used, or m24 follow-up image respectively. An overview over all considered
features and their individual classification performance can be found in Appendix E.
The most discriminative structure for AD vs. HC separation was the hippocampus (dm12=1.40,
dm24=1.88). Based on m12 atrophy a bACCm12 of 78% (SENS: 67%, SPEC: 88%) was calculated,
for m24 atrophy a balanced accuracy of 85% respectively. Combining all derived atrophy features
in a RF classifier substantially increased classification results to bACCm12: 84%; bACCm24: 88%.
Hippocampal atrophy was also a very good feature for classifying progressive and stable MCI
patients: bACCm12: 67%; bACCm24: 74%. However, the highest individual classification accuracy
was obtained at m12 for the medial temporal gyrus (bACCm12: 70%, SENS: 65%, SPEC: 75%) and
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Table 5.5: Classification results in % (6-fold cross-validation, LDA 100 runs, RF/SVM 20 runs) for
separating AD from CN based on volume change from baseline to m12 (top) or m24
(bottom). Individual structures are sorted by effect size. The 20 structures with highest
effect size are listed explicitly. Significant group differences indicated by + (p < 0.05)
and ++ (p < 0.001). Bonferroni corrected significance in parentheses.
AD patients (N = 195, PositivesP) vs. Healthy Controls (N = 290, NegativesN) (longitudinal analysis, bl!m12)
structure ACC (bACC) SENS SPEC mean (SD) [%]P mean (SD) [%]N effect size (d) p-value sig. (corr.)
RandomForest (all features) 85 (84) 78 90
SVM (all features) 84 (82) 71 93
Ventricles 75 (74) 64 83 7.2 (4.6) 2.8 (3.0) 1.202 <0.00001 ++ (++)
BrainTissue 70 (70) 67 72 -1.3 (1.1) -0.5 (0.8) 0.862 <0.00001 ++ (++)
WhiteMatter 73 (73) 68 77 -0.8 (1.0) -0.2 (0.7) 0.736 <0.00001 ++ (++)
CorticalGreyMatter 65 (64) 62 67 -1.9 (2.3) -0.8 (1.4) 0.585 <0.00001 ++ (++)
Brain 64 (64) 63 65 -0.9 (1.0) -0.4 (0.7) 0.574 <0.00001 ++ (++)
DeepGreyMatter 66 (64) 57 71 -1.4 (1.7) -0.8 (1.3) 0.455 <0.00001 ++ (++)
Hippocampus 80 (78) 67 88 -4.8 (3.7) -1.1 (1.7) 1.400 <0.00001 ++ (++)
InfLatVent 79 (77) 69 86 7.5 (5.5) 1.8 (3.3) 1.334 <0.00001 ++ (++)
LeftHippocampus 80 (78) 70 87 -4.9 (4.2) -1.1 (1.7) 1.287 <0.00001 ++ (++)
MTG 76 (74) 67 82 -3.8 (2.8) -1.1 (1.5) 1.274 <0.00001 ++ (++)
RightInfLatVent 77 (75) 65 84 7.4 (6.4) 1.8 (3.3) 1.185 <0.00001 ++ (++)
RightLateralVentricle 75 (73) 63 83 7.5 (5.1) 2.8 (3.1) 1.170 <0.00001 ++ (++)
LeftInfLatVent 78 (76) 70 83 7.5 (5.8) 1.7 (4.4) 1.166 <0.00001 ++ (++)
LateralVentricle 74 (72) 62 83 7.6 (4.9) 3.0 (3.2) 1.160 <0.00001 ++ (++)
RightHippocampus 78 (75) 62 89 -4.8 (4.5) -1.1 (2.1) 1.138 <0.00001 ++ (++)
LeftLateralVentricle 74 (72) 63 81 7.6 (4.9) 3.1 (3.4) 1.085 <0.00001 ++ (++)
PP 77 (76) 70 81 -6.7 (5.5) -2.0 (3.5) 1.075 <0.00001 ++ (++)
CerebralWhiteMatter 76 (74) 67 82 -0.9 (0.9) -0.2 (0.6) 0.914 <0.00001 ++ (++)
PT 70 (69) 62 76 -5.8 (5.3) -2.1 (3.1) 0.898 <0.00001 ++ (++)
ITG 72 (71) 67 75 -2.7 (2.7) -1.0 (1.3) 0.866 <0.00001 ++ (++)
FuG 69 (68) 63 73 -1.7 (1.7) -0.5 (1.1) 0.852 <0.00001 ++ (++)
Amygdala 76 (74) 66 83 -3.3 (5.0) -0.5 (2.0) 0.787 <0.00001 ++ (++)
EntA 69 (69) 65 72 -3.7 (4.1) -1.2 (2.8) 0.747 <0.00001 ++ (++)
TMP 72 (71) 67 74 -4.3 (4.6) -1.8 (2.8) 0.700 <0.00001 ++ (++)
LeftAmygdala 73 (70) 58 82 -3.6 (6.2) -0.5 (2.5) 0.699 <0.00001 ++ (++)
SMG 64 (64) 61 67 -2.9 (3.5) -1.1 (2.1) 0.674 <0.00001 ++ (++)
AD patients (N = 117, PositivesP) vs. Healthy Controls (N = 168, NegativesN) (longitudinal analysis, bl!m24)
structure ACC (bACC) SENS SPEC mean (SD) [%]P mean (SD) [%]N effect size (d) p-value sig. (corr.)
RandomForest (all features) 89 (88) 81 94
SVM (all features) 89 (88) 80 95
Ventricles 83 (81) 70 92 14.7 (7.9) 5.8 (3.7) 1.531 <0.00001 ++ (++)
BrainTissue 80 (78) 71 86 -2.6 (1.3) -1.1 (0.8) 1.353 <0.00001 ++ (++)
WhiteMatter 75 (74) 65 82 -1.8 (1.4) -0.6 (0.8) 1.121 <0.00001 ++ (++)
CorticalGreyMatter 73 (73) 69 77 -3.5 (2.4) -1.6 (1.7) 0.928 <0.00001 ++ (++)
Brain 68 (67) 65 70 -1.5 (1.0) -0.8 (0.7) 0.847 <0.00001 ++ (++)
DeepGreyMatter 67 (66) 63 69 -2.3 (1.8) -1.3 (1.3) 0.604 <0.00001 ++ (++)
Hippocampus 87 (85) 77 94 -10.2 (6.2) -2.0 (2.4) 1.880 <0.00001 ++ (++)
InfLatVent 84 (83) 76 90 15.9 (8.8) 3.5 (4.5) 1.871 <0.00001 ++ (++)
RightInfLatVent 83 (82) 73 90 16.1 (9.7) 3.5 (4.9) 1.728 <0.00001 ++ (++)
LeftHippocampus 86 (84) 77 92 -9.9 (6.6) -1.9 (2.7) 1.701 <0.00001 ++ (++)
LeftInfLatVent 80 (78) 69 88 15.5 (9.5) 3.5 (5.2) 1.652 <0.00001 ++ (++)
MTG 83 (81) 70 92 -6.8 (4.1) -2.0 (1.6) 1.651 <0.00001 ++ (++)
RightHippocampus 84 (81) 69 94 -10.5 (7.6) -2.0 (2.6) 1.617 <0.00001 ++ (++)
ITG 83 (81) 71 91 -5.3 (3.3) -1.6 (1.4) 1.603 <0.00001 ++ (++)
FuG 85 (83) 72 93 -3.7 (2.7) -0.7 (0.9) 1.588 <0.00001 ++ (++)
LeftLateralVentricle 82 (80) 71 89 15.6 (8.2) 6.5 (4.4) 1.470 <0.00001 ++ (++)
PP 80 (79) 73 85 -10.9 (6.1) -3.9 (3.5) 1.466 <0.00001 ++ (++)
LateralVentricle 80 (78) 65 90 15.4 (8.5) 6.3 (4.0) 1.454 <0.00001 ++ (++)
TMP 84 (82) 75 90 -8.2 (5.1) -2.8 (2.5) 1.430 <0.00001 ++ (++)
RightLateralVentricle 80 (77) 63 92 15.1 (9.3) 6.2 (4.0) 1.331 <0.00001 ++ (++)
PT 78 (77) 70 83 -10.0 (6.2) -3.8 (3.5) 1.276 <0.00001 ++ (++)
EntA 80 (79) 72 86 -7.0 (5.5) -2.2 (3.1) 1.151 <0.00001 ++ (++)
CerebralWhiteMatter 75 (74) 65 83 -1.9 (1.3) -0.7 (0.9) 1.138 <0.00001 ++ (++)
Amygdala 81 (79) 70 89 -7.3 (6.7) -1.7 (3.7) 1.076 <0.00001 ++ (++)
RightAmygdala 79 (77) 69 85 -7.6 (7.0) -1.8 (4.2) 1.050 <0.00001 ++ (++)
SMG 71 (70) 61 78 -5.7 (4.6) -2.2 (2.6) 0.968 <0.00001 ++ (++)
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Table 5.6: Classification results in % (6-fold cross-validation, LDA 100 runs, RF/SVM 20 runs) for
separating progressive from stable MCI based on volume change from baseline to m12
(top) or m24 (bottom). Individual structures are sorted by effect size. The 20 structures
with highest effect size are listed explicitly. Significant group differences indicated by +
(p < 0.05) and ++ (p < 0.001). Bonferroni corrected significance in parentheses.
progressive MCI (N = 168, PositivesP) vs. stable MCI (N = 149, NegativesN) (longitudinal analysis, bl!m12)
structure ACC (bACC) SENS SPEC mean (SD) [%]P mean (SD) [%]N effect size (d) p-value sig. (corr.)
RandomForest (all features) 74 (73) 77 70
SVM (all features) 74 (74) 72 75
Ventricles 68 (69) 63 74 6.8 (4.3) 3.4 (3.1) 0.890 <0.00001 ++ (++)
BrainTissue 63 (63) 64 63 -1.2 (1.0) -0.6 (0.8) 0.652 <0.00001 ++ (++)
CorticalGreyMatter 64 (64) 67 61 -1.8 (1.7) -0.8 (1.3) 0.608 <0.00001 ++ (++)
Brain 58 (58) 62 54 -0.8 (0.8) -0.4 (0.6) 0.495 0.00002 ++ (+)
DeepGreyMatter 64 (64) 62 66 -1.3 (1.2) -0.7 (1.3) 0.428 0.00017 ++ (+)
WhiteMatter 63 (63) 61 64 -0.6 (0.9) -0.4 (0.7) 0.310 0.00615 + (o)
Hippocampus 67 (67) 59 76 -4.1 (3.2) -1.7 (2.2) 0.867 <0.00001 ++ (++)
LateralVentricle 67 (68) 61 75 7.1 (4.6) 3.6 (3.4) 0.866 <0.00001 ++ (++)
InfLatVent 69 (69) 63 75 6.7 (5.6) 2.6 (3.8) 0.845 <0.00001 ++ (++)
LeftHippocampus 67 (68) 60 75 -4.2 (3.3) -1.7 (2.5) 0.845 <0.00001 ++ (++)
LeftLateralVentricle 66 (67) 60 73 7.2 (4.8) 3.6 (3.5) 0.836 <0.00001 ++ (++)
RightLateralVentricle 67 (67) 62 72 7.0 (4.6) 3.6 (3.6) 0.828 <0.00001 ++ (++)
MTG 70 (70) 65 75 -3.1 (2.4) -1.4 (1.8) 0.807 <0.00001 ++ (++)
ITG 67 (67) 64 70 -2.5 (2.0) -1.1 (1.6) 0.793 <0.00001 ++ (++)
LeftInfLatVent 68 (69) 62 76 6.7 (6.2) 2.4 (4.3) 0.783 <0.00001 ++ (++)
EntA 67 (67) 67 68 -4.0 (3.7) -1.4 (3.3) 0.749 <0.00001 ++ (++)
PT 68 (68) 63 73 -5.5 (4.5) -2.6 (3.3) 0.727 <0.00001 ++ (++)
RightInfLatVent 64 (64) 58 71 6.7 (6.2) 2.7 (4.4) 0.726 <0.00001 ++ (++)
FuG 66 (66) 63 69 -1.5 (1.6) -0.5 (1.1) 0.694 <0.00001 ++ (++)
PP 66 (67) 64 70 -5.8 (4.6) -2.9 (3.9) 0.692 <0.00001 ++ (++)
RightHippocampus 65 (65) 57 73 -4.0 (3.9) -1.7 (2.8) 0.677 <0.00001 ++ (++)
3rdVentricle 64 (64) 61 67 4.7 (3.8) 2.5 (3.7) 0.590 <0.00001 ++ (++)
Amygdala 65 (66) 58 73 -3.2 (4.1) -1.2 (2.8) 0.577 <0.00001 ++ (++)
RightAmygdala 64 (64) 56 73 -3.7 (5.5) -1.1 (3.3) 0.567 <0.00001 ++ (++)
TTG 61 (62) 61 62 -4.4 (4.2) -2.2 (3.5) 0.558 <0.00001 ++ (++)
TMP 64 (64) 64 64 -3.9 (3.7) -2.2 (3.0) 0.524 <0.00001 ++ (++)
progressive MCI (N = 140, PositivesP) vs. stable MCI (N = 107, NegativesN) (longitudinal analysis, bl!m24)
structure ACC (bACC) SENS SPEC mean (SD) [%]P mean (SD) [%]N effect size (d) p-value sig. (corr.)
RandomForest (all features) 79 (78) 82 74
SVM (all features) 76 (76) 76 76
Ventricles 71 (72) 65 80 13.7 (7.4) 7.1 (5.6) 0.989 <0.00001 ++ (++)
BrainTissue 68 (69) 62 76 -2.3 (1.5) -1.2 (1.0) 0.845 <0.00001 ++ (++)
DeepGreyMatter 66 (67) 64 69 -2.1 (1.4) -1.2 (1.0) 0.714 <0.00001 ++ (++)
CorticalGreyMatter 65 (66) 61 71 -3.2 (2.5) -1.7 (1.6) 0.707 <0.00001 ++ (++)
Brain 63 (63) 60 67 -1.5 (1.1) -0.8 (0.7) 0.707 <0.00001 ++ (++)
WhiteMatter 64 (65) 55 74 -1.6 (1.3) -0.8 (1.0) 0.661 <0.00001 ++ (++)
FuG 75 (76) 69 83 -3.1 (2.1) -1.0 (1.4) 1.141 <0.00001 ++ (++)
Hippocampus 73 (74) 68 80 -8.9 (5.1) -3.7 (3.8) 1.118 <0.00001 ++ (++)
LeftHippocampus 74 (74) 72 77 -9.3 (5.6) -3.8 (4.2) 1.083 <0.00001 ++ (++)
EntA 71 (72) 66 77 -7.4 (4.7) -2.8 (3.6) 1.070 <0.00001 ++ (++)
InfLatVent 70 (72) 62 81 14.6 (8.9) 6.2 (6.6) 1.053 <0.00001 ++ (++)
MTG 72 (74) 64 83 -6.1 (3.9) -2.6 (2.6) 1.016 <0.00001 ++ (++)
LeftInfLatVent 68 (69) 60 79 14.7 (9.4) 6.4 (6.8) 0.987 <0.00001 ++ (++)
PT 68 (68) 62 75 -9.7 (5.6) -4.7 (4.2) 0.971 <0.00001 ++ (++)
LateralVentricle 70 (71) 64 78 14.4 (7.9) 7.5 (6.0) 0.960 <0.00001 ++ (++)
ITG 72 (73) 66 80 -4.7 (2.9) -2.1 (2.2) 0.958 <0.00001 ++ (++)
LeftLateralVentricle 69 (70) 62 77 14.6 (8.2) 7.6 (6.1) 0.956 <0.00001 ++ (++)
RightInfLatVent 66 (68) 60 76 14.3 (10.1) 5.9 (7.4) 0.923 <0.00001 ++ (++)
RightHippocampus 71 (72) 65 79 -8.6 (5.7) -3.7 (4.6) 0.920 <0.00001 ++ (++)
RightLateralVentricle 69 (70) 61 79 14.1 (8.1) 7.5 (6.3) 0.907 <0.00001 ++ (++)
Amygdala 67 (68) 61 76 -6.4 (5.2) -2.9 (3.5) 0.770 <0.00001 ++ (++)
TTG 65 (66) 62 70 -8.0 (5.3) -4.4 (4.1) 0.752 <0.00001 ++ (++)
PHG 66 (68) 58 77 -3.5 (2.8) -1.5 (2.4) 0.746 <0.00001 ++ (++)
3rdVentricle 64 (65) 61 68 9.1 (6.2) 4.7 (5.5) 0.740 <0.00001 ++ (++)
PP 68 (69) 65 72 -10.0 (5.7) -5.9 (5.5) 0.728 <0.00001 ++ (++)
TMP 68 (69) 64 74 -6.9 (4.5) -3.9 (3.6) 0.721 <0.00001 ++ (++)
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the inferior lateral ventricles (bACCm12: 69%, SENS: 63%, SPEC: 75%). Over 24 months, atrophy
in the fusiform gyrus was most informative to classify MCI subjects (bACCm24: 76%). Exploiting
all available longitudinal features in a RF classifier further increased MCI classification accuracy to
bACCm12: 73%; bACCm24: 78%.
Ventricular enlargement is more discriminative than a reduction in brain tissue for both AD vs.
HC and pMCI vs. sMCI classification.
5.6 Discussion
In Section 4.2 MALP-EM4Dwas compared to other state-of-the-art approaches (Wolz et al., 2010b;
Leung et al., 2010a) on a common, identical dataset. In this chapter a set of 1069 baseline, 802 m12
and 532 m24 follow-up images from the ADNI-1/-GO/-2 cohort was analysed. Given this large
number of images the performed analysis should generalise to other datasets.
Table 5.7: Overview over selected articles that use features from T1w MR images from the ADNI
cohort. Table adapted from Falahati et al. (2014). CTH: cortical thickness, ENR: elas-
tic net regression, HV: hippocampus volume, LLE: locally linear embedding, MBL:
manifold-based learning, MIL: multiple instance learning, OPLS: orthogonal partial least
square to latent structure, SR: spare regression, TBM: tensor-based morphometry.
Article Dataset (field strength) Features Classifier AD vs. HC pMCI vs. sMCI
bACC SENS SPEC NAD/NHC bACC SENS SPEC NpMCI/NsMCI
MALP-EM ADNI1/Go/2 (1.5/3T) ROI volumes RF 86 83 90 322/404 68 72 64 177/166
MALP-EM ADNI1/Go/2 (1.5/3T) ROI volumes SVM 89 86 92 322/404 67 70 64 177/166
Coupe´ et al. (2012b) ADNI1 (1.5T) ROI volumes and LDA 90.5 87 94 198/231 73.5 73 74 167/238
grading features
Chincarini et al. (2011) ADNI1 (1.5T) intensity and textural features SVM 91.5 89 94 144/189 68.5 72 65 136/166
features from 9 ROIs
Guerrero et al. (2014) ADNI1 (1.5T) learned ROIs via SR + MBL SVM 85.5 86 85 106/175 71 75 67 116/114
Liu et al. (2013) ADNI1 (1.5T) ROI volumes, CTH ENR + LLE 89.5 86 93 86/137 68 80 56 97/93
Tong et al. (2014) ADNI1 (1.5T) local intensity patches MIL 89 85 93 198/231 70 67 73 167/238
Wee et al. (2013) ADNI1 (1.5T) correlative and ROI-based SVM 92.4 90.4 94.3 198/200 74.0 63.5 84.4 89/111
morphological features
Westman et al. (2013) ADNI1 (1.5T) ROI volumes, CTH, OPLS 91.5 90 93 187/225 71.2 75.9 66.5 87/200
curvature and folding features
Wolz et al. (2011) ADNI1 (1.5T) HV, CTH, TBM, MBL LDA 89 93 85 198/231 68 67 69 167/238
A selection of articles is summarised in Table 5.7 to put the calculated classification results into
the context of those reported in the literature. When comparing results to other studies it must
be noted that these usually use other ADNI subsets. A further potential confounding factor is the
definition of the sMCI and pMCI disease groups. The stratification of MCI subjects into sMCI and
pMCI respectively was defined in Section 5.1. However, this definition is not identical throughout
published studies.
The presented cross-sectional classification results (cf . Section 5.5.1.2) are very similar to those
presented in Wolz et al. (2011), which are based on the ADNI-1 cohort. In this work the authors
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classified AD vs. HC (bACC: 89%, SENS: 93%, SPEC: 85%) and pMCI vs. sMCI (bACC: 68%,
SENS: 67%, SPEC: 69%) based on a multitude of features including more abstract features from
TBM and manifold-learning based methods. Other studies report even higher classification results
of up to bACC: 92.4% for AD vs. HC and bACC: 74.0% for pMCI vs. sMCI classification (Wee
et al., 2013). In contrast to the presented analysis, the articles shown in Table 5.7 analysed the 1.5T
images of ADNI-1 only. Also usually more complex features such as cortical features (Wolz et al.,
2011; Westman et al., 2013; Liu et al., 2013; Wee et al., 2013), textural features (Chincarini et al.,
2011), manifold-based features (Wolz et al., 2011; Liu et al., 2013) or grading based features (Coupe´
et al., 2012b) are employed. In summary, the results presented in this chapter are comparable to the
state-of-the-art. This is encouraging as a large and heterogeneous dataset was analysed acquired at
both 1.5T and 3T using structural volumes, which are trivial to interpret, only.
Furthermore, structures that were found to be most discriminative agree well with those high-
lighted in Fennema-Notestine et al. (2009). Examples are the hippocampus, amygdala, entorhinal
area and regions within the temporal gyrus in general.
Using MALP-EM4D and hippocampal atrophy a bACCm12 of 78% and bACCm24 of 85% was
calculated for classifying AD vs. HC. These results are similar to those obtained on a different
ADNI subset with a method dedicated to hippocampal atrophy measurement (Wolz et al., 2010b):
bACCm12 of 82% (SENS: 81%, SPEC: 83%); bACCm24 of 86% (SENS: 85%, SPEC: 87%).
The results for AD vs. HC classification using all longitudinal features are similar to those using
all structural volumes at baseline. However, classification accuracies substantially above 90% were
not expected due to potential bias in the study data caused by for example variations in scanner
type, field strength or clinical centres. This is in contrast to the pMCI vs. sMCI classification.
Using longitudinal information available at the month 24 follow-up visit increased classification
accuracy for the MCI groups from 68% at baseline to 78% using a RF classifier. This confirms the
discriminative value of increased structural atrophy in MCI patients that progress to AD. In contrast
to patients with AD, atrophy in MCI patients has not yet manifested itself in substantially reduced
structural volumes at baseline.
In a large meta-analysis by Barnes et al. (2009b) the authors conclude that the annualised hip-
pocampus atrophy of healthy elderly people is -1.4% and for patients with AD -4.6%. The rate of
hippocampal volume change that was calculated in this chapter is comparable with -1.1% (±1.7)
for healthy controls and -4.8% (±3.7) for AD subjects. For brain tissue a mean reduction of -0.5%
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(±0.8) and -1.3% (±1.1) from baseline to m12 follow-up was observed for HC and AD groups.
These results are in line with previously published annual brain atrophy rates of around -0.6% for
controls and -1.5% for AD patients respectively (Leung et al., 2010b). These comparisons suggest
that MALP-EM4D yields informative and realistic atrophy measurements on individual structures
while providing a comprehensive overview of structural change throughout the whole brain.
The presented sample sizes and atrophy rates are comparable to the results calculated on the
ADNI-1 subset of 309 subjects in Section 4.2. This is encouraging as it indicates that the results
from the smaller subset generalise quite well and the method is rather robust towards variations
in field strengths. Nevertheless, as briefly discussed in Section 5.4, significant differences were
found between the healthy subjects scanned at 1.5T and 3T respectively. Including field strength
into the regression model did not consistently improve results and was not further investigated
in this study. The influence of the field strength on both the segmentation of individual images
and the quantification of atrophy needs to be further explored. Another field for future work is to
determine the ideal combination strategy for the individually measured atrophy rates to maximise
their discriminative potential.
For the four structures hippocampus, amygdala, inferior lateral ventricle and lateral ventricle their
counterparts in the left/right brain hemisphere were analysed separately. The results suggest that
structural change in the left hippocampus is slightly more discriminative than change in the right
hippocampus. For the other investigated structures there is no consistent trend. Overall features of
corresponding structures in both brain hemispheres perform similar for all investigated structures
and combining them seems, in summary, beneficial.
The use of either SVM or RF classifiers provided substantial improvements over the results ob-
tained using individual features only. Overall both approaches performed similar with slight advan-
tages for either of them in individual experiments.
5.7 Conclusion
Using the ADNI cohort the presented results confirm that MALP-EM (cf . Chapter 3) has the poten-
tial to support the analysis and classification of patient groups on a per structure basis. Calculated
accuracies of up to 89% for AD vs. HC classification at baseline, using multiple structures as
features, are in line with the state-of-the-art. The conducted experiments confirmed a benefit of
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correcting for nuisance factors such as age, gender and brain size. Further, m12 and m24 atro-
phy rates were calculated for those subjects with respective imaging information available. Using
MALP-EM4D (cf . Chapter 4) atrophy rates and corresponding sample sizes were determined for
a multitude of brain structures simultaneously. A clear difference was observed between subjects
converting from the MCI stage to AD and those that do not. The conducted experiments confirm
the methods’ potential to analyse the whole brain rather than individual structures only. A particular
strength is that the methods allow both the accurate analysis of single images (MALP-EM) as well
as image series (MALP-EM4D). Thus the presented methodology has strong potential to support
both cross-sectional and longitudinal studies that include MR imaging of the brain.
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6 Automated brain morphometry in patients
with traumatic brain injury
Abstract: In the previous chapter MR brain images acquired from a large cohort of subjects with
and without dementia were analysed. On this data it was confirmed that the methodology developed
in this thesis has the potential to support automated brain morphometry by providing informative,
disease-related measures based on either single time point MR images (structural volumes) or lon-
gitudinal MR images (structural atrophy). The main characteristic of patients with AD is ongoing
brain atrophy and atrophy within the structures of the MTL in particular. In contrast to AD, brain
injury in TBI is caused by a sudden event and can be very heterogeneous in its manifestation. Typ-
ical consequences of a head injury such as brain midline shift or the presence of contusions are
not characteristic for AD. In this chapter, an analysis is presented of a cohort of T1w MR images
prospectively acquired from patients who sustained mild to severe TBI. The goal is to investigate
the applicability of the methodology developed in Chapter 3 (MALP-EM) and Chapter 4 (MALP-
EM4D) to extract meaningful ROIs from MR brain images of patients with substantially altered
brain structure. As segmentation quality can not be quantified directly in the absence of reference
segmentations, the potential value of volume and asymmetry measures as a predictor of outcome
is investigated instead. These features are quantified from brain MRI at the acute/subacute stage1
of the injury (median: 19 days after injury), to predict the disability outcome of 67 patients at the
chronic disease stage (median: 229 days after injury). Further, differences in structural atrophy
are investigated between groups of varying disease outcome severity. Patients with unfavourable
outcome prognosis show increased white matter atrophy.
This chapter is organised as follows: First, an overview is given over the study data in Section
1Following the definition used in Newcombe et al. (2015), the images in this study were taken either in the acute or
subacute phase. For readability both stages will be referred to as ’acute’.
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6.1. The applied methods are briefly described in Section 6.2. Section 6.3 summarises the extracted
imaging features and describes the classification approach. In Section 6.4.1, a cross-sectional anal-
ysis at the acute stage of the injury explores whether individual structural volumes have potential to
predict injury outcome. Further, a longitudinal analysis is performed in Section 6.4.2 and structural
atrophy rates are calculated between images acquired in the acute and chronic disease stage. Group
differences are investigated between patient groups of distinct outcome categories. In Section 6.6
the findings are discussed and segmentation results are illustrated that were obtained on brain MR
images with disease related changes such as for example subdural haematomas, substantial struc-
tural deformation or atrophy. This chapter concludes with a brief summary in Section 6.6.
6.1 Materials
The imaging data was acquired at Turku University Hospital, Finland in the course of the TBI-
care project (http://www.tbicare.eu, last accessed 29 June 2015). For the T1w MR images an
MPRAGE sequence was acquired on a Siemens Verio 3T system with the following parameters:
TR 2300 ms, TE 2.98 ms, TI 900 ms, flip angle 9°, matrix size 256⇥249⇥176 and an isotropic
voxel size of 1.0mm ⇥ 1.0mm ⇥ 1.0 mm, sagittal slices, using Prescan Normalizer, 2D distortion
correction and a standard 12 channel head coil.
Over the course of the project a total of 141 subjects with mild to severe TBI have had MR
images taken both at the acute stage of the injury (baseline) and in the chronic phase (follow-up)
of the disease. In total 120 subjects were processed for which both baseline and follow-up images
were available when the analysis was started in December 2013. After visual review, six subjects
were excluded for the following reasons:
• TBI031, TBI073: Images seem to be from the same subject, but labelled with different IDs
• TBI116: The processed baseline image was acquired very late (3 months after the injury)
• TBI152: The baseline and follow-up images are identical
• TBI157: Too short follow-up interval (⇡ 1 month) and poor image quality
• TBI184: Poor image quality, brain extraction not sufficiently accurate
In the following the remaining 114 patients are considered, which are summarised in Table 6.1.
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Table 6.1: Overview of all processed MR images with patient gender, patient age, scan time rela-
tive to injury, GCS, MCS and injury severity.
low disability moderate disability severe disability
GOSe 7 & 8 5 & 6 3 & 4
# of subjects 69 32 13
gender (# male / # female) 47/22 21/11 4/9
years of age (median [min; max]) 40 [18; 82] 51 [19; 83] 74 [33; 86]
days since injury, acute scan (median [min; max]) 14 [1; 50] 22 [1; 51] 22 [4; 51]
days since injury, chronic scan (median [min; max]) 230 [151; 399] 228 [177; 429] 251 [180; 422]
GCS (median [min; max]) 15 [3; 15] 15 [3; 15] 14 [2; 15]
Marshall score (median [min; max]) 1 [1; 5] 2 [1; 5] 5 [2; 5]
injury severity† (median [min; max]) 2 [1; 4] 2.5 [2; 5] 3 [2; 5]
†: 1: very mild, 2: mild, 3: moderate, 4: severe, 5: very severe
6.1.1 Clinical information
In addition to MR imaging data the clinical variables age, gender, GCS, MCS, GOSe and injury
severity were available. After the head injury the GCS is potentially assessed several times, e.g.
at the injury site, at hospital admission, in the intensive care unit. The GCS might not have been
recorded for each patient at each time point. Thus a pragmatic approach was followed and the
GCS score chosen that was recorded first. This is usually either at the injury site or at admission
to the hospital. The MCS groups 5 and 6 were pooled together (cf . Table C.1), which means that
the MCS scores did not distinguish between evacuated and non-evacuated mass lesions. Further
the GOSe groups 3 & 4, 5 & 6 and 7 & 8 are summarised into three patient groups with severe,
moderate and low disability outcome respectively. This was necessary to obtain reasonable group
sizes and corresponds to using the GOS five point scale instead of the eight point GOSe (cf . Table
D.1). The GOSe score was assessed on the day when the follow-up MR image was acquired. Injury
severity was classified based on either the GCS or the duration of PTA depending on which one gave
the higher severity (Schoenberger et al., 2009; Arlinghaus et al., 2011). A widely used approach
for classifying the duration of PTA was employed where less than 24 hours is mild, 1 to 7 days
moderate, 1 to 4 weeks severe and more than four weeks very severe (Schoenberger et al., 2009;
Arlinghaus et al., 2011).
Next to the imaging information the dataset includes a multitude of clinical data such as metabolomics.
However, this data will not be further exploited in the following analyses.
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Figure 6.1: Boxplots of age, GCS, MCS and injury severity of patients with low, moderate or severe
disability outcome. Shown are only subjects of the age-matched dataset.
6.1.2 Age-matching of patient groups
The study groups which are summarised in Table 6.1 show a significant mismatch in age (p <
0.001 for all groups with respect to the severe outcome group). It is important to account for
these substantial differences when studying changes caused by the disease to minimise age-related
effects. Due to the limited size of the study cohort this is a challenging endeavour. The group with
severe disability outcome has the fewest samples and subjects are significantly older in age. In order
to not further reduce the size of this group, all subjects were removed from the low and moderate
disability outcome groups that are younger than 45 years of age. The age difference between the
groups was no longer significant (p > 0.05) after this correction. This approach improved the age-
match between study groups, however, reduced the number of study subjects from 114 to 67. An
overview over the remaining subjects that will be studied in the following is provided in Table 6.2.
The distribution of age, GCS and MCS is illustrated with respect to the three outcome groups in
Figure 6.1.
Table 6.2: Overview of theMR images used for the analysis with patient gender, patient age, scan
time relative to injury, GCS, MCS and injury severity.
low disability moderate disability severe disability
GOSe 7 & 8 5 & 6 3 & 4
# of subjects 32 22 13
gender (# male / # female) 21/11 14/8 4/9
years of age (median [min; max]) 63 [45; 82] 58 [46; 83] 74 [33; 86]
days since injury, acute scan (median [min; max]) 15 [1; 50] 23 [2; 51] 22 [4; 51]
days since injury, chronic scan (median [min; max]) 225 [151; 276] 227 [177; 429] 251 [180; 422]
GCS (median [min; max]) 15 [3; 15] 15 [3; 15] 14 [2; 15]
Marshall score (median [min; max]) 1 [1; 5] 2 [1; 5] 5 [2; 5]
injury severity† (median [min; max]) 2 [1; 4] 3 [2; 4] 3 [2; 5]
†: 1: very mild, 2: mild, 3: moderate, 4: severe, 5: very severe
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6.2 Methods
All available images were preprocessed by first correcting for intensity inhomogeneities with the
N4 bias correction algorithm (Tustison et al., 2010). Images were subsequently brain extracted
using pincram (Heckemann et al., 2015), an iterative, atlas-based method that was developed with
particular focus on robustness. Each image was then segmented individually using MALP-EM as
described in Chapter 3. Longitudinal changes were measured with MALP-EM4D as described in
Chapter 4. As brain atlases the 30 manually annotated NMM brain atlases were employed (cf . Sec-
tion 2.2.5). In the context of TBI, gross structural changes can be expected between both imaging
time points. Thus the weighted differential bias field correction procedure was used which was
introduced in Section 4.2.2.4. This is in contrast to the processing of the ADNI dataset in Chapter
5. Otherwise, the applied methods are, except for the additional N4 bias correction, identical to the
one described and applied in Chapter 5.
All brain masks and segmentation results were visually reviewed to ensure reasonable accuracy,
allowing for pathology. A typical segmentation result is visualised in Figure 6.2.
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Figure 6.2: Example cross-sectional segmentation results of images at the acute stage of a TBI.
Top: TBI 010 2 8, male, 21 years of age, mild TBI, GCS: 15, GOSe: 8, MCS: 1, fall
accident, image acquired 2 days after injury. Bottom: TBI038, female, 47 years of age,
mild TBI, GCS: 15, GOSe: 4, MCS: 5, fall, image acquired 4 days after injury with
clear sequelae of intra-cerebral haematoma.
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6.3 Features and classification
Group differences were investigated between GOS groups with a focus on the comparison of pa-
tients with low and severe disability outcome. Classification experiments were performed to quan-
tify the accuracy of predicting the GOS outcome category when using imaging information avail-
able at the acute disease stage.
All 67 subjects were analysed cross-sectionally at the acute stage of the TBI and longitudinally
employing the follow-up image acquired in the chronic phase of the disease. As features all avail-
able non-cortical structural volumes were used, however, corresponding volumes in the left and
right brain hemisphere were merged (28/2+7=21 non-cortical features). Note that the seven non-
cortical structures 3rd ventricles, 4th ventricle, brain stem, CSF, cerebellar vermal lobule I-V, cere-
bellar vermal lobule VI-VII and cerebellar vermal lobule VIII-X have no symmetric counterpart.
Individual structures were summarised into ventricles, cortical GM, deep GM, WM, brain tissue
and brain volume (brain tissue including ventricles/CSF) (6 features). The optic chiasm was ex-
cluded from the analysis due to its very small size. Due to the limited number of study subjects and
the heterogeneity of the injury, cortical structures were investigated as surrogate structure (cortical
GM) rather than individually.
In the cross-sectional analysis at the acute stage structural asymmetry was quantified as the AAI
(cf . Equation 3.17 in Chapter 3). The AAI was calculated for the 14 non-cortical structures ap-
pearing in both brain hemispheres and the six surrogate structures. Additionally the AAIs of all
individual non-cortical, cortical and all brain structures were added up. Note that the sum of for
example all cortical AAIs is different to the AAI of the cortical GM surrogate structure. The seg-
mentations at the acute stage were calculated with MALP-EM and not MALP-EM4D as the latter
exploits information of later scanning time points, which is not available at baseline. Further, the
five non-imaging features age, gender, GCS, MCS and injury severity were considered.
For the longitudinal analysis structural volumes of all 67 subjects were extracted based on the
respective MALP-EM4D segmentations. Atrophy rates were calculated as described in Section
4.2.3.2. The volume change was measured for the six surrogate structures and for the individual
21 non-cortical structures. This yields, considering age and gender, 29 features for the longitudinal
analysis. Even though the analysis was limited to changes in structural volume, other longitudinal
alterations such as changes in brain symmetry could be investigated.
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For classification 100 runs of a 6-fold CV were chosen using LDA for individual features and
SVM or RF classifiers when combining multiple features. The sameMATLAB classification frame-
work was used as in Chapter 5 that relies on classify (LDA), TreeBagger (RF, 100 trees) and
libSVM (SVM, (Chang and Lin, 2011)). Note that in contrast to the analysis on the ADNI dataset
100 runs were chosen for the multi-feature classifiers. The motivation for this is two-fold: a) due to
the smaller group sizes this is computationally more feasible, b) variations in classification results
were observed when using only 20 CV repetitions. This might be caused by the small group sizes.
As in Chapter 5 the features were normalised individually based on the respective training set to the
range 0 to 1 for the SVM classification. Both the LDA classifier, which was used for single-feature
classification only, and the RF classifier do not require feature normalisation. No explicit correction
for age, gender or head size was applied. This is further discussed in Section 6.5.
Significance levels were quantified as p-values of two-sided, unpaired Student’s t-tests. Further,
effect sizes were calculated as Cohen’s d by dividing the differences of the sample means (absolute
value) by their pooled standard deviation (Cohen, 1988; Fennema-Notestine et al., 2009; Wang
et al., 2013b).
6.4 Results
6.4.1 Cross-sectional analysis
Individual brain ROIs were extracted from the acute T1w MR images. From these ROIs features
(volume, asymmetry) were derived and their potential investigated to discriminate TBI patients ac-
cording to their outcome severity. Example segmentation results of a TBI patient with low disability
outcome and a patient with severe disability outcome are shown in Figure 6.2.
The subject shown in the top row sustained a mild TBI with a favourable disease outcome (GOSe:
8) and had no visible intracranial pathological changes on CT (MCS: 1). The subject shown in
the bottom row sustained a mild TBI with a more unfavourable disease outcome (GOSe: 4) and
substantial pathological changes (MCS: 5). Before the actual TBI event the patient suffered a
spontaneous intra-cerebral haematoma due to an untreated hypertension.
The distribution of structural volumes for nine selected ROIs with respect to the three considered
outcome categories low, moderate and severe disability is shown in Figure 6.3. Several subcor-
tical structures were identified that are of particularly small size in subjects with severe disability
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Figure 6.3: Boxplots of selected structural volumes (first row), surrogate structures (second row)
and asymmetry indices (third row) with respect to the investigated disease outcome
groups. Features selected based on their performance in classifying severe disability vs.
low disability outcome (cf . Table 6.3).
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Table 6.3: Classification results in % (6-fold cross-validation, LDA/RF/SVM 100 runs) obtained
separating TBI patients with a severe disability from patients with low disability outcome
based on structural volumes and asymmetry at the acute stage of the injury. Individual
structures are sorted by effect size. Significant group differences indicated by + (p <
0.05) and ++ (p < 0.001). Bonferroni corrected significance in parentheses.
Severe disability (N = 13, PositivesP) vs. Low disability (N = 32, NegativesN) (acute stage)
structure ACC (bACC) SENS SPEC mean (SD) [mm3]P mean (SD) [mm3]N effect size (d) p-value sig. (corr.)
RandomForest (all features) 85 (79) 65 93
SVM (all features) 87 (84) 76 92
RandomForest (imaging only) 85 (79) 65 93
SVM (imaging only) 83 (77) 62 92
RandomForest (non-imaging only) 82 (77) 67 88
SVM (non-imaging only) 82 (77) 62 91
RandomForest (age and gender only) 69 (60) 39 81
SVM (age and gender only) 70 (50) 1 99
MarshallScore 84 (80) 69 91 3.9 (1.4) 1.6 (1.1) 1.907 <0.00001 ++ (++)
InjurySeverity 71 (66) 54 78 2.8 (1.0) 2.3 (0.7) 0.724 0.03308 + (o)
Gender (female = 0, male = 1) 67 (67) 69 66 0.3 (0.5) 0.7 (0.5) 0.723 0.03331 + (o)
GlasgowComaScale 72 (59) 29 89 11.9 (4.6) 14.1 (2.2) 0.700 0.03912 + (o)
Age 55 (54) 54 55 67.2 (15.9) 61.1 (10.1) 0.514 0.12518 o (o)
Ventricles 72 (71) 68 74 58766.8 (18808.4) 38131.9 (13556.0) 1.357 0.00017 ++ (+)
CorticalGreyMatter 70 (70) 70 71 459934.2 (63395.6) 524318.2 (64687.5) 1.001 0.00398 + (o)
DeepGreyMatter 74 (74) 74 75 164564.8 (20726.5) 181380.2 (22209.8) 0.771 0.02373 + (o)
BrainTissue 60 (60) 60 60 1130166.1 (102464.8) 1198466.6 (135087.2) 0.539 0.10886 o (o)
Brain 58 (59) 62 57 1191022.6 (110493.8) 1238799.0 (138060.0) 0.365 0.27348 o (o)
WhiteMatter 50 (46) 37 55 505667.1 (82222.8) 492768.2 (71084.9) 0.173 0.60062 o (o)
AccumbensArea 82 (85) 91 79 460.0 (150.5) 696.3 (138.7) 1.664 <0.00001 ++ (++)
Hippocampus 80 (81) 83 79 5136.2 (1030.6) 6572.2 (873.5) 1.561 0.00002 ++ (+)
Amygdala 73 (76) 83 68 1795.5 (321.1) 2280.9 (380.7) 1.329 0.00022 ++ (+)
LateralVentricle 75 (74) 73 76 51162.3 (17123.4) 32704.8 (12459.3) 1.326 0.00022 ++ (+)
InfLatVent 81 (75) 62 89 3131.4 (1360.4) 1913.3 (676.5) 1.324 0.00023 ++ (+)
ThalamusProper 73 (74) 76 72 11584.6 (1556.0) 13832.8 (1845.3) 1.271 0.00037 ++ (+)
BasalForebrain 74 (75) 77 72 548.7 (232.3) 840.4 (233.9) 1.250 0.00045 ++ (+)
CerebellarVermalLobulesI-V 75 (74) 72 76 3471.9 (535.9) 4242.3 (699.1) 1.171 0.00092 ++ (+)
3rdVentricle 71 (71) 69 72 2288.6 (814.2) 1552.5 (617.3) 1.086 0.00194 + (o)
Putamen 76 (76) 77 75 6066.7 (2492.2) 7849.7 (1338.7) 1.025 0.00326 + (o)
BrainStem 69 (69) 71 68 17417.2 (2275.5) 19651.1 (2739.4) 0.853 0.01291 + (o)
CerebellumWhiteMatter 73 (72) 69 74 36782.2 (7917.1) 30605.9 (8306.2) 0.753 0.02697 + (o)
VentralDC 56 (55) 54 56 8247.1 (1062.4) 8961.7 (1114.9) 0.649 0.05477 o (o)
CerebellarVermalLobulesVIII-X 57 (62) 74 51 2659.5 (304.5) 2902.0 (420.4) 0.619 0.06650 o (o)
CerebellumExterior 64 (64) 63 64 94910.8 (12670.3) 101795.8 (13850.8) 0.509 0.12919 o (o)
4thVentricle 60 (55) 45 66 2184.5 (673.2) 1961.2 (526.9) 0.391 0.24153 o (o)
Caudate 53 (47) 35 60 7388.5 (3739.3) 6613.9 (1066.8) 0.356 0.28451 o (o)
Pallidum 52 (51) 48 54 2801.2 (796.4) 2990.8 (504.4) 0.316 0.34230 o (o)
CerebellarVermalLobulesVI-VII 54 (54) 54 54 2076.6 (384.4) 2150.0 (299.1) 0.226 0.49648 o (o)
CSF 47 (45) 42 48 2025.5 (719.9) 2140.6 (538.2) 0.194 0.55923 o (o)
CerebralWhiteMatter 43 (38) 28 49 468884.8 (76690.5) 462162.3 (67838.9) 0.095 0.77302 o (o)
AsymmetryAllCortical† 76 (74) 69 79 846.2 (160.7) 690.8 (88.0) 1.374 0.00014 ++ (+)
AsymmetryAll† 81 (73) 54 91 1108.3 (369.6) 826.6 (107.9) 1.306 0.00027 ++ (+)
AsymmetryWhiteMatter 75 (69) 55 82 10.5 (8.5) 4.2 (3.1) 1.220 0.00059 ++ (+)
AsymmetryCerebralWhiteMatter 76 (68) 48 88 10.2 (9.5) 3.8 (2.8) 1.150 0.00110 + (o)
AsymmetryAmygdala 82 (78) 68 87 16.9 (12.5) 7.7 (5.9) 1.119 0.00145 + (o)
AsymmetryBrain 75 (72) 64 79 4.0 (3.3) 1.6 (1.5) 1.086 0.00194 + (o)
AsymmetryBrainTissue 81 (73) 54 92 5.2 (5.2) 1.9 (1.7) 1.068 0.00226 + (o)
AsymmetryCorticalGreyMatter 79 (72) 55 89 4.9 (4.6) 2.0 (2.3) 0.938 0.00663 + (o)
AsymmetryAllNonCortical† 79 (71) 50 91 262.0 (245.1) 135.8 (46.7) 0.932 0.00695 + (o)
AsymmetryCerebellumWhiteMatter 69 (69) 69 69 19.2 (13.9) 10.5 (7.8) 0.887 0.00997 + (o)
AsymmetryPutamen 75 (63) 34 92 24.2 (44.3) 4.2 (4.8) 0.844 0.01384 + (o)
AsymmetryAccumbensArea 66 (62) 53 71 23.4 (18.8) 12.7 (10.2) 0.805 0.01850 + (o)
AsymmetryCaudate 71 (63) 46 81 17.3 (23.1) 7.2 (6.0) 0.759 0.02585 + (o)
AsymmetryDeepGreyMatter 72 (66) 52 81 3.9 (4.2) 2.0 (1.9) 0.706 0.03743 + (o)
AsymmetryThalamusProper 75 (60) 27 94 14.2 (35.4) 2.2 (2.0) 0.642 0.05762 o (o)
AsymmetryVentricles 68 (59) 39 79 27.8 (32.4) 15.4 (13.5) 0.600 0.07507 o (o)
AsymmetryHippocampus 63 (57) 43 71 16.2 (16.2) 9.9 (7.3) 0.595 0.07721 o (o)
AsymmetryPallidum 68 (56) 28 84 15.9 (32.6) 5.5 (5.4) 0.580 0.08469 o (o)
AsymmetryLateralVentricle 66 (57) 38 77 31.5 (35.6) 18.2 (15.6) 0.574 0.08797 o (o)
AsymmetryVentralDC 65 (56) 36 76 9.5 (17.3) 4.2 (2.7) 0.556 0.09791 o (o)
AsymmetryBasalForebrain 63 (55) 37 74 37.3 (40.4) 24.4 (17.1) 0.498 0.13745 o (o)
AsymmetryCerebellumExterior 68 (64) 54 74 4.8 (3.1) 3.5 (3.7) 0.373 0.26322 o (o)
AsymmetryInfLatVent 40 (37) 29 45 21.5 (20.5) 21.6 (17.7) 0.008 0.98119 o (o)
†: Sum of the AAIs of the individual structures.
outcome as compared to those patients with a low disability outcome (cf . Table 6.3). The four struc-
tures with the largest effect size are the accumbens (Cohen’s d = 1.66), hippocampus (d = 1.56),
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amygdala (d = 1.33) and the thalamus (d = 1.27). These differences are significant after Bonferroni
correction for multiple comparisons. Overall, a larger ventricular volume (d = 1.36) and lower cor-
tical GM volume (d = 1.0) was observed among patients with unfavourable outcome as compared
to those with a good outcome prognosis. Asymmetry throughout the whole brain and in particular
within the cortex and WM was significantly higher in patients with severe disability outcome than
in the low disability outcome group. The group with moderate outcome disability had overall a
wider spread (variance) of the measured features and was thus less well separated from both the
low and severe outcome groups.
Further it was investigated whether the disability outcome of a patient can be predicted using
only features that are available at the acute stage of the injury. The classification results for severe
vs. moderate and moderate vs. low disability outcome classification can be found in Appendix F in
Table F.1. In the following the focus will be on the separation of low vs. severe disability outcome
groups. Results of this experiment are summarised in Table 6.3.
The volume of the accumbens provided the best group separation with the highest bACC of
85% (SENS: 91%, SPEC: 79%). Next to the accumbens, several structures were predictive for
the disease outcome including hippocampus (bACC: 81%), amygdala (bACC: 76%) and thalamus
(bACC: 75%).
Available features were combined into multi-feature classifiers. Using a SVM, imaging infor-
mation only yielded similar results (bACC: 77 %) to those obtained with non-imaging information
only (bACC: 77 %). Clinical variables and measurements from imaging contained complementary
information. Their combination increased classification accuracy to bACC: 84 % (SENS: 76%,
SPEC: 92%).
6.4.2 Longitudinal analysis
Further a longitudinal analysis was performed to investigate the volume change of individual ROIs
between the acute stage of the injury and the follow-up visit in the chronic phase of the disease.
Example segmentation results obtained on two subjects with low and moderate disability outcome
are shown in Figure 6.4.
The correlation of structural atrophy rates with patient groups of distinct disease outcome was
investigated. Specifically, classification accuracies, effect sizes and p-values were calculated to
quantify group separation. The distribution of the volume change of six selected structures is shown
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Figure 6.4: Example longitudinal segmentation results of images at the acute and chronic stage of
a TBI. Top: TBI061, male, 69 years of age, GCS: 14, GOSe: 8, MCS: 1, fall accident,
acute/chronic image acquired 8/265 days after injury. Bottom: TBI142, male, 51 years
of age, GCS: 3, GOSe: 6, MCS: 5, transport accident, acute/chronic image acquired
2/383 days after injury, diffuse axonal injury. The difference image of subject TBI142
illustrates the clear ventricular enlargement (measured: 47%), hippocampal atrophy (-
6.2%) and reduction of brain stem volume (-13%).
in Figure 6.5 for the three considered outcome groups. Quantitative results for moderate vs. low and
severe vs. moderate outcome disability can be found in Appendix F in Table F.2. In the following
the focus is on the comparison of severe and low disability outcome for which quantitative results
are summarised in Table 6.4.
Substantial ventricular expansion (11.6%) was observed in patients with poor disease outcome.
In contrast brain tissue and in particular cerebral WM (-3.1%), brain stem (-3.1%) and thalamus
(-4.2%) showed increased atrophy.
The clearest group separation was calculated for atrophy of the cerebralWM (d = 1.29, p⇡ 10 3).
Volumetric change of individual ROIs, such as the thalamus, brain stem and cerebellum WM were
significantly different (d > 0.8, p < 0.05) between patients with low and severe outcome disability.
Significant group differences were found for cortical GM atrophy and ventricular enlargement with
effect sizes above 0.7. Cerebral WM is, however, the only individual structure which remained
statistically different between the groups after correcting for multiple comparisons.
The most discriminative structure in terms of accuracy was atrophy of the whole brain (bACC:
77 %, SENS: 70%, SPEC: 84%) and the brain stem (bACC: 76 %, SENS: 70%, SPEC: 81%).
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Figure 6.5: Boxplots of change rates of selected ROIs with respect to the investigated disease out-
come groups. Features selected based on their performance in classifying severe dis-
ability vs. low disability outcome (cf . Table 6.4).
.
A combination of all measured atrophy rates in a multi-feature classifiers did not further improve
classification results, e.g. using a RF classifier resulted in bACC: 69 %.
6.5 Discussion
The potential presence of pathologies such as haemorrhage lesions, contusions or a substantial
midline shift pose particular challenges for the analysis of brain MRI in TBI. Three example image
series with a high degree of injury are visualised with overlaid segmentation results in Figure 6.6.
Clinical information and a brief description of the images is provided in the figure caption.
These examples show clear segmentation inaccuracies observed for example for the hippocam-
pus, putamen or the caudate (white arrows). The inclusion of haemorrhage lesions in both WM
and cortical GM ROIs (blue arrows) is a limitation of the proposed segmentation framework. This
is expected as atlas-based approached are restricted to the labelling of structures that are repre-
sented in the reference atlases. Assuming that explicit segmentations of pathologies (e.g. lesions)
are available (e.g. via dedicated lesion segmentation), this allows to determine the location of le-
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Table 6.4: Classification results in % (6-fold cross-validation, LDA/RF/SVM 100 runs) obtained
separating TBI patients with a severe disability from patients with low disability out-
come based on structural volume changes between the acute and chronic disease stage.
Significant group differences indicated by + (p < 0.05) and ++ (p < 0.001). Bonferroni
corrected significance in parentheses.
Severe disability (N = 13, PositivesP) vs. Low disability (N = 32, NegativesN) (longitudinal analysis, bl!follow-up)
structure ACC (bACC) SENS SPEC mean (SD) [%]P mean (SD) [%]N effect size (d) p-value sig. (corr.)
RandomForest (all features) 77 (69) 52 86
SVM (all features) 75 (64) 36 91
Gender (female = 0, male = 1) 67 (67) 69 66 0.3 (0.5) 0.7 (0.5) 0.723 0.03331 + (o)
Age 55 (55) 54 55 67.2 (15.9) 61.1 (10.1) 0.514 0.12518 o (o)
WhiteMatter 75 (67) 47 87 -3.0 (2.8) -0.6 (1.2) 1.323 0.00023 ++ (+)
BrainTissue 79 (75) 66 84 -3.0 (2.4) -0.6 (2.0) 1.130 0.00133 + (+)
Brain 80 (77) 70 84 -2.0 (1.7) -0.4 (1.6) 1.020 0.00339 + (o)
DeepGreyMatter 70 (69) 64 73 -2.7 (2.2) -0.5 (2.5) 0.896 0.00929 + (o)
CorticalGreyMatter 78 (75) 66 84 -3.0 (3.2) -0.7 (2.9) 0.780 0.02223 + (o)
Ventricles 68 (63) 50 76 11.6 (12.0) 4.2 (9.7) 0.711 0.03627 + (o)
CerebralWhiteMatter 75 (67) 47 87 -3.1 (3.0) -0.7 (1.2) 1.293 0.00030 ++ (+)
CerebellumExterior 70 (67) 60 74 -3.1 (3.1) -0.3 (2.9) 0.933 0.00691 + (o)
BrainStem 78 (76) 70 81 -3.1 (3.3) -0.8 (2.1) 0.922 0.00758 + (o)
CerebellumWhiteMatter 72 (72) 73 72 -1.3 (1.3) -0.1 (1.3) 0.884 0.01019 + (o)
ThalamusProper 72 (66) 52 80 -4.2 (3.5) -1.6 (3.1) 0.824 0.01605 + (o)
LateralVentricle 69 (63) 51 76 12.8 (12.0) 4.7 (10.7) 0.725 0.03289 + (o)
Amygdala 57 (47) 26 69 -2.6 (6.7) 0.0 (2.5) 0.622 0.06518 o (o)
Hippocampus 73 (65) 46 83 -4.8 (10.6) -1.1 (2.9) 0.614 0.06895 o (o)
CerebellarVermalLobulesVI-VII 68 (65) 58 72 -2.1 (3.9) -0.1 (3.1) 0.613 0.06917 o (o)
CSF 66 (61) 49 72 6.2 (6.5) 3.2 (6.0) 0.500 0.13556 o (o)
Putamen 58 (51) 34 67 -0.1 (0.8) 0.1 (0.4) 0.497 0.13840 o (o)
VentralDC 76 (74) 68 79 -2.5 (1.8) -1.2 (3.0) 0.480 0.15191 o (o)
4thVentricle 61 (61) 61 61 0.3 (7.5) -2.2 (4.5) 0.468 0.16234 o (o)
InfLatVent 69 (64) 52 76 7.7 (19.6) 3.0 (8.0) 0.380 0.25411 o (o)
CerebellarVermalLobulesI-V 59 (57) 52 62 -0.9 (1.6) -0.5 (1.0) 0.355 0.28602 o (o)
CerebellarVermalLobulesVIII-X 65 (64) 62 66 -0.3 (1.9) 0.4 (2.3) 0.331 0.32032 o (o)
3rdVentricle 56 (53) 45 60 5.2 (8.4) 2.4 (9.2) 0.316 0.34251 o (o)
Caudate 39 (37) 30 43 0.1 (12.6) -1.1 (6.6) 0.132 0.69072 o (o)
AccumbensArea 49 (47) 43 52 -0.2 (3.0) -0.5 (1.7) 0.118 0.72056 o (o)
BasalForebrain 44 (41) 34 48 1.2 (16.6) 2.7 (14.6) 0.096 0.77201 o (o)
Pallidum 56 (44) 15 72 0.2 (0.8) 0.2 (1.1) 0.023 0.94465 o (o)
sions relative to anatomical structure. However, in the present approach this can lead to a substantial
bias as it artificially increases a structure’s volume (e.g. cortical GM, blue arrows). The inclusion
or exclusion of pathology in the brain mask (orange arrow) can have an even more severe effect.
It can lead, as shown in the top row of Figure 6.6, to an overestimation of the reduction of brain
tissue or WM volume. The explicit segmentation of pathology or structures that are not available
in the atlases is highly desirable in this context and should be pursued in future research. Another
limitation is related to the refinement of spatial priors introduced in Chapter 3. The refinement of
priors compensates inaccuracies in the atlas alignment based on the intensity profiles within the MR
image. However, priors between labels with similar intensity profile are not corrected. In extreme
cases this can lead to mislabeling of these structures (e.g. CSF$ background). An example can be
observed in the segmentation results of TBI047 (middle row) or TBI114 (bottom row) where parts
of the inferior lateral ventricle are incorrectly labelled as background (cf . red arrow).
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Figure 6.6: Example longitudinal segmentation results of images at the acute and chronic stage of
a TBI. Top row, TBI150: male, 68 years of age, GCS: 15, GOSe: 5, MCS: 5, un-
clear accident, acute/chronic image acquired 14/264 days after injury, craniotomy and
evacuation of an acute SDH, intracranial haematoma induced brain destruction2. Mid-
dle row, TBI047: male, 62 years of age, GCS: 13, GOSe: 3, MCS: 5, fall accident,
acute/chronic image acquired 29/306 days after injury, craniotomy and evacuation of an
acute subdural haemorrhage, broad gliosis on left temporal lobe. Bottom row, TBI114,
male, 69 years of age, GCS: 14, GOSe: 5, MCS: 5, cycling accident, acute/chronic
image acquired 51/233 days after injury, no craniotomy, traumatic subarachnoid haem-
orrhage, intracranial haematoma with surrounding oedema in left temporal lobe, central
and cortical atrophy.
2these are incomplete reproductions of the radiological reports
In this chapter, the segmentation quality could not be evaluated quantitatively. Manual reference
segmentations of the images were not available and a quantitative quality assessment through ex-
perts (cf . Chapter 3) is prohibitive. Thus a different approach was used by assessing the methods
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indirectly. Instead of quantifying the actual segmentation quality, the disease-relevance of extracted
measurements in the context of classification was analysed. Specifically, several classification ex-
periments were conducted to investigate whether measures of structural volume, asymmetry and
volume change are meaningful features in patients with TBI. In this setup both the assessment of
segmentation accuracy and the validation of measured features as predictors of disease outcome
are coupled a priori. In Chapter 3 and Chapter 4 the employed segmentation methodology was
evaluated and accuracy assessed quantitatively. Further, a non-expert visually reviewed the seg-
mentations calculated in this chapter to rule out gross failures. Cf . Figure 6.2 and Figure 6.4 for
included subjects with segmentations considered successful, however, affected by pathology. With
this limitation in mind, the assumption is made that anatomical structures throughout the study co-
hort were segmented successfully. The goal of the performed analysis was therefore to show the
potential of derived quantitative measures as valid biomarkers that are predictive for the outcome
of a head trauma.
Quantified features extracted from acute MR imaging allowed a specific prediction whether a pa-
tient will have a negative outcome diagnosis (SPEC: 94%), when classified against the low disability
outcome group. In this experiment a high sensitivity was observed using volumes of structural ROIs
(e.g. SENS accumbens: 91%, SENS hippocampus: 83%) and high specificity using symmetry-
based features (e.g. SPEC AAI of all structures: 91%). This suggests that brain symmetry is only a
“necessary” criterion for a favourable disease outcome while asymmetry is a “sufficient” criterion
for unfavourable outcome. This is in agreement with the findings presented in Chapter 3 on another
dataset. However, it must be noted that there is a trade-off between SENS and SPEC, which should
be further investigated using for example ROC curves (cf . Chapter 3, Figure 3.11).
In Strangman et al. (2010) the authors reported that structural volumes correlate with the potential
of patients to recover within a memory rehabilitation program. In this study, structural volumes
were extracted from 50 TBI patients several years after the injury in the chronic stage. The authors
raise the question whether structural volumes extracted at the acute stage have similar potential. The
results of the presented study in this chapter are encouraging: structural volumes (e.g. hippocampus,
thalamus) were identified that are predictive for the outcome of the disease. These findings agree
with those presented in Strangman et al. (2010). The influence of brain capacity/reserve on the
ability to recover from a TBI needs to be further investigated.
The conducted longitudinal analysis revealed increased atrophy in the WM, brainstem and tha-
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lamus which was also shown in other studies (Warner et al., 2010b; Newcombe et al., 2015). In
contrast to Warner et al. (2010b), significant changes for the cerebellum but not for the amygdala
were found in this chapter. However, when comparing to other studies the substantial heterogeneity
of TBI studies must be considered: In comparison to the study presented in this thesis, Warner et al.
(2010b) analysed 25 patients with DAI and 22 age-matched controls where patients had a lower
GCS of 6.2±4.5 (mean±SD) and were much younger (26.8±11.3 years).
In the conducted analyses, the significance of many findings could not be confirmed after correct-
ing for multiple comparisons. However, the performed Bonferroni correction is very conservative
and the calculated effect sizes indicate that significance levels could be increased on a larger cohort.
In summary, the experiments confirm that the developed algorithms can be valuable when automat-
ically analysing cohorts with images covering a wide range of significantly altered brain anatomy.
A simple approach was chosen to account for the uneven age distribution between patients of
the investigated outcome categories. This resulted in a substantial reduction of the number of study
subjects (N = 131!N = 67). Even though no subjects were excluded from the severe disability
outcome group (N = 13), this is a limitation of the conducted experiments as the number of subjects
(or samples) per group is small. In the future the applicability of more sophisticated methods to
adjust for selection bias, such as inverse-probability weighting (Haneuse et al., 2009), should be
explored.
In addition to the performed age matching, experiments were carried out to employ the regression
models trained on the healthy control subjects from ADNI (cf . Chapter 5) to account for differences
in age, gender and brain size. Preliminary results that are not included here suggest that correction
for brain size is not beneficial. One possible explanation is that the calculated brain size estimate
may be distorted by TBI-related brain pathology, such as lesions or contusions. Correcting for either
age and gender did not substantially alter the results presented in Table 6.3. Correcting for both age
and gender using a multi-variate regression approach reduced the discriminative value of the inves-
tigated structures. It should be noted that the ADNI subjects are overall older than the TBI subjects
so that the trained model needs to be extrapolated in order to be applicable to the TBI dataset. One
hypothesis is therefore that the regression model trained on ADNI data is not straightforward ap-
plicable, due to confounding cohort differences in patient age but also acquisition protocol. These
effects require a deeper analysis so that no explicit correction for age or gender was performed.
195
No clear benefit was observed of combining all available measurements within multi-feature
classifiers except when predicting severe and low disability outcome at baseline based on structural
volumes. Classifiers were not explicitly tuned. Given the size of the study cohort and the large
number of features a lack of generalisation of the classifiers/overfitting might be a problem that
should be further investigated in the future.
6.6 Conclusion
In this chapter 67 subjects were analysed from a recently acquired cohort of mild to moderate TBI
patients. The conducted analyses demonstrate that the methodology developed in Chapters 3 and
4 allows the extraction of meaningful biomarkers from MR brain images such as the volume or
volumetric change of individual ROIs. It was confirmed that imaging information can add pre-
dictive value when performing an outcome prognosis at the acute stage of the injury. Structural
volumes, measured from acute MR images, of the accumbens, hippocampus, amygdala and thala-
mus were related to the disease outcome. Both WM and brain atrophy was increased in patients
with unfavourable outcome prognosis. Overall, the employed methodology has potential to support
automated brain morphometry in patients with TBI.
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7 Patch-based Evaluation of Image
Segmentation
This chapter is based on:
C. Ledig, W. Shi, W. Bai, and D. Rueckert, “Patch-based Evaluation of Image Segmentation”,
Computer Vision and Pattern Recognition (CVPR), pp. 3065-3072, 2014.
Abstract: The quantification of similarity between image segmentations is a complex yet im-
portant task. The ideal similarity measure should be unbiased to segmentations of different volume
and complexity, and be able to quantify and visualise segmentation bias. Similarity measures based
on overlap, e.g. Dice score, or surface distances, e.g. Hausdorff distance, clearly do not satisfy
all of these properties. To address this problem, Patch-based Evaluation of Image Segmentation
(PEIS) is introduced, a general method to assess segmentation quality. The method is based on
finding patch correspondences and the associated patch displacements, which allow the estimation
of segmentation bias. Both the agreement of the segmentation boundary and the conservation of
the segmentation shape is quantified. Furthermore, the segmentation complexity within patches is
assessed to weight the contribution of local segmentation similarity to the global score. PEIS is
evaluated on both synthetic data and two medical imaging datasets. On synthetic data evidence
is provided that PEIS, in comparison to the Dice score, produces more comparable scores across
segmentations of varying size, has increased sensitivity and estimates segmentation bias accurately.
On cardiac MR images, it is demonstrated that PEIS can evaluate the performance of a segmenta-
tion method independent of the complexity of the segmentation under consideration. On brain MR
images, five different automatic hippocampus segmentation techniques are compared using PEIS.
Finally, the segmentation bias is visualised on a selection of the cases.
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The main goal of this thesis is the development of automatic whole-brain segmentation methods.
These methods have been evaluated using established similarity measures such as the Dice coeffi-
cient (Dice, 1945) (DC). While DC is a widely used measure to compare competing segmentation
approaches (Landman and Warfield, 2012; Asman et al., 2013a) it has some limitations such as the
strong dependence of the observed value range on the size and shape of the segmentation under
investigation. The aim of this chapter is to present an alternative similarity measure that overcomes
some of the limitations of existing techniques and can provide relevant additional information when
evaluating image segmentations.
7.1 Introduction
The validation of automatic segmentation methods usually relies on the comparison to reference
segmentations, ideally annotated by an expert observer. However, evaluation is inherently difficult
as similarity features are hard to define and potentially subjective. Furthermore manual expert seg-
mentations cannot be considered as gold standard as they are subject to both significant inter- and
intrasubject variability (Chalana and Kim, 1997; Gerig et al., 2001; Warfield et al., 2004). Warfield
et al. (2004) presented a popular method, STAPLE (cf . Section 2.1.3.6), to estimate a probable
ground truth given several manual expert segmentations. However, assuming a reliable ground
truth or reference segmentation is available, the problem of comparison remains. The importance
of quantifying segmentation accuracy in the context of biological imaging was formulated almost
40 years ago (Yasnoff et al., 1977; Udupa et al., 2006). However, while the development of seg-
mentation algorithms is an active research area, the progress in developing evaluation methods is
more limited (Zhang, 1996; Udupa et al., 2006; Chang et al., 2009).
The measurement of similarity between two different sets or image segmentations is thus an
ongoing challenge (Dice, 1945; Tversky, 1977; Unnikrishnan et al., 2007; Ca´rdenes et al., 2009).
The most popular approaches to quantify segmentation similarity in medical imaging are based on
overlap (Dice, 1945; Crum et al., 2006), with the Dice coefficient being the most renowned repre-
sentative. With the so called ratio model Tversky (1977) presented a framework that generalised the
widely used Dice (Dice, 1945) and Jaccard (Jaccard, 1912) similarity index. A thorough examina-
tion of the Dice and Jaccard index is presented in Chang et al. (2009). Generalised overlap measures
focusing on fuzzy multi-label segmentations are described in Crum et al. (2006). In Ca´rdenes et al.
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(2009), the authors modified the ratio model by weighting wrongly segmented pixels in 2D, or vox-
els in 3D respectively, based on their spatial distance from the reference label. Another family of
measures is based on the surface distance between segmentations (Chalana and Kim, 1997; Aspert
et al., 2002; Pichon et al., 2004; Ca´rdenes et al., 2009; Heimann et al., 2009). Examples are the
Yasnoff discrepancy (Yasnoff et al., 1977) or the Hausdorff distance (Huttenlocher et al., 1993),
which is highly sensitive to errors (Pichon et al., 2004). Taking the distance between misclassified
voxels and ground truth into account is important (Pichon et al., 2004; Crum et al., 2006; Ca´rdenes
et al., 2009).
Next to this, other methods have been proposed, often with focus on a particular application.
In Gerig et al. (2001) the authors have developed a tool that assesses object segmentations with
both overlap and distance-based measures. By visualising segmentation differences the tool was
employed to increase intrarater reliability of manually obtained hippocampus segmentations (Gerig
et al., 2001). Pichon et al. (2004) propose to use statistics based on surface distances to estimate
segmentation bias. Another method employs confidence maps of multiple reference segmentations
to quantify segmentations in 2D (Restif, 2007). Juneja et al. (2013) introduced the validation index
which is based on multiple expert segmentations to support radiotherapy planning. Recently a
method based on genetic programming was proposed (Vojodi et al., 2013) that combines single
measures for colour image segmentation.
A good overview over different segmentation evaluation approaches is given in Zhang (1996);
Udupa et al. (2006); Zhang et al. (2008).
7.1.1 Contribution and overview
In the following, inspired by Unnikrishnan et al. (2007), the desired attributes of a similarity mea-
sure for image segmentation are postulated:
• Comparable scores: Scores calculated on segmentations of varying size and boundary com-
plexity should be comparable. This is desirable as it renders the comparison of automatic
segmentation methods less sensitive towards the evaluation dataset or characteristics of the
reference segmentation under consideration.
• Shape conservation: The measure should assess the preservation of the shape of segmen-
tation boundaries. This is desirable as varying definitions of segmentation protocols or the
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presence of partial volume effects in low-resolution images can produce different segmenta-
tion boundaries that are, however, similar in shape.
• Boundary conformity: It should measure the agreement of segmentation boundaries. This is
desirable as a good segmentation not only preserves shape but also matches the segmentation
boundaries.
• Segmentation bias: The measure should allow the detection and visualisation of segmentation
bias, such as over- or under-segmentation. This is desirable as it provides an insight into the
systematic differences between segmentations. Visualisation of segmentation bias can also
support the development and tuning of automatic segmentation methods.
• Similarity: The ability to quantify visual similarity rather than pure overlap. This is desirable
as especially segmentations of structures with a high surface to volume ratio, such as vessel
segmentations, can be highly similar while having imperfect overlap.
Based on the ratio model (Tversky, 1977), the Patch-based Evaluation of Image Segmentation
(PEIS) is proposed. PEIS is formulated for binary segmentations. While PEIS can be generalised
to multi-label segmentations, this is beyond the scope of this chapter and left for future work.
For each voxel a patch displacement vector is found that locally transforms the reference segmen-
tation into the test segmentation. This voxel-wise displacement allows the estimation and visualisa-
tion of segmentation bias. It furthermore allows the quantification of how well a test segmentation
conserves shape and matches segmentation boundaries. The presented approach is inspired by
patch-based methods that have been used successfully in image synthesis (Liang et al., 2001) or
image denoising (Kervrann and Boulanger, 2006). More recently patch-based approaches have also
enjoyed increasing popularity in the medical imaging community and have been applied to image
segmentation (Coupe´ et al., 2011; Asman and Landman, 2013). Secondly, it is proposed to employ
the local segmentation complexity within patches to control the contribution of local segmentation
similarity to the global score. This allows improving sensitivity in regions that are non-trivial to
segment. The approach extends pure overlap measures and allows for a quantitative assessment
of segmentation bias. PEIS is evaluated on both synthetic and real medical imaging data: PEIS is
compared to the Dice score on synthetic data and to both Dice score and the average surface dis-
tance (ASD), as used in Heimann et al. (2009), on real datasets from cardiac and brain MR images.
Visual evidence is provided that PEIS allows the visualisation of segmentation bias.
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The remaining chapter is organised as follows: The original formulation of the ratio model is
reviewed and PEIS is presented in Section 7.2. PEIS is then evaluated on synthetic and real datasets
in Section 7.3. The findings will be discussed in Section 7.4. Finally conclusions are formulated
and future work is outlined in Section 7.5.
7.2 Method
7.2.1 Framework: The ratio model (RM)
Given a binary reference segmentation R, the goal is to measure the similarity of a test segmentation
S= {si=1...N} to R= {ri=1...N}. In the following it is assumed that si,ri 2 {0,1},8i 2W⇢Nd . Here
d = 2,3 is the image dimension and i serially numbers the N voxels in W. W is the subset of Nd
where not both si and ri are zero.
The ratio model (RM) framework, originally described by Tversky (1977), can be stated as:
RM(S,R) =
q f (S\R)
q f (S\R)+a f (S\R)+b f (R\S) (7.1)
In this chapter a similar notation to the one in Tversky (1977) is used, where the scale f describes
a family of similarity measures based on the global parameters q,a,b. In the standard formulation
f (S) is the cardinality of the set S. For q = 1 and a = b = 12 this model reduces to the widely
used Dice coefficient (Dice, 1945). For q = 1 and a = b = 1 the formulation yields the Jaccard
coefficient respectively (Jaccard, 1912). More details on the characteristics of this formulation can
be found in Tversky (1977).
In the context of classification, one can consider f (S\R) as true positive (TP), f (S \R) as false
positive (FP) and f (R\S) as false negative (FN) fraction of the test segmentation S and the reference
segmentation R. The false positives and false negatives are summarised as false labels (FL= FP+
FN). Thus the non-directional case, a = b, is modelled where the denominator reduces to qTP+
aFL. Here false positives and false negatives are equally penalised. In the following a novel way
of modelling the scale f is presented.
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7.2.2 Patch-based ratio model (PBRM)
Standard overlap measures are restricted to the evaluation of the voxel-wise agreement of seg-
mentations. Here, a novel patch-based approach is proposed to relax this constraint by finding a
voxel-wise displacement that transforms the reference segmentation R locally into the test segmen-
tation S. A patch extraction operator is given by Np(·). Np(R(i)) extracts a patch of the reference
segmentation at position i, Np(S( j)) a patch of the test segmentation at position j accordingly.
To compare two patches the sum of absolute differences is calculated between Np(R(i)) and
Np(S( j)). This difference is defined as:
D(i, j) = |Np(R(i)) Np(S( j))| (7.2)
At a certain position i an optimal patch displacement D(i) = (D(i)x,D(i)y,D(i)z) is derived that
locally minimises D(i, j). This is equivalent to maximising the agreement of a fixed patch in R,
Np(R(i)), with a moving test patch in S, Np(S( j)). The optimisation is described in Section 7.2.3.
In the following, i0 denotes the index that yields the best locally matching test patch Np(S(i0)) for
a given reference patch Np(R(i)). Thus i0 corresponds to i displaced by the optimal displacement
D(i). For a certain displacement D(i), the spatial patch overlap between the reference patch and
the displaced test patch is defined as A(D(i)). Spatial overlaps, A(D), are illustrated for different
displacements D in yellow in Figure 7.1. A(D) only depends on D and is thus independent of the
segmentation content within the patches.
Assuming that the optimal displacement D(i) and thus the corresponding i0 was found, a voxel-
wise segmentation similarity index g 2 [0;1] is defined as g(i) = 1.0  D(i,i0)|Np(·)| and a spatial similarity
index t 2 [0;1] as t(i) = A(D(i))|Np(·)| . These indices are normalised by the number of voxels within
a patch, |Np(·)|, and thus the maximal possible patch dissimilarity. By defining t based on the
amount of spatial overlap of the corresponding patches, it is ensured that both g and t take on
comparable values. This formulation thus allows the averaging of g and t to a combined similarity
score h(i) = 0.5⇥ (g(i)+ t(i)).
In the notation of the ratio model (Tversky, 1977), Âih(i) denotes the true positive fraction,
f (S\R), while Âi (1.0 h(i)) summarises the falsely segmented fraction, f (S\R) and f (R\S).
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Figure 7.1: The spatial overlaps A between the supports of a reference patch (grey) and a moving
test patch (dark red) is shown in yellow. For increasing patch displacements D= (Dx,Dy)
the spatial overlap decreases. If two displacements have the same L1-norm (both exam-
ples shown on the right with ||(1, 1)||1 = ||(2,0)||1 = 2) the proposed method favours
a diagonal displacement as A(1, 1) > A(2,0). The reference centre is indicated as
circle. The centres of the test patches are indicated as crosses and correspond to the
displacements shown in Figure 7.2.
The patch-based ratio model (PBRM) is formulated as:
PBRM(S,R) =
qÂih(i)
qÂih(i)+aÂi (1.0 h(i))
(7.3)
7.2.3 Optimisation of local patch correspondences
To ensure that a locally optimal patch correspondence i0 is found it is assumed that D(i, j) mono-
tonically decreases with increasing distance di j from the reference position i. Here di j denotes the
L1-distance between the position of two voxels i and j in image space. To obtain i0, solutions i0k are
calculated for different levels of distance k that minimiseD(i, j) for all j with L1-distance di j equal
to k (8 j : di j = k). At a certain level k only test patches are considered that are centred at a voxel
j with L1-distance k from i, di j = k. Specifically, at a certain level k the following optimisation
problem is solved to calculate i0k for a given position i in the reference segmentation:
i0k =argmin
j
D(i, j)
s. t. di j = k
(7.4)
The optimisation process for an example reference patch is shown in Figure 7.2. In the case that
there are multiple possible solutions that minimise D(i, ·), the first found displacement is chosen
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Figure 7.2: Calculation of optimal patch centers i0k at different distance-levels k. An example of a
reference patch is shown in grey, while the best matching patches at the three corre-
sponding distance-levels (k = 0,1,2) are shown in dark red.
that yields the maximal spatial patch overlap A(D) which is illustrated in Figure 7.1. This will,
for a certain distance-level k, favour diagonal over purely horizontal or vertical displacements (cf .
Figure 7.1).
Then the locally optimal voxel-specific displacement D(i), determined by i0, is calculated by
solving the following optimisation problem:
i0 =argmin
i0k
D(i, i0k)
s. t. D(i, i00) D(i, i01)  · · ·>D(i, i0k) (7.5)
The monotonicity constraint ensures that the best matching patch is found locally. The proposed
strategy also renders the search very efficient, as it provides an efficient stopping criterion for the
calculation of i0k. The calculation can be stopped once D(i, i0k+1) > D(i, i0k). With this formulation
the need for a fixed search neighbourhood is avoided. This is usually required to allow for a tractable
computation. Hence, the presented approach can find arbitrary large displacements.
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7.2.4 Patch-based Evaluation of Image Segmentation (PEIS)
Determining the parameters q,a globally yields a measure to which correctly or falsely segmented
voxels equally contribute. For large structures with a low surface to volume ratio this is problematic
as the overall measure is dominated by the large number of true positives in the interior of the
structure. This problem is addressed by introducing spatially varying parameters q(i),a(i) into the
model. The following formulation presents a data-driven way to increase the measure’s sensitivity
in the relevant regions, e.g. regions close to the boundary, when comparing structures.
The following describes the complete patch-based spatially varying ratio model:
PEIS(S,R) = Âi q(i)h(i)
Âi q(i)h(i)+Âia(i)(1 h(i))
(7.6)
There are different ways to model q(i) and a(i). In this work it was chosen to determine q(i)
and a(i) based on the complexity of the reference patch under consideration. This complexity is
quantified by counting the number of facets nfacets(i) that separate adjacent voxels with different
labels in the reference patch Np(R(i)) with centre i. Then q(i) and a(i) can be calculated as:
q(i) = nfacets(i)
nmaxfacets
a(i) = 1.0 q(i) (7.7)
Here nmaxfacets is chosen in the order of the number of voxels within a patch of maximal complexity.
For a given patch width or patch size pw the maximal number of facets is chosen to be nmaxfacets =
4⇥ (pw  1) (2D) or nmaxfacets = 4⇥ (pw  1)⇥ pw (3D). This corresponds to the number of facets
contained in a patch separated by a diagonal line (2D) or diagonal plane (3D). Example patches
of varying patch complexity are shown in Figure 7.3. Furthermore, nmaxfacets serves as a threshold for
nfacets(i) to ensure 0  q(i) 1.
With this formulation the contribution of correct labels q(i) is higher in patches that are difficult
to segment (high complexity) than in those that have little complexity or are even homogeneous
(nfacets(i) = 0). In contrary, false labels of “easy to segment” or quite homogeneous regions have
a high weight a(i) and thus degrade the measure more seriously than false labels in “difficult to
segment” patches.
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nfacets= 0 nfacets= 8 nmaxfacets= 16 nfacets= 9 
Figure 7.3: Example reference patches of varying complexity. Foreground segmentation is shown
in grey and corresponding facets in blue. The patch shown on the right has maximal
complexity of nmaxfacets = 4⇥ (pw 1) = 16 for a 2D patch with width pw = 5.
Estimated bias b=Δ!n 
Estimated Δ 
Reference patch 
Test patch 
Patch-normal: n 
+5 
-5 
Estimated  
bias 0 
Figure 7.4: left: Example comparison of a polygon (test segmentation, outlined in dark red) to a
circle (reference, outlined in black). Patch-correspondences of fixed reference patches
(green) and moving test patches (orange). Vectors represent patch-normals n (dark
blue), optimal patch displacements D (light blue) and the projections of D on n (red)
which represents the estimated segmentation bias. The distance transform of the refer-
ence segmentation is shown in a rainbow colour scheme. right: Estimated voxel-wise
segmentation bias b(i) = n(i) ·D(i) within the domain W.
7.2.5 Quantification of segmentation bias
In addition to the similarity score, the presented approach also provides a displacement vector
D(i) = (D(i)x,D(i)y,D(i)z) quantifying the local spatial difference between test and reference seg-
mentation. In the following, a single measure is derived that quantifies the segmentation bias based
on D. Specifically, the interest is if a segmentation is too generous (“over-segmentation”) or too
conservative (“under-segmentation”).
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First, for a patch with centre i a vector is calculated that is referred to as patch-normal n(i). This
patch-normal is calculated based on the Euclidean distance transform T (R) of the zero level-set in
the reference segmentation. Specifically, n(i) is computed as the average first derivative of T (R) at
segmented voxels in the reference patch Np(R(i)). This can be formalised as:
n(i) =  1
Z Âj2Np(R(i))
d(R( j))—T (R)( j) (7.8)
Here j indexes the voxels in the reference patchNp(R(i)) and d(·) indicates if R( j) is segmented. Z
is a factor that normalises n(i) to unit length. This defines n(i) as a patch-normal representing the
most significant direction of the transition “from the segmented to the unsegmented region”.
Together with the calculated patch displacement D(i), the patch-normal n(i) allows the quan-
tification of over- or under-segmentation by calculating the scalar product b(i) = n(i) ·D(i). If a
certain patch is displaced along n(i) then b(i) > 0 indicates over-segmentation. b(i) < 0 indicates
under-segmentation accordingly. Figure 7.4 illustrates the bias estimation based on the example of
comparing a five sided regular polygon to a reference circle.
Furthermore, the weighted mean µb and the standard deviation sb is calculated to quantify sys-
tematic segmentation bias. As weights the q(i) are employed to focus the bias calculation on patches
that contain edges. The translational bias is estimated for all directions, x,y,z, based on the compo-
nents of D(i) and patch complexities (q(i)x,q(i)y,q(i)z) calculated based on facets perpendicular to
the corresponding directions. Table 7.1 summarises the proposed quantities.
Calculation Description
PEIS Equation 7.6 similarity
µb 1Âq(i) Âi q(i)(n(i) ·D(i)) segmentation bias
sb [ 1Âq(i) Âi q(i)(b(i) µb)2]
1
2 shape conservation
µd2{x,y,z} 1Âq(i)d Âi q(i)dD(i)d translational bias (µ)
sd2{x,y,z} [ 1Âq(i)d Âi q(i)d(D(i)d µd)2]
1
2 translational bias (s)
Table 7.1: Overview over all quantities available through PEIS and their description.
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x 
y 
circles polygons crosses cardiac brain
Figure 7.5: Overview over employed datasets. Synthetic datasets with reference segmentation
outline (black) and example test segmentation outlines (dark red). Medical imaging
datasets with overlaid ground truth reference segmentation. Cardiac MR image with
outlined right ventricle myocardium (yellow) and blood pool (red), and a MR brain
scan with overlaid hippocampus segmentation (yellow).
7.3 Experiments and results
7.3.1 Materials
The presented measure PEIS was evaluated on both synthetic and real data. Geometric objects were
created synthetically to show that PEIS yields, in contrast to the Dice score, comparable scores on
structures of different size and has the potential to quantify shape conservation.
• Circles: Two-dimensional circles of varying radiuses (CSrS) were compared to two reference
circles with fixed radius (CRrR , rR = 15 or rR = 80 ). In each experiment the radiuses of the
test segmentations, rS, varied from rR 10 to rR+10.
• Polygons: Two-dimensional regular polygons with a varying number of sides were compared
to a reference circle with fixed radius (rR = 50). The polygons approximate the circle and
have a fixed area of Ap = pr2R and thus the same area as the circle. The number of polygon
sides varied from 3 to 50.
To evaluate PEIS on vessel-like structures with high surface to volume ratio a dataset of synthetic
crosses was created. This dataset was used to confirm that PEIS accurately estimates translational
bias and compares shape similarity rather than pure overlap.
• Crosses: Three-dimensional crosses with varying centre (cx = 10cos(t),cy = 10sin(t),cz = 1)
parameterised by t 2 [0,2p] were compared to a reference cross centred at the origin. All
crosses are one voxel thick and have a length of 100.
Furthermore, the characteristics of PEIS were investigated on real medical imaging data. Automatic
segmentations were compared to available manual ground truth segmentations. On a cardiac dataset
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(Petitjean et al., 2012) it was shown that PEIS provides comparable scores between segmentations
of different volume and topology. On a brain imaging dataset (Landman and Warfield, 2012) it was
shown that PEIS can be used to rank automatic segmentation methods and allows the visualisation
of segmentation bias. The employed datasets from the medical imaging domain are:
• Cardiac data: Automatic segmentations were calculated based on 16 training subjects used in
a recent Right Ventricle (RV) Segmentation Challenge (Petitjean et al., 2012, 2015). The Dice
score, average surface distance (ASD) and PEIS score were calculated for the myocardium
and the blood pool. The reference segmentations were obtained manually by experts (Petit-
jean et al., 2015).
• Brain data: Automatic segmentations were calculated on 20 subjects from the NMM brain at-
las used for evaluation in a recent whole-brain segmentation challenge (Landman andWarfield,
2012). The Dice score and PEIS were compared on the hippocampus segmentations calcu-
lated by the five best performing methods in the challenge. The reference segmentations were
obtained manually by experts (cf . Section 2.2.5). The focus was on the hippocampus as its
accurate segmentation has been proven to be of high value for the diagnosis and outcome
prediction of dementia patients, in AD in particular.
An overview over the datasets is provided in Figure 7.5.
7.3.2 Results on synthetic data
On synthetically generated data, it is observed that PEIS, in contrast to the Dice coefficient, fulfils
the desired characteristics: comparable scores, shape conservation, boundary conformity, segmen-
tation bias and similarity.
In a first experiment the synthetically generated circles were used. This experiment, as sum-
marised in Figure 7.6, confirms that the measured segmentation bias µb quantifies boundary con-
formity as it represents the true bias for both under- and over-segmentation. The low standard
deviation sb underlines shape conservation. PEIS provides comparable scores for different refer-
ence radiuses. In contrast to that, Dice scores increase with increasing radiuses. Dice scores are
reasonably discriminative only for deviations from a circle with a rather small radius (CR15), as it
tends to degenerate for circles with larger radiuses (CR80). The vast number of true positives in the
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Figure 7.6: Circles experiments for reference radiuses rR = 15 (left) and rR = 80 (right): Different
similarity scores (colours) and segmentation bias µb (black, sb as error bars).
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Figure 7.7: Polygons experiment: Different similarity scores (left) and estimated shape conserva-
tion, sb (right).
interior of large structures dominate the overlap measure and the Dice score looses its sensitivity to
small deviations from the reference.
In a second experiment, the polygons were compared to a reference circle of fixed radius. Fig-
ure 7.7 illustrates the calculated similarities. With high Dice scores, e.g. 0.91 for the comparison
of a square to a circle, the Dice coefficient is unable to detect the significant shape differences
between objects of equivalent area/volume. PEIS detects differences over a wide spectrum and is
able to quantify the shape differences between segmentations (sb). A visualisation of the segmen-
tation bias is illustrated in Figure 7.4, confirming the potential of PEIS to quantify and visualise
segmentation bias.
In the final experiment on synthetic data the ability of PEIS was evaluated to detect translational
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Figure 7.8: Crosses experiment: Estimated translational bias for all coordinate directions (sx,y,z
as error bars). Crosses were translated by (cx = 10cos(t),cy = 10sin(t),cz = 1 with
t 2 [0,2p]).
bias in the segmentation: For this, the 3D crosses were translated along a circular trajectory. While
a Dice score of almost zero, due to neglectable overlap, fails to quantify any similarity, non-zero
PEIS scores of 0.21±0.06 (mean±SD) confirm that PEIS quantifies similarity rather than pure
overlap. PEIS yields comparable scores while moving the test cross in a constant distance around
the reference cross. As shown in Figure 7.8, PEIS also provides a good estimate for the translational
bias (µx,µy,µz) for all coordinate directions with almost zero variance (sx = sy = sz ⇡ 0).
7.3.3 Results on medical imaging data
In this section, PEIS is employed to evaluate segmentations of medical imaging data. Firstly, evi-
dence is obtained that PEIS provides comparable scores on cardiac data: The measured segmenta-
tion accuracy was compared for segmentations of the myocardium, a thin, ring-like structure, and
the blood pool, a structure with a rather low surface to volume ratio. Even though both structures
share a segmentation boundary (cf . Figure 7.5), both the Dice score and the ASD (Heimann et al.,
2009) provide similarity scores of significantly different levels. In contrast to this, PEIS remains
comparable, as illustrated in Figure 7.9. This is important as it indicates that the proposed measure
is indeed independent of the topology and volume of the segmentation under consideration. This
result also suggests that PEIS has the potential to compare different segmentation methods over
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Figure 7.9: Similarity scores calculated on cardiac data segmented into myocardium and blood
pool. Both the Dice coefficient and the ASD do not yield comparable scores for struc-
tures of different complexities.
different datasets.
Secondly, PEIS was applied to evaluate the hippocampus segmentations of the five best perform-
ing methods in a recent whole-brain segmentation challenge (Landman and Warfield, 2012). The
results are summarised in Table 7.2. Here, PEIS produces a similar ranking as the Dice coefficient,
which was used in the challenge. More interesting, however, is the additional information provided
through PEIS. The best performing method is also the method that best conserves the segmentation
shape, lowest sb. Furthermore it is possible to obtain the visualisation of the segmentation bias on
right hippocampus segmentations of the five methods (Figure 7.10).
These experiments on real data confirm that PEIS allows the quantification and visualisation of
segmentation bias, yields comparable scores and adds information regarding shape conservation.
CIS JHU MALP EM⇤ PICSL Joint NLS PICSL BC
Dice 0.851 0.861 0.862 0.866 0.870
PEIS 0.788 0.801 0.799 0.809 0.810
µb -0.007 -0.069 0.011 -0.007 -0.017
sb 0.541 0.483 0.492 0.471 0.468
⇤ based on an early version of MALP-EM (Ledig et al., 2012a).
Table 7.2: Similarity scores (Dice coefficient, PEIS) and mean segmentation bias (µb) and shape
conservation (sb) averaged over 20 hippocampus segmentations for different methods.
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CIS JHU MALP EM PICSL Joint NLS PICSL BC
Figure 7.10: Visualisation in coronal view of segmentation bias for the right hippocampus of
three random subjects (rows) for five automatic segmentation methods (columns).
Colours relate to positive bias or over-segmentation (red) and negative bias or under-
segmentation (blue).
7.4 Discussion
It was shown that PEIS yields comparable scores on real medical imaging datasets, which sets it
apart from many existing approaches such as the Dice coefficient or surface-based distance mea-
sures. In the presented formulation, PEIS is not independent of the resolution level of a segmen-
tation as the spatial similarity t is linked to the voxel-wise patch displacement. E.g. in the circles
experiments (cf . Figure 7.6), PEIS will yield lower scores if the data is resampled at a higher reso-
lution. Dependent on the application this may or may not be appropriate. However, the estimated
segmentation bias, if calculated in millimetres, is comparable. In general it is difficult to compare
or even rank similarity measures as they usually provide complementary information. However, it
was shown that PEIS provides a large spectrum of information including shape conservation and
bias estimation. As PEIS finds patches of the reference segmentation in the test segmentation, it
provides a directional measure. This differs from the Dice coefficient, which is non-directional.
While non-directionality seems a desirable attribute it brings the risk that the measure’s scores may
be biased towards certain test segmentations. A further discussion of directionality can be found
in Tversky (1977). The presented optimisation approach of PEIS is efficient, has no fixed search
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window size and identifies a local optimum, which is desired for this application. In the conducted
experiments, a patch size of 5⇥5⇥5 voxels was chosen. This is similar to commonly used patch-
based segmentation methods, e.g. Coupe´ et al. (2011). In the conducted experiments the runtimes
of PEIS and ASD were comparable in terms of computational effort.
7.5 Conclusion and future work
In this chapter the novel approach Patch-based Evaluation of Image Segmentation (PEIS) was in-
troduced for the comparison of binary segmentations. It was demonstrated on both synthetic data
and real medical imaging data that PEIS has the potential to fulfil the key characteristics which
are important for the evaluation of image segmentation: Providing a similarity score that is both
comparable over different applications and informative. The presented measure has been shown
to be sensitive to small, but critical shape differences of objects with varying size. Furthermore,
PEIS yields a voxel-wise bias estimate which allows the quantification of systematic boundary dif-
ferences of both shape and translational nature. Especially the possibility to visualise segmentation
bias is valuable when comparing segmentations. This can support the development and tuning of
automatic segmentation methods. With the incorporation of locally varying weights based on patch
complexity, PEIS extends the standard ratio model. This is a step away from pure overlap measures
towards measures with a focus on segmentation similarity.
In this work PEIS was evaluated based on the combined quantity h= 0.5(g+t). However, PEIS
can be based on other scales such as the pure segmentation similarity g or the pure spatial similarity
t. In the future it will be interesting to investigate whether PEIS can be adapted by varying the patch-
size to define similarity at different levels of detail. The presented optimisation strategy can poten-
tially be employed in other patch-based applications, such as label fusion (Asman and Landman,
2013; Coupe´ et al., 2011). It is desirable to extend PEIS to multi-label segmentations. A publicly
available implementation has been released (https://biomedia.doc.ic.ac.uk/software/, last
accessed 17 November 2015). The presented experiments have shown that PEIS is able to recover
rigid transformations, which links PEIS to image registration. Potentially not only segmentation
bias but also a deformation field relating reference and test segmentation can be recovered.
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8 Conclusion
The main contribution of this thesis is the development and implementation of a robust and auto-
matic method (MALP-EM, cf . Chapter 3) to segment T1w MR images of the whole brain into its
individual anatomical ROIs. While there are numerous established methods that perform this task,
MALP-EM has been shown to be particularly accurate (Landman et al., 2012) while being robust in
the presence of disease-related atrophy or severe brain deformation due to e.g. head trauma (Ledig
et al., 2015). Further MALP-EM was extended to be applicable to the analysis of longitudinal
image series (MALP-EM4D, cf . Chapter 4). In contrast to many other state-of-the-art methods
that measure volume change over time of individual structures only, MALP-EM4D allows atro-
phy measurement of more than a hundred structures simultaneously. During the development of
MALP-EM4D particular focus was placed on the avoidance of bias caused by image distortions
such as differential bias fields or by asymmetric image processing (e.g. registration).
Both MALP-EM and MALP-EM4D were then employed to analyse a large cohort of patients
with AD (cf . Chapter 5) and a prospectively acquired cohort of patients that sustained a TBI (cf .
Chapter 6). The methods’ potential to support cross-sectional and longitudinal image studies was
confirmed on both datasets. Established findings in the AD literature were confirmed such as the
potential of volumes of MTL structures to discriminate patients with AD from healthy control
subjects. The calculated atrophy rates are comparable to those published in meta-analyses articles
and clearly related to the progression of dementia. The ADNI cohort has been extensively studied
in the past, which makes it an ideal resource to validate novel techniques. In this thesis, it was
shown that a multi-structure analysis of the whole brain has a discriminative power comparable to
highly sophisticated machine learning approaches, while allowing for an intuitive interpretation.
Clinical interpretability of biomarkers has been a particular goal of this thesis as it can lower the
barrier to translate research methodology into clinical practice. The physical meaning of volume
or volume change is clear, while the interpretation of features that are derived from more involved
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approaches such as sparse representations, manifold learning or patch-correspondences is often less
obvious. A strength of the performed study is also the processing of 5074 images acquired from
1674 distinct subjects from ADNI-1/-GO/-2. For each image/subject structural volumes and volume
changes of a large number of individual brain structures were quantified. These features can be a
valuable resource for future analyses, such as investigating the progression of structural volumes
with healthy aging. It was shown that measurements of distinct anatomical structures can provide
complementary information that can be exploited in multi-feature classifiers.
In contrast to disease progression in dementia, the disease-related processes that follow a head
trauma are studied less extensively. In TBI research it is therefore particularly interesting to analyse
processes within the whole brain rather than restricting the focus to selected ROIs only. Quanti-
fying atrophy over the months following the injury allows a better characterisation of the disease
progression in TBI. In an analysis of 67 patients with mild to moderate TBI disease-related volume
loss of e.g. total brain tissue and white matter but also individual structures such as the thalamus
or the brain stem was found. Further, the conducted experiments present evidence that reduced
hippocampal volume at the acute disease stage might predict poor outcome of a head trauma. The
correlation between hippocampal volume at injury and outcome diagnosis needs to be confirmed
and further investigated.
Next to the developed segmentation methodology, a novel measurement was proposed to quan-
tify the similarity of image segmentations (PEIS, cf . Chapter 7). The PEIS software has been
made publicly available. In this context several desirable attributes have been defined that an ideal
measure of similarity should possess. The conducted experiments confirmed that PEIS provides a
promising framework that has the potential to fulfil these characteristics. When compared to widely
used measures such as the Dice coefficient or the average surface distance, PEIS can provide a more
complete assessment of similarity with respect to the defined criteria. A particular strength of PEIS
is that it allows the visualisation of segmentation bias which can provide valuable information when
developing and optimising segmentation methodology.
8.1 Limitations
The presented segmentation methods rely on manually annotated brain atlases of healthy subjects.
During the development of both MALP-EM and MALP-EM4D the focus was placed on robustness.
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However, in the presence of pathology the registration algorithm can fail to establish an accurate
transformation when aligning the atlases to the target image. In these difficult cases an essential
assumption in image registration of an existing and smooth one-to-one mapping between the images
is often violated. The proposed method was designed to correct obvious labelling errors due to
misregistration based on the image intensities. Nevertheless, the framework is not able to explicitly
segment pathology that is not represented in the atlases such as lesions, contusions or tumours. This
can result in pathologies being included in one or more ROIs (e.g. within the WM, Figure 4.5). It
can be argued that image segmentations thus need to be reviewed individually to exclude affected
ROIs from a further analysis. In this thesis not all segmentation results were explicitly reviewed
to ensure that each individual ROI was segmented accurately. Rather, the overall segmentation
result was checked and it was investigated whether the whole feature set contains disease-relevant
information even though individual measurements might be affected by pathology.
Another limitation originates in the imaging cohorts and the corresponding clinical data used in
this thesis. As ADNI-2 is still a continuously growing resource it is difficult to define a standardised
evaluation set. In this work some pragmatic choices had been made. Thus the ADNI study subset
was defined based on the images that had been available and processed at the time of the analysis.
The lists of the processed image identifiers have been published online to enable other researchers
to compare their results to those reported here. Another challenge when comparing results across
studies are variations in the definition of disease stages, e.g. the definition of sMCI/pMCI.
In the TBI analysis substantial age differences between patients of different disease outcome cat-
egories were observed. This problem was addressed by defining an ad-hoc rule to exclude subjects
so that age differences are no longer significant at the expense of substantially reducing the study
cohort. Subsequent studies should investigate and consider the effects of confounding factors such
as age, gender, but also smoking or education carefully. Furthermore, the performed volumetric
analysis did not account for focal lesions or early oedema that might be present at the acute disease
stage. This is problematic as structural volumes measured shortly after the injury event are likely
to be distorted by effects due to neuropathology such as brain swelling. Finally, measured changes
in structural volume are likely not exclusively attributable to actual modifications of brain anatomy
including cell death. Instead, measurements are potentially distorted by changes of pathology such
as a reduction of swelling. This is a limitation and needs to be considered when interpreting both
cross-sectional biomarkers at the acute time point and longitudinal measurements.
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In this thesis the focus was placed on binary classification experiments. This means that patients
(samples) were classified into either of two classes presuming that one of both is correct. This is a
substantial simplification of realistic clinical scenarios where usually more than two diagnosis (e.g.
dementia types, disease stages) or multiple outcome scenarios (e.g. GOSe scores) are possible. With
this in mind the application of a classification framework allowing for multi-class classification is
desirable. In dementia diagnosis this could support the differential diagnosis of distinct dementias
such as FTD, LBD, VD and AD. In the context of TBI, outcome prediction at a finer level is also of
significant interest.
8.2 Future work
In the future the benefits of applying MALP-EM4D to more than two time points should be ex-
plored. For example adding information of the m12 image when estimating baseline!m24 atrophy
has the potential to reduce measurement bias and thus sample sizes. This also allows the consistent
measurement of volumetric changes at several time points leading to a finer temporal resolution of
measurements and thus better understanding of disease processes. For example, in another study
(Newcombe et al., 2015) a version of MALP-EM4D was employed to process up to five time points
and increased WM loss in patients with moderate-to-severe TBI was reported.
In the work towards this thesis, a large set of features quantifying brain anatomy was calculated
that can enable research beyond the analyses performed and presented here. For example, the effect
of nuisance factors such as age, gender, brain size but also field strength can be further explored
using the healthy control subjects from ADNI. Another important field for future research is the
differential diagnosis of dementia types. In this context it might be interesting to calculate additional
features such as shape descriptors or cortical thickness measurements based on the segmentation
estimates.
In addition aWM atlas is currently integrated into both the MALP-EM andMALP-EM4D frame-
works to further parcelate the rather large ROIs denoted as ’cerebral white matter’ in the NMM atlas.
Beyond allowing for a structural analysis of different WM subregions this is a crucial prerequisite
for established DWI pipelines. The source code and binaries of both MALP-EM and MALP-EM4D
will be made available. In combination with a python script that integrates the complete pipeline,
this allows both clinicians and researchers to apply and improve on the work presented in this thesis.
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A first version of this updated framework is currently tested at the Cambridge University Hospital,
UK. The approximate runtime to process a standard T1w image depends on the computing envi-
ronment but is estimated at around 10 hours using a single CPU core. The pipeline can be run
parallelised so that computation times between 1 and 2 hours are realistic on a desktop computer
using 6 cores. This includes all steps relevant for MALP-EM: bias correction, brain extraction, atlas
alignment, atlas fusion and label refinement.
The problem of explicitly segmenting pathologies is a further direction of research. Two promis-
ing approaches to address this limitation are 1) the targeted segmentation of different pathologies
(e.g. contusions, lesions) using machine learning (e.g. deep learning, RFs) and 2) the detection of
outlier voxels that do not match the intensity characteristics of the label. The calculated structural
segmentations are then a useful resource to put both pathology or outliers in general into spatial
context. Quantifying distinct lesion types and lesion sizes can result in valuable features that allow
a deeper investigation of the disease progression in TBI. It is expected that imaging information
from multiple MR protocols such as T2w, FLAIR or SWI sequences but also DWI images needs to
be incorporated to achieve these goals.
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B ROIs defined in the NMM atlas
Table B.1: Structure names of non-cortical structures in NMM brain atlas. Original ROI IDs were
remapped to be consecutive.
non-cortical structure abbreviation ID (right/left)
3rd ventricle 3rdVent 1
4th Ventricle 4thVent 2
Accumbens Area AccA 3/4
Amygdala Am 5/6
Brain Stem BS 7
Caudate Cau 8/9
Cerebellum Exterior CblmExt 10/11
Cerebellum White Matter CblmWM 12/13
Cerebral Exterior excluded CrblExt 14/15
Cerebral White Matter CrblWM 16/17
Cerebrospinal Fluid CSF 18
Hippocampus Hc 19/20
Inf. Lateral Ventricle infLV 21/22
Lateral Ventricle LV 23/24
Pallidum Pa 25/26
Putamen Pu 27/28
Thalamus Proper Th 29/30
Ventral DC vDC 31/32
Vessel excluded Vsl 33/34
Optic Chiasm OptC 35
Cerebellar Vermal Lobules I-V CVL1t5 36
Cerebellar Vermal Lobules VI-VII CVL6t7 37
Cerebellar Vermal Lobules VIII-X CVL8t10 38
Basal Forebrain BF 40/39
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Table B.2: Structure names of cortical structures in NMM brain atlas.
cortical structure abbreviation ID (right/left)
anterior cingulate gyrus ACgG 41/42
anterior insula AIns 43/44
anterior orbital gyrus AOrG 45/46
angular gyrus AnG 47/48
calcarine cortex Calc 49/50
central operculum CO 51/52
cuneus Cun 53/54
entorhinal area Ent 55/56
frontal operculum FO 57/58
frontal pole FRP 59/60
fusiform gyrus FuG 61/62
gyrus rectus GRe 63/64
inferior occipital gyrus IOG 65/66
inferior temporal gyrus ITG 67/68
lingual gyrus LiG 69/70
lateral orbital gyrus LOrG 71/72
middle cingulate gyrus MCgG 73/74
medial frontal cortex MFC 75/76
middle frontal gyrus MFG 77/78
middle occipital gyrus MOG 79/80
medial orbital gyrus MOrG 81/82
postcentral gyrus medial segment MPoG 83/84
precentral gyrus medial segment MPrG 85/86
superior frontal gyrus medial segment MSFG 87/88
middle temporal gyrus MTG 89/90
occipital pole OCP 91/92
occipital fusiform gyrus OFuG 93/94
opercular part of the inferior frontal gyrus OpIFG 95/96
orbital part of the inferior frontal gyrus OrIFG 97/98
posterior cingulate gyrus PCgG 99/100
precuneus PCu 101/102
parahippocampal gyrus PHG 103/104
posterior insula PIns 105/106
parietal operculum PO 107/108
postcentral gyrus PoG 109/110
posterior orbital gyrus POrG 111/112
planum polare PP 113/114
precentral gyrus PrG 115/116
planum temporale PT 117/118
subcallosal area SCA 119/120
superior frontal gyrus SFG 121/122
supplementary motor cortex SMC 123/124
supramarginal gyrus SMG 125/126
superior occipital gyrus SOG 127/128
superior parietal lobule SPL 129/130
superior temporal gyrus STG 131/132
temporal pole TMP 133/134
triangular part of the inferior frontal gyrus TrIFG 135/136
transverse temporal gyrus TTG 137/138
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C The Marshall Classification System
Table C.1: Marshall Classification system based on and modified from Marshall et al. (1991).
Marshall class Description
1 Diffuse injury (DI) I no visible intracranial pathological changes seen on CT
2 Diffuse injury II cisterns are present with midline shift of 0–5 mm and/or:
lesions densities present;
no high or mixed density lesion >25 cm3 may include bone fragments and foreign bodies⇤
3 Diffuse injury III (swelling) cisterns compressed or absent with midline shift of 0–5 mm; no high
or mixed density lesion >25 cm3
4 Diffuse injury IV (shift) midline shift >5 mm; no high or mixed density lesion > 25 cm3
5 Evacuated mass lesion (EML) any lesion surgically evacuated
6 Non-evacuated mass lesion (NEML)† high or mixed density lesion >25 cm3; not surgically evacuated
⇤As may be the case in depressed skull fractures.
†Merged into group 5 in data provided by Turku University Hospital.
D The Glasgow Outcome Scale
Table D.1: Glasgow Outcome Scale based on and modified from Jennett and Bond (1975); Jennett
et al. (1981).
GOS extended GOS Description
1 (D) 1 (D) Dead
2 (VS) 2 (VS) Vegetative state: no evidence of meaningful responsiveness.
3 (SD) 3 (SD-) Severe disability: conscious, but unable to live independently4 (SD+) due to mental or physical disability.
4 (MD) 5 (MD-) Moderate disability: able to live independently,6 (MD+) limited ability to return to work or school.
5 (GR) 7 (GR-) Good recovery: capacity to resume normal occupational and social activities,8 (GR+) minor deficits possible.
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E ADNI classification results
E.1 Cross-sectional analysis at baseline (AD vs. HC, uncorrected volumes)
Table E.1: Classification results in % (6-fold CV, LDA 100 runs, RF/SVM 20 runs) for separating
AD from CN. Significant group differences indicated by + (p< 0.05) and ++ (p< 0.001).
Bonferroni corrected significance in parentheses. Sorted by effect size.
AD patients (N = 322, PositivesP) vs. Healthy Controls (N = 404, NegativesN) (baseline analysis, uncorrected volumes)
structure ACC (bACC) SENS SPEC mean (SD) [mm3] P mean (SD) [mm3]N effect size (d) p-value sig. (corr.)
RandomForest (all features) 85 (85) 81 88
SVM (all features) 90 (90) 86 93
Gender (female = 0, male = 1) 52 (52) 55 50 0.5 (0.5) 0.5 (0.5) 0.099 0.18349 o (o)
Age 51 (51) 51 51 75.1 (7.7) 74.9 (5.7) 0.027 0.71340 o (o)
Ventricles 66 (65) 55 75 63295.6 (28189.0) 46227.4 (20971.9) 0.698 <0.00001 ++ (++)
CorticalGreyMatter 61 (61) 62 60 491782.0 (56040.1) 519904.6 (50579.3) 0.530 <0.00001 ++ (++)
BrainTissue 56 (56) 57 55 1133344.3 (118326.9) 1163549.9 (110731.1) 0.265 0.00042 ++ (+)
DeepGreyMatter 55 (55) 57 54 172879.2 (18868.2) 175625.6 (16551.2) 0.156 0.03725 + (o)
Brain 54 (55) 56 53 1199158.5 (132290.9) 1212115.6 (118623.9) 0.104 0.16526 o (o)
WhiteMatter 48 (47) 47 48 468683.1 (62373.7) 468019.7 (60538.5) 0.011 0.88497 o (o)
LeftHippocampus 76 (76) 76 75 2608.0 (479.7) 3221.8 (434.3) 1.349 <0.00001 ++ (++)
Amygdala 75 (75) 73 78 1825.9 (388.6) 2296.6 (314.5) 1.348 <0.00001 ++ (++)
Hippocampus 75 (75) 75 75 5429.2 (943.8) 6601.4 (825.8) 1.332 <0.00001 ++ (++)
RightAmygdala 75 (75) 73 76 925.6 (209.5) 1168.0 (171.6) 1.280 <0.00001 ++ (++)
EntA 73 (73) 71 75 3427.5 (675.5) 4245.4 (609.2) 1.279 <0.00001 ++ (++)
LeftAmygdala 75 (75) 73 77 900.3 (205.1) 1128.6 (162.7) 1.250 <0.00001 ++ (++)
RightHippocampus 73 (73) 71 75 2821.2 (546.5) 3379.6 (427.4) 1.154 <0.00001 ++ (++)
InfLatVent 73 (72) 58 85 3432.1 (1556.6) 2107.1 (825.3) 1.099 <0.00001 ++ (++)
LeftInfLatVent 75 (74) 63 85 1652.9 (765.4) 1006.8 (420.7) 1.079 <0.00001 ++ (++)
RightInfLatVent 70 (68) 55 82 1779.3 (902.2) 1100.3 (447.5) 0.988 <0.00001 ++ (++)
ITG 66 (66) 66 65 21776.6 (3325.8) 24529.3 (2916.2) 0.887 <0.00001 ++ (++)
PHG 66 (66) 68 65 6447.4 (977.5) 7217.3 (899.2) 0.824 <0.00001 ++ (++)
AnG 67 (67) 67 67 15507.5 (2580.5) 17559.5 (2480.9) 0.812 <0.00001 ++ (++)
MTG 64 (64) 66 62 25677.9 (4030.6) 28511.8 (3713.2) 0.735 <0.00001 ++ (++)
TMP 64 (63) 61 65 13730.4 (2468.4) 15339.5 (2004.0) 0.724 <0.00001 ++ (++)
LateralVentricle 65 (64) 55 73 55184.7 (26190.1) 39883.0 (19481.1) 0.674 <0.00001 ++ (++)
LeftLateralVentricle 66 (65) 55 75 29062.5 (14264.5) 20827.4 (10483.3) 0.669 <0.00001 ++ (++)
SMG 62 (63) 64 61 13731.4 (2077.6) 15086.0 (2006.8) 0.664 <0.00001 ++ (++)
RightLateralVentricle 63 (62) 54 71 26122.3 (12557.2) 19055.6 (9403.3) 0.647 <0.00001 ++ (++)
STG 63 (63) 62 63 12671.1 (2031.8) 13889.0 (1933.7) 0.616 <0.00001 ++ (++)
OFuG 60 (60) 61 60 7382.1 (1324.3) 8129.7 (1267.7) 0.578 <0.00001 ++ (++)
ThalamusProper 61 (61) 63 60 12486.4 (1477.5) 13304.8 (1426.0) 0.565 <0.00001 ++ (++)
3rdVentricle 60 (60) 54 65 2319.7 (828.7) 1891.2 (721.5) 0.556 <0.00001 ++ (++)
BasalForebrain 62 (62) 64 60 795.6 (215.5) 914.0 (213.2) 0.552 <0.00001 ++ (++)
FuG 60 (61) 63 59 15951.4 (2428.3) 17131.2 (2281.3) 0.503 <0.00001 ++ (++)
AIns 62 (62) 63 60 8241.7 (1225.1) 8820.0 (1142.4) 0.490 <0.00001 ++ (++)
AccumbensArea 60 (60) 57 62 617.0 (184.6) 695.7 (148.3) 0.475 <0.00001 ++ (++)
MOG 59 (59) 61 57 10087.5 (1773.4) 10837.5 (1524.1) 0.457 <0.00001 ++ (++)
IOG 58 (58) 57 59 11413.2 (2016.2) 12233.2 (1815.4) 0.430 <0.00001 ++ (++)
SPL 58 (58) 59 57 16943.2 (2469.3) 17977.7 (2441.6) 0.422 <0.00001 ++ (++)
PIns 58 (59) 60 57 4482.8 (701.8) 4771.4 (703.1) 0.411 <0.00001 ++ (++)
PP 58 (58) 60 55 3682.5 (589.7) 3912.8 (549.4) 0.406 <0.00001 ++ (++)
FO 57 (57) 58 55 3504.1 (549.2) 3718.8 (539.9) 0.395 <0.00001 ++ (++)
MFG 59 (59) 60 59 33109.0 (5125.3) 34968.2 (4791.0) 0.376 <0.00001 ++ (++)
SFG 56 (57) 58 55 26326.6 (3837.4) 27676.8 (3441.8) 0.373 <0.00001 ++ (++)
PT 57 (57) 61 54 3658.7 (712.6) 3926.4 (769.4) 0.359 <0.00001 ++ (++)
TrIFG 54 (54) 55 54 6113.5 (1082.3) 6494.0 (1071.5) 0.354 <0.00001 ++ (++)
Caudate 58 (56) 43 69 7535.3 (2705.8) 6812.7 (1705.2) 0.328 0.00001 ++ (+)
Putamen 56 (56) 57 55 7455.9 (1342.8) 7878.8 (1331.8) 0.316 0.00003 ++ (+)
SCA 56 (57) 58 55 2367.0 (496.3) 2510.7 (434.7) 0.310 0.00004 ++ (+)
PCu 55 (56) 58 53 21742.5 (3583.1) 22743.6 (3039.0) 0.304 0.00005 ++ (+)
PCgG 56 (56) 57 55 8494.1 (1311.2) 8862.3 (1128.5) 0.304 0.00005 ++ (+)
CSF 57 (56) 51 61 2419.4 (579.6) 2250.7 (598.6) 0.286 0.00014 ++ (+)
POrG 55 (55) 57 54 6068.4 (927.5) 6312.4 (859.2) 0.274 0.00026 ++ (+)
MCgG 55 (54) 48 60 10326.7 (1674.5) 9905.0 (1511.3) 0.266 0.00040 ++ (+)
MSFG 56 (57) 61 53 12685.2 (2000.5) 13151.5 (1735.4) 0.251 0.00082 ++ (o)
SOG 55 (55) 57 54 7063.8 (1242.6) 7354.8 (1136.5) 0.246 0.00106 + (o)
MFC 54 (54) 54 54 3510.2 (716.9) 3663.4 (603.6) 0.233 0.00185 + (o)
OCP 53 (53) 57 50 4494.6 (931.2) 4728.0 (1076.0) 0.230 0.00215 + (o)
CerebellarVermalLobulesI-V 54 (54) 56 52 4464.0 (672.4) 4616.9 (672.9) 0.227 0.00244 + (o)
OrIFG 55 (55) 60 50 2749.4 (587.8) 2879.5 (568.2) 0.225 0.00263 + (o)
LOrG 54 (55) 57 52 3713.5 (688.9) 3853.3 (600.1) 0.218 0.00363 + (o)
OpIFG 52 (53) 57 49 5649.2 (1036.1) 5864.9 (1065.5) 0.205 0.00624 + (o)
GRe 53 (53) 55 52 3228.0 (549.0) 3335.1 (512.8) 0.202 0.00691 + (o)
PO 54 (55) 58 52 4251.3 (792.1) 4409.9 (796.3) 0.200 0.00770 + (o)
CerebellumWhiteMatter 54 (52) 40 65 32795.7 (8328.0) 31344.3 (7506.8) 0.184 0.01393 + (o)
SMC 53 (53) 57 49 10285.9 (1713.6) 10567.8 (1418.9) 0.181 0.01558 + (o)
AOrG 51 (51) 52 50 3804.7 (617.0) 3906.9 (598.1) 0.168 0.02448 + (o)
TTG 56 (57) 62 52 2387.0 (557.6) 2477.1 (532.0) 0.166 0.02684 + (o)
CerebellarVermalLobulesVI-VII 53 (53) 50 55 2417.3 (432.6) 2355.7 (390.0) 0.150 0.04435 + (o)
PoG 53 (53) 55 51 18093.5 (2551.3) 18449.6 (2321.8) 0.147 0.04984 + (o)
MPoG 54 (54) 56 52 1644.7 (394.0) 1699.2 (370.6) 0.143 0.05604 o (o)
PrG 52 (52) 53 51 23676.0 (3462.6) 24096.7 (3052.7) 0.130 0.08268 o (o)
CO 53 (53) 55 51 7785.8 (1114.5) 7923.9 (1090.1) 0.125 0.09374 o (o)
Calc 53 (53) 50 55 7085.9 (1722.2) 6884.2 (1531.2) 0.125 0.09586 o (o)
FRP 51 (52) 53 50 5444.2 (1113.1) 5565.8 (996.7) 0.116 0.12123 o (o)
MPrG 53 (53) 55 51 5428.2 (957.0) 5531.1 (847.0) 0.115 0.12515 o (o)
MOrG 52 (52) 54 51 8243.5 (1150.7) 8361.5 (1010.3) 0.110 0.14236 o (o)
ACg 51 (51) 54 49 8487.7 (1576.8) 8613.8 (1458.5) 0.083 0.26466 o (o)
VentralDC 51 (51) 52 50 8448.8 (965.4) 8523.1 (931.8) 0.079 0.29369 o (o)
BrainStem 50 (50) 52 49 18742.3 (2233.9) 18885.5 (2141.8) 0.066 0.38005 o (o)
Pallidum 51 (51) 49 52 2668.2 (454.5) 2645.4 (394.7) 0.054 0.47061 o (o)
Cun 49 (49) 49 48 10691.9 (2079.7) 10753.0 (1794.8) 0.032 0.67110 o (o)
CerebellarVermalLobulesVIII-X 48 (48) 47 49 2823.6 (474.2) 2814.5 (428.5) 0.020 0.78685 o (o)
4thVentricle 48 (48) 45 51 2359.0 (691.3) 2346.0 (690.8) 0.019 0.80132 o (o)
CerebralWhiteMatter 48 (48) 49 48 435887.4 (58972.0) 436675.4 (56880.4) 0.014 0.85528 o (o)
CerebellumExterior 48 (48) 48 49 97168.8 (12890.5) 97279.6 (11151.4) 0.009 0.90128 o (o)
LiG 48 (48) 47 48 18512.9 (2794.7) 18524.4 (2476.3) 0.004 0.95334 o (o)
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E.2 Cross-sectional analysis at baseline (AD vs. HC, corrected volumes)
Table E.2: Classification results in % (6-fold CV, LDA 100 runs, RF/SVM 20 runs) for separating
AD from CN. Significant group differences indicated by + (p< 0.05) and ++ (p< 0.001).
Bonferroni corrected significance in parentheses. Sorted by effect size.
AD patients (N = 322, PositivesP) vs. Healthy Controls (N = 404, NegativesN) (baseline analysis, †volumes corrected for age/gender/brain size)
structure ACC (bACC) SENS SPEC mean (SD) [mm3]P,† mean (SD) [mm3]N,† effect size (d) p-value sig. (corr.)
RandomForest (all features) 87 (86) 83 90
SVM (all features) 90 (89) 86 92
Gender (female = 0, male = 1) 52 (52) 55 50 0.5 (0.5) 0.5 (0.5) 0.099 0.18349 o (o)
Age 50 (50) 50 50 75.1 (7.7) 74.9 (5.7) 0.027 0.71340 o (o)
BrainTissue 72 (71) 63 78 -17942.8 (22718.7) 0 (17403.6) 0.900 <0.00001 ++ (++)
CorticalGreyMatter 68 (67) 63 72 -23635.9 (28907.3) 0 (24078.1) 0.898 <0.00001 ++ (++)
Ventricles 72 (71) 63 79 17757.3 (22639.6) 0 (17293.9) 0.895 <0.00001 ++ (++)
WhiteMatter 57 (56) 51 61 7242.2 (29309.8) 0 (28686.1) 0.250 0.00086 ++ (o)
DeepGreyMatter 52 (52) 50 54 -1549.1 (13310.2) 0 (11142.2) 0.127 0.08834 o (o)
Brain 54 (55) 56 53 1199158.5 (132290.9) 1212115.6 (118623.9) 0.104 0.16526 o (o)
Amygdala 80 (80) 76 84 -452.0 (332.0) 0 (250.5) 1.561 <0.00001 ++ (++)
Hippocampus 78 (78) 75 80 -1115.4 (817.7) 0 (660.7) 1.519 <0.00001 ++ (++)
EntA 78 (78) 76 80 -801.3 (583.3) 0 (485.3) 1.509 <0.00001 ++ (++)
LeftHippocampus 79 (78) 76 81 -588.1 (423.1) 0 (364.6) 1.502 <0.00001 ++ (++)
RightAmygdala 80 (80) 77 83 -232.2 (182.6) 0 (139.4) 1.452 <0.00001 ++ (++)
LeftAmygdala 78 (78) 75 81 -219.8 (179.7) 0 (135.5) 1.403 <0.00001 ++ (++)
RightHippocampus 76 (75) 71 79 -527.3 (488.0) 0 (339.1) 1.280 <0.00001 ++ (++)
InfLatVent 78 (77) 65 89 1330.8 (1367.4) 0 (702.2) 1.267 <0.00001 ++ (++)
LeftInfLatVent 77 (76) 66 86 649.5 (677.1) 0 (360.6) 1.237 <0.00001 ++ (++)
ITG 71 (71) 69 73 -2588.0 (2506.9) 0 (1954.5) 1.168 <0.00001 ++ (++)
RightInfLatVent 75 (73) 59 87 681.3 (814.9) 0 (391.3) 1.106 <0.00001 ++ (++)
PHG 68 (68) 64 72 -739.8 (832.6) 0 (702.4) 0.970 <0.00001 ++ (++)
MTG 69 (69) 69 70 -2534.0 (2853.0) 0 (2411.3) 0.969 <0.00001 ++ (++)
AnG 68 (67) 65 70 -1880.5 (2345.6) 0 (1973.2) 0.876 <0.00001 ++ (++)
TMP 66 (65) 64 67 -1521.7 (1967.2) 0 (1539.3) 0.873 <0.00001 ++ (++)
LateralVentricle 71 (70) 62 78 15972.2 (21196.2) 0 (16214.4) 0.859 <0.00001 ++ (++)
LeftLateralVentricle 70 (69) 61 76 8584.7 (11586.9) 0 (8816.1) 0.847 <0.00001 ++ (++)
RightLateralVentricle 70 (69) 59 78 7387.5 (10387.1) 0 (7883.2) 0.814 <0.00001 ++ (++)
STG 65 (65) 64 66 -1100.3 (1610.7) 0 (1478.6) 0.715 <0.00001 ++ (++)
3rdVentricle 67 (66) 63 70 434.3 (699.9) 0 (591.1) 0.677 <0.00001 ++ (++)
SMG 64 (64) 63 65 -1196.5 (2003.1) 0 (1697.8) 0.650 <0.00001 ++ (++)
ThalamusProper 63 (63) 61 65 -680.6 (1214.1) 0 (1005.2) 0.617 <0.00001 ++ (++)
FuG 62 (62) 62 61 -1072.1 (1750.6) 0 (1769.3) 0.609 <0.00001 ++ (++)
OFuG 60 (60) 58 62 -690.7 (1225.8) 0 (1061.2) 0.607 <0.00001 ++ (++)
BasalForebrain 63 (63) 66 61 -109.6 (195.4) 0 (189.3) 0.571 <0.00001 ++ (++)
AIns 59 (60) 62 58 -509.3 (995.9) 0 (915.4) 0.535 <0.00001 ++ (++)
MOG 60 (60) 61 59 -643.3 (1375.1) 0 (1195.7) 0.503 <0.00001 ++ (++)
IOG 59 (59) 60 59 -697.2 (1571.8) 0 (1386.2) 0.474 <0.00001 ++ (++)
AccumbensArea 60 (60) 59 61 -71.7 (177.2) 0 (138.5) 0.457 <0.00001 ++ (++)
PP 58 (58) 61 56 -200.0 (464.5) 0 (433.4) 0.447 <0.00001 ++ (++)
MCgG 58 (57) 54 60 544.3 (1270.6) 0 (1190.1) 0.444 <0.00001 ++ (++)
PIns 58 (58) 58 58 -231.1 (524.6) 0 (547.9) 0.430 <0.00001 ++ (++)
MFG 58 (58) 56 60 -1467.9 (3689.2) 0 (3194.1) 0.429 <0.00001 ++ (++)
SPL 56 (56) 57 56 -867.5 (2175.8) 0 (1972.5) 0.420 <0.00001 ++ (++)
SFG 59 (59) 60 58 -1124.3 (3032.2) 0 (2632.7) 0.399 <0.00001 ++ (++)
Caudate 58 (57) 46 68 799.5 (2447.8) 0 (1597.5) 0.396 <0.00001 ++ (++)
FO 60 (60) 59 60 -187.3 (506.5) 0 (458.7) 0.390 <0.00001 ++ (++)
PT 56 (56) 58 55 -232.4 (590.0) 0 (636.4) 0.377 <0.00001 ++ (++)
TrIFG 57 (57) 56 58 -331.8 (985.1) 0 (933.4) 0.347 <0.00001 ++ (++)
PCu 56 (56) 57 54 -788.1 (2502.1) 0 (2124.3) 0.343 <0.00001 ++ (++)
PCgG 57 (57) 59 56 -306.1 (960.5) 0 (898.4) 0.330 0.00001 ++ (++)
SCA 58 (58) 58 59 -124.5 (441.7) 0 (388.6) 0.301 0.00006 ++ (+)
POrG 57 (57) 54 59 -211.0 (738.1) 0 (685.9) 0.297 0.00008 ++ (+)
CSF 58 (58) 53 62 172.5 (621.2) 0 (545.8) 0.297 0.00008 ++ (+)
Putamen 57 (57) 58 56 -367.5 (1300.2) 0 (1243.1) 0.290 0.00012 ++ (+)
MSFG 54 (54) 55 53 -349.9 (1447.4) 0 (1334.5) 0.253 0.00076 ++ (o)
MFC 53 (53) 54 53 -123.9 (577.8) 0 (493.6) 0.233 0.00192 + (o)
CerebellumWhiteMatter 55 (54) 44 64 1677.9 (7982.2) 0 (6947.8) 0.226 0.00257 + (o)
OCP 53 (54) 57 50 -207.2 (815.9) 0 (999.5) 0.225 0.00274 + (o)
SOG 55 (56) 58 53 -220.0 (1044.7) 0 (974.8) 0.219 0.00354 + (o)
CerebralWhiteMatter 56 (55) 52 58 5564.3 (26392.1) 0 (25736.3) 0.214 0.00434 + (o)
OrIFG 55 (56) 59 52 -109.5 (518.0) 0 (510.3) 0.213 0.00446 + (o)
LOrG 52 (52) 53 51 -111.8 (565.6) 0 (492.2) 0.213 0.00456 + (o)
CerebellarVermalLobulesI-V 56 (56) 57 55 -128.8 (620.1) 0 (632.2) 0.205 0.00610 + (o)
Calc 53 (53) 51 55 275.0 (1536.7) 0 (1432.9) 0.186 0.01309 + (o)
CerebellarVermalLobulesVI-VII 54 (54) 52 55 71.0 (401.3) 0 (370.4) 0.185 0.01368 + (o)
OpIFG 51 (51) 53 50 -153.5 (890.2) 0 (909.9) 0.170 0.02290 + (o)
GRe 52 (52) 54 51 -77.1 (463.7) 0 (463.0) 0.166 0.02614 + (o)
SMC 52 (52) 54 51 -192.1 (1309.9) 0 (1108.0) 0.160 0.03273 + (o)
PO 53 (53) 54 52 -105.0 (682.3) 0 (637.7) 0.160 0.03303 + (o)
AOrG 52 (52) 52 52 -71.6 (483.0) 0 (464.7) 0.151 0.04301 + (o)
TTG 54 (54) 56 53 -70.4 (481.9) 0 (455.3) 0.151 0.04398 + (o)
MPoG 53 (53) 53 53 -44.8 (377.8) 0 (348.2) 0.124 0.09769 o (o)
PrG 52 (53) 55 50 -262.1 (2723.4) 0 (2472.1) 0.101 0.17534 o (o)
Pallidum 54 (54) 55 53 38.0 (418.7) 0 (362.0) 0.098 0.19090 o (o)
PoG 52 (52) 52 52 -189.2 (2124.4) 0 (1913.6) 0.094 0.20803 o (o)
FRP 50 (50) 53 47 -76.0 (962.3) 0 (901.5) 0.082 0.27406 o (o)
MPrG 51 (51) 53 50 -58.2 (819.9) 0 (747.4) 0.075 0.31847 o (o)
CO 50 (50) 51 49 -58.3 (783.8) 0 (796.8) 0.074 0.32384 o (o)
MOrG 51 (51) 53 49 -61.3 (943.0) 0 (819.7) 0.070 0.34945 o (o)
CerebellarVermalLobulesVIII-X 51 (51) 51 51 22.1 (423.1) 0 (375.1) 0.056 0.45705 o (o)
LiG 51 (51) 51 51 106.4 (2022.0) 0 (1846.7) 0.055 0.46010 o (o)
CerebellumExterior 52 (52) 52 51 442.1 (10408.6) 0 (8931.0) 0.046 0.53842 o (o)
4thVentricle 50 (50) 46 54 19.9 (646.4) 0 (643.3) 0.031 0.67923 o (o)
Cun 48 (48) 46 49 33.2 (1619.0) 0 (1403.3) 0.022 0.76765 o (o)
VentralDC 47 (47) 46 47 -13.7 (709.3) 0 (597.0) 0.021 0.77728 o (o)
BrainStem 48 (48) 47 48 17.8 (1574.8) 0 (1484.5) 0.012 0.87624 o (o)
ACg 47 (47) 47 48 -5.9 (1178.5) 0 (1101.8) 0.005 0.94417 o (o)
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E.3 Cross-sectional analysis at baseline (pMCI vs. sMCI, corrected volumes)
Table E.3: Classification results in % (6-fold CV, LDA 100 runs, RF/SVM 20 runs) for separating
progressive from stable MCI. Significant group differences indicated by + (p < 0.05)
and ++ (p < 0.001). Bonferroni corrected significance in parentheses. Sorted by effect
size.
progressive MCI (N = 177, PositivesP) vs. stable MCI (N = 166, NegativesN) (baseline analysis, †volumes corrected for age/gender/brain size)
structure ACC (bACC) SENS SPEC mean (SD) [mm3]P,† mean (SD) [mm3]N,† effect size (d) p-value sig. (corr.)
RandomForest (all features) 68 (68) 72 64
SVM (all features) 67 (67) 70 64
Age 47 (47) 45 48 73.5 (7.6) 73.8 (7.6) 0.029 0.78516 o (o)
Gender (female = 0, male = 1) 45 (45) 45 45 0.6 (0.5) 0.6 (0.5) 0.006 0.95829 o (o)
BrainTissue 60 (60) 51 69 -12652.2 (20144.6) -4372.1 (20741.3) 0.405 0.00021 ++ (+)
Ventricles 60 (60) 51 70 12483.5 (20045.3) 4427.7 (20676.8) 0.396 0.00029 ++ (+)
CorticalGreyMatter 56 (56) 55 56 -16743.9 (27348.8) -6929.4 (26948.6) 0.361 0.00091 ++ (o)
Brain 51 (51) 52 49 1222424.9 (131084.2) 1238635.5 (118830.2) 0.129 0.23200 o (o)
WhiteMatter 48 (48) 47 49 5966.3 (27919.1) 4607.3 (26735.5) 0.050 0.64592 o (o)
DeepGreyMatter 47 (47) 46 48 -1874.6 (11838.0) -2050.0 (11988.8) 0.015 0.89167 o (o)
Amygdala 65 (65) 63 68 -387.4 (308.7) -149.4 (352.2) 0.720 <0.00001 ++ (++)
LeftAmygdala 62 (62) 61 64 -191.6 (161.2) -70.4 (189.7) 0.690 <0.00001 ++ (++)
InfLatVent 64 (64) 54 74 1034.0 (1097.9) 358.6 (903.1) 0.670 <0.00001 ++ (++)
LeftInfLatVent 65 (65) 56 75 480.0 (538.2) 156.3 (451.1) 0.650 <0.00001 ++ (++)
RightAmygdala 65 (65) 63 67 -195.8 (176.7) -79.0 (184.1) 0.648 <0.00001 ++ (++)
EntA 61 (61) 61 60 -678.3 (565.7) -294.0 (622.8) 0.647 <0.00001 ++ (++)
RightInfLatVent 64 (64) 54 74 554.0 (689.1) 202.3 (527.5) 0.571 <0.00001 ++ (++)
Hippocampus 61 (61) 63 60 -1042.8 (817.1) -604.7 (786.1) 0.546 <0.00001 ++ (++)
RightHippocampus 63 (63) 61 64 -514.7 (442.9) -287.7 (408.3) 0.532 <0.00001 ++ (++)
MTG 60 (60) 59 60 -2305.3 (2698.1) -925.8 (2708.9) 0.510 <0.00001 ++ (++)
AnG 60 (60) 61 59 -1579.0 (2223.0) -495.7 (2084.0) 0.502 <0.00001 ++ (++)
LeftHippocampus 61 (61) 62 60 -528.1 (429.6) -317.0 (425.8) 0.493 <0.00001 ++ (++)
CSF 59 (59) 54 64 156.4 (533.9) -61.6 (491.3) 0.424 0.00010 ++ (+)
3rdVentricle 59 (59) 55 64 376.2 (661.3) 113.9 (639.9) 0.403 0.00023 ++ (+)
LateralVentricle 60 (61) 51 70 11080.2 (18700.0) 3986.3 (19536.4) 0.371 0.00066 ++ (o)
RightLateralVentricle 60 (60) 51 69 5078.1 (9151.1) 1656.3 (9510.1) 0.367 0.00077 ++ (o)
LeftLateralVentricle 59 (59) 51 68 6002.1 (10336.4) 2330.0 (10722.7) 0.349 0.00136 + (o)
STG 57 (57) 57 56 -1048.8 (1509.9) -513.8 (1583.2) 0.346 0.00149 + (o)
ITG 57 (57) 57 56 -1510.5 (2300.7) -691.2 (2482.3) 0.343 0.00165 + (o)
TMP 58 (58) 58 58 -875.3 (1703.2) -310.1 (1766.7) 0.326 0.00275 + (o)
MCgG 55 (55) 50 60 472.7 (1159.1) 78.4 (1292.7) 0.322 0.00311 + (o)
BasalForebrain 57 (57) 57 57 -108.9 (190.9) -45.6 (207.0) 0.318 0.00346 + (o)
IOG 56 (56) 59 52 -466.0 (1583.2) 17.9 (1546.6) 0.309 0.00449 + (o)
FuG 56 (56) 57 55 -776.1 (1755.3) -257.5 (1632.4) 0.306 0.00495 + (o)
MOG 58 (58) 59 56 -445.8 (1531.4) -25.6 (1245.4) 0.300 0.00579 + (o)
OFuG 56 (56) 55 57 -415.3 (1153.0) -57.9 (1242.7) 0.299 0.00604 + (o)
AccumbensArea 59 (59) 55 63 -66.5 (162.8) -24.3 (137.4) 0.279 0.01012 + (o)
ThalamusProper 56 (55) 57 54 -650.7 (1342.2) -310.3 (1187.7) 0.268 0.01356 + (o)
Putamen 59 (59) 59 60 -356.0 (1372.3) -28.0 (1071.7) 0.265 0.01454 + (o)
SMG 53 (53) 53 53 -880.2 (1933.5) -376.0 (1924.4) 0.261 0.01608 + (o)
OrIFG 58 (58) 60 55 -111.1 (518.9) 16.4 (489.0) 0.253 0.01998 + (o)
PIns 58 (58) 59 57 -216.3 (569.6) -82.3 (486.6) 0.252 0.02010 + (o)
AIns 56 (55) 60 51 -403.2 (892.4) -175.9 (937.7) 0.248 0.02206 + (o)
FO 58 (58) 61 54 -189.9 (473.2) -73.5 (468.1) 0.247 0.02266 + (o)
FRP 55 (55) 55 55 -178.4 (995.6) 58.1 (978.8) 0.239 0.02731 + (o)
PCgG 53 (53) 57 50 -176.8 (851.6) 35.2 (947.5) 0.236 0.02984 + (o)
SFG 51 (51) 50 53 -891.9 (2741.4) -274.6 (2842.4) 0.221 0.04139 + (o)
MSFG 55 (55) 54 56 -383.6 (1538.4) -69.4 (1404.0) 0.213 0.04948 + (o)
PO 58 (58) 58 57 -150.2 (668.2) -12.6 (636.3) 0.211 0.05185 o (o)
PrG 53 (53) 51 54 327.2 (3003.8) -269.9 (2644.4) 0.211 0.05213 o (o)
SPL 55 (55) 57 53 -513.7 (2105.3) -91.4 (1985.5) 0.206 0.05715 o (o)
PCu 55 (55) 54 57 -543.4 (2447.9) -80.3 (2204.2) 0.198 0.06707 o (o)
PHG 56 (56) 56 55 -553.9 (799.3) -403.9 (766.7) 0.191 0.07742 o (o)
Calc 53 (54) 48 59 313.9 (1471.6) 72.0 (1551.3) 0.160 0.13935 o (o)
MFG 49 (49) 51 47 -1109.3 (3500.4) -578.0 (3119.2) 0.160 0.13961 o (o)
SMC 53 (53) 52 53 -71.7 (1254.1) -267.8 (1219.8) 0.158 0.14334 o (o)
Caudate 51 (51) 39 63 490.3 (2016.4) 172.7 (2103.6) 0.154 0.15432 o (o)
CerebellarVermalLobulesVI-VII 53 (54) 49 58 62.9 (350.8) 6.4 (396.3) 0.151 0.16198 o (o)
BrainStem 50 (51) 49 52 35.3 (1656.3) -201.8 (1493.6) 0.150 0.16584 o (o)
TrIFG 53 (53) 54 51 -328.1 (972.6) -183.2 (958.8) 0.150 0.16586 o (o)
GRe 54 (54) 57 51 -40.2 (484.7) 31.6 (507.6) 0.145 0.18101 o (o)
PP 54 (54) 56 53 -209.2 (444.7) -153.5 (405.8) 0.131 0.22693 o (o)
MPrG 49 (49) 47 50 141.9 (981.1) 32.8 (760.2) 0.124 0.25265 o (o)
VentralDC 53 (53) 52 53 -55.7 (672.9) -132.9 (624.4) 0.119 0.27208 o (o)
OCP 52 (52) 53 51 25.5 (1055.1) 136.3 (908.3) 0.112 0.29959 o (o)
SCA 50 (50) 51 49 -90.4 (407.2) -46.3 (381.1) 0.112 0.30165 o (o)
PT 55 (55) 55 54 -274.9 (635.1) -208.9 (575.4) 0.109 0.31490 o (o)
ACg 51 (51) 52 50 -161.8 (1157.0) -40.5 (1133.5) 0.106 0.32780 o (o)
CerebellumExterior 53 (53) 50 56 271.9 (9093.7) -695.3 (9828.3) 0.102 0.34449 o (o)
OpIFG 52 (52) 50 54 -164.8 (946.5) -74.3 (994.5) 0.093 0.38867 o (o)
LOrG 49 (49) 48 49 -94.9 (526.9) -46.4 (610.2) 0.085 0.43046 o (o)
SOG 52 (51) 54 49 -30.6 (1105.4) 51.4 (890.3) 0.081 0.45156 o (o)
MPoG 50 (50) 49 51 -50.0 (374.9) -74.2 (365.0) 0.066 0.54466 o (o)
POrG 51 (51) 54 49 -127.2 (678.0) -85.1 (691.7) 0.061 0.56966 o (o)
PoG 52 (52) 52 52 225.5 (2211.5) 100.1 (1992.6) 0.059 0.58233 o (o)
CerebellarVermalLobulesI-V 49 (49) 50 48 -88.1 (588.0) -56.4 (617.9) 0.053 0.62643 o (o)
CerebellumWhiteMatter 49 (49) 42 56 1633.9 (8349.6) 1274.0 (6934.3) 0.047 0.66544 o (o)
LiG 49 (49) 49 49 26.2 (2037.7) -61.0 (2098.3) 0.042 0.69632 o (o)
CerebralWhiteMatter 46 (46) 47 46 4332.4 (25782.2) 3333.3 (25445.0) 0.039 0.71838 o (o)
4thVentricle 48 (48) 45 52 -6.9 (571.0) -31.1 (681.2) 0.039 0.72152 o (o)
TTG 46 (46) 47 45 -48.6 (506.4) -36.1 (443.2) 0.026 0.80827 o (o)
MFC 48 (48) 49 46 -145.6 (598.9) -131.3 (575.9) 0.024 0.82244 o (o)
Pallidum 47 (47) 48 47 9.3 (383.8) 2.4 (364.6) 0.018 0.86516 o (o)
Cun 47 (47) 46 48 129.0 (1484.4) 102.5 (1449.4) 0.018 0.86737 o (o)
MOrG 46 (46) 47 45 4.1 (835.1) -8.5 (900.9) 0.015 0.89268 o (o)
CO 46 (46) 46 46 -96.2 (783.1) -107.0 (830.1) 0.013 0.90184 o (o)
CerebellarVermalLobulesVIII-X 46 (46) 47 45 11.7 (406.8) 17.1 (421.7) 0.013 0.90479 o (o)
AOrG 46 (46) 46 46 -73.3 (451.4) -78.7 (502.9) 0.011 0.91793 o (o)
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E.4 Longitudinal analysis (baseline!m12, AD vs. HC)
Table E.4: Classification results in % (6-fold CV, LDA 100 runs, RF/SVM 20 runs) for separating
AD from CN. Significant group differences indicated by + (p< 0.05) and ++ (p< 0.001).
Bonferroni corrected significance in parentheses. Sorted by effect size.
AD patients (N = 195, PositivesP) vs. Healthy Controls (N = 290, NegativesN) (longitudinal analysis, bl!m12)
structure ACC (bACC) SENS SPEC mean (SD) [%]P mean (SD) [%]N effect size (d) p-value sig. (corr.)
RandomForest (all features) 85 (84) 78 90
SVM (all features) 84 (82) 71 93
Age 54 (54) 53 54 75.3 (7.7) 74.8 (5.6) 0.072 0.43678 o (o)
Gender (female = 0, male = 1) 48 (48) 50 46 0.5 (0.5) 0.5 (0.5) 0.042 0.64808 o (o)
Ventricles 75 (74) 64 83 7.2 (4.6) 2.8 (3.0) 1.202 <0.00001 ++ (++)
BrainTissue 70 (70) 67 72 -1.3 (1.1) -0.5 (0.8) 0.862 <0.00001 ++ (++)
WhiteMatter 73 (73) 68 77 -0.8 (1.0) -0.2 (0.7) 0.736 <0.00001 ++ (++)
CorticalGreyMatter 65 (64) 62 67 -1.9 (2.3) -0.8 (1.4) 0.585 <0.00001 ++ (++)
Brain 64 (64) 63 65 -0.9 (1.0) -0.4 (0.7) 0.574 <0.00001 ++ (++)
DeepGreyMatter 66 (64) 57 71 -1.4 (1.7) -0.8 (1.3) 0.455 <0.00001 ++ (++)
Hippocampus 80 (78) 67 88 -4.8 (3.7) -1.1 (1.7) 1.400 <0.00001 ++ (++)
InfLatVent 79 (77) 69 86 7.5 (5.5) 1.8 (3.3) 1.334 <0.00001 ++ (++)
LeftHippocampus 80 (78) 70 87 -4.9 (4.2) -1.1 (1.7) 1.287 <0.00001 ++ (++)
MTG 76 (74) 67 82 -3.8 (2.8) -1.1 (1.5) 1.274 <0.00001 ++ (++)
RightInfLatVent 77 (75) 65 84 7.4 (6.4) 1.8 (3.3) 1.185 <0.00001 ++ (++)
RightLateralVentricle 75 (73) 63 83 7.5 (5.1) 2.8 (3.1) 1.170 <0.00001 ++ (++)
LeftInfLatVent 78 (76) 70 83 7.5 (5.8) 1.7 (4.4) 1.166 <0.00001 ++ (++)
LateralVentricle 74 (72) 62 83 7.6 (4.9) 3.0 (3.2) 1.160 <0.00001 ++ (++)
RightHippocampus 78 (75) 62 89 -4.8 (4.5) -1.1 (2.1) 1.138 <0.00001 ++ (++)
LeftLateralVentricle 74 (72) 63 81 7.6 (4.9) 3.1 (3.4) 1.085 <0.00001 ++ (++)
PP 77 (76) 70 81 -6.7 (5.5) -2.0 (3.5) 1.075 <0.00001 ++ (++)
CerebralWhiteMatter 76 (74) 67 82 -0.9 (0.9) -0.2 (0.6) 0.914 <0.00001 ++ (++)
PT 70 (69) 62 76 -5.8 (5.3) -2.1 (3.1) 0.898 <0.00001 ++ (++)
ITG 72 (71) 67 75 -2.7 (2.7) -1.0 (1.3) 0.866 <0.00001 ++ (++)
FuG 69 (68) 63 73 -1.7 (1.7) -0.5 (1.1) 0.852 <0.00001 ++ (++)
Amygdala 76 (74) 66 83 -3.3 (5.0) -0.5 (2.0) 0.787 <0.00001 ++ (++)
EntA 69 (69) 65 72 -3.7 (4.1) -1.2 (2.8) 0.747 <0.00001 ++ (++)
TMP 72 (71) 67 74 -4.3 (4.6) -1.8 (2.8) 0.700 <0.00001 ++ (++)
LeftAmygdala 73 (70) 58 82 -3.6 (6.2) -0.5 (2.5) 0.699 <0.00001 ++ (++)
SMG 64 (64) 61 67 -2.9 (3.5) -1.1 (2.1) 0.674 <0.00001 ++ (++)
RightAmygdala 74 (73) 67 79 -3.3 (6.1) -0.5 (2.5) 0.631 <0.00001 ++ (++)
TTG 67 (66) 62 70 -4.6 (5.3) -1.9 (3.6) 0.604 <0.00001 ++ (++)
AnG 63 (62) 58 66 -2.6 (3.7) -0.9 (2.2) 0.598 <0.00001 ++ (++)
AIns 65 (64) 59 68 -2.0 (2.7) -0.7 (1.9) 0.562 <0.00001 ++ (++)
MSFG 60 (59) 57 61 -2.4 (3.4) -0.7 (2.6) 0.551 <0.00001 ++ (++)
PHG 61 (60) 57 63 -1.7 (2.5) -0.6 (1.8) 0.521 <0.00001 ++ (++)
Caudate 64 (63) 60 67 -4.7 (5.6) -2.3 (3.7) 0.512 <0.00001 ++ (++)
IOG 64 (63) 58 69 -2.2 (3.4) -0.9 (2.2) 0.442 <0.00001 ++ (++)
SMC 60 (60) 58 62 -1.9 (3.2) -0.7 (2.5) 0.434 <0.00001 ++ (++)
3rdVentricle 63 (62) 57 67 4.1 (4.4) 2.4 (3.6) 0.427 <0.00001 ++ (++)
OrIFG 60 (60) 59 62 -2.8 (3.7) -1.3 (3.6) 0.425 <0.00001 ++ (++)
FO 58 (58) 54 61 -1.9 (3.8) -0.6 (2.3) 0.406 0.00001 ++ (+)
PCu 60 (60) 59 60 -1.2 (3.1) -0.2 (2.0) 0.395 0.00002 ++ (+)
PCgG 57 (56) 53 59 -0.8 (1.9) -0.1 (1.7) 0.385 0.00004 ++ (+)
MFG 60 (60) 61 59 -2.0 (3.8) -0.9 (2.1) 0.384 0.00004 ++ (+)
ACg 60 (60) 58 62 -1.6 (3.4) -0.5 (2.3) 0.384 0.00004 ++ (+)
SFG 59 (59) 57 61 -2.1 (4.1) -0.9 (2.4) 0.354 0.00015 ++ (+)
MOrG 59 (58) 54 62 -1.9 (4.5) -0.6 (3.0) 0.352 0.00016 ++ (+)
TrIFG 60 (59) 56 62 -2.4 (3.6) -1.4 (2.5) 0.348 0.00019 ++ (+)
ThalamusProper 72 (71) 63 79 -2.2 (2.3) -1.1 (3.9) 0.331 0.00038 ++ (+)
BrainStem 55 (53) 45 61 -0.9 (1.3) -0.6 (0.9) 0.310 0.00089 ++ (o)
MFC 60 (60) 57 63 -1.8 (4.5) -0.6 (3.4) 0.303 0.00116 + (o)
MOG 58 (58) 56 60 -1.7 (4.1) -0.7 (2.6) 0.299 0.00133 + (o)
4thVentricle 58 (57) 51 62 2.4 (6.2) 0.9 (4.5) 0.295 0.00152 + (o)
CSF 56 (55) 54 57 1.1 (3.7) 0.1 (3.2) 0.289 0.00192 + (o)
OFuG 55 (55) 53 56 -1.0 (3.3) -0.2 (2.5) 0.277 0.00294 + (o)
SPL 60 (59) 58 60 -2.0 (4.0) -1.0 (3.0) 0.274 0.00320 + (o)
OpIFG 56 (56) 54 58 -2.1 (4.4) -1.2 (2.8) 0.270 0.00369 + (o)
POrG 56 (56) 56 56 -1.3 (3.3) -0.6 (2.4) 0.236 0.01130 + (o)
CerebellumExterior 60 (58) 49 68 -1.3 (2.6) -0.8 (2.1) 0.229 0.01382 + (o)
MPrG 55 (54) 53 56 -1.0 (3.9) -0.3 (3.2) 0.194 0.03708 + (o)
LOrG 56 (56) 55 57 -2.7 (4.8) -1.7 (5.1) 0.192 0.03847 + (o)
SOG 58 (57) 56 59 -1.6 (4.6) -0.8 (3.5) 0.187 0.04441 + (o)
SCA 58 (58) 59 57 -2.6 (10.0) -1.3 (4.5) 0.176 0.05788 o (o)
LiG 55 (56) 60 52 -0.3 (1.9) -0.0 (1.6) 0.175 0.05999 o (o)
PrG 55 (55) 55 55 -1.4 (4.1) -0.8 (2.9) 0.167 0.07119 o (o)
MCgG 54 (54) 55 54 -0.5 (2.6) -0.1 (2.5) 0.158 0.08770 o (o)
PIns 55 (54) 50 58 -1.4 (3.4) -1.0 (2.5) 0.148 0.11160 o (o)
Pallidum 58 (52) 21 83 0.3 (2.9) -0.1 (2.2) 0.141 0.12864 o (o)
FRP 58 (57) 51 62 -3.9 (15.3) -2.3 (14.0) 0.111 0.23076 o (o)
AccumbensArea 56 (49) 13 85 3.0 (50.3) -0.5 (7.0) 0.109 0.23774 o (o)
VentralDC 53 (53) 54 53 -0.7 (2.0) -0.5 (1.6) 0.107 0.24813 o (o)
GRe 56 (56) 55 57 -2.1 (6.7) -1.5 (7.0) 0.097 0.29359 o (o)
CerebellarVermalLobulesVIII-X 54 (53) 52 55 -0.6 (2.8) -0.4 (2.0) 0.096 0.30009 o (o)
PO 52 (52) 53 51 -0.1 (3.9) -0.4 (2.7) 0.089 0.33509 o (o)
Cun 50 (51) 53 48 -0.3 (3.5) -0.6 (3.9) 0.087 0.34872 o (o)
AOrG 53 (52) 49 55 -1.5 (5.1) -1.1 (3.8) 0.086 0.35288 o (o)
CerebellarVermalLobulesI-V 49 (49) 47 51 -0.5 (2.5) -0.3 (1.8) 0.083 0.37161 o (o)
OCP 53 (51) 46 57 -3.1 (10.4) -2.2 (11.5) 0.081 0.38148 o (o)
Putamen 54 (49) 28 71 -0.1 (1.4) -0.0 (0.8) 0.075 0.41924 o (o)
MPoG 50 (50) 50 50 -0.9 (8.4) -0.5 (5.0) 0.057 0.54043 o (o)
BasalForebrain 51 (50) 47 53 -2.1 (12.9) -1.6 (9.1) 0.046 0.62158 o (o)
PoG 50 (50) 52 49 -1.1 (4.8) -0.9 (3.3) 0.045 0.62950 o (o)
CerebellumWhiteMatter 53 (50) 31 68 0.6 (7.2) 0.4 (5.3) 0.036 0.69917 o (o)
CerebellarVermalLobulesVI-VII 49 (48) 47 50 0.2 (4.3) 0.1 (3.7) 0.029 0.75272 o (o)
CO 48 (48) 47 48 -0.5 (3.7) -0.6 (2.6) 0.025 0.78620 o (o)
Calc 48 (47) 45 50 -0.1 (3.5) -0.2 (3.1) 0.019 0.83368 o (o)
STG 48 (48) 46 50 -0.6 (2.6) -0.6 (1.8) 0.010 0.91377 o (o)
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E.5 Longitudinal analysis (baseline!m12, pMCI vs. sMCI)
Table E.5: Classification results in % (6-fold CV, LDA 100 runs, RF/SVM 20 runs) for separating
progressive from stable MCI. Significant group differences indicated by + (p < 0.05)
and ++ (p < 0.001). Bonferroni corrected significance in parentheses. Sorted by effect
size.
progressive MCI (N = 168, PositivesP) vs. stable MCI (N = 149, NegativesN) (longitudinal analysis, bl!m12)
structure ACC (bACC) SENS SPEC mean (SD) [%]P mean (SD) [%]N effect size (d) p-value sig. (corr.)
RandomForest (all features) 74 (73) 77 70
SVM (all features) 74 (74) 72 75
Age 49 (49) 46 51 73.6 (7.6) 74.0 (7.4) 0.050 0.65912 o (o)
Gender (female = 0, male = 1) 45 (45) 45 45 0.6 (0.5) 0.6 (0.5) 0.001 0.99199 o (o)
Ventricles 68 (69) 63 74 6.8 (4.3) 3.4 (3.1) 0.890 <0.00001 ++ (++)
BrainTissue 63 (63) 64 63 -1.2 (1.0) -0.6 (0.8) 0.652 <0.00001 ++ (++)
CorticalGreyMatter 64 (64) 67 61 -1.8 (1.7) -0.8 (1.3) 0.608 <0.00001 ++ (++)
Brain 58 (58) 62 54 -0.8 (0.8) -0.4 (0.6) 0.495 0.00002 ++ (+)
DeepGreyMatter 64 (64) 62 66 -1.3 (1.2) -0.7 (1.3) 0.428 0.00017 ++ (+)
WhiteMatter 63 (63) 61 64 -0.6 (0.9) -0.4 (0.7) 0.310 0.00615 + (o)
Hippocampus 67 (67) 59 76 -4.1 (3.2) -1.7 (2.2) 0.867 <0.00001 ++ (++)
LateralVentricle 67 (68) 61 75 7.1 (4.6) 3.6 (3.4) 0.866 <0.00001 ++ (++)
InfLatVent 69 (69) 63 75 6.7 (5.6) 2.6 (3.8) 0.845 <0.00001 ++ (++)
LeftHippocampus 67 (68) 60 75 -4.2 (3.3) -1.7 (2.5) 0.845 <0.00001 ++ (++)
LeftLateralVentricle 66 (67) 60 73 7.2 (4.8) 3.6 (3.5) 0.836 <0.00001 ++ (++)
RightLateralVentricle 67 (67) 62 72 7.0 (4.6) 3.6 (3.6) 0.828 <0.00001 ++ (++)
MTG 70 (70) 65 75 -3.1 (2.4) -1.4 (1.8) 0.807 <0.00001 ++ (++)
ITG 67 (67) 64 70 -2.5 (2.0) -1.1 (1.6) 0.793 <0.00001 ++ (++)
LeftInfLatVent 68 (69) 62 76 6.7 (6.2) 2.4 (4.3) 0.783 <0.00001 ++ (++)
EntA 67 (67) 67 68 -4.0 (3.7) -1.4 (3.3) 0.749 <0.00001 ++ (++)
PT 68 (68) 63 73 -5.5 (4.5) -2.6 (3.3) 0.727 <0.00001 ++ (++)
RightInfLatVent 64 (64) 58 71 6.7 (6.2) 2.7 (4.4) 0.726 <0.00001 ++ (++)
FuG 66 (66) 63 69 -1.5 (1.6) -0.5 (1.1) 0.694 <0.00001 ++ (++)
PP 66 (67) 64 70 -5.8 (4.6) -2.9 (3.9) 0.692 <0.00001 ++ (++)
RightHippocampus 65 (65) 57 73 -4.0 (3.9) -1.7 (2.8) 0.677 <0.00001 ++ (++)
3rdVentricle 64 (64) 61 67 4.7 (3.8) 2.5 (3.7) 0.590 <0.00001 ++ (++)
Amygdala 65 (66) 58 73 -3.2 (4.1) -1.2 (2.8) 0.577 <0.00001 ++ (++)
RightAmygdala 64 (64) 56 73 -3.7 (5.5) -1.1 (3.3) 0.567 <0.00001 ++ (++)
TTG 61 (62) 61 62 -4.4 (4.2) -2.2 (3.5) 0.558 <0.00001 ++ (++)
TMP 64 (64) 64 64 -3.9 (3.7) -2.2 (3.0) 0.524 <0.00001 ++ (++)
Caudate 62 (62) 62 62 -4.8 (5.2) -2.4 (3.9) 0.510 <0.00001 ++ (++)
SPL 64 (64) 67 62 -2.1 (2.8) -0.7 (2.9) 0.502 0.00001 ++ (++)
SMG 62 (62) 61 62 -2.6 (2.9) -1.3 (2.5) 0.489 0.00002 ++ (+)
PHG 58 (58) 57 60 -1.7 (2.2) -0.7 (1.9) 0.478 0.00003 ++ (+)
MOG 58 (58) 51 65 -2.0 (3.2) -0.8 (2.1) 0.442 0.00011 ++ (+)
AnG 61 (61) 59 63 -2.1 (2.9) -1.0 (2.2) 0.432 0.00015 ++ (+)
MSFG 59 (59) 58 59 -2.2 (3.0) -1.0 (2.4) 0.428 0.00017 ++ (+)
AIns 56 (56) 55 57 -1.5 (2.2) -0.7 (1.8) 0.387 0.00065 ++ (o)
LeftAmygdala 62 (63) 53 72 -2.8 (4.5) -1.3 (3.5) 0.376 0.00095 ++ (o)
TrIFG 60 (60) 57 63 -2.6 (3.0) -1.6 (2.5) 0.366 0.00127 + (o)
BrainStem 62 (61) 68 55 -0.8 (0.9) -0.3 (1.7) 0.362 0.00144 + (o)
IOG 56 (57) 52 62 -1.8 (2.5) -1.0 (2.1) 0.347 0.00220 + (o)
SMC 54 (54) 53 55 -1.7 (2.9) -0.8 (2.4) 0.333 0.00328 + (o)
OCP 57 (57) 53 61 -4.4 (13.1) -0.5 (10.0) 0.332 0.00337 + (o)
OrIFG 55 (55) 51 59 -3.0 (3.4) -1.9 (2.9) 0.332 0.00339 + (o)
SFG 58 (58) 55 61 -2.1 (3.0) -1.1 (2.9) 0.318 0.00498 + (o)
MFG 58 (58) 58 58 -1.9 (2.7) -1.1 (2.4) 0.317 0.00516 + (o)
PCgG 58 (58) 52 63 -0.7 (1.8) -0.1 (1.6) 0.314 0.00562 + (o)
PCu 55 (56) 53 58 -1.0 (2.5) -0.4 (1.9) 0.295 0.00923 + (o)
CerebralWhiteMatter 62 (63) 60 65 -0.6 (0.8) -0.4 (0.7) 0.284 0.01201 + (o)
FO 55 (55) 51 60 -1.9 (3.3) -1.0 (2.8) 0.284 0.01224 + (o)
ThalamusProper 65 (65) 55 76 -2.6 (7.3) -1.1 (2.8) 0.273 0.01582 + (o)
LiG 55 (55) 54 56 -0.4 (1.5) -0.0 (1.4) 0.268 0.01794 + (o)
OFuG 54 (54) 51 57 -1.2 (2.9) -0.5 (2.8) 0.249 0.02748 + (o)
MOrG 55 (55) 53 56 -1.6 (2.6) -0.9 (3.1) 0.245 0.02999 + (o)
LOrG 54 (54) 53 55 -2.4 (4.1) -1.3 (4.7) 0.245 0.03029 + (o)
Cun 53 (53) 53 54 -0.5 (3.6) 0.3 (3.0) 0.231 0.04104 + (o)
SOG 55 (55) 55 55 -1.6 (4.7) -0.6 (3.9) 0.229 0.04284 + (o)
SCA 57 (57) 58 56 -2.9 (6.8) -1.4 (7.1) 0.225 0.04654 + (o)
MFC 53 (53) 51 56 -1.4 (3.9) -0.5 (4.1) 0.222 0.04980 + (o)
OpIFG 58 (58) 60 56 -1.7 (3.2) -1.1 (2.3) 0.217 0.05489 o (o)
GRe 53 (53) 56 51 -1.9 (5.4) -0.5 (7.2) 0.215 0.05712 o (o)
AOrG 52 (53) 47 58 -2.1 (4.1) -1.2 (4.0) 0.210 0.06272 o (o)
POrG 55 (55) 55 54 -0.8 (2.9) -0.2 (2.7) 0.210 0.06305 o (o)
CSF 53 (53) 52 55 1.0 (3.4) 0.4 (3.6) 0.186 0.10005 o (o)
PrG 55 (55) 59 51 -1.1 (2.9) -0.6 (3.1) 0.173 0.12492 o (o)
Putamen 48 (50) 18 82 -0.4 (3.5) 0.1 (1.2) 0.170 0.13126 o (o)
PIns 54 (54) 53 55 -0.9 (2.8) -0.5 (1.9) 0.168 0.13708 o (o)
AccumbensArea 55 (56) 38 75 -1.3 (9.7) 0.1 (7.8) 0.167 0.13805 o (o)
ACg 52 (53) 47 58 -1.3 (2.7) -0.9 (2.7) 0.160 0.15511 o (o)
CerebellarVermalLobulesI-V 55 (55) 51 59 -0.6 (1.3) -0.3 (2.1) 0.153 0.17461 o (o)
CO 52 (52) 48 56 -0.7 (2.9) -0.3 (2.3) 0.150 0.18303 o (o)
BasalForebrain 54 (54) 55 53 -1.5 (10.3) -0.1 (9.8) 0.138 0.22106 o (o)
CerebellumExterior 55 (56) 52 59 -1.0 (1.6) -0.8 (2.1) 0.137 0.22484 o (o)
CerebellumWhiteMatter 56 (55) 66 44 -0.3 (3.3) 0.2 (4.1) 0.128 0.25500 o (o)
STG 52 (52) 57 48 -0.6 (2.4) -0.3 (1.8) 0.127 0.26171 o (o)
Calc 52 (52) 54 51 -0.3 (3.4) 0.0 (2.4) 0.126 0.26340 o (o)
MCgG 49 (48) 51 46 -0.3 (2.2) -0.0 (2.2) 0.118 0.29487 o (o)
PoG 52 (52) 55 49 -1.1 (3.9) -0.8 (2.9) 0.095 0.39793 o (o)
MPoG 50 (50) 54 45 -0.1 (7.2) 0.4 (5.0) 0.091 0.42142 o (o)
FRP 48 (48) 54 41 -2.4 (9.7) -1.6 (16.5) 0.056 0.62168 o (o)
CerebellarVermalLobulesVIII-X 48 (48) 47 49 -0.4 (2.4) -0.5 (2.8) 0.056 0.62187 o (o)
PO 49 (49) 51 48 -0.1 (3.7) 0.0 (2.8) 0.052 0.64691 o (o)
Pallidum 49 (50) 38 62 -0.1 (3.0) 0.0 (3.0) 0.051 0.65324 o (o)
CerebellarVermalLobulesVI-VII 47 (47) 46 47 -0.1 (4.1) 0.1 (3.7) 0.050 0.65863 o (o)
MPrG 47 (47) 47 46 -0.5 (2.8) -0.5 (2.8) 0.028 0.80310 o (o)
VentralDC 49 (49) 51 47 -0.6 (1.9) -0.5 (3.1) 0.021 0.85372 o (o)
4thVentricle 46 (47) 45 48 2.1 (7.0) 2.0 (5.5) 0.018 0.87648 o (o)
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E.6 Longitudinal analysis (baseline!m24, AD vs. HC)
Table E.6: Classification results in % (6-fold CV, LDA 100 runs, RF/SVM 20 runs) for separating
AD from CN. Significant group differences indicated by + (p< 0.05) and ++ (p< 0.001).
Bonferroni corrected significance in parentheses. Sorted by effect size.
AD patients (N=117, PositivesP) vs. Healthy Controls (N=168, NegativesN) (longitudinal analysis, bl!m24)
structure ACC (bACC) SENS SPEC mean (SD) [%]P mean (SD) [%]N effect size (d) p-value sig. (corr.)
RandomForest (all features) 89 (88) 81 94
SVM (all features) 89 (88) 80 95
Age 47 (47) 46 47 75.5 (7.7) 75.9 (5.2) 0.061 0.61542 o (o)
Gender (female=0, male=1) 49 (48) 44 52 0.5 (0.5) 0.6 (0.5) 0.059 0.62275 o (o)
Ventricles 83 (81) 70 92 14.7 (7.9) 5.8 (3.7) 1.531 <0.00001 ++ (++)
BrainTissue 80 (78) 71 86 -2.6 (1.3) -1.1 (0.8) 1.353 <0.00001 ++ (++)
WhiteMatter 75 (74) 65 82 -1.8 (1.4) -0.6 (0.8) 1.121 <0.00001 ++ (++)
CorticalGreyMatter 73 (73) 69 77 -3.5 (2.4) -1.6 (1.7) 0.928 <0.00001 ++ (++)
Brain 68 (67) 65 70 -1.5 (1.0) -0.8 (0.7) 0.847 <0.00001 ++ (++)
DeepGreyMatter 67 (66) 63 69 -2.3 (1.8) -1.3 (1.3) 0.604 <0.00001 ++ (++)
Hippocampus 87 (85) 77 94 -10.2 (6.2) -2.0 (2.4) 1.880 <0.00001 ++ (++)
InfLatVent 84 (83) 76 90 15.9 (8.8) 3.5 (4.5) 1.871 <0.00001 ++ (++)
RightInfLatVent 83 (82) 73 90 16.1 (9.7) 3.5 (4.9) 1.728 <0.00001 ++ (++)
LeftHippocampus 86 (84) 77 92 -9.9 (6.6) -1.9 (2.7) 1.701 <0.00001 ++ (++)
LeftInfLatVent 80 (78) 69 88 15.5 (9.5) 3.5 (5.2) 1.652 <0.00001 ++ (++)
MTG 83 (81) 70 92 -6.8 (4.1) -2.0 (1.6) 1.651 <0.00001 ++ (++)
RightHippocampus 84 (81) 69 94 -10.5 (7.6) -2.0 (2.6) 1.617 <0.00001 ++ (++)
ITG 83 (81) 71 91 -5.3 (3.3) -1.6 (1.4) 1.603 <0.00001 ++ (++)
FuG 85 (83) 72 93 -3.7 (2.7) -0.7 (0.9) 1.588 <0.00001 ++ (++)
LeftLateralVentricle 82 (80) 71 89 15.6 (8.2) 6.5 (4.4) 1.470 <0.00001 ++ (++)
PP 80 (79) 73 85 -10.9 (6.1) -3.9 (3.5) 1.466 <0.00001 ++ (++)
LateralVentricle 80 (78) 65 90 15.4 (8.5) 6.3 (4.0) 1.454 <0.00001 ++ (++)
TMP 84 (82) 75 90 -8.2 (5.1) -2.8 (2.5) 1.430 <0.00001 ++ (++)
RightLateralVentricle 80 (77) 63 92 15.1 (9.3) 6.2 (4.0) 1.331 <0.00001 ++ (++)
PT 78 (77) 70 83 -10.0 (6.2) -3.8 (3.5) 1.276 <0.00001 ++ (++)
EntA 80 (79) 72 86 -7.0 (5.5) -2.2 (3.1) 1.151 <0.00001 ++ (++)
CerebralWhiteMatter 75 (74) 65 83 -1.9 (1.3) -0.7 (0.9) 1.138 <0.00001 ++ (++)
Amygdala 81 (79) 70 89 -7.3 (6.7) -1.7 (3.7) 1.076 <0.00001 ++ (++)
RightAmygdala 79 (77) 69 85 -7.6 (7.0) -1.8 (4.2) 1.050 <0.00001 ++ (++)
SMG 71 (70) 61 78 -5.7 (4.6) -2.2 (2.6) 0.968 <0.00001 ++ (++)
AIns 73 (73) 67 78 -3.6 (3.4) -1.1 (2.0) 0.965 <0.00001 ++ (++)
3rdVentricle 70 (69) 65 74 8.4 (5.7) 4.1 (4.0) 0.904 <0.00001 ++ (++)
PHG 73 (71) 65 78 -3.4 (3.7) -0.9 (2.0) 0.901 <0.00001 ++ (++)
LeftAmygdala 79 (77) 65 89 -7.1 (8.7) -1.7 (3.9) 0.863 <0.00001 ++ (++)
ThalamusProper 78 (77) 67 86 -4.5 (3.5) -2.0 (2.8) 0.838 <0.00001 ++ (++)
MSFG 71 (70) 68 73 -4.7 (3.9) -2.1 (2.8) 0.789 <0.00001 ++ (++)
PCgG 67 (65) 57 73 -2.1 (2.7) -0.6 (1.7) 0.729 <0.00001 ++ (++)
AnG 69 (67) 60 75 -4.5 (4.4) -2.0 (2.7) 0.718 <0.00001 ++ (++)
FO 69 (68) 58 77 -4.8 (5.5) -1.8 (3.0) 0.706 <0.00001 ++ (++)
TTG 70 (70) 65 74 -7.0 (6.8) -3.4 (3.3) 0.705 <0.00001 ++ (++)
IOG 64 (63) 57 70 -3.8 (3.5) -1.8 (2.5) 0.671 <0.00001 ++ (++)
POrG 61 (61) 63 59 -2.7 (3.0) -0.9 (2.7) 0.628 <0.00001 ++ (++)
PCu 69 (67) 58 76 -2.7 (3.7) -1.0 (2.2) 0.601 <0.00001 ++ (++)
SMC 62 (62) 57 66 -3.9 (3.9) -2.0 (2.5) 0.595 <0.00001 ++ (++)
OrIFG 63 (62) 58 67 -4.8 (4.7) -2.5 (3.6) 0.573 <0.00001 ++ (++)
MFG 61 (60) 58 63 -3.5 (3.8) -1.9 (2.6) 0.521 0.00002 ++ (+)
MOrG 64 (63) 61 66 -3.3 (4.5) -1.4 (3.1) 0.509 0.00003 ++ (+)
ACg 62 (60) 50 70 -3.3 (4.0) -1.7 (2.4) 0.505 0.00004 ++ (+)
BrainStem 60 (59) 53 65 -1.5 (1.4) -1.0 (1.0) 0.456 0.00018 ++ (+)
MOG 61 (60) 58 63 -3.1 (4.0) -1.3 (4.2) 0.452 0.00021 ++ (+)
SPL 64 (64) 63 65 -3.6 (5.0) -1.7 (3.9) 0.446 0.00025 ++ (+)
TrIFG 62 (60) 54 67 -3.8 (3.5) -2.4 (2.9) 0.443 0.00028 ++ (+)
LOrG 62 (61) 53 69 -4.9 (6.1) -2.5 (5.5) 0.426 0.00047 ++ (+)
OpIFG 60 (59) 57 62 -3.5 (3.7) -2.1 (2.9) 0.423 0.00051 ++ (+)
CSF 59 (58) 58 59 2.0 (5.1) 0.1 (4.1) 0.412 0.00072 ++ (o)
SCA 63 (63) 61 64 -5.9 (13.2) -2.1 (6.2) 0.388 0.00141 + (o)
MFC 61 (60) 55 65 -3.4 (5.6) -1.7 (4.0) 0.354 0.00356 + (o)
GRe 64 (63) 61 66 -4.3 (8.0) -1.7 (6.9) 0.347 0.00427 + (o)
OFuG 59 (59) 60 58 -1.6 (3.1) -0.6 (3.0) 0.331 0.00636 + (o)
Caudate 61 (61) 58 63 -5.9 (9.5) -3.6 (4.4) 0.328 0.00683 + (o)
STG 55 (55) 52 58 -1.7 (3.2) -0.9 (2.0) 0.306 0.01145 + (o)
PrG 58 (58) 60 57 -2.7 (3.8) -1.8 (3.4) 0.252 0.03747 + (o)
AOrG 54 (54) 53 55 -2.6 (4.9) -1.6 (3.4) 0.243 0.04413 + (o)
4thVentricle 60 (59) 55 63 3.8 (7.0) 2.3 (5.8) 0.240 0.04731 + (o)
SFG 57 (57) 59 55 -2.7 (4.0) -2.0 (3.2) 0.209 0.08426 o (o)
CerebellumExterior 60 (60) 56 63 -1.9 (2.9) -1.4 (2.0) 0.200 0.09756 o (o)
LiG 53 (53) 56 51 -0.8 (3.1) -0.3 (2.3) 0.193 0.10963 o (o)
Putamen 59 (53) 22 84 -0.4 (3.0) 0.1 (2.0) 0.192 0.11187 o (o)
MCgG 57 (57) 56 57 -1.3 (3.4) -0.7 (2.3) 0.190 0.11579 o (o)
VentralDC 57 (57) 53 61 -1.3 (1.8) -1.0 (2.4) 0.180 0.13700 o (o)
SOG 58 (58) 59 56 -2.6 (5.8) -1.5 (6.6) 0.175 0.14836 o (o)
Pallidum 52 (53) 62 45 0.2 (3.5) -0.2 (2.0) 0.164 0.17299 o (o)
CerebellarVermalLobulesI-V 54 (52) 43 62 -1.3 (3.5) -0.7 (4.4) 0.164 0.17424 o (o)
PIns 54 (53) 52 55 -1.7 (4.1) -1.2 (2.7) 0.141 0.24371 o (o)
PO 52 (51) 48 54 -1.6 (4.6) -1.2 (3.2) 0.109 0.36791 o (o)
FRP 58 (57) 50 63 -5.3 (18.9) -3.6 (14.8) 0.107 0.37505 o (o)
CO 53 (52) 48 56 -1.9 (4.2) -1.6 (3.1) 0.105 0.38495 o (o)
Cun 54 (53) 49 58 -0.1 (4.8) -0.6 (7.4) 0.077 0.52528 o (o)
MPoG 48 (48) 44 51 -1.1 (8.5) -1.6 (5.5) 0.074 0.54109 o (o)
BasalForebrain 48 (48) 48 48 -2.6 (16.4) -3.4 (9.7) 0.062 0.60717 o (o)
AccumbensArea 58 (52) 18 86 2.6 (60.0) 0.1 (16.1) 0.061 0.61555 o (o)
CerebellumWhiteMatter 49 (52) 69 35 0.1 (7.1) 0.4 (4.8) 0.057 0.63523 o (o)
MPrG 48 (48) 46 50 -1.8 (3.9) -1.7 (3.7) 0.043 0.71987 o (o)
CerebellarVermalLobulesVIII-X 46 (47) 53 40 -1.0 (3.0) -1.2 (6.2) 0.039 0.74661 o (o)
PoG 48 (47) 47 48 -1.9 (5.0) -1.7 (4.1) 0.027 0.82435 o (o)
OCP 49 (49) 48 49 -2.4 (17.0) -2.1 (17.1) 0.015 0.90207 o (o)
CerebellarVermalLobulesVI-VII 47 (47) 46 48 -0.3 (4.7) -0.4 (4.5) 0.014 0.90530 o (o)
Calc 47 (46) 43 49 -0.8 (4.8) -0.8 (3.3) 0.013 0.91102 o (o)
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E.7 Longitudinal analysis (baseline!m24, pMCI vs. sMCI)
Table E.7: Classification results in % (6-fold CV, LDA 100 runs, RF/SVM 20 runs) for separating
progressive from stable MCI. Significant group differences indicated by + (p < 0.05)
and ++ (p < 0.001). Bonferroni corrected significance in parentheses. Sorted by effect
size.
progressive MCI (N = 140, PositivesP) vs. stable MCI (N = 107, NegativesN) (longitudinal analysis, bl!m24)
structure ACC (bACC) SENS SPEC mean (SD) [%]P mean (SD) [%]N effect size (d) p-value sig. (corr.)
RandomForest (all features) 79 (78) 82 74
SVM (all features) 76 (76) 76 76
Age 54 (54) 51 58 73.3 (7.8) 74.7 (7.5) 0.176 0.17108 o (o)
Gender (female = 0, male = 1) 46 (47) 40 54 0.6 (0.5) 0.6 (0.5) 0.053 0.67739 o (o)
Ventricles 71 (72) 65 80 13.7 (7.4) 7.1 (5.6) 0.989 <0.00001 ++ (++)
BrainTissue 68 (69) 62 76 -2.3 (1.5) -1.2 (1.0) 0.845 <0.00001 ++ (++)
DeepGreyMatter 66 (67) 64 69 -2.1 (1.4) -1.2 (1.0) 0.714 <0.00001 ++ (++)
CorticalGreyMatter 65 (66) 61 71 -3.2 (2.5) -1.7 (1.6) 0.707 <0.00001 ++ (++)
Brain 63 (63) 60 67 -1.5 (1.1) -0.8 (0.7) 0.707 <0.00001 ++ (++)
WhiteMatter 64 (65) 55 74 -1.6 (1.3) -0.8 (1.0) 0.661 <0.00001 ++ (++)
FuG 75 (76) 69 83 -3.1 (2.1) -1.0 (1.4) 1.141 <0.00001 ++ (++)
Hippocampus 73 (74) 68 80 -8.9 (5.1) -3.7 (3.8) 1.118 <0.00001 ++ (++)
LeftHippocampus 74 (74) 72 77 -9.3 (5.6) -3.8 (4.2) 1.083 <0.00001 ++ (++)
EntA 71 (72) 66 77 -7.4 (4.7) -2.8 (3.6) 1.070 <0.00001 ++ (++)
InfLatVent 70 (72) 62 81 14.6 (8.9) 6.2 (6.6) 1.053 <0.00001 ++ (++)
MTG 72 (74) 64 83 -6.1 (3.9) -2.6 (2.6) 1.016 <0.00001 ++ (++)
LeftInfLatVent 68 (69) 60 79 14.7 (9.4) 6.4 (6.8) 0.987 <0.00001 ++ (++)
PT 68 (68) 62 75 -9.7 (5.6) -4.7 (4.2) 0.971 <0.00001 ++ (++)
LateralVentricle 70 (71) 64 78 14.4 (7.9) 7.5 (6.0) 0.960 <0.00001 ++ (++)
ITG 72 (73) 66 80 -4.7 (2.9) -2.1 (2.2) 0.958 <0.00001 ++ (++)
LeftLateralVentricle 69 (70) 62 77 14.6 (8.2) 7.6 (6.1) 0.956 <0.00001 ++ (++)
RightInfLatVent 66 (68) 60 76 14.3 (10.1) 5.9 (7.4) 0.923 <0.00001 ++ (++)
RightHippocampus 71 (72) 65 79 -8.6 (5.7) -3.7 (4.6) 0.920 <0.00001 ++ (++)
RightLateralVentricle 69 (70) 61 79 14.1 (8.1) 7.5 (6.3) 0.907 <0.00001 ++ (++)
Amygdala 67 (68) 61 76 -6.4 (5.2) -2.9 (3.5) 0.770 <0.00001 ++ (++)
TTG 65 (66) 62 70 -8.0 (5.3) -4.4 (4.1) 0.752 <0.00001 ++ (++)
PHG 66 (68) 58 77 -3.5 (2.8) -1.5 (2.4) 0.746 <0.00001 ++ (++)
3rdVentricle 64 (65) 61 68 9.1 (6.2) 4.7 (5.5) 0.740 <0.00001 ++ (++)
PP 68 (69) 65 72 -10.0 (5.7) -5.9 (5.5) 0.728 <0.00001 ++ (++)
TMP 68 (69) 64 74 -6.9 (4.5) -3.9 (3.6) 0.721 <0.00001 ++ (++)
RightAmygdala 67 (68) 62 73 -6.5 (6.3) -2.7 (4.3) 0.688 <0.00001 ++ (++)
CerebralWhiteMatter 65 (66) 58 73 -1.6 (1.3) -0.9 (1.0) 0.635 <0.00001 ++ (++)
SMG 62 (64) 54 74 -4.8 (4.0) -2.5 (2.8) 0.633 <0.00001 ++ (++)
LeftAmygdala 65 (66) 60 72 -6.4 (6.0) -3.2 (4.2) 0.605 <0.00001 ++ (++)
PCgG 62 (62) 57 67 -1.7 (2.3) -0.5 (1.6) 0.577 0.00001 ++ (++)
MOG 63 (64) 55 74 -3.3 (4.1) -1.3 (2.8) 0.570 0.00001 ++ (+)
MSFG 63 (63) 59 67 -4.2 (4.0) -2.2 (3.0) 0.551 0.00003 ++ (+)
AIns 58 (59) 53 66 -2.8 (3.0) -1.4 (2.0) 0.529 0.00005 ++ (+)
SCA 65 (65) 69 61 -5.8 (8.0) -2.1 (7.1) 0.480 0.00023 ++ (+)
AnG 61 (62) 56 69 -3.9 (4.9) -2.0 (2.8) 0.478 0.00024 ++ (+)
BrainStem 58 (58) 59 57 -1.3 (1.4) -0.6 (1.4) 0.462 0.00038 ++ (+)
FO 61 (63) 52 73 -4.5 (5.6) -2.3 (3.7) 0.462 0.00039 ++ (+)
CerebellumExterior 65 (65) 64 66 -1.9 (2.0) -1.1 (1.3) 0.434 0.00085 ++ (o)
MFG 58 (59) 54 64 -3.3 (3.7) -2.0 (2.4) 0.432 0.00090 ++ (o)
PCu 61 (62) 58 65 -2.3 (3.9) -1.0 (2.0) 0.430 0.00093 ++ (o)
IOG 63 (64) 59 69 -3.1 (3.8) -1.7 (2.4) 0.417 0.00133 + (o)
SPL 62 (61) 63 59 -3.4 (4.7) -1.7 (3.3) 0.408 0.00167 + (o)
LiG 58 (57) 59 55 -0.9 (2.2) -0.1 (2.0) 0.405 0.00181 + (o)
MOrG 59 (59) 58 60 -3.0 (2.9) -1.8 (3.5) 0.398 0.00218 + (o)
OCP 59 (58) 61 56 -3.9 (11.9) 0.0 (9.7) 0.352 0.00660 + (o)
AccumbensArea 63 (65) 52 77 -2.3 (5.5) -0.5 (5.1) 0.342 0.00827 + (o)
ThalamusProper 66 (67) 56 79 -4.7 (8.7) -2.4 (2.5) 0.341 0.00844 + (o)
SMC 54 (55) 51 59 -3.3 (3.8) -2.1 (2.8) 0.335 0.00972 + (o)
TrIFG 58 (59) 52 65 -3.7 (3.7) -2.7 (2.6) 0.320 0.01334 + (o)
CSF 58 (58) 60 56 1.3 (5.1) -0.1 (4.0) 0.318 0.01404 + (o)
LOrG 57 (58) 53 62 -4.2 (4.4) -2.8 (5.1) 0.309 0.01673 + (o)
OrIFG 59 (59) 53 65 -4.5 (5.0) -3.1 (3.4) 0.309 0.01695 + (o)
Caudate 59 (59) 57 61 -5.6 (8.1) -3.5 (5.8) 0.302 0.01965 + (o)
CerebellumWhiteMatter 61 (59) 73 45 -0.6 (2.7) 0.3 (3.3) 0.300 0.02030 + (o)
STG 58 (58) 52 65 -1.5 (3.3) -0.7 (2.1) 0.294 0.02284 + (o)
OpIFG 58 (58) 53 63 -3.1 (4.5) -2.0 (2.4) 0.287 0.02644 + (o)
AOrG 55 (56) 51 60 -3.2 (5.1) -1.9 (4.0) 0.285 0.02752 + (o)
SOG 57 (57) 56 57 -2.9 (5.7) -1.6 (3.7) 0.269 0.03737 + (o)
ACg 55 (55) 52 59 -2.7 (3.8) -1.8 (3.1) 0.261 0.04334 + (o)
SFG 59 (60) 56 64 -2.9 (3.8) -2.0 (2.8) 0.253 0.05003 o (o)
Calc 58 (57) 64 51 -0.7 (4.9) 0.4 (4.4) 0.241 0.06227 o (o)
MFC 58 (60) 49 70 -3.9 (5.9) -2.6 (4.6) 0.237 0.06573 o (o)
POrG 55 (55) 55 55 -2.0 (3.2) -1.3 (2.8) 0.236 0.06716 o (o)
GRe 59 (60) 52 67 -4.4 (6.6) -3.0 (5.7) 0.229 0.07521 o (o)
PrG 55 (55) 56 53 -2.2 (3.7) -1.4 (3.0) 0.229 0.07632 o (o)
CO 54 (54) 50 59 -1.8 (4.5) -1.0 (3.0) 0.193 0.13491 o (o)
PIns 53 (54) 51 57 -1.8 (3.2) -1.3 (2.4) 0.192 0.13540 o (o)
OFuG 57 (57) 57 58 -1.5 (3.7) -1.0 (2.3) 0.166 0.19645 o (o)
PO 56 (56) 53 59 -1.2 (5.0) -0.5 (3.5) 0.165 0.19971 o (o)
FRP 56 (56) 55 57 -4.9 (13.3) -3.0 (16.1) 0.129 0.31612 o (o)
CerebellarVermalLobulesI-V 56 (56) 54 58 -1.1 (2.1) -0.8 (2.1) 0.128 0.31896 o (o)
Pallidum 48 (52) 23 81 0.4 (4.3) -0.0 (2.1) 0.118 0.35737 o (o)
CerebellarVermalLobulesVIII-X 51 (52) 49 55 -1.1 (2.7) -0.8 (2.2) 0.118 0.36012 o (o)
MCgG 51 (51) 51 50 -1.1 (2.9) -0.8 (2.4) 0.117 0.36161 o (o)
PoG 52 (52) 52 52 -1.7 (4.7) -1.4 (3.2) 0.092 0.47252 o (o)
CerebellarVermalLobulesVI-VII 51 (51) 49 52 -0.8 (4.7) -0.4 (4.2) 0.085 0.50816 o (o)
4thVentricle 54 (54) 50 58 2.7 (7.4) 2.2 (6.0) 0.076 0.55268 o (o)
MPrG 51 (51) 54 48 -1.5 (3.6) -1.3 (3.0) 0.072 0.57329 o (o)
BasalForebrain 47 (46) 48 45 -2.7 (13.1) -1.9 (10.0) 0.066 0.60690 o (o)
VentralDC 51 (51) 52 50 -1.1 (2.5) -0.9 (2.3) 0.060 0.64346 o (o)
Putamen 47 (49) 40 57 -0.1 (2.0) -0.0 (0.7) 0.034 0.79321 o (o)
Cun 46 (46) 45 47 -0.1 (4.3) -0.1 (2.6) 0.003 0.98036 o (o)
MPoG 47 (47) 46 47 -0.8 (6.7) -0.8 (4.1) 0.001 0.99373 o (o)
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F TBI classification results
F.1 Cross-sectional analysis at acute stage
Table F.1: Classification results in % (6-fold cross-validation, LDA/RF/SVM 100 runs) obtained
separating TBI patients with a severe disability from patients with moderate disability
outcome based on structural volumes at the acute stage of the injury (top). Classification
of patients with moderate and low disability outcome (bottom). Individual structures are
sorted by effect size. Significant group differences indicated by + (p < 0.05) and ++ (p
< 0.001). Bonferroni corrected significance in parentheses.
Severe disability (N = 13, PositivesP) vs. Moderate disability (N = 22, NegativesN) (cross-sectional analysis, acute stage
structure ACC (bACC) SENS SPEC mean (SD) [mm3]P mean (SD) [mm3]N effect size (d) p-value sig. (corr.)
RandomForest (all features incl. asymmetry) 63 (57) 34 81
SVM (all features incl. asymmetry) 64 (60) 46 74
Gender (female = 0, male = 1) 66 (66) 69 64 0.3 (0.5) 0.6 (0.5) 0.673 0.06287 o (o)
Age 64 (63) 55 70 67.2 (15.9) 58.8 (10.0) 0.672 0.06331 o (o)
MarshallScore 57 (58) 62 55 3.9 (1.4) 3.0 (1.9) 0.510 0.15465 o (o)
GlasgowComaScale 45 (40) 21 58 11.9 (4.6) 12.6 (3.9) 0.170 0.62934 o (o)
InjurySeverity 38 (38) 35 40 2.8 (1.0) 2.8 (0.8) 0.083 0.81296 o (o)
DeepGreyMatter 67 (68) 73 63 164564.8 (20726.5) 180076.7 (20887.9) 0.745 0.04082 + (o)
CorticalGreyMatter 67 (67) 66 68 459934.2 (63395.6) 494829.1 (39983.4) 0.701 0.05339 o (o)
BrainTissue 55 (55) 54 56 1130166.1 (102464.8) 1181045.4 (89378.0) 0.539 0.13272 o (o)
Ventricles 69 (67) 62 73 58766.8 (18808.4) 49592.9 (22303.5) 0.435 0.22267 o (o)
Brain 59 (58) 58 59 1191022.6 (110493.8) 1232890.5 (98415.8) 0.407 0.25346 o (o)
WhiteMatter 35 (34) 30 39 505667.1 (82222.8) 506139.5 (76357.7) 0.006 0.98638 o (o)
CerebellarVermalLobulesVIII-X 77 (78) 84 73 2659.5 (304.5) 3110.6 (394.1) 1.239 0.00121 + (o)
AccumbensArea 76 (78) 84 71 460.0 (150.5) 609.9 (125.5) 1.110 0.00327 + (o)
Amygdala 65 (67) 75 59 1795.5 (321.1) 2161.0 (378.9) 1.018 0.00642 + (o)
ThalamusProper 60 (61) 63 59 11584.6 (1556.0) 13072.5 (1826.3) 0.859 0.01955 + (o)
BrainStem 61 (62) 67 57 17417.2 (2275.5) 19416.8 (2417.5) 0.845 0.02144 + (o)
BasalForebrain 63 (66) 77 55 548.7 (232.3) 773.2 (290.7) 0.829 0.02383 + (o)
Hippocampus 64 (64) 62 66 5136.2 (1030.6) 6033.6 (1261.9) 0.759 0.03743 + (o)
CerebellarVermalLobulesI-V 63 (64) 68 59 3471.9 (535.9) 3949.6 (704.4) 0.737 0.04283 + (o)
VentralDC 61 (59) 54 64 8247.1 (1062.4) 8844.7 (880.6) 0.629 0.08149 o (o)
CerebellumExterior 61 (62) 66 57 94910.8 (12670.3) 103457.0 (14443.9) 0.618 0.08647 o (o)
Putamen 73 (74) 76 72 6066.7 (2492.2) 7087.0 (1586.9) 0.519 0.14721 o (o)
Pallidum 54 (54) 54 54 2801.2 (796.4) 3063.0 (442.4) 0.439 0.21786 o (o)
LateralVentricle 69 (68) 62 74 51162.3 (17123.4) 42726.9 (20449.5) 0.437 0.22046 o (o)
CerebellumWhiteMatter 65 (66) 69 63 36782.2 (7917.1) 33401.6 (8837.8) 0.397 0.26456 o (o)
InfLatVent 61 (61) 58 63 3131.4 (1360.4) 2649.1 (1182.9) 0.386 0.27817 o (o)
Caudate 63 (59) 43 74 7388.5 (3739.3) 6400.6 (1557.5) 0.384 0.28063 o (o)
CSF 52 (52) 51 52 2025.5 (719.9) 2194.0 (558.1) 0.271 0.44433 o (o)
3rdVentricle 60 (58) 54 63 2288.6 (814.2) 2076.9 (941.1) 0.236 0.50451 o (o)
4thVentricle 38 (36) 30 42 2184.5 (673.2) 2140.1 (576.0) 0.072 0.83738 o (o)
CerebralWhiteMatter 37 (36) 35 38 468884.8 (76690.5) 472738.0 (70658.1) 0.053 0.88084 o (o)
CerebellarVermalLobulesVI-VII 39 (39) 38 40 2076.6 (384.4) 2096.5 (498.0) 0.043 0.90263 o (o)
Moderate disability (N = 22, PositivesP) vs. Low disability (N = 32, NegativesN) (cross-sectional analysis, acute stage)
structure ACC (bACC) SENS SPEC mean (SD) [mm3]P mean (SD) [mm3]N effect size (d) p-value sig. (corr.)
RandomForest (all features incl. asymmetry) 61 (56) 32 80
SVM (all features incl. asymmetry) 68 (64) 43 85
MarshallScore 72 (68) 45 91 3.0 (1.9) 1.6 (1.1) 0.975 0.00091 ++ (+)
InjurySeverity 69 (66) 55 78 2.8 (0.8) 2.3 (0.7) 0.666 0.01981 + (o)
GlasgowComaScale 65 (60) 32 87 12.6 (3.9) 14.1 (2.2) 0.483 0.08720 o (o)
Age 58 (59) 62 56 58.8 (10.0) 61.1 (10.1) 0.223 0.42386 o (o)
Gender (female = 0, male = 1) 40 (38) 28 48 0.6 (0.5) 0.7 (0.5) 0.041 0.88325 o (o)
Ventricles 61 (61) 58 64 49592.9 (22303.5) 38131.9 (13556.0) 0.650 0.02268 + (o)
CorticalGreyMatter 66 (67) 71 63 494829.1 (39983.4) 524318.2 (64687.5) 0.526 0.06297 o (o)
WhiteMatter 46 (44) 35 54 506139.5 (76357.7) 492768.2 (71084.9) 0.183 0.51279 o (o)
BrainTissue 49 (49) 49 48 1181045.4 (89378.0) 1198466.6 (135087.2) 0.147 0.59861 o (o)
DeepGreyMatter 42 (41) 38 44 180076.7 (20887.9) 181380.2 (22209.8) 0.060 0.82903 o (o)
Brain 40 (40) 39 40 1232890.5 (98415.8) 1238799.0 (138060.0) 0.048 0.86362 o (o)
InfLatVent 71 (69) 60 78 2649.1 (1182.9) 1913.3 (676.5) 0.804 0.00543 + (o)
3rdVentricle 61 (61) 56 65 2076.9 (941.1) 1552.5 (617.3) 0.686 0.01660 + (o)
AccumbensArea 58 (59) 64 53 609.9 (125.5) 696.3 (138.7) 0.647 0.02332 + (o)
LateralVentricle 62 (61) 57 65 42726.9 (20449.5) 32704.8 (12459.3) 0.620 0.02953 + (o)
Putamen 57 (56) 51 61 7087.0 (1586.9) 7849.7 (1338.7) 0.528 0.06207 o (o)
Hippocampus 54 (53) 49 58 6033.6 (1261.9) 6572.2 (873.5) 0.514 0.06913 o (o)
CerebellarVermalLobulesVIII-X 65 (65) 66 65 3110.6 (394.1) 2902.0 (420.4) 0.509 0.07185 o (o)
CerebellarVermalLobulesI-V 60 (61) 64 58 3949.6 (704.4) 4242.3 (699.1) 0.417 0.13786 o (o)
ThalamusProper 60 (61) 68 54 13072.5 (1826.3) 13832.8 (1845.3) 0.414 0.14127 o (o)
CerebellumWhiteMatter 56 (54) 45 64 33401.6 (8837.8) 30605.9 (8306.2) 0.328 0.24176 o (o)
4thVentricle 62 (62) 59 65 2140.1 (576.0) 1961.2 (526.9) 0.327 0.24336 o (o)
Amygdala 60 (60) 58 62 2161.0 (378.9) 2280.9 (380.7) 0.315 0.26007 o (o)
BasalForebrain 52 (51) 46 55 773.2 (290.7) 840.4 (233.9) 0.260 0.35230 o (o)
Caudate 51 (51) 50 51 6400.6 (1557.5) 6613.9 (1066.8) 0.166 0.55236 o (o)
CerebralWhiteMatter 43 (41) 33 50 472738.0 (70658.1) 462162.3 (67838.9) 0.153 0.58231 o (o)
Pallidum 49 (48) 41 54 3063.0 (442.4) 2990.8 (504.4) 0.151 0.58912 o (o)
CerebellarVermalLobulesVI-VII 48 (47) 43 52 2096.5 (498.0) 2150.0 (299.1) 0.137 0.62397 o (o)
CerebellumExterior 45 (44) 40 49 103457.0 (14443.9) 101795.8 (13850.8) 0.118 0.67217 o (o)
VentralDC 44 (44) 47 41 8844.7 (880.6) 8961.7 (1114.9) 0.114 0.68245 o (o)
CSF 45 (45) 42 47 2194.0 (558.1) 2140.6 (538.2) 0.098 0.72593 o (o)
BrainStem 44 (44) 47 42 19416.8 (2417.5) 19651.1 (2739.4) 0.090 0.74754 o (o)
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F.2 Longitudinal analysis (baseline!follow-up)
Table F.2: Classification results in % (6-fold cross-validation, LDA/RF/SVM 100 runs) obtained
separating TBI patients with a severe disability from patients with moderate disability
outcome based on structural volume changes between the acute and chronic disease stage
(top). Classification of patients with moderate disability and low disability outcome (bot-
tom). The individual structures are sorted by effect size. Significant group differences
indicated by + (p < 0.05) and ++ (p < 0.001). Bonferroni corrected significance in
parentheses.
Severe disability (N = 13, PositivesP) vs. Moderate disability (N = 22, NegativesN) (longitudinal analysis, bl!follow-up)
structure ACC (bACC) SENS SPEC mean (SD) [%]P mean (SD) [%]N effect size (d) p-value sig. (corr.)
RandomForest (all features) 59 (53) 29 76
SVM (all features) 56 (50) 25 75
Gender (female = 0, male = 1) 66 (66) 69 64 0.3 (0.5) 0.6 (0.5) 0.673 0.06287 o (o)
Age 65 (63) 55 70 67.2 (15.9) 58.8 (10.0) 0.672 0.06331 o (o)
DeepGreyMatter 62 (59) 48 70 -2.7 (2.2) -1.2 (2.3) 0.639 0.07664 o (o)
Brain 61 (62) 65 59 -2.0 (1.7) -1.3 (2.3) 0.352 0.32098 o (o)
BrainTissue 56 (54) 48 61 -3.0 (2.4) -2.1 (3.2) 0.310 0.38205 o (o)
CorticalGreyMatter 51 (51) 51 52 -3.0 (3.2) -1.9 (4.3) 0.279 0.43074 o (o)
WhiteMatter 49 (46) 37 56 -3.0 (2.8) -2.5 (3.3) 0.154 0.66288 o (o)
Ventricles 37 (36) 35 37 11.6 (12.0) 11.6 (17.8) 0.001 0.99774 o (o)
CerebellumExterior 69 (66) 57 75 -3.1 (3.1) -0.6 (2.4) 0.933 0.01173 + (o)
CerebellarVermalLobulesVI-VII 60 (60) 61 59 -2.1 (3.9) 0.4 (3.8) 0.668 0.06477 o (o)
CerebellumWhiteMatter 67 (64) 52 75 -1.3 (1.3) -0.6 (1.4) 0.535 0.13539 o (o)
Caudate 50 (51) 53 48 0.1 (12.6) -4.7 (12.3) 0.385 0.27928 o (o)
BrainStem 65 (62) 52 73 -3.1 (3.3) -2.0 (3.2) 0.332 0.34973 o (o)
AccumbensArea 47 (55) 89 22 -0.2 (3.0) -3.6 (13.1) 0.316 0.37305 o (o)
Hippocampus 58 (53) 36 70 -4.8 (10.6) -2.2 (6.7) 0.313 0.37795 o (o)
VentralDC 68 (67) 62 72 -2.5 (1.8) -1.4 (4.3) 0.294 0.40675 o (o)
Pallidum 37 (46) 78 13 0.2 (0.8) 0.8 (3.2) 0.233 0.50989 o (o)
BasalForebrain 50 (50) 47 52 1.2 (16.6) 5.2 (17.1) 0.233 0.51037 o (o)
CerebellarVermalLobulesI-V 42 (42) 44 40 -0.9 (1.6) -1.3 (2.1) 0.201 0.56983 o (o)
CerebellarVermalLobulesVIII-X 43 (43) 46 41 -0.3 (1.9) -0.9 (3.9) 0.187 0.59611 o (o)
Amygdala 44 (40) 21 58 -2.6 (6.7) -1.6 (5.1) 0.168 0.63403 o (o)
CSF 54 (51) 40 62 6.2 (6.5) 4.7 (10.8) 0.160 0.65057 o (o)
4thVentricle 45 (47) 54 41 0.3 (7.5) 2.3 (15.1) 0.153 0.66533 o (o)
CerebralWhiteMatter 47 (45) 35 54 -3.1 (3.0) -2.7 (3.6) 0.138 0.69533 o (o)
3rdVentricle 45 (46) 52 41 5.2 (8.4) 6.8 (17.0) 0.112 0.75025 o (o)
Putamen 37 (43) 64 22 -0.1 (0.8) -0.3 (2.2) 0.071 0.84134 o (o)
ThalamusProper 41 (39) 33 45 -4.2 (3.5) -3.9 (6.2) 0.053 0.88026 o (o)
LateralVentricle 37 (37) 34 40 12.8 (12.0) 12.5 (18.8) 0.018 0.95937 o (o)
InfLatVent 38 (39) 41 37 7.7 (19.6) 7.8 (24.3) 0.006 0.98701 o (o)
Moderate disability (N = 22, PositivesP) vs. Low disability (N = 32, NegativesN) (longitudinal analysis, bl!follow-up)
structure ACC (bACC) SENS SPEC mean (SD) [%]P mean (SD) [%]N effect size (d) p-value sig. (corr.)
RandomForest (all features) 62 (59) 47 72
SVM (all features) 65 (58) 21 94
Age 59 (59) 62 56 58.8 (10.0) 61.1 (10.1) 0.223 0.42386 o (o)
Gender (female = 0, male = 1) 39 (38) 30 46 0.6 (0.5) 0.7 (0.5) 0.041 0.88325 o (o)
WhiteMatter 69 (66) 47 85 -2.5 (3.3) -0.6 (1.2) 0.820 0.00460 + (o)
BrainTissue 70 (67) 51 84 -2.1 (3.2) -0.6 (2.0) 0.570 0.04449 + (o)
Ventricles 62 (60) 44 76 11.6 (17.8) 4.2 (9.7) 0.545 0.05460 o (o)
Brain 72 (69) 55 83 -1.3 (2.3) -0.4 (1.6) 0.461 0.10190 o (o)
CorticalGreyMatter 70 (68) 58 78 -1.9 (4.3) -0.7 (2.9) 0.346 0.21716 o (o)
DeepGreyMatter 59 (57) 48 66 -1.2 (2.3) -0.5 (2.5) 0.300 0.28432 o (o)
CerebralWhiteMatter 69 (66) 47 85 -2.7 (3.6) -0.7 (1.2) 0.817 0.00474 + (o)
LateralVentricle 59 (56) 36 75 12.5 (18.8) 4.7 (10.7) 0.531 0.06072 o (o)
CerebellarVermalLobulesI-V 61 (59) 48 69 -1.3 (2.1) -0.5 (1.0) 0.527 0.06274 o (o)
ThalamusProper 65 (62) 45 78 -3.9 (6.2) -1.6 (3.1) 0.515 0.06844 o (o)
BrainStem 66 (64) 54 74 -2.0 (3.2) -0.8 (2.1) 0.470 0.09576 o (o)
4thVentricle 60 (58) 50 67 2.3 (15.1) -2.2 (4.5) 0.444 0.11507 o (o)
CerebellarVermalLobulesVIII-X 64 (61) 48 74 -0.9 (3.9) 0.4 (2.3) 0.441 0.11719 o (o)
Amygdala 58 (57) 53 61 -1.6 (5.1) -0.0 (2.5) 0.424 0.13221 o (o)
Caudate 59 (57) 43 70 -4.7 (12.3) -1.1 (6.6) 0.389 0.16652 o (o)
AccumbensArea 59 (53) 20 87 -3.6 (13.1) -0.5 (1.7) 0.367 0.19060 o (o)
3rdVentricle 60 (58) 47 68 6.8 (17.0) 2.4 (9.2) 0.345 0.21816 o (o)
CerebellumWhiteMatter 59 (58) 50 66 -0.6 (1.4) -0.1 (1.3) 0.341 0.22407 o (o)
InfLatVent 58 (53) 31 76 7.8 (24.3) 3.0 (8.0) 0.291 0.29794 o (o)
Pallidum 55 (49) 14 83 0.8 (3.2) 0.2 (1.1) 0.287 0.30512 o (o)
Putamen 60 (57) 38 75 -0.3 (2.2) 0.1 (0.4) 0.271 0.33165 o (o)
Hippocampus 56 (53) 36 70 -2.2 (6.7) -1.1 (2.9) 0.237 0.39550 o (o)
CSF 51 (48) 32 64 4.7 (10.8) 3.2 (6.0) 0.188 0.49978 o (o)
BasalForebrain 51 (50) 47 53 5.2 (17.1) 2.7 (14.6) 0.159 0.56781 o (o)
CerebellarVermalLobulesVI-VII 44 (43) 40 47 0.4 (3.8) -0.1 (3.1) 0.151 0.58850 o (o)
CerebellumExterior 47 (46) 39 52 -0.6 (2.4) -0.3 (2.9) 0.103 0.71168 o (o)
VentralDC 49 (47) 36 57 -1.4 (4.3) -1.2 (3.0) 0.066 0.81394 o (o)
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